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Abstract 
The precise mechanism of chromosome condensation and decondensation remains a 
mystery, despite progress over the last 20 years aimed at identifying components 
essential to the compaction of the genome during mitosis. A multiprotein complex, 
condensin, is considered to play a crucial role in this process along with having been 
shown to be essential for proper chromosome segregation during mitosis. This complex, 
conserved from yeast to humans, has been best characterised in Xenopus egg extracts 
and yeast. It consists of two SMC (Structural Maintenance of Chromosomes) proteins, 
SMC2 and SMC4, forming a heterodimer, and three non-SMC proteins, CAP-D2, CAP-
G and CAP-H. 
In this study, I analysed the localization and role of the CAP-D2 non-SMC 
condensin subunit and its effects on the stability of the condensin complex. I 
demonstrated that a condensin complex exists in Drosophila embryos, containing CAP-
D2, the anticipated SMC2 and SMC4 proteins, and the CAP-H/Barren and CAP-G (non-
SMC) subunits. CAP-D2 is a nuclear protein throughout the cell cycle, increasing in 
level during S phase, present on chromosome axes in mitosis, and still present on 
chromosomes as they start to decondense late in mitosis. The consequences of CAP-D2 
loss after dsRNA-mediated interference were analysed, and it was discovered that the 
protein is essential for chromosome arm and centromere resolution. The loss of CAP- 
D2 after RNAi had additional downstream consequences on the stability of CAP-H, the 
localization of DNA topoisomerase II and other condensin subunits, chromosome 
segregation, and the dynamics of chromosome passenger and metaphase checkpoint 
proteins. Furthermore, even after interfering with two components important for 
chromosome architecture (DNA topoisomerase II and condensin), chromosomes were 
still able to compact, paving the way for the identification of further components or 
activities required for this essential process. 
Analysis of an SMC2 mutation showed severe chromosome abnormalities 
similar to those observed after CAP-D2 depletion. Chromosome organisation was 
compromised, sister chromatid resolution was lost and chromosomes failed to segregate 
properly during anaphase. Nevertheless, overall chromosome compaction was normal in 
the majority of mitotic cells, suggesting that the entire condensin complex is primarily 
required for resolution of sister chromatids and establishment of mitotic chromosome 
architecture rather than chromosome compaction in Drosophila. In addition levels of 
the other condensin subunits and other chromosomal proteins were greatly affected in 
this mutant. 
A condensin TI complex has been recently identified in vertebrate cell, consisting 
of the two SMC subunits: SMC2 and SMC4, and three non-SMC subunits, CAP-133, 
CAP-1-12 and CAP-G2. Sequence analysis suggests the existence in Drosophila of CAP- 
D3 and CAP-1-12, but not CAP-G2. An examination of the Drosophila CAP-133 
condensin II subunit has been performed and preliminary results suggest a role of this 
protein and likely of the entire condensin 11 complex in male meiosis. 
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Cell division and in general the regulation of the cell cycle constitute fundamental 
procedures for the continuation of life. Understanding the cell cycle is important for 
the resolution of defects that cause human diseases such as cancer and genetic 
abnormalities. The architecture and function of the mitotic chromosomes determines 
among others, the success of mitosis and the generation of two new healthy cells. The 
establishment of cohesion between the two sister chromatids during DNA replication 
and the proper condensation of the chromosomes at the onset of mitosis outline some 
of the most important events for the successful completion of cell division. These two 
things assure firstly that the two sister chromatids will remain attached to each other 
until the metaphase to anaphase transition in order to resist the tension applied by the 
spindle and secondly that they will compact to form a mitotic chromosome. 
Interactions between the mitotic chromosomes and the mitotic spindle result in the 
separation of sister chromatids and their migration to the opposite poles during 
anaphase. Thus, mitotic chromosome dynamics are attractive for research. In this 
thesis, I have attempted to analyse the contribution of different condensin components 
to chromosome dynamics in the fruit fly Drosophila melanogaster. 
1.1. Overview of the Cell Cycle 
A cell goes through the cell cycle in order to give rise to two daughter cells which are 
identical to the parent cell. The cell cycle is divided into four phases: S phase (DNA 
synthetic phase), in which the DNA is replicated, mitosis (M phase), which upon its 
completion gives rise to two daughter cells, and the two gap phases (GI: the interval 
between the end of mitosis and DNA replication [S phase], and G2: the interval 
between DNA replication and the entry into mitosis). S phase and the two gap phases 
are referred to as interphase. Each of these phases is important for the correct 
progression of the cell cycle. 
Gi phase. 
During GI phase in metazoans, the cell makes the decision whether to proceed into 
another cell cycle or to remain in a non-dividing state either permanently 
(differentiation) or temporarily. Kinases play crucial roles for the passage from this 
point through the cell cycle, but also for other checkpoints during the cell cycle and 
appear to be necessary in all eukaryotes. The cell cycle regulatory kinases are activated 
after their association with a subunit called cyclin. Thus, they are termed cyclin 
dependent kinases (CDKs) and their regulation depends on different cyclins (Morgan, 
1997; Murray, 2004; Doree and 1-lunt, 2002). Cyclins are a diverse group of proteins 
with a highly conserved "cyclin box". They owe their name to their observed cyclic 
accumulation and destruction during the cell cycle. The Cdk4/6-cyclin D complex along 
with other molecules is the major regulator for the passage from the restriction point (the 
point after which the cell cycle will proceed even if proliferating signals are withdrawn) 
to the onset of S phase (Donjerkovic and Scott, 2000; Ekholm and Reed, 2000). Cdk2-
cyclin E is responsible for a second wave of phosphorylations that culminates in the 
transcription of genes that are essential for the initiation of DNA replication 
(Donjerkovic and Scott, 2000; Lee and Yang, 2003). 
S phase 
Genetic information in the form of DNA has to be inherited from the parent to the two 
daughter cells intact and accurately. DNA replication is responsible for the accuracy 
that occurs during the synthetic phase (S phase). Replication begins at certain sites of 
the chromosomal DNA termed Origins of Replication. Eukaryotes initiate replication 
at many origins distributed along the chromosomes in contrast to prokaryotes that have 
a single origin of replication. In budding yeast (Saccharomyces cerevisiae), replication 
begins within Autonomously Replicating Sequences (ARS) and a pre-replication 
complex assembles at every replication origin before the onset of S phase (Toone et al., 
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1997). One of the members of this pre-replication complex is the ORC complex 
(origin of recognition complex), which consists of six proteins and probably is 
implicated in the initiation of DNA replication. Recent studies have shown that 
preferred origins of DNA replication exist and a pre-replication complex is assembled 
in mammalian cells as well, but these origins are much more complexed (Gerbi et al., 
2002). The initiation of DNA replication, in mammals, seems to be triggered by a 
combination of protein kinases, including Cdk2-cyclin E and Cdk2-cyclin A kinases, 
as well as a specialised kinase Cdc7p-Dbf4p (Reed, 1997; Sciafani, 2000). 
Experiments have shown that there is a very distinctive pattern of DNA synthesis 
occurring at different times of S phase. Euchromatin replicates early on throughout the 
nucleus, while later replicating regions appear concentrated around the nucleoli and 
other areas of more condensed chromatin. Towards the end of S phase, replication is 
concentrated in heterochromatic areas. Besides DNA replication, two other important 
events occur during S phase. The first is the establishment of cohesion between the two 
replicated sister chromatids (Nasmyth, 2001) and the second event is the duplication of 
the centrosome (microtubule organising centre), which requires phosphorylation by the 
Cdk2-cyclin E or Cdk2-cyclin A kinases (Tarapore et al., 2002; Winey, 1999; Meraldi, 
1999 et al.). 
G2 phase 
G2 represents the interval between the end of S phase and the beginning of mitotic 
prophase. During this phase, and in particular at the G2/M transition, dramatic 
morphological and physiological changes occur. Responsible for these changes are 
different inhibitory or stimulatory protein kinases and phosphatases among which are the 
Cdk2-cyclin A kinase, the Cdkl-cyclin B kinase and the family of Cdc25 phosphatases 
(Smits and Medema, 2001; Jackman and Pines, 1997; Nilsson and Hoffmann, 2000). In 
late S and G2 phases, activation of the Cdc25B phosphatase activates the Cdk2-cyclin A 
kinase, which regulates several events at the G2/M transition such as chromosome 
condensation and microtubule behaviour (Goldstone et al., 2001; Pollard and Earnshaw, 
2002). At this point of the cycle, the separated centrosomes are transformed into spindle 
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poles, initiating microtubule organisation and formation of the spindle over the surface 
of the nucleus (Pollard and Earnshaw, 2002). 
Cdkl-cyclin B, the major mitotic kinase, also seems to have a significant role at 
the G2/M transition. Cyclin B is newly synthesised at the latest stage of S and at the 
beginning of G2 phases and is associated with the Cdkl kinase (Smits and Medema, 
2001). Cdkl kinase is present at a constant level throughout the cell cycle and is 
distributed diffusely throughout the cell. The Cdkl -cyclin B heterodimer is exported 
from and imported into the nucleus, spending most of the time in the cytoplasm 
associated with microtubules. This enzyme accumulates into the nucleus later on, after 
the phosphorylation of cyclin B by a kinase. Before that, a phosphatase called Cdc25C 
is activated probably by a member of another family of kinases called the Polo family 
(Myer et al., 2005). This activation results in the accumulation of Cdc25C into the 
nucleus. Then the Cdc25C activates the Cdkl-cyclin B kinase, which acts on the 
nuclear lamina and causes nuclear envelope breakdown at the onset of prometaphase 
(Smits and Medema, 2001). 
DNA damage checkpoints 
DNA damage checkpoint is the mechanism that detects damaged DNA and 
generates a signal that arrests cells in the G 1 phase of the cell cycle, slows down S 
phase (DNA synthesis), arrests cells in the G2 phase, and increase the transcription of 
genes encoding proteins that participate in DNA replication and repair (Elledge, 1996). 
These physiological responses, that facilitate DNA repair processes, are thought to be 
induced by both prokaryotes and eukaryotes. The position of arrest within the cell 
cycle varies depending upon the phase in which the damage is sensed. The delay/arrest 
of cell cycle progression that provides time for DNA repair or, when the damage is 
beyond the repair, may permanently prevent cell proliferation by cellular senescence, is 
mediated by a network of signalling pathways referred to as cell cycle checkpoints 
(Lukas et al., 2004). 
Mitosis 
Mitosis results in the formation of two daughter cells from a single cell. Mitotic events 
are subdivided into six phases: prophase, prometaphase, metaphase, anaphase, 
telophase and cytokinesis (Figure 1.1). 
Prophase 
Prophase is the first stage of mitosis and is characterised by various nuclear and 
cytoplasmic changes. At the onset of prophase, chromosomes condense starting from 
isolated patches of chromatin at the nuclear periphery and they become visible as two 
distinct sister chromatids closely paired along their entire length. As chromosomes 
condense, proteins of the kinetochore multiprotein complex move from the cytoplasm 
into the nucleus and associate with the kinetochores. A kinetochore is a button like 
structure on the centromeric heterochromatin, which directs chromosomal movements 
during mitosis (Pollard and Earnshaw, 2002). 
At this point of the cell cycle, histone Hi is phosphoiylated by Cdkl -cyclin B in 
vivo (Swank etal., 1997) and histone 1-13 by Aurora B kinase (Adams et al., 2001). It is 
thought that the unfolding of the local chromatin due to histone phosphorylation may 
permit binding of different factors such as the condensin complex (Hirano, 2002). Also 
topoisomerase II, an enzyme that can change DNA topology by passing one double helix 
strand through another and which locates at centromeres and along mitotic chromosome 
arms, seems to be connected to chromosome condensation at the onset of prophase 
(Wang, 2002). Dramatic changes occur in the cytoplasm during prophase. Most of the 
cytoskeleton reorganises but especially so the microtubule network. The extented 
microtubule network that covers the whole cytoplasm during interphase is converted into 
two dense radial arrays, called asters, of short dynamic microtubules around each 
centrosome. y-tubulin (a minor tubulin isoform) ring complexes (y-TURC) in the 
pericentriolar material nucleate the microtubules so that each aster acts as a microtubule 
organising centre (MTOC). Most of the actin and intermediate filaments disassemble 
(including the nuclear lamina), the Golgi apparatus and the endoplasmic reticulum 
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fragment, endocytosis and exocytosis are greatly decreased and protein synthesis stops 
by the action of Cdkl-cyclin B (Pollard and Earnshaw, 2002). 
Prom etaphase 
Prometaphase is mainly characterised by nuclear envelope disassembly and interactions 
between microtubules and kinetochores in order to align the chromosomes in a group 
midway between the poles. Every mitotic chromosome has two opposite kinetochores, 
one on each sister chromatid, which are attached to opposite spindle poles. This bipolar 
orientation is important for giving a balance of opposing forces, that together with the 
action of kinesins (a family of motor proteins distributed along the chromosome arms), 
results in a movement of the chromosomes to a point midway between the spindle poles. 
During prometaphase the assembly of the mitotic spindle that starts from prophase with 
the separation of the asters, is completed. At this point, cyclin A is degraded (Pollard 
and Eamshaw, 2002). 
Metaphase 
Metaphase is a very short period of the cell cycle. At this phase all chromosomes are 
properly attached to microtubules from opposite poles and they are situated midway 
between the two spindle poles. Once the chromosomes are properly aligned in the 
middle of the spindle, they form a structure called the metaphase plate (Pollard and 
Earnshaw, 2002). The proper alignment of chromosomes and the achievement of 
bipolar orientation is critical for the accuracy of segregation of replicated chromosomes. 
For this reason, entry into anaphase is delayed by the metaphase checkpoint or spindle 
assembly checkpoint. This checkpoint involves protein kinases and other factors that are 
associated with kinetochores during prophase or prometaphase and dissociate from 
kinetochores after these are stably attached to the spindle (Rieder and Maiato, 2004; 
Musacchio and Hardwick, 2002). One of these kinases is BubRi which locates at the 
outer plate of the kinetochore and it appears to interact with CENP-E, the giant kinesin 
protein that associates with chromosomes during nuclear envelope breakdown (Maiato 




anaphase B anaphase A 
telophase 
	 cytokinesis 
Figure 1.1. Overview of the phases of mitosis in a typical metazoan cell. 
Spindle and astral microtubules are shown in green, chromosomes and 
kinetochores are shown in dark blue and red respectively and the nuclear 
envelope is shown in black. 
along with other factors satisfy the metaphase checkpoint (Cleveland et al., 2003; 
Musacchio and Hardwick, 2002). 
Anaphase 
During the critical stage of anaphase, sister chromatids move to opposite spindle poles 
(anaphase A) and the poles move apart (anaphase B). The entry into anaphase is 
triggered by a drop in Cdkl activity and is completed by APC/C-directed cleavage of 
proteins including securin and cyclin B by proteosomes (Imiger, 2002). The shortening 
of the microtubules that are attached to kinetochores (kinetochore microtubules) and the 
involvement of motor proteins that are present on the chromosomes contribute to 
chromosome movement during anaphase A. In anaphase B, spindle poles separate from 
one another. Due to this, the spindle is elongated and the interpolar microtubules 
(microtubules that connect the two spindle poles) are reorganised into a highly organised 
central spindle between the separating chromatids (Pollard and Eamshaw, 2002). 
Telophase 
During telophase the nuclear envelope reassembles around the segregated chromosomes. 
Other dramatic changes at this point prepare the cell for the ensuing division of the cell 
(Pollard and Eamshaw, 2002). 
Cytokinesis 
Cytokinesis is the process that divides the mother cell into two daughter cells. In animal 
cells, a contractile ring is formed by actin filaments and separates the daughter cells 
from one another. The central spindle appears to play a critical role in early and late 
cytokinesis. It contains kinesins and components called chromosomal passengers, which 
seem to be essential for the completion of cytokinesis (Pollard and Eamshaw, 2002). 
1.2. Chromosome condensation 
Chromosomal DNA, if stretched end to end, measures about 2 metres in any one cell of 
the human body and therefore must be highly folded to fit into a nucleus of only 10 im 
diameter. DNA has to condense even further prior to cell division in order to form the 
highly compact metaphase chromosome comprising two distinct sister chromatids, 
capable of withstanding anaphase segregation (Heck, 1997; McHugh and Heck, 2003; 
Swedlow and Hirano, 2003). Several levels of packing enable DNA to achieve this 
packaging and a number of structural proteins are involved. The simplest level of 
packing involves the winding of DNA around octamers of core histories in a structure 
called the nucleosome. This shortens DNA about 7-fold relative to naked DNA 
(Kornberg, 1974; Olins et al., 1976; Richmond et al., 1984). The folding of regularly 
spaced nucleosomes forms a shorter, thicker filament, called the 30 nm chromatin fibre, 
in which the DNA is about 40-fold more compact than when naked (Widom and KIug, 
1985; Williams eta!, 1986; Woodcock and Dimitrov, 2001; Woodcock et al., 1984). 
The most highly condensed and least understood stage takes place prior to chromosome 
segregation when the DNA in metaphase chromosomes of higher eukaryotic cells is 
compacted nearly 10,000-fold in length (Li et al., 1998). The way that chromatin 
organizes into this higher-order structure of mitotic chromosomes is not well understood 
and the different models that have been proposed remain controversial (Belmont, 2002; 
Swedlow and Hirano, 2003). 
1.2.1. First level of compaction: the nucleosome 
Interphase nucleosomal chromatin under low salt conditions appears (by electron 
microscopy) as "beads on a string" with a diameter of about 10 nm. This packaging 
results when 166 bp of DNA winds around an octamer of core histories in a left-handed 
superhelix following a helical path along the surface of the octamer (Figure 1.2). The 
histone octamer consists of an [H3]2:[H4]2 tetramer, flanked on either side by an 
H2A:H2B heterodimer. Each core historic has a compact domain of 70 to 80 amino acid 
residues and a flexible N-terminal tail of approximately 30 amino acids outside the 
nucleosome (Pollard and Earnshaw, 2002). These N-terminal tails allow the 
nucleosomes to pack into a 30 im-i fibre, while specific modifications of the tails are 
crucial for modulation of chromatin structure (Figure 1.2). This fibre has been variously 
modelled as either a solenoidal coiling, random or organized folding of the nucleosomal 
fibre - its actual structure remains undetermined. Fragility of the 30 nm fibre during 
preparation is likely responsible for the inability to unambiguously ascertain its 
architecture (Pollard and Earnshaw, 2002; Woodcock and Dimitrov, 2001). 
Histone Hi, or other linker histones, binds to a variable amount of "linker" DNA 
that extends between adjacent nucleosomes (Pollard and Earnshaw, 2002). The N-
terminal tails of the histones are also important for extra-nucleosomal interactions. The 
variants of linker histone differ from the core histones in that the globular central 
domain is flanked by unstructured basic domains at both the N- and C-termini. Historic 
Hi resides at the side of the nucleosome where DNA enters and exits the nucleosome. 
The master cell cycle regulatory kinase, CDK1 (cdc2:cyclinB), phosphorylates serine 
and threonine residues on the histone Hl tails in vivo during mitosis (Swank et al., 
1997). Hyperphosphorylation of histone HI was originally thought to be important for 
mitotic chromosome condensation (Bradbury, 1992) but recent studies show that 
phosphorylation is not required for this process (Guo et al., 1995; Ohsumi et al., 1993; 
Roth and Allis, 1992; Shen et al., 1995). 
Mitosis-specific phosphorylation of histone H3 at serine- 10 (by Aurora B kinase) 
coincides with the initiation of chromosome condensation, suggesting that 
phosphorylation of histone H3 drives chromosome compaction (Hendzel et al., 1997). 
However, the effects of histone H3 phosphorylation on chromosome condensation 
appear to be variable between several studies (Swedlow and Hirano, 2003), and it seems 
unlikely to be required for this process. Moreover, the N-terminal tails of histones may 
also be acetylated or methylated, resulting in an epigenetic "histone code" important for 
gene expression or assembly of heterochromatin (Cosgrove et al., 2004; Turner, 2002). 
1.2.2. Above and beyond the nucleososme- mitotic chromosome condensation 
The mechanism for packaging the 30 nm fibre into the highly compact, characteristc 
rod-shaped mitotic chromosomes remains a fundamental question for modern cell 
biologists (Belmont, 2002; Swedlow and Hirano, 2003). The shortening of DNA by 
roughly 10,000-fold is essential for the proper physical separation of sister chromatids to 
opposite poles, e.g. in order to avoid cleavage of the genome by an ingressing cleavage 
furrow. In addition, chromosomes must be properly aligned via their kinetochores to 
10 
ensure that one of each chromatid pair ends up in each new daughter cell. However, 
early approaches utilizing electron microscopy to examine isolated native mitotic 
chromosomes only served to confirm that the DNA is indeed very densely packed within 
chromosomes. 
Several approaches have been utilized in an attempt to expose the factors 
underlying higher order chromosome structure. One classical view, based on the 
appearance of DNA in sperm (Inoué and Sato, 1964), suggests that folding or helical 
coiling of the 30 nm fibre into increasingly larger structures gives rise to a condensed 
chromosome (Figure 1.2.A) (Belmont et al., 1987; Sedat and Manuelidis, 1978). 
Recently a higher order folding has been tested by stably integrating tandem arrays of 
bacterial lac operator sequences into human cells that express GFP fused to the lac 
repressor. This strategy generates a marked chromatin locus that can be specifically 
visualised by fluorescence or electron microscopy (Belmont and Bruce, 1994; Swedlow 
and Hirano, 2003). In this study, the analysis of chromosome decondensation between 
telophase and early GI indicated one or more levels of compaction between the 30 nm 
chromatin fibre and an —100-130 nm chromonema fibre, which itself folded into 
telophase chromosomes (Figure 1.2.A) (Belmont and Bruce, 1994). Furthermore, 
ultrustructural analysis of two different transgene insertion sites , both spanning less than 
the full chromatin width, provided strong support for hierarchical models of 
chromosome architecture (Strukov et al., 2003). Specifically, 250 nm diameter folding 
subunit was visualised directly within fully condensed metaphase chromosomes. 
Nevertheless, further experiments using this strategy will prove if folded domains self 
assemble into progressively larger structures. 
On the other hand, some of the first hints about large scale chromatin folding 
were obtained after depleting core histories from highly purified mitotic chromosomes 
(either with a high salt concentration or polyanions which compete with histories by 
charge) under conditions that maintain residual non-histone proteins. Long extended 
loops of DNA (about 15-100 kb) surrounded a protein core that retained the general size 
and shape of a native chromosome (Paulson and Laemmli, 1977). These striking images 
led to a model known as the "radial loop model" in which the folding of the chromatin 
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fibre into loops was mediated by proteins of an insoluble chromosome "scaffold" that 
was essential for the final size and shape of a chromosome (Figure 1 .2.B) (Marsden and 
Laemmli, 1979). In the presence of 2M NaCI, the scaffold and DNA halo were stable, 
suggesting that the scaffold may hold DNA loops in a compact conformation (Laemmli 
et al., 1978). In the same study, when nucleases were used to isolate the scaffold 
without its associated DNA halo, it was suggested that the structural integrity of the 
scaffold was independent of DNA. In another approach, scaffolds were able to contract 
and expand in a reversible way in response to alterations in ionic strength (Eamshaw and 
Laemmli, 1983), suggesting that similar conformational changes of native chromosomes 
may result from salt induced changes in scaffold structure. Furthermore, scaffolds were 
found to be fibrous in nature and to retain differentiated regions that appear to derive 
from the kinetochores and chromatid axes (Earnshaw and Laemmli, 1983). These 
observations, in conjunction with experimental data proposing that ordering of 
chromatin is similar throughout the cell cycle, let to a hypothetical model suggesting that 
the increased compaction during mitosis (particularly during metaphase) is probably a 
consequence of transitions of the scaffold structure from a dispersed interphase network 
to a contracted mitotic conformation (Belmont, 2002; Earnshaw and Laemmli, 1983). 
However, the organisation of the 30 nm fibre into the 15-100 kb loops is not 
enough to account for the compaction of the genome in mitotic chromosomes. A model 
in which regular helical coiling of the loops in metaphase chromosomes (Boy de la Tour 
and Laemmli, 1988; Maeshima and Laemmli, 2003; Rattner and Lin, 1985) results in 
paired sister chromatids of opposite helical handedness (mirror symmetry) (Boy de la 
Tour and Laemmli, 1988), may also contribute to higher order packaging (Figure 1.2.13). 
This model was a variation of the basic radial model. 
Nevertheless, with such severe extraction methods, the scaffold was considered 
by many to be an artefact, a result of inappropriate protein interactions created during 
preparation of this fraction (Belmont, 2002; McHugh and Heck, 2003). For this reason, 
a detailed biochemical and functional analysis of the scaffold components was required 
to resolve the controversy. Evidence for chromatin loops existing in native 
chromosomes, derived from examination of lampbrush chromosomes, where 
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chromosome loop domains were easily observed. Lampbrush chromosomes are found 
in oocytes of amphibia and other organisms and their chromatin loops are sites of 
intense transcriptional activity, required to produce the stockpiles of components needed 
for cell division during early development of the fertilised egg (Pollard and Earnshaw, 
2002). The loops are particularly visible because each DNA loop is coated with many 
RNA transcripts together with proteins that package them. 
Further support for the concept of a mitotic chromosome scaffold came from the 
identification of cis-acting DNA sequences interacting with the proteinaceous 
component. Using low salt conditions, which extract most of the histone and non-
histone proteins but preserve the specific interactions of the DNA loops and the scaffold, 
specific DNA attachment sites were mapped. These sequences identified were called 
scaffold attachment regions (SARs) (Hart and Laemmli, 1998; Mirkovitch et al., 1987; 
Mirkovitch et al., 1984). SAR sequences were identified in both nuclear (nuclear 
matrix, interphase nuclei) and mitotic scaffolds (Mirkovitch et al., 1987). DNA 
sequences that associate preferentially with nuclear matrix are defined as MARs (matrix 
attachment regions). SARs/MARs are AT-rich DNA sequences and the DNA between 
two SAR sequences separated by up to 100 kb of DNA, would form a chromatin loop 
(Hart and Laemmli, 1998; Saitoh and Laemmli, 1994). Using AT-specific fluorochrome 
dyes, SARs were visualised as a queue along the longitudinal axis of the chromosome 
that alternately followed a fairly linear or tightly coiled path (Saitoh and Laemmli, 
1994). This alternating folding pattern was proposed as a link between chromosome 
structure and the banding patterns observed on mitotic chromosomes with several dyes. 
In the Q bands (AT-rich), the AT queue is tightly coiled or folded while the R bands 
(GC-rich) contain a more central (unfolded) AT queue. A number of proteins such as 
Topoisomerase II (a protein of the chromosome scaffold), histone H 1 and HMG-I/Y 
were shown to bind SARs highly selectively (Adachi et al., 1989; Izaurralde et al., 1989; 
Zhao et a!, 1993). However, when labelled chromosome regions with altered SAR 
sequences were engineered, using the lac operator/repressor system, no defect was 
observed in chromosome organisation (Strukov et al, 2003). In the same study, when 
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folding/coiling 
Figure 1.2. Hierarchical models for mitotic chromosome organisation. 
The first level of compaction involves the winding of DNA around octamers of core 
histories in a structure called the nucleosome, resulting in a 10 nm fiber which provides 
a 6-7 fold linear compaction of DNA. The folding of regularly spaced nucleosomes 
forms a shorter, thicker filament, called the 30 nm chromatin fiber, in which the DNA 
is about 40-fold more compact than when naked. A. The chromonema fiber model 
proposes that folding and/or coiling of the chromatin fiber would create higher-order 
domains that could fold into progressively larger structures (400-700 nm), possibly 
based on protein:protein or protein:DNA interactions between neighbouring chromatin 
fibers (Belmont and Bruce, 1994). B. The radial loop domain model proposes that the 
chromatin fiber folds into loops, mediated by proteins in the chromosome scaffold and 
cis-acting SAR sequences (Hart and Laemmli, 1998), while regular helical coiling of 
the loops results in the formation of metaphase chromosomes (400-700 nm). 
ultrustructural analysis of two different transgene insertion sites, both spanning less than 
the full chromatin width, clearly contradicted predictions of the radial loop model while 
provided strong support for hierarchical models of chromosome architecture. 
Specifically, 250 nm diameter folding subunit was visualised directly within fully 
condensed metaphase chromosomes. 
To test the role of SARs in chromatin condensation, artificial proteins (MATH 
proteins) which bind to these regions (but have no other obvious direct effect on 
condensation) were constructed (Strick and Laemmli, 1995). MATH proteins had 
multiple tandem copies of the AT hook, a 14 residue sequence from HMGI-Y proteins 
with high affinity for the minor groove of extensive poly dT stretches of DNA. These 
proteins might compete with true condensation factors for binding sites and therefore 
disrupt the condensation process. The MATH proteins were demonstrated to 
specifically bind SARs in chromatin and chromosomes while MATH20 (a protein 
containing 20 hooks) disrupted the normal events of mitotic chromosome assembly 
when added to Xenopus laevis egg extracts. However, titration of SARs with MATH20 
blocked only shape determination of chromatids, rather than chromatin condensation per 
Se. When MATH20 was added after formation of chromatids, the latter collapsed and 
they reshaped by an active mitotic process into spherical chromatin balls, suggesting the 
requirement of SARs in the shape maintenance of chromosomes (Strick and Laemmli, 
1995). However, the significance of these experiments for chromosome condensation in 
vivo has been questioned (Koshland and Strunnikov, 1996). The abnormal chromosome 
morphology could be a consequence of the binding of true condensation factors to non-
SAR regions of the chromatin. Thus, condensation could still proceed but the final 
chromosome structure would be defective. Moreover, as similar morphological defects 
have been reported in cells deficient in topoisomerase ha (also a factor in chromosome 
condensation and segregation), it appears that the competitive binding of MATH20 to 
SARs may genuinely reflect the importance of these cis-acting sequences for 
chromosome assembly (Grue et al., 1998; Hirano and Mitchison, 1993). 
Since cis-acting sequences are significant for mitotic chromosome architecture, it 
might be expected that the location of specific sequences within the mitotic chromosome 
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would be defined. Using fluorescence in situ hybridazitation to extracted metaphase 
chromosomes, it was shown that specific human DNA sequences occupy distinctive 
positions with respect to the axial region of chromosomes and that the DNA is organised 
into loops emanating from this region (Bickmore and Oghene, 1996). However, 
experiments with the GFP-/ac repressor chromatin marker or FISH on extracted 
chromosome halos, suggested that chromosome architecture is fairly dynamic and that 
most sequences do not localise within a certain region of the chromosome. It appears 
that the position of a sequence at a particular time is depended on the cell cycle state and 
transcriptional activity (Swedlow and Hirano, 2003). Furthermore, the axial localisation 
of several sequences marked with the GFP-lac repressor system was only observed 
during metaphase but not during prophase or prometaphase, suggesting that a major 
structural transition occurs at late stages of condensation, between prophase and 
metaphase. This structural transition is consistent with all chromosome models 
involving coiling/uncoiling of an underlying chromatid, including coiled-radial loop and 
coiled-chromonema models (Dietzel and Belmont, 2001). 
An alternative approach to chromosome structural analysis, monitored changes in 
chromosome elasticity and deformability by using micromechanical force 
measurements. Firstly, measurements of both longitudinal deformability and bending 
rigidity were performed on in vitro assembled chromosomes in Xenopus egg extract by 
using specially designed micropipettes (Houchmandzadeh and Dimitrov, 1999). The 
relationship between the values of these two parameters was found to be most consistent 
with models in which mitotic chromosomes are composed of thin rigid cores of protein 
surrounded by a soft envelope, as predicted by the scaffold hypothesis. Similarly, 
several other studies revealed that when chromosomes were stretched under controlled 
conditions allowing force measurements, mitotic chromosomes could be stretched five 
times their native length without permanent elongation (Houchmandzadeh et al., 1997; 
Nicklas, 1983; Poirier et al., 2000). The remarkably elasticity of chromosomes could 
suggest that the mechanical integrity of mitotic chromosomes is maintained by a 
proteinaceous axial core. However, recent experiments by Poirier and Marko by using 
micromechanical force measurement during nuclease digestion seem to rule out the 
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possibility that mitotic chromosome structure is based on a mechanically contiguous 
proteinaceous scaffold (Poirier and Marko, 2002). In this study, as DNA cuts are 
introduced within a mitotic chromosome by either micrococcal nuclease or frequently 
cutting restriction enzymes, first chromosome elasticity is lost and then the chromosome 
is completely dissolved. These data suggest that the mechanical integrity of 
chromosomes is largely dependent on DNA (chromatin network) and is maintained by 
cross-links between chromatin fibres. The frequency of these cross-links is estimated to 
be about every 15 kb (Poirier and Marko, 2002). Nonetheless, measures of chromosome 
stiffness by different groups have varied widely making it difficult to build a definitive 
model of chromosome architecture (Marshall et al., 2001; Swedlow and Hirano, 2003). 
Undoubtedly, it could be possible that both the chromosome scaffold and DNA, 
contribute to the structural integrity of chromosomes. Bearing in mind that the question 
of whether the native scaffold is stabilised through protein-protein interactions is 
unresolved (Gasser et al., 1986), it could be suggested that the proteins of the scaffold 
are not contiguously connected through the chromosome and that DNA itself links the 
scaffold together (Poirier and Marko, 2002). 
1.3. Biochemical analysis of the chromosome scaffold and the components of 
mitotic chromosomes 
Biochemical analysis of scaffolds, isolated from extracted mitotic chromosomes, 
revealed two major components Sc I and Sc2 (Sc I at 170 kDa and Sc2 at 135 kDa) and a 
number of smaller, less abundant proteins (Lewis and Laemmli, 1982; Gassmann et al., 
2004). The identification of Scl as DNA topoisomerase II (Earnshaw et al., 1985; 
Gasser et al., 1986) and Sc2 as an SMC protein (a subunit of the condensin complex) 
(Saitoh et al., 1994), provided the first evidences that proteins involved in mitotic 
chromosome dynamics were components of the scaffold fraction. In addition to this, 
characterization of chromosomes remodelled from sperm chromatin in Xenopus egg 
extracts, resulted in the identification of several protein components binding to these in 
vitro assembled structures. The mitotic chromosome fraction contained histories and 
linker histones, topoisomerase ha, chromokinesin, the chromatin remodeling ATPase 
17 
ISWI, and a complex subsequently named condensin (Hirano et al., 1997; Hirano and 
Mitchison, 1994; MacCallum, 2002; Vernos et al., 1995). These studies demonstrated 
that mitotic chromosomes are rich in ATPases, which are likely important to induce 
conformational changes of chromosomes and to support microtubule-dependent 
movement of chromosomes (Swedlow and Hirano, 2003). 
1.3.1. The role of topoisomerase II during mitosis 
Topoisomerase II is an ATP-dependent enzyme that can alter DNA topology by passing 
one double-strand helix through another via a transient double-strand break, an activity 
necessary for the resolution of catenated sister DNA strands (Wang, 2002). 
While yeast and Drosophila have a single topoisomerase II gene, there are two distinct 
isoforms in higher eukaryotes, topoisomerase [Eu (170 kDa) and topoisomerase UP (180 
kDa) that are encoded by different genes. Topoisomerase ha and 11J3 have identical 
catalytic activities in vitro but different localisation patterns in vivo (Porter and Fan, 
2004a; Swedlow and Hirano, 2003). Nearly all the topoisomerase ha is concentrated in 
mitotic chromosomes and is preferentially expressed in proliferating cells, increasing in 
S, peaking in G2/M and diminishing in G  phase (Heck et al., 1988). By contrast, 
immunolabeling studies have suggested that topoisomerase 1113 is diffusely 
nucleoplasmic in interphase and mitosis (Chaly et al, 1996; Meyer et al., 1997), with its 
levels not changing significantly throughout the cell cycle. However recent studies have 
concluded that a minor but significant fraction of 1113 is associated with mitotic 
chromatin (Christensen et al., 2002; Null et al., 2002). Nevertheless, it seems that while 
topoisomerase ha is essential for mitosis, topoisomerase 1113 is dispensable and its main 
function and whether it has an accessory role in mitotic chromosome structure remains 
unresolved. Furthermore, more complexity arises from the discovery that both 
topoisomerase genes give rise to splice variants, in conjunction with the uncertainty over 
whether topoisomerase II protein, which has a dimerisation domain, exists as homo-
and/or heterodimers (Porter and Fan, 2004a). 
Localisation studies in different species revealed disparate results for the 
distribution of topoisomerase 11 on mitotic chromosomes. In higher eukaryotes this 
enzyme showed an axial distribution through the core of hypotonically swollen 
chromosome arms (Eamshaw and Heck, 1985; Gasser et al., 1986; Maeshima and 
Laemmli, 2003; Saitoh and Laemmli, 1994), and/or an apparent concentration at the 
centromeres (Cobb et al., 1999; Maeshima and Laemmli, 2003; Taagepera et al., 1993). 
Laemmli and colleagues (Laemmli et al., 1978) proposed that closure of chromatin loops 
was one function of the mitotic chromosome scaffold. Thus, the axial contribution of 
topoisomerase II may reflect the localisation of the protein at the base of chromosome 
loops. Indeed, localisation of topoisomerase II at the axial region of swollen chicken 
chromosomes and the aggregation of a subset of chromosomal DNA after addition of 
anti-topoisomerase II antibodies to swollen chromosomes, suggested that the protein is 
localised in numerous separate "islets" on a small subset of chromosomal sequences 
(Earnshaw and Heck, 1985). Furthermore, topoisomerase 11 was shown to bind AT-rich 
SARs highly selectively and to associate with the mitotic chromosome scaffold (Adachi 
et al., 1989; Hart and Laemmli, 1998), while examination of meiotic chicken 
chromosomes showed mainly an axial distribution with some association with 
centromeres and synaptonemal complexes (Moens and Earnshaw, 1989). However, this 
distribution of topoisomerase II predicts that mitotic chromosome condensation should 
require stoichiometric levels of the enzyme, a certain quantity of topoisomerase II for 
the association of each chromosome loop to the scaffold. That was confirmed, when, 
after immunodepletion of topoisomerase II in an in vitro chromosome assembly system, 
the endogenous levels of the protein were required in order to restore the complete 
condensation activity (Adachi et al., 1991). 
Nonetheless, examination of the role of topoisomerase II in mitotic chromosome 
assembly and organisation in vitro, using Xenopus egg extract, suggested that while 
topoisomerase II activity was required for chromosome assembly and organisation, it did 
not appear to play a scaffolding role in the structural maintenance of chromosomes 
(Hirano and Mitchison, 1993). In the same study, analysis of the localisation of 
topoisomerase II revealed that the protein was not restricted to the chromosome axis but 
was uniformly distributed throughout the condensed chromosomes. Similarly, studies 
examining historic depleted HeLa chromosomes (Boy de la Tour and Laemmli, 1988) 
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and in vivo studies in Drosophila revealed the protein to have a more uniform 
distribution on chromosomes (Buchenau et al., 1993; Swedlow et al., 1993). 
The different localisation patterns of topoisomerase IT on mitotic chromosomes 
may reflect differences in the fixation and preparation conditions used in several of these 
studies, species-specific differences in the chromosomal distribution of topoisomerase TI, 
or even differential specificity of the different topoisomerase TI antibodies used in these 
studies, that may detect distinct subsets at different chromosomal locations (Warburton 
and Earnshaw, 1997). Studies focusing on cell cycle distribution of topoisomerase IT, in 
diverse mammalian cell lines representing both eutherians and metatherians (human, 
mouse, rat, Chinese hamster, rat kangaroo, wallaby and Indian muntjac), revealed that 
the staining pattern Of this enzyme changes as cells progress through mitosis (Rattner et 
al., 1996; Sumner, 1996). Particularly, staining by indirect immunofluorescence using 
antibodies against topoisomerase ha showed a punctuate staining of variable intensity in 
interphase, in all species examined. In prophase, as chromosomes start to condense, 
topoisomerase ha was distributed on individual chromosomes and the levels of the 
protein appeared highest. In metaphase the intensity of topoisomerase ha was found to 
be highest at the centromeres in all species examined, while the axial pattern along the 
arms was still present. During anaphase, the centromeric topoisomerase II intensity 
decreased to a level similar to that on the chromosome arms. 
The centromeric accumulation of topoisomerase II observed from prometaphase 
until early anaphase (Christensen et al., 2002; Gorbsky, 1994; Maeshima and Laemmli, 
2003; Null et al., 2002; Rattner et al., 1996; Sumner, 1996; Taagepera et al., 1993) and 
during prophase of meiosis I (Cobb et al., 1999; Moens and Earnshaw, 1989) suggests 
that this protein may have a specific function at centromeres. Indeed, inhibition of 
topoisomerase II activity using the ICRF- 193 drug inhibitor, prevented the accumulation 
of topoisomerase II at the centromeres and disrupted the compaction of centromeric 
heterochromatin beneath the kinetochore and kinetochore structure (Rattner et al., 1996). 
Similarly, when DNA damage was caused in human cells undergoing mitosis using an 
inhibitor of topoisomerase ha, defects in kinetochore attatchment and function were 
observed which in turn led to activation of the Mad-2 based spindle assembly checkpoint 
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(Mikhailov et al., 2002). The presence of topoisomerase II at the centromeres has also 
been related to centromeric cohesion as a function of the scaffold, in contrast to its role 
in separating entangled sister chromatids. This is supported by the observation that 
chromatids separate in the centromere region but not along their arms when cells 
entering anaphase are treated with topoisomerase II inhibitors (Downes et al., 1991; 
Gorbsky, 1994). Moreover, conjugation of topoisomerase II with the small ubiquitin-
related modifier (SUMO), specifically affects the separation of sister centromeres but 
not the catalytic activity of the enzyme (Bachant et al., 2002), suggesting that a specific 
subpopulation of topoisomerase II functions at centromeres. 
Furthermore, post-translational modifications of topoisomerase II such as 
phosphorylation have been associated with the mitotic activity of this protein. 
Phosphorylation of topoisomerase IT has been demonstrated in vitro by various kinases 
(Porter and Farr, 2004a) and its phosphorylation increases during the S and G2/M phases 
(Estey et al, 1987). Both topoisomerase 110 and 1113 are phosphorylated (Ishida et al., 
1996; Ishida et al., 2001; Kimura et al., 1996; Wells et al., 1995; Wells and Hickson, 
1995). Since topoisomerase I10 plays an essential role in cell proliferation, many 
studies tried to analyse how its activity and localisation are affected by phosphorylation. 
Using antibodies against various phospho-oligopeptides of topoisomerase TIo, it was 
revealed that while phosphorylation of topoisomerase ha at threonine 1342 occurs in 
vivo throughout the cell cycle (Ishida et al., 1996), phosphorylation at serine 1212 occurs 
only during mitosis (Ishida et al., 2001). Moreover, phosphorylated topoisomerase 110 
at serine 1212 re-localises from chromosome arms to the centromeres and this 
movement is blocked by an inhibitor of topoisomerase II activity. 
However, the idea of an immobilised topoisomerase II as a part of a static 
structural scaffold has been questioned and in vivo studies of fluorescently labelled 
topoisomerase II in human cells and Drosophila have revealed a dynamic behaviour of 
the protein during mitosis (Christensen et al., 2002; Swedlow et al., 1993; Tavormina et 
al., 2002). When rhodamine-labeled topoisomerase II was injected into Drosophila 
embryos, it was demonstrated that this enzyme was uniformly present throughout 
chromosomes, reaching its maximum at prometaphase and minimum at telophase 
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(Swedlow et al., 1993). In the same study, it was noted that two pools of the protein 
leave the chromosome, one following prophase and the other following anaphase, 
suggesting that there may be different forms of the enzyme with different functions or 
localisations. 
In human cells, GFP-tagged topoisomerase IIo was reported to localise along the 
axial regions and centromeres of metaphase chromosomes (Tavormina et al., 2002). 
During anaphase, the centromeric pools of the protein were diminished while the 
cytoplasmic population was increased. Furthermore, fluorescence recovery after 
photobleaching (FRAP) revealed that topoisomerase Ilu was extremely mobile and that 
the whole chromosomal population was in equilibrium with a large cytoplasmic pool. 
However, the catalytic activity of the enzyme was essential for the rapid dynamic 
exchange between chromosomal and cytoplasmic populations, since recovery after 
photobleaching was blocked by treatment of cells with drugs that trap topoisomerase ha 
on DNA as a "closed clamp". Taking in account that the recovery after photobleaching 
was less than 100%, it could be suggested that a subpopulation of the chromosome and 
kinetochore associated topoisomerase ha was more stably associated. A similar study 
of GFP-tagged topoisomerase ha and 1113 resulted in very similar results for the hIcL 
isoform (Christensen et al., 2002). During interphase the two isoforms accumulated in 
nucleoli, while in mitosis only topoisomerase ha was chromosome-associated to high 
level. FRAP experiments revealed that the entire complement of both isoforms was 
completely mobile and free to exchange between nuclear subcompartments in 
interphase. During mitosis, topoisomerase ha was also completely mobile and it 
showed a uniform distribution on the chromosomes in contrast to the axial localisation 
reported previously by Tavormina et al (Tavormina et al., 2002). However, it was also 
demonstrated in this study that a minor fraction of topoisomerase 1113 associates with 
chromosomes during mitosis, suggesting that both isoforms could play a role in mitotic 
chromosome architecture and chromosome segregation. Taken together, these data 
support the idea of a dynamic behaviour of topoisomerase II during the cell cycle and 
that this protein is not an immobile component of the scaffold. 
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Whether topoisomerase II is a "scaffold" component, does not rule out its role in 
mitotic chromosome dynamics along with other proteins important for chromosome 
assembly. Topoisomerase II activity is required for the resolution of the catenated 
strands of DNA so that each chromatid of a pair becomes an individual unit, facilitating 
successful separation during anaphase (Gimenez-Abian et al., 2000). Indeed, mutations 
in topoisomerase II in both Saccharornyces cerevisiae and Schizosaccharomyces pombe 
were lethal in mitosis, with sister chromatids failing to segregate properly (DiNardo et 
al., 1984; Holm et al., 1985; Uemura and Yanagida, 1984). Further analysis in S. pombe 
revealed that topoisomerase II was also required for the final stages of chromosome 
condensation, possibly in collaboration with the condensin complex (Uemura et al., 
1987). However, the role of topoisomerase II in the process of chromosome 
condensation has been controversial since disruption of its function in different 
organisms resulted in different chromosome morphologies (Swedlow and Hirano, 2003; 
Warburton and Earnshaw, 1997). In contrast to S. pombe, in S. cerevisiae, establishment 
and maintenance of chromosome condensation (although very difficult to see in this 
organism) is independent of topoisomerase II activity (Lavoie et al., 2002). In Xenopus 
egg extracts, inhibitors of topoisomerase II (Hirano and Mitchison, 1991; Newport and 
Spann, 1987) or immunodepletion of topoisomerase II (Adachi et al., 1991; Wood and 
Earnshaw, 1990) prevented complete condensation of chromosomes. 
In mammalian cells, matters are complicated by the proposed existence of a 
temporary G2 topoisomerase TI-dependent checkpoint that regulates entry into mitosis. 
When the checkpoint is evaded, cells that attempt mitotic chromosome condensation 
produce highly elongated and imperfectly condensed chromosomal structures (Downes 
et al., 1991). Interestingly, in another study of the formation of mitotic chromosomes 
during checkpoint override after G2 arrest with topoisomerase II inhibitors, it was 
demonstrated that topoisomerase TI-dependent decatenation was not required to remodel 
chromatin into a condensed chromosome with two axial cores (Andreassen et al., 1997). 
Likewise, extraction of topoisomerase II from condensed chromosomes did not affect 
chromosome morphology, but was required for the establishment of chromosome 
assembly and condensation (Hirano and Mitchison, 1993), suggesting that the role of 
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topoisomerase II in achieving full condensation was enzymatic, not structural. Recently, 
analysis of a conditional topoisomerase II mutation in mammalian cells revealed that 
topoisomerase ha plays a largely redundant role in chromosome condensation, but an 
essential catalytic role in chromosome segregation (Carpenter and Porter, 2004). 
In Drosophila, inhibition of topoisomerase II by injection of antibodies or 
enzyme inhibitors to blastoderm embryos, interfered with the condensation of chromatin 
and its proper arrangement into a metaphase plate (Buchenau et al., 1993). Furthermore, 
depletion of topoisomerase II by RNAi in Drosophila resulted in a 2.5-fold decrease in 
the level of chromatin compaction but overall chromosome condensation occurred 
without topoisomerase II (Chang et al., 2003). In the same study, chromosome 
morphology was abnormal and one or more chromosome arms frequently stretched out 
from the metaphase plate, suggesting an unexpected role for topo II in chromosome arm 
congression. Finally the decatanation activity of topoisomerase 11 allows the formation 
of cytologically distinguishable pairs of apposed sister chromatids, a process known as 
sister chromatid resolution (Gimenez-Abian et al., 1995; Losada et al., 2002), and the 
complete separation of sister chromatids in anaphase (Holm et al., 1985; Shamu and 
Murray, 1992; Uemura and Yanagida, 1984). The most prominent defects observed 
after disruption of the topoisomerase II activity are defects in chromatid segregation and 
the formation of chromosome bridges during anaphase (Swedlow and Hirano, 2003). 
The distribution of topoisomerase TI and its contribution to the hypothetical 
chromosome scaffold remains controversial. It is possible that a subpopulation of 
topoisomerase II associates with SAR regions during mitosis, while other pools 
associate with other sequences which have a role distinct from that of the scaffold 
(Swedlow and Hirano, 2003). It should also be noted that topoisomerase II can function 
as an ATP-dependent protein clamp (Wang, 2002) and the enzyme might be 
immobilized on DNA or chromosomes when its ATPase cycle is inactive. Furthermore 
the role of topoisomerase H activity in chromosome condensation remains unclear. Two 
different proposals have emerged, one supporting that topoisomerase II is essential for 
complete chromosome condensation (Adachi et al., 1991; Newport and Spann, 1987; 
Uemura et al., 1987; Wood and Eamshaw, 1990), while the other suggests that although 
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the enzyme is required for the establishment of condensation, it is unnecessary for 
maintenance of the condensed state (Hirano and Mitchison, 1993). The definitive role of 
topoisomerase II in chromosome assembly during mitosis remains to be determined but 
will likely be dependent on other factors such as development or genome organisation. 
However, it is obvious that topoisomerase II alone can not bring together chromosome 
organisation suggesting that other factors are also implicated in this process. 
1.3.2. The SMC family 
ScIl, the second abundant component of the chromosome scaffold to be 
identified is a member of the SMC family of proteins (Saitoh et al., 1994). Originally 
discovered in S. cerevisiae (Larionov et al., 1985; Strunnikov et al., 1993), the SMCs 
(stability of Mini chromosomes, later Structural Maintenance of chromosomes) are 
known to be present in species from mycoplasma to mammals, constituting a family of 
highly conserved and ubiquitous proteins, called the SMC family (Cobbe and Heck, 
2000; Cobbe and Heck, 2004; Hirano, 1999). All members are large polypeptides with a 
molecular mass of 110-170 kDa and they share a similar structural organisation (Cobbe 
and Heck, 2000; Strunnikov and Jessberger, 1999). Secondary structure analysis 
predicts the proteins to have two extended coiled-coil domains of 250-400 residues, 
which are separated by a central globular hinge region of about 150 amino acid residues 
(Figure 1.3.A). The N- and C- termini at the end of the coiled-coil domains are highly 
conserved among SMC proteins (Strunnikov and Jessberger, 1999). The N-terminal 
domain contains an ATP binding motif (a putative Walker A box) (Saitoh et al., 1994) 
and it has been shown to bind an ATP analogue (Akhmedov et al., 1998). The C-
terminal domain contains a "DA" box resembling a Walker B motif (ATP hydrolysis 
signal) (Saitoh et al., 1994; Walker et al., 1982) and it has been shown to bind DNA, 
with preference for AT-rich sequences such as SARs and MARs (Akhmedov et al., 
1998; Graumann et al., 1998). Originally Saitoh et at. (1994) suggested a model for the 
molecular architecture of SMC proteins, proposing the formation of a functional ATPase 
domain by uniting the "DA" box with the ATP-binding motif A. Indeed, 
crystallographic studies confirmed that a functional ATPase pocket is jointly formed by 
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the close contact of the N- and C- terminal regions (Lowe et al., 2001), while directed 
mutagenesis showed that both motifs contribute to ATP binding and hydrolysis (Hirano 
et al., 2001). Since SMC proteins generally form dimers (Hirano et al., 1997; Melby et 
al., 1998), initially it was thought, that dimer formation is mediated by antiparallel 
arrangement of the coiled-coil domains of two SMC proteins, producing a symmetrical 
molecule with both the N- and C- termini at each end (Melby et al., 1998). Furthermore, 
it was believed that the central hinge was flexible and allowed opening and closing of 
the two arms (Hirano et al., 2001). However, recent studies have indicated that the 
coiled-coil regions of an individual SMC fold back onto each other in an intra-molecular 
manner and that dimerisation is mediated by hinge-hinge interactions of the self-folded 
monomers (Figure 1.3.B) (Haering et al., 2002; Hirano and Hirano, 2002). Most of the 
molecular architecture studies of SMCs have been performed with bacterial SMCs, but 
the conserved structure between eukaryotic and prokaryotic SMC proteins strongly 
suggests that they all share similar structural organisation. 
Most bacteria and archaeal species contain a single smc gene, suggesting that 
bacteria and archaeal SMC proteins are likely to function as homodimers (Hirano, 1999; 
Hirano, 2002). The Gram-positive bacteria have an SMC protein with a domain 
structure similar to the eukaryotic SMCs (Melby et al., 1998). A subclass of Gram-
negative bacteria, including E. coil, lack SMC proteins but they contain a muKB gene 
that encodes for a protein with structural and functional similarities to SMCs (Hiraga, 
2000). The only difference is that the MuKB protein does not have the "DA" box at the 
C-terminus (Graumann etal., 1998). The MukB protein has features of a myosin-like 
motor protein and is involved in chromosome condensation and/or movement (Hiraga, 
1992; Hu etal., 1996; Niki et al., 1991; Wake and Errington, 1995). mukE and mukF 
which are in an operon with mukB, are also required for efficient chromosome 
partitioning and their products are thought to interact with MukB (Yamanaka et al., 
1996). 
Most of the functional studies on SMC genes focused on the corresponding gene 
from Bacillus subtiiis, bsSMC. Genetic studies of this protein suggested that BsSMC 
protein is essential for chromosome condensation and partitioning (Britton et al., 1998; 
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Moriya et al., 1998). Immunolocalisation studies revealed that the protein is associated 
with the chromosome but is also present in discrete foci near the poles of the cell 
(Graumanii et al., 1998; Volkov et al., 2003). The redistribution of BsSMC protein 
within the cell, depending on the growth phase and the stage of the cell cycle, suggests a 
dynamic movement of the protein and a functional contribution to chromosome 
condensation and segregation. Recently, it has been proposed that chromosome 
segregation in B. subtilis takes place in at least two steps an SMC-independent step in 
which origins of replication move apart and a subsequent SMC-dependent step in which 
newly duplicated chromosomes condense and segregate (Graumann, 2000). Therefore, 
it seems that BsSMC is not a required component of the mitotic motor that initially 
drives origins apart after their duplication but is needed to maintain the conserved 
arrangement of the daughter chromosomes and for their faithful segregation (Graurnann, 
2000; Weitao et al., 2000). Initially, biochemical studies using direct franctionation of 
B. subtilis protein extract indicated that no other proteins interact with the BsSMC 
protein or if a complex exists, the subunits bind to the BsSMC either transiently or with 
low affinity (Hirano and Hirano, 1998). However, recent studies have shown that the 
BsSMC protein interacts in vivo with two highly conserved prokaryotic proteins, ScpA 
and ScpB (Mascarenhas et al., 2002; Soppa et al., 2002), which bind to the SMC head 
domains (Volkov et al., 2003). SMC colocalises with its interacting partners, ScpA and 
ScpB, and the specific localisation of SMC depends on both Scp proteins suggesting that 
all three proteins may be complexed together (Volkov et al., 2003). Furthermore, in the 
same study, purified SMCs showed non-specific binding to double-stranded DNA 
(independent of Scp proteins or ATP), which were retained on DNA after binding to 
closed circular DNA but not to linear DNA. Hirano and Hirano (1998), showed that the 
BsSMC preferentially bound to single-stranded DNA (ssDNA) and that it has a DNA-
stimulated ATPase activity much greater with ssDNA than with double-stranded DNA 
(Hirano and Hirano, 1998). Moreover, BsSMC formed large nucleoprotein aggregates 
in an ATP-dependent and ssDNA-specific manner, possibly forming a primitive type of 
chromosome condensation that occurs during segregation of bacterial chromosomes. 
Interestingly, mutations in the hinge domain disturbed dimerisation of BsSMCs and 
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reduced the ability to interact with DNA (Hirano and Hirano, 2002), suggesting that the 
major DNA-binding activity does not reside in the ATPase catalytic domains at the ends 
of a dimmer, but instead at the hinge regions. In contrast, in another study the SMC 
head domains and hinge region did not show strong DNA binding activity, suggesting 
that the coiled-coil regions in SMC mediate an association with DNA in a ring-like 
structure (Volkov et al., 2003). A model emerging from this study proposes that an 
SMC complex forms condensation centres that actively affect global chromosome 
compaction from a defined position on the bacterial nucleoid. 
Eukaryotic SMCs comprise at least six distinct subfamilies (SMC I-SMC6), 
which are organised in three pairs of heterodimers. According to this pairing, eukaryotic 
SMCs are classified in the following subgroups: SMCJ and SMC3, SMC2 and SMC4, 
and SMC5 and SMC6. These heterodimers are further associated with other non-SMC 
subunits to form functional multiprotein complexes. SMCs have been shown to be 
implicated in different functions according to their associating subunits. The 
SMC1/SMC3 heterodimer is part of the cohesin complex, responsible for sister 
chromatid cohesion, (Guacci et al., 1997; Losada et al., 2002; Michaelis et al., 1997; 
Tóth et al., 1999) and is also involved in recombination as part of the RC-1 complex 
(Jessberger et al., 1996). The SMC2/SMC4 heterodimer is suggested to have a role in 
mediating mitotic chromosome condensation, as part of the condensin complex (Hirano 
and Mitchison, 1994; Sutani and Yanagida, 1997; Sutani et al., 1999). A form of this 
complex also participates in dosage compensation in Caenorhabditis elegans (Chuang et 
al., 1994; Lieb etal., 1998; Lieb et al., 1996). Finally, the SMC5 and SMC6 proteins are 
part of a complex which is involved in DNA repair (Fousteri and Lehmann, 2000; 
Fujioka et al., 2002; Harvey et al., 2004). 
The ability of particular eukaryotic SMC molecules to associate as heterodimers 
is suggested by their coimmunoprecipitation in roughly equimolar amounts (Darwiche et 
al., 1999; Hirano and Mitchison, 1994; Lieb et al., 1998; Losada et al., 1998; Schmiesing 
et al., 1998; Sutani et al., 1999). The potential for eukaryotic SMCs to form 
homodimers has been demonstrated only when individual proteins were highly 
overexpressed, possibly having titrated out the natural SMC partner (Strunnikov et al., 
1995). Moreover, it seems that homodimers are not functional as their in vitro activity 
depends on the combined presence of both subunits (Kimura and Hirano, 1997; Kimura 
et al., 1999; Schmiesing et al., 1998; Sutani and Yanagida, 1997). In addition, mutation 
of only one SMC partner produces defects in vivo (Chuang et al., 1994; Lieb et al., 1998; 
Michaelis et al., 1997; Saka et al., 1994; Steffensen et al., 2001; Strunnikov et al., 1995; 
Strunnikov et al., 1993). The hypothesis that more than two SMC proteins may 
participate in one complex is precluded, first by considering the overall mass of isolated 
SMC-containing complexes and the known mass of their other components (Hirano et 
al., 1997; Hirano and Mitchison, 1994; Losada et al., 1998; Sutani and Yanagida, 1997; 
Sutani et al., 1999) and secondly by unsuccessful attempts to detect complexes 
containing more than two SMC proteins (Haering et al., 2002). 
1.4. The condensin complex and mitotic chromosome condensation 
Mitotic chromosome condensation consists of a process in which interphase chromatin is 
1) compacted, and 2) resolved into two distinct rod-shaped sister chromatids. Recent 
studies have contributed to the unraveling of this process. Initially, mutations in two 
proteins, Cut3p and Cutl4p in S. pombe, were found to exhibit defects in chromosome 
condensation and to display a 'cut' phenotype in which septation occurs in the absence 
of normal nuclear division (Saka et al., 1994). Subsequently, a five subunit "condensin" 
complex was identified biochemically in Xenopus (Hirano et al., 1997; Hirano and 
Mitchison, 1994) and subsequently found in Schizosaccharomycespombe (Sutani et al., 
1999), Saccharomyces cerevisiae (Freeman et al., 2000), Homo sapiens (Kimura et al, 
2001; Schmiesing et al., 2000) Caenorhabditis elegans (Chuang et al., 1994; Hagstrom 
et al., 2002; Lieb et al., 1998; Lieb et al., 1996) and Drosophila melanogaster (Bhat et 
al., 1996; Savvidou et al., In Press; Steffensen et a!, 2001). This complex was termed 
"condensin" and consisted of two SMC proteins (CAP-E/SMC2/Cut14 and CAP-
C/SMC4/Cut3) and three non-SMC subunits (CAP-D2/Ycs4/Cndl, CAP-G/Ycs5/Cnd3, 
and CAP-H/Bml/Cnd2) (Figure 1.3.13). Most subunits have been identified in all 
eukaryotes examined to date (Cobbe and Heck, 2000). Genetic studies in yeast and 
Drosophila have shown that each of the condensin subunits is essential and is required 
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Figure 1.3. A. Secondary structure of SMC proteins. SMCs have two extended 
coiled-coil domains which are separated by a central hinge. The N- and C- termini 
at the end of the coiled-coil domains are highly conserved among SMC proteins. 
The N-terminal domain contains an ATP binding motif (a putative Walker A box), 
while the C-terminal domain contains a 'DA' box resembling a Walker B motif 
(ATP hydrolysis motif). 
B. Representation of the condensin complex, showing the SMC2/SMC4 
heterodimer and three regulatory non-SMC proteins, named after their Xenopus 
orthologues. The names of available Drosophila mutants for each of the proteins 
are shown in parentheses. The depicted position of the non-SMC subunits is 
random, since no specific data exist for the way that these proteins interact with 
each other and with the SMC subunits. 
for proper condensation and/or segregation of mitotic chromosomes (Losada and Hirano, 
2001). Where chromosomes are clearly visible, the main phenotype observed in the 
condensin mutants is a severe defect in chromosome segregation during anaphase. The 
failure to segregate leads to the formation of so-called anaphase bridges, a phenotype 
also observed in topoisomerase II mutants supporting the idea that topoisomerase II is 
important for mitotic chromosome assembly (Hirano, 2002). Recently, a second 
condensin complex, called condensin II, was identified in vertebrates (Ono et al., 2003). 
This complex shares the same two SMC subunits as the original complex, now named 
condensin I, but appears to contain different non-SMC subunits (named CAP-133, CAP-
G2, and CAP-1-12). 
CAP-D2/CAP-D3 and CAP-G/CAP-G2 non-SMC subunits, share a structural 
motif called the HEAT repeats (Neuwald and Hirano, 2000; Ono et al., 2003). The 
HEAT (Huntingtin, Elongation factor 3, A-subunit of protein phosphatase A, TOR) 
repeats are tandem repeats of an a-helical structural unit that create a protein-recognition 
interface with an extended solenoidal shape and on which other proteins can assemble 
(Andrade et al., 2001). It is possible that HEAT repeats could serve as a scaffold that 
would be involved in condensin complex assembly, condensin-condensin interactions or 
interactions between condensin and chromatin components such as histones, as well as 
other chromosomal proteins involved in chromosome assembly. In addition to CAP-
D2/CAP-D3 and CAP-G/CAP-G2, a number of other proteins have been found to 
contain HEAT repeats. These proteins have other functions such as nuclear transport 
(importin f3), transcriptional control (TAF-172/Motl) and chromatid cohesion 
(Scc2/Mis4 and Pds5/BimD/Spo76). Recently, BarrenlCAP-H has been classified into a 
new superfamily of eukaryotic and prokaryotic proteins, called kleisin (Schleiffer et al., 
2003). This family also includes ScpA, Sccl (mitotic cohesin complex) and Rec8 
(meiotic cohesin complex). The N- and C-terminal domains of the kleisin proteins are 
conserved and they define the members of this family. 
The subcellular localisation of the condensin subunits during the cell cycle seems 
to vary among different organisms, suggesting that condensin function may be regulated 
by multiple mechanisms. In X laevis, D. melanogaster, S. pombe and H. sapiens the 
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condensin subunits associate with chromatin at early stages of chromosome 
condensation and dissociate at the exit of mitosis, as chromosomes decondense (Bhat et 
A, 1996; Cabello et al., 2001; Cubizolles et al., 1998; Hirano and Mitchison, 1994; 
Schmiesing et al., 2000; Sutani et al., 1999). While several studies support the idea that 
the condensin complex is required from prophase onward (Cabello et al., 2001; Dej et 
al., 2004; Hagstrom et al., 2002; Hudson et al., 2003; Kaitna et al., 2002), recent 
localisation studies on human cells showed that condensin I associates with 
chromosomes in prometaphase and only low levels are present on chromosomes in 
prophase (Maeshima and Laemmli, 2003). This suggests that the formation of prophase 
chromatids may occur independently of condensin I or with interphase levels of 
chromatin-bound condensin. Alternatively, it could be possible that an early stage of 
condensation within the prophase nucleus is mediated by condensin [I, which is 
predominantly nuclear throughout interphase and is loaded onto chromosomes during 
prophase, while condensin I associates with chromosomes only after envelope break 
down (Ono et al., 2004; Hirano, 2005). However, during interphase the localisation of 
the condensin I complex tends to differ among different organisms. In chicken, the ScIl 
protein homologue of SMC2/XCAP-E, appears to be nuclear during interphase but leaks 
out of the nucleus during nuclear preparation (Saitoh et al., 1994). In human cells the 
majority of the condensin I complex localises in the cytoplasm during interphase while 
some remains as foci in the interphase nucleus (Ball et al., 2002; Cabello et al., 2001; 
Schmiesing et al., 1998; Schmiesing et al., 2000). The subcellular distribution of the 
entire complex in human cells may be regulated in a cell cycle-dependent manner. The 
major fraction of Drosophila SMC4 and Barren (CAP-H) is cytoplasmic, while a minor 
fraction is associated with chromatin in telophase and interphase (Steffensen et al., 
2001). In contrast Drosophila CAP-D2 appears to be nuclear throughout interphase 
(Savvidou et al., In Press). In Xenopus, all five members of the condensin appear to be 
nuclear during interphase (Hirano et al., 1997) and to associate with the granular 
compartment of the nucleolus (Uzbekov et al., 2003), suggesting sequestration to this 
structure or a role in the organisation of the nucleolus and/or ribosome biogenesis. In 
Xenopus, the phosphorylation of the non-SMC subunits may be required for the mitosis- 
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specific association of the condensin complex with chromatin (Hirano et al., 1997). 
However this phosphorylation does not seem to be sufficient for the association of 
condensin with chromatin, suggesting that other factors are involved in this process. In 
S. pombe, all five condensin subunits are cytoplasmic during interphase and accumulate 
in the nucleus during mitosis (fungal mitosis occurs within a nucleus) (Sutani et al., 
1999), suggesting that condensin activity is regulated by shuttling in and out of the 
nucleus. A possible explanation is that the condensin complex might be active 
throughout the cell cycle and that the nuclear localisation of the complex has to be 
regulated. Furthermore, it has been shown that the nuclear import of the complex 
depends on phosphorylation of the Cut3 (SMC4) subunit and this phosphorylation is 
likely to be performed by Cdc2 kinase. In S. cerevisiae, the condensin complex localises 
to the nucleus and associates with chromatin throughout the cell cycle (Bhalla et al., 
2002; Freeman et al., 2000; Ouspenski et al., 2000), but specifically concentrates at the 
rDNA region during G2/M phase (Freeman et al., 2000). It has been suggested that the 
complex may be implicated in suppressing inter-repeat rDNA recombination and 
believed to be required for silencing at the silent mating loci (Bhalla et al., 2002). 
Studies of condensin function have resulted in conflicting hypotheses as to the 
role of this complex. In Xenopus, when condensin was depleted from mitotic extracts 
before or after condensation, unreplicated chromatin failed to assemble into individual 
chromatids or became completely disorganised, suggesting that the complex was 
required for both assembly and maintenance of mitotic chromosomes (Hirano et al., 
1997; Hirano and Mitchison, 1994). In vivo analysis of the chromosome condensation 
process was initially performed on mutants in S. pombe (Saka et al., 1994; Sutani et al., 
1999) and later on in S. cerevisiae (Lavoie et al., 2000; Ouspenski et al., 2000; 
Strunnikov et al., 1995) and Drosophila (Bhat et al., 1996). Mutants in Cut3 and Cut 14 
genes (SMC4 and SMC2, respectively) of S. pombe exhibited chromosome condensation 
defects and displayed a 'cut' phenotype where septation (cell division) occurred with 
incompletely separated chromosomes (Saka et al., 1994). Fluorescence in situ 
hybridization in these mutants demonstrated that the length of mitotic chromosome arms 
increased while the centromeric DNA could separate and move to the opposite poles 
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normally. Similar segregation defects were observed in S. cerevisiae in SMC2/4 and 
Brnlp (CAP-H) mutants (Bhalla et al., 2002; Freeman et al., 2000; Lavoie et al., 2000; 
Ouspenski et al., 2000; Strunnikov et al., 1995). Fluorescent in situ hybridisation 
analysis showed that condensation was defective, suggesting that the segregation defect 
was a consequence of insufficient condensation. In S. pombe and S. cerevisiae, studies 
have shown that all members of the condensin complex are required for proper 
chromosome condensation and segregation (Lavoie et al., 2002; Ouspenski et al., 2000; 
Strunnikov et al., 1995; Sutani etal., 1999). 
In contrast, genetic studies in D. melanogaster (in SMC4, Barren and CAP-G 
mutants) and C. elegans showed that resolution between the sister chromatids rather than 
condensation of the chromosomes was compromised when the condensin complex was 
disrupted (Bhat et al., 1996; Dej et al., 2004; Hagstrom et al., 2002; Steffensen et al., 
2001). In both organisms, a high degree of compaction relative to interphase was 
accomplished and a bipolar metaphase plate formed. However, severe chromosome 
segregation defects and chromosome breakage were observed in anaphase and telophase. 
DmSMC4 and DmCAP-D2 RNAi in Drosophila cultured cells confirmed the 
requirement of these proteins for chromosome organisation and segregation (Coelho et 
al., 2003; Savvidou et al., In Press). A common phenotype of the absence of condensin 
subunits in most organisms is the formation of chromosome bridges due to incomplete 
resolution and ensuing failure of sister chromatids to separate completely during 
anaphase (Hagstrom and Meyer, 2003). Particular insight was gleaned when the 
robustness of chromosome architecture was assessed after SMC2 knock-out in DT40 
cells 	while chromosomes still reached normal levels of condensation, clear defects in 
association of other non-histone chromosomal proteins was observed (Hudson et al., 
2003), resulting in compromised structural integrity. 
Recently, depletion of human condensin I by RNAi produced swollen, unresolved 
chromosomes (Ono et al., 2003; Watrin and Legagneux, 2005), while depletion of condensin II 
resulted in curly, irregularly-shaped chromosomes (Ono et al., 2003; Ono et al., 2004). 
Furthermore, the centromere/kinetochore regions were structurally disorganised from the 
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depletion of either condensin I or II subunits suggesting a specific role for both complexes in 
centromere organisation (Ono et al., 2004). 
1.4.1. Biochemical and real-time activities of condensin complex 
Even though the way that the condensin complex accomplishes condensation (if it does) 
is far from understood, much of the current knowledge of condensin comes from the 
characterisation of the complex from Xenopus egg extract. Condensin was first 
identified using an in vitro chromosome assembly process in which demembranated 
sperm nuclei were added to a Xenopus egg extract (Hirano et al., 1997; Hirano and 
Mitchison, 1994). The complex was termed 13S according to its sucrose sedimentation 
coefficient. The 13S holocomplex is composed of two subcomplexes: an 8S core 
subcomplex consisting of the two SMCs (XCAP-C and XCAP-E) and an uS regulatory 
subcomplex consisting of the three non-SMC subunits (XCAP-D2, XCAP-G and 
XCAP-H) (Hirano et al., 1997; Kimura and Hirano, 2000). The 13S condensin complex, 
in contrast to topoisomerase II, has been shown to be required for both the establishment 
and maintenance of chromosome condensation (Hirano et al., 1997; Hirano and 
Mitchison, 1993; Hirano and Mitchison, 1994). Each of the condensin subunits is 
essential and required for proper organisation and segregation of mitotic chromosomes, 
but exactly how the complex contributes to these processes is still unclear. 
Purified 13S and 8S complexes have been shown to bind DNA in vitro but only 
the 13S complex can be recruited onto chromatin (Kimura and Hirano, 2000). The 13S 
condensin complex displays a DNA-stimulated ATPase activity and reconfigures DNA 
in an ATP-dependent manner (Hirano et al., 2001; Kimura and Hirano, 1997; Kimura 
and Hirano, 2000). It introduces positive supercoils into relaxed circular DNA in the 
presence of topoisomerase I and it converts nicked circular DNA into positively knotted 
forms in the presence of topoisomerase II in vitro (Kimura et al., 1999). The 
predominant products in this assay are positive 3-noded knots, suggesting that condensin 
has the ability not only to induce positive supercoiling of DNA but also to orient the 
introduced supercoils into a solenoidal form. 
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Recent observations of the condensin complex by electron spectroscopic 
imaging, suggest that a single condensin complex organises two oriented supercoils in 
its bound region by hydrolysing ATP (Bazett-Jones et al., 2002). In this way, it induces 
a superhelical tension that propagates into the protein-free region of DNA. The binding 
of condensin to DNA seems to be ATP-dependent and condensin-condensin interactions 
may not be essential for the supercoiling reaction. A model based on these observations 
proposes that a single condensin complex introduces two positive supercoils by a 
trapping mechanism (Haering et al., 2002) and forms a topological link between the 
condensin "clamp" and the trapped DNA strands. If a free translocation of the DNA 
strands is allowed without disrupting the topological link, a positive loop of DNA would 
be created that is constrained by the clamp. An array of positive loops directed by the 
concerted action of condensin might then contribute to mitotic chromosome organisation 
(Figure 1.4.A) (Swedlow and Hirano, 2003). Another model called, the superhelical 
tension model, predicts that local positive supercoiling driven by condensin introduces 
compensatory superhelical tension into the neighbouring region of DNA, which in turn 
acts as a driving force for the compaction of a chromatin fibre (Figure 1 .4.B) (Kimura 
and Hirano, 1997). Despite the fact that there is no evidence for the occurrence of such 
a superhelical tension in metaphase chromosomes, several other models of chromosome 
organisation predict successive coiling of chromatin fibres (Belmont and Bruce, 1994), 
which should also result in superhelical tension. 
Neither 8S nor the 11 S subcomplexes could bind to chromatin and induce 
supercoiling activity in the Xenopus in vitro chromosome assembly assay. However, 
even though both SMC subunits share ATP binding domains, SMC heterodimers 
showed a weak ATPase activity which was not stimulated by DNA (Kimura and Hirano, 
2000). The 8S subcomplex also failed to change DNA conformation in the 
topoisomerase-based supercoiling assays. In S. cerevisiae, the DNA-bound species 
became resistant to salt extraction at high SMC2/SMC4:DNA ratios (Stray and Lindsley, 
2003). However, the reaction remained reversible, as the subcomplex had the ability to 
bind competitor DNA. Furthermore, in the presence of ATP, high molar ratios of S. 
cerevisiae SMC2/SMC4 subcomplex promoted a geometric change in circular DNA that 
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could be trapped as knots by topoisomerase II but not as supercoils by topoisomerase I. 
Similarly, the SMC2/SMC4 subcomplex of S. pombe also formed large protein/DNA 
complexes, but failed to exhibit ATPase activity (Yoshimura et al., 2002). Taken 
together, these data suggest that the non-SMC subcomplex plays an important regulatory 
role in ATPase activity and chromatin binding of the 13S holocomplex. Indeed, the 
three non-SMC subunits, CAP-D2, CAP-G and CAP-H have been shown to bind to one 
(or both) of the catalytic ends of the SMC heterodimer (Anderson et al., 2002; 
Yoshimura et al., 2002). They have been proposed to have dual roles in the regulation 
of condensin function: one is to activate the SMC ATPases to perform ATP-dependent 
supercoiling activity, and the other is to allow the holocomplex to associate with 
chromatin in a mitosis-specific manner (Kimura and Hirano, 2000). 
Even though the above biochemical and spectroscopic data show that structural 
changes are induced by addition of condensin to naked DNA templates, many essential 
questions of how condensin actually mediates chromosome assembly still remain 
unanswered. Does condensin drive chromosome assembly directly or does it help to set 
up a structure that loads other critical assembly factors (Porter et al., 2004b)? Two 
groups using either magnetic field or optical trap methods, acting on beads attached to 
the end of DNA have tried to analyse condensin activity on single DNA molecules (Case 
et al., 2004; Strick et al., 2004). These studies showed that both vertebrate and bacterial 
condensins drive DNA compaction in a stepwise, ATP-dependent fashion with a 
surprising level of cooperativity. The measurement of individual compaction steps 
revealed approximately 60 nm step sizes and these values are in agreement with the 
results obtained by spectroscopic imaging (Bazett-Jones et al., 2002). MukBEF required 
nucleotide binding for activity and it could compact DNA in the presence of either ATP 
or a non-hydrolyzable form of ATP (Case et al., 2004). In contrast Xenopus condensin 
required ATP for stable DNA binding but required nucleotide hydrolysis for DNA 
compaction. ATP binding by the Bacillus subtilis condensin complex was necessary for 
the closure of the two arms of the condensin complex (Hirano and Hirano, 2004). Taken 
together, these results suggest that condensin binds DNA in an open form, but it can 
compact DNA only in its closed state which is induced, at least partly, by ATP binding. 
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Figure 1.4. Hypothetical models for the mechanical contribution of 
condensin to chromosome organization. 
In this model condensin traps two positive supercoils, thereby forming a 
topological link between the protein "clamp" and the trapped DNA strands. If a 
free translocation of the DNA strands is allowed without disrupting the topological 
link, a positive loop of DNA would be created. An array of positive loops directed 
by the conserted action of condensin might contribute to chromatin compaction. 
Superhelical helical tension model. In this model, local positive supercoiling 
activity driven by condensin introduces a compensatory, negative superhelical 
tension into the neighbouring region of DNA. This tension may in turn act as a 
driving force for the compaction of a chromatin fiber. 
A speculative model for condensin assembly that incorporates the highly 
ordered and cooperative condensin-condensin and condensin-DNA interactions. 
Adapted from Swedlow and Hirano (2003). 
From both studies (Case et al., 2004; Strick et al., 2004), it seems that a high degree of 
cooperativity of binding between individual condensin molecules is important for 
condensin activity. In conclusion, it can be suggested that condensin complexes can 
organise themselves onto a DNA template in a highly ordered fashion, probably 
involving intramolecular interactions between condensin components (Figure 1.4.Q. 
These condensin-condensin interactions could form a contiguous structural island and 
other proteins such as DNA topoisomerase II, chromatin remodelling factors or 
chromokinesin could collaborate with condensin in these specific sites in order to 
organise higher order chromosome structure (Porter et al., 2004b). 
But how does condensin bind DNA? Interestingly, a recent biochemical study 
showed that that the SMC head domains and hinge region do not have strong DNA 
binding activity, suggesting that the coiled-coil regions in SMCs mediate an association 
with DNA and they may bind to DNA as a ring-like structure (Volkov et al., 2003). 
Similarly, cohesin, a related SMC-containing complex, has been proposed to trap 
double-stranded DNA between the two arms of the SMC1-SMC3 heterodimer (Gruber 
et al., 2003; Haering et al., 2002; Haering and Nasmyth, 2003). In this model the non-
SMC subcomplex acts as a clamp, which controls the capture and release of the substrate 
DNA by the SMC dimer. Another study, using atomic force microscopy suggests that 
condensin could form a DNA loop by folding two distantly located DNA segments 
(Yoshimura et al., 2002). Thus, dynamic trapping of two DNA segments within the 
two-armed structure may be the fundamental mechanism of action that is shared by all 
SMC proteins, including condensin and cohesin (Haering et al., 2002). The catalytic 
domain of SMC proteins is similar to that of ABC (ATP  binding cassette) transporters 
(Lowe et al., 2001; Saitoh et al., 1994). These transporters comprise a large family of 
membrane-bound ATPases actively transporting small molecules across a cellular 
membrane. Furthermore, the geometry of protein structure between the ATPase domain 
of SMCs and ABC proteins is very similar (Locher et al., 2002). Therefore, it has been 
proposed that ATP binding and hydrolysis allows the closing/opening of the two coiled-
coil arms, similar to the association/dissociation of the two catalytic domains of the 
ABC transporters (Hirano et al., 2001). 
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1.4.2. Regulation of condensin through phosphorylation 
In Xenopus the supercoiling activity of 13 S condensin has been shown to require mitosis 
specific phosphorylation of the three non-SMC subunits by Cdc2 (Cdkl-Cyclin B), the 
major mitotic kinase (Hirano et al., 1997; Kimura et al., 1998). XCAP-132 is 
phosphorylated at its C-terminus probably directly by Cdc2, while XCAP-H is 
phosphoiylated most likely by Cdc2 but also by other kinases (Kimura et al., 1998). 
This hyperphosphorylation of the itS subcomplex has been proposed to activate the 
ATPase activity of the SMC heterodimer and to allow the 13S holocomplex to associate 
with chromatin in a mitosis specific manner (Kimura and Hirano, 2000). In human cells, 
condensin is phosphoiylated throughout the cell cycle but mitosis-specific 
phosphorylation of the three non-SMC subunits at specific sites by the Cdc2 kinase, has 
been shown to be responsible for chromosomal targeting of condensin (Kimura et al., 
2001; Takemoto et al., 2003). Furthermore, the supercoiling activity of human 
condensin increased dramatically after phosphorylation. In S. pombe, phosphorylation 
of Cut3/SMC4 at threonine-19 by Cdc2 is necessary for the translocation of the 
condensin complex from the cytoplasm into the nucleus (Sutani et al., 1999) but not for 
its supercoiling activity. This phosphorylation site is not conserved in human condensin, 
suggesting that the regulation of chromatin targeting may be species-specific. 
1.4.3. Targeting of the condensin complex to chromosomes 
Even though mitosis-specific phosphorylation of condensin subunits has been shown in 
Xenopus and human cells to be required for the association of condensin complex with 
chromosomes, it seems that this phosphorylation is not sufficient for this loading and 
that other mitotically activated factors are involved (Kimura and Hirano, 2000). 
A non-histone candidate for such a receptor is AKAP95, an A-kinase (cAMP-
dependent protein kinase) anchoring protein of 95 kDa, which in human cells it has been 
shown to function as a targeting protein for the condensin complex (Collas et al., 1999; 
Steen et al., 2000). AKAP95 is localised in the nuclear matrix during interphase, 
relocalises to chromatin upon mitosis and targets condensin after nuclear envelope break 
down in mitotic HeLa cells. Immunodepletion experiments in human cell mitotic 
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extracts showed that AKAP95 is required for the recruitment of condensin 
independently of the anchoring and activity of the PKA (Collas et al., 1999). In 
AKAP95 depleted extracts, the amount of recruited condensin complex and the extent of 
chromosome condensation was proportional to the concentration of recombinant 
AKAP95 that was added back to the rescue experiments (Steen et al., 2000). A model 
emerging from these observations, proposes that the AKAP95 would act as a structural 
platform for the loading of condensin. Furthermore two-hyprid and GST-pull down 
experiments showed that AKAP95 and CAP-H ineract directly (Eide et al., 2002). 
However, this does not preclude the existence of additional factors that contribute to the 
loading of condensin onto chromatin. Interestingly, during the first mitosis in mouse 
embryos only maternal chromosomes require AKAP95 for condensin recruitment while 
parental chromosomes recruit condensin in an AKAP95-independent manner (Bomar et 
al., 2002), suggesting that different mechanisms exist depending on the structure and/or 
biochemical composition of chromatin. 
Recently, it has been shown that the C-terminus of the human condensin subunit 
CNAPI/CAP-D2 possesses a mitotic chromosome-targeting domain that does not 
require the other condensin components (Ball et al., 2002). The same region also 
contains a functional bipartite nuclear localisation signal. A mutated CNAP1/CAP-D2 
missing the C-terminal chromosome-targeting domain was able to form a complete 
condensin complex but failed to associate with mitotic chromosomes, suggesting that 
CNAP1/CAPD2 is responsible for the recruitment of the human condensin complex onto 
chromosomes. This targeting is thought to be mediated by direct interactions with 
histories Hi and H3 in vitro. The H3 interaction appears to be mediated through the 
historic tail, and a subfragment containing the targeting domain ofCNAP1/CAP-D2 was 
found to interact with histone H3 in vivo. However, these results are contradictory to the 
observation that in Xenopus the uS non-SMC subcomplex was unable to bind 
chromatin by itself (Kimura and Hirano, 2000). Several explanations have emerged to 
reconcile these observations such as that the other two non-SMC subunits repress the 
targeting function ofCNAP1/CAPD2 and this repression is finally released with the 
formation of the condensin holocomplex. Alternatively, stable association of 
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CNAP l/CAPD2 with chromatin may require additional factors which may be missing in 
the Xenopus in vitro system, or that there may be species-specific differences between 
human and Xenopus systems (Ball et al., 2002). 
1.4.4. Other factors involved in condensin loading and chromosome condensation: 
role for histone H3 phosphorylation. 
The phosphorylation of histone H3 at the onset of mitosis has been proposed to play a 
role in condensin recruitment and chromosome condensation. Historic H3 is 
phosphorylated on serine 10 in the N-terminal tail during late G2/early prophase 
(Hendzel et al., 1997), an event that coincides with the initiation of chromosome 
condensation. Aurora B has been proposed to be the physiological kinase that 
phosphorylates histone H3 during mitosis (Giet and Glover, 2001; Hsu et al., 2000; 
Speliotes et al., 2000) and this kinase is a member of the chromosomal passenger 
complex along with INCENP, Survivin, Borealin, and TD-60 (Adams et al., 2001 a; 
Gassmann et al., 2004; Sampath et al., 2004). Chromosome passengers localise to 
centromeres at prometaphase and metaphase, associate with the central spindle at the 
onset of anaphase and finally localise to the midbody in cytokinesis. Both INCENP and 
Survivin are required for the correct targeting of Aurora B in mitosis. 
A model that connects the phosphorylation of histone H3 and chromosome 
condensation proposes that the modification of the histone may send a signal to initiate 
chromosome condensation and this phosphorylation could function as a receptor for the 
recruitment of proteins such as the condensin complex (Hirano, 2002). Histone H3 
mutations in Tetrahymena therm ophila have shown abnormal chromosome condensation 
and extensive chromosome loss (Lanlal et al., 1999), while phosphorylation of H3 has 
been shown to be required for proper chromosome condensation and segregation (Wei et 
al., 1999). In mammalian cells, analysis of histone H3 phosphorylation during mitosis 
revealed that phosphorylation is necessary for the initiation, but not maintenance, of 
chromosome condensation in these cells (Van Hooser et al., 1998). When Aurora B was 
depleted by RNAi in Drosophila, Barren/CAP-H was not properly targeted to 
chromosomes (Giet and Glover, 2001). Similarly in C. elegans, depletion of Aurora B 
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prevented the association of SMC4 with mitotic chromosomes (Hagstrom et al., 2002). 
However, CNAP1/CAPD2 was shown to bind histone H3 in vitro, regardless of the H3 
phosphorylation state (Ball et al., 2002). Moreover, other studies suggest that neither the 
recruiting of the condensin complex, nor chromosome condensation are affected when 
phosphorylation of histone H3 is reduced by depletion of Aurora B in Xenopus egg 
extracts (MacCallum et al., 2002). In the same organism, the condensin complex can 
interact with "tail-less" nucleosomes (de La Barre et al., 2000), while artificial induction 
of H3 phosphorylation is not sufficient to recruit condensin to chromosomes (Murnion et 
al., 2001). Nevertheless, studies with intact or tail-less histories in Xenopus showed that 
the flexible tails of histories are important for chromosome assembly, each one with 
differing efficiency, while nucleosomes are necessary for recruiting chromosome 
assembly factors different from topoisomerase 11 and condensin (de La Bane et al., 
2000). Furthermore, the N-terminus of H2B was shown to be essential for chromosome 
condensation in Xenopus but not that of histone H3 or its phosphorylation (de la Bane, 
2001). In S. cerevisiae phosphorylation of histone H3 on serine 10 is dispensable for 
cell cycle progression (Hsu et al., 2000). In plants, H3 phosphorylation occurs in late 
prophase on already quite compact chromosomes and is restricted to the pericentromeric 
heterochromatin (Kaszas and Cande,, 2000). 
Whether phosphorylation of H3 on serine 10 is essential for chromosome 
dynamics remains controversial. However, speculative models tried to explain the 
relationship between histone H3 phosphorylation and chromosome dynamics. One of 
these models implicates Aurora B in regulating the cohesin complex (holds sister 
chromatids together). Polo-like kinase regulates the dissociation of cohesin from 
chromatin that occurs at the onset of mitosis in vertebrate cells (Sumara et al., 2002). 
Another study showed that Aurora B kinase cooperates with polo-like kinase to facilitate 
the dissociation of cohesin in Xenopus egg extract (Losada et al., 2002). Depletion of 
the two kinases blocked cohesin release and compromised the resolution of sister 
chromatids, while rod-shaped chromosomes with a normal level of compaction were still 
assembled. Aurora B, unlike polo-like kinase, can not phosphorylate cohesin subunits in 
vitro. One possible scenario is that phosphorylation of histone H3 by Aurora B directly 
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contributes to the resolution of sister chromatids, possibly by enchancing the structural 
flexibility of the chromatin fibres or by increasing the electrostatic repulsion between the 
two chromatids (Swedlow and Hirano, 2003). This model could explain several 
previous observations. First, the resolution of chromatids occurs along with 
phosphorylation of histone H3 and chromosome compaction during prophase. Second, 
in S cerevisiae whereas H3 phosphorylation is dispensable, neither prophase release of 
cohesin nor sister chromatid resolution is prominent in this organism (Hsu et al., 2000). 
Third, Aurora B is required for the release of arm cohesion during meiosis I in C. 
elegans (Kaitna et al., 2002; Rogers et al., 2002) implicating that this function of Aurora 
B may be utilised in both mitosis and meiosis. 
Nevertheless, a completely different model, called 'the ready production label', 
proposes that cells use the phosphorylation of histone H3 to mark the chromosomes 
when they are ready to progress through anaphase and telophase (de la Barre et al., 
2001). This model was based on the observation that in all experimental systems 
described, including plants, chromosomes were heavily phosphorylated at metaphase 
and dephosphorylated upon exit of mitosis. Thus H3 phosphorylation could be viewed 
as a type of 'ready production label', and this label would have to be attached to histone 
H3 once the chromosomes had passed through the various checkpoints and have reached 
metaphase. Consistent with this model, is the observation that the main defects 
associated with deficiencies of H3 phosphorylation occurred after metaphase (Hans and 
Dimitrov, 2001). However, future work is necessary to clarify the exact role of H3 
phosphorylation in mitotic chromosome dynamics. 
Finally in addition to the phosphorylation on Serl 0, it has been shown that 
histone H3 is also phosphorylated on serine 28 probably by Aurora B (Goto et al., 1999; 
Goto et al., 2002) and on threonine 11 (Preuss, 2003) in a mitosis-specific manner. 
However, it is unclear whether these modifications are causally linked. While the role 
of these phosphorylations in chromosome dynamics remains to be determined, it seems 
that in Xenopus the phosphorylation at serine 28 is not essential for chromosome 
condensation (de la Barre et al., 2001). 
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1.4.5. Condensin complex and interphase 
Beside their essential contribution to mitotic chromosome dynamics the condensin 
subunits appear to play important roles at non-mitotic stages of the cell cycle as well. In 
C. elegans, transcription from each of the X chromosomes is reduced two-fold in 
hermaphrodites (XX) of this organism, to match the level of X-linked gene expression in 
males (XO), a process that is known as dosage compensation. Among the proteins that 
are implicated in this pathway are MIX-1, DPY-27, DPY-26 and DPY-28 (Meyer, 
2000). The discovery that DPY-27 is an SMC4 variant provided the first hint that SMC 
proteins may be involved in this process (Chuang et al., 1994; Chuang et al., 1996). 
Subsequently, MIX-i was identified as an SMC2 homologue required for both mitotic 
chromosome behaviour and dosage compensation (Lieb et al., 1998). The restricted 
localisation of MIX-i on the X chromosome was dependent on DPY-27. Like 
condensin, the dosage compensation complex consists of a MIX-I/DPY-27 (SMC2/4) 
heterodimer and at least two non-SMC subunits, DPY-26 and DPY-28 (Hagstrom and 
Meyer, 2003; Lieb et al., 1996). In contrast, the conventional condensin complex in C. 
elegans consists of MIX-1, SMC4 (Hagstrom et al., 2002) and a non-SMC subunit, 
HCP-6 (Stear and Roth, 2002), that belongs to the condensin 11-specific subunits (Ono et 
al., 2003). It has been suggested that the two complexes are functioning in a similar way 
by altering the higher-order structure of chromosomes, one to regulate gene expression 
and the other to act on chromosome condensation. 
Another example of a role for the condensin complex in transcriptional control 
comes from the study of the Bithorax (BX-C) complex in Drosophila. Genes of this 
genomic region are maintained epigenetically active or repressed throughout 
development by a balance of Trithorax-group and Polycomb-group proteins. These 
proteins bind to cis-acting sequences named polycomb-responsive elements (PRE). It 
has been shown that Barren/CAP-H and topoisomerase II cooperate with the Polycomb-
group proteins to maintain the silent state of gene expression (Lupo et al., 2001). 
Furthermore, in a Barren mutant, PRE-induced gene silencing was shown to be 
impaired. Whether the conventional condensin complex or a variant thereof is involved 
in this process is not known. 
45 
Ycs4/CAP-D2 and SMC4 but not SMC2 appear to be required for transcriptional 
silencing at the mating-type loci in S. cerevisiae (Bhalla et al., 2002). This suggests that, 
as in the case of dosage compensation in C. elegans, a specialised variant of the 
canonical condensin complex may be involved in this process. Similarly, Cnd2/CAP-H 
was recently shown to be required for the activity ofCdsl/Chk2 (a G2 checkpoint 
kinase) in S. pombe (Aono et al., 2002). Although all the other condensin components in 
S. pombe were also required for full Cdsl activity, the SMC2/Cutl4 and SMC4/Cut3 
proteins did not seem to be necessary for viability in the presence of hydroxyurea during 
S phase, suggesting that this non-mitotic function may be supported by unique subsets of 
condensin components. 
1.4.6. Interphase chromosome functions and mitotic chromosome condensation 
Several perturbations of interphase chromatin function seem to affect the formation of 
chromosomes in the subsequent mitosis. In Drosophila, mutants affecting ORC2, a 
component of the Origin Recognition Complex, disrupted the normal pattern of 
chromosomal replication in S phase and produced irregularly-condensed mitotic 
chromosomes (Loupart et al., 2000). The abnormally-late replicating regions of 
euchromatin exhibited the greatest problems in mitotic condensation. Interestingly, 
another study of ORC2, ORC3, and ORC5 showed that the mitotic chromosomes were 
shorter and thicker than wild type (Pflumm and Botchan, 2001). Also, it was observed 
that mutations in other replication factors such as MCM1O, MCM4 and PCNA displayed 
a similar phenotype as the ORC mutants, suggesting that this phenotype is not a specific 
consequence of ORC disruption, but rather that it correlates with abnormal replication 
(Christensen et al., 2003; Pflumm and Botchan, 2001). These observations led to a 
model that links DNA replication and mitotic chromosome condensation, where the 
density of functional replication origins determines the size of DNA loops and thereby 
modulates the shape of mitotic chromosomes. However, mutations in RFC4, a subunit 
of the replication factor C complex, caused aberrant checkpoint control in response to 
inhibition of DNA replication or damage to chromosomes (Krause et al., 2001). This 
mutant also displayed striking defects in mitotic chromosome cohesion and 
me 
condensation which are believe to be due to inhibition of multiple RFC complexes 
important for replication, DNA structure checkpoint and cohesin. It could however be 
possible, that the mitotic phenotypes observed in the mutants described above, are a 
result of indirect effects of the perturbation of cell cycle progression (though phenotypes 
not seen with chemical inhibitors). 
1.5. Respective roles for the condensin complex and topoisomerase If in 
chromosome dynamics 
Condensin mutants in several organisms (Bhalla et al., 2002; Hagstrom et al., 2002; 
Saka et al., 1994; Steffensen et al., 2001; Strunnikov et al., 1995; Sutani et al., 1999) 
display very similar phenotypes to those of topoisomerase II (DiNardo et al., 1984,-
Holm 
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et al., 1985; Uemura et al., 1987) with obvious effects on chromosome 
condensation (compaction and resolution) and segregation. As previously mentioned, 
localisation studies revealed that topoisomerase II is axially distributed in the 
chromosome arms with some concentration at the centromeres, a distribution that is also 
observed for condensin subunits (Maeshima and Laemmli, 2003; Steffensen et al., 
2001). The localisation pattern and the phenotype after the depletion of either the 
condensin complex or Topo II suggest that these two components of the chromosome 
scaffold may collaborate to bring about chromosome compaction and organisation. 
However, the two components are sequentially loaded onto chromosomes, suggesting 
that chromosome assembly is taking place in two steps (Maeshima and Laemmli, 2003). 
Topoisomerase II is loaded onto chromatid axis during prophase whereas condensin is 
loaded only during prometaphase. Double staining for topoisomerase II and condensin 
generated a "barber pole" appearance and the two components alternate along the 
solenoidal axis. Nevertheless, topoisomerase II was mislocalised on SMC2-depleted 
chromosomes in chicken DT40 cells and CAP-D2-depleted cells in Drosophila, 
suggesting that condensin is required for the recruitment of topoisomerase II along 
chromatid axes and at centromeres (Hudson et al., 2003; Savvidou et al, In Press). 
Furthermore, immunodepletion and immunoblocking experiments in Xenopus indicate 
that both topoisomerase II and the condensin complex are required for chromosome 
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condensation. However, whereas topoisomerase II is only required for the establishment 
of chromosome condensation in this organism (Hirano and Mitchison, 1993), the 
condensin complex is required for both establishment and maintenance of chromosome 
structure (Hirano and Mitchison, 1994). Biochemical and localisation studies in 
Drosophila showed that CAP-HlBarren associated with topoisomerase II throughout 
mitosis, while SMC4 appeared to be responsible for the axial localisation of 
topoisomerase II on the chromosomes and for its decatenation activity (Bhat et al., 1996; 
Coelho et al., 2003). However, in S. pombe, the localisation but not the activity of Topo 
II was affected in condensin mutants (Bhalla et al., 2002), while Topo IT localization to 
well-defined axial structures in Xenopus was independent of condensin (Cuvier and 
Hirano, 2003). Given that chromosomes experience different constraints depending on 
the cell, organism, or time in development, it is perhaps not surprising that a 'unified' 
hypothesis regarding these two components has not emerged. 
1.6. Condensin complex II 
Recently, a second condensin complex, called condensin 11, was identified in vertebrates 
(Ono et al., 2003; Yeong et al., 2003). This complex shares the same two SMC subunits 
as the original condensin complex, now named condensin I, but appears to contain 
different non-SMC subunits (named CAP-D3, CAP-G2, and CAP412). The condensin 
complex II was originally identified in human cells and Xenopus but all of the three non-
SMC subunits were found in Arabidopsis thaliana, suggesting that condensin II is 
widespread among the eukaryotic kingdoms. The D. melanogaster genome lacks a 
sequence encoding CAP-G2 whereas none of the condensin 11-specific non-SMC genes 
are present in S. pombe or S. cerevisiae. Intriquingly, the genome of C. elegans encodes 
for the three condensin 11-specific subunits but none of the condensin I specific subunits. 
The CAP-D3 and CAP-G2 proteins contain HEAT repeats (Ono et al., 2003), while 
CAP-H2 corresponds to kleisin-13 (Schleiffer et al., 2003). 
The two complexes appear to alternate along the axis of metaphase chromatids 
but show a unique distribution at the centromere/kinetochore region (Ono et al., 2004). 
Depletion of these complexes in Xenopus and HeLa cells produced distinct defects in 
chromosome morphology, suggesting that the complexes may contribute differently to 
mitotic chromosome architecture (Ono et al., 2003). Depletion of either of the SMC 
subunits resulted in fuzzy, cloud-like chromosomes in which no sister chromatids could 
be distinguished. Depletion of condensin I produced swollen chromosomes, while 
depletion of condensin II resulted in curly, irregularly-shaped chromosomes. 
Furthermore, the centromere/kinetochore regions were structurally disorganised from the 
depletion of either condensin I or II subunits suggesting a specific role for both 
complexes in centromere organisation (Ono et al., 2004). Similarly, another study in 
mammalian cells showed that the two complexes associate sequentially with 
chromosomes: condensin II is predominantly nuclear during interphase and associates 
with chromatin in prophase, in contrast to condensin I which is cytoplasmic and thus can 
interact with chromosomes only after envelope breakdown (Hirota et al., 2004). In this 
study, RNAi analysis revealed distinct functions for the two complexes in mitotic 
chromosome assembly. Condensin II is required for chromosome condensation in early 
prophase, whereas condensin I is required for the complete dissociation of cohesin from 
chromosome arms, for chromosome shortening and for normal timing of progression 
through prometaphase and metaphase. Further analysis of these two complexes in 
mammalian cells and in other organisms will hopefully elucidate their distinct 
contributions to mitotic chromosome architecture. 
1.7. 	Conclusions 
How do chromatin fibres fold and organise into mitotic chromosomes? The precise 
mechanism of chromosome organisation remains a mystery, despite progress over the 
last 25 years aimed at identifying components essential to the compaction of the genome 
during mitosis. Modem experimental approaches are now providing novel insights into 
the old questions and raise exciting sets of new questions. Indeed, recent studies of 
condensin have resolved the old controversy by showing that non-histone proteins in 
addition to histories play an essential role in mitotic chromosome structure. However, it 
seems that condensin is only one piece of a complicated puzzle and the interplay of 
condensin with other factors is far from completely understood. Depending on the exact 
interacting partners, several condensin variants exist with roles in both mitotic and non-
mitotic functions. It could be suggested that these diverse functions are fulfilled by 
similar mechanisms involving chromatin remodelling and local distortions of DNA. 
Nevertheless, contributing data suggest that the proposed actions of condensins and 
topoisomerase II alone are not sufficient for mitotic chromosome assembly, paving the 
way for the identification of further components or activities required for this essential 
process. These may include proteins involved in DNA replication (Christensen et al., 
2003; Dej et al., 2004; Loupart et al., 2000; Pflumm and Botchan, 2001) or diverse 
factors such as kinases (Yu et al., 2004) and proteases (McHugh et al., 2004), 
demonstrating that much remains to be learnt about the full requirements for 
chromosome condensation. 
1.8. 	The cohesin complex and sister chromatid cohesion 
Sister chromatid cohesion is established between the two replicated sister chromatids 
during S phase by an evolutionarily conserved protein complex called cohesin. The 
cohesin complex consists of a heterodimer of SMC 1 and SMC3 and two additional non-
SMC subunits called Sccl/Mcdl/Rad2l and Scc3/SA (Losada and Hirano, 2001). 
Vertebrate cells have two isoforms of SA: SAT and SA2. In meiosis, there is a meiosis-
specific cohesin subunit homologous to 5cc 1, known as Rec8 (Buonomo et al., 2000). 
The cohesin complex was first identified in Xenopus and then in S. cerevisiae, S. pombe, 
Drosophila and humans (Losada et al., 2000; Sumara et al., 2000; Tomonaga et al., 
2000; Tóth et al., 1999; Vass et al., 2003; Warren et al., 2000a). Mutations in cohesin 
subunits cause precocious sister chromatid separation (Guacci et al., 1994; Michaelis et 
al., 1997; TOth et al., 1999), while mutations that prevent cohesin from being removed 
inhibit chromosome separation (Haufet al., 2001; Rogers et al., 2002; Uhlmann et al., 
1999). 
In most organisms, cohesin associates with chromosomes during G  but it is only 
during S phase that it gets tightly associated and generates cohesion between sister 
DNAs as they emerge from replication forks (Riedel et al., 2004). The role of cohesin 
during Gi, is, however, not understood. Sister chromatid cohesion is maintained until 
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the metaphase to anaphase transition when chromatids separate to opposite poles. While 
in yeast cohesin dissociates from chromosomes at the beginning of anaphase (Guacci et 
al., 1997; Michaelis et al., 1997), in vertebrates and flies most of the cohesin complex 
(95%) dissociates from chromosomes in prophase and only a small amount of cohesin 
can be detected at centromeric regions (Losada and Hirano, 2001). Cohesin is also 
essential for meiosis and its chromosomal location clearly parallels the differential 
cohesion events of meiosis I and II. During meiosis I, in which homologues pair, 
cohesin localises all along the arms. It is released along the arms when homologues 
segregate at the end of meiosis I, but remains at the centromeres until the end of meiosis 
II to keep the sister chromatids paired until their segregation (Hagstrom and Meyer, 
2003). 
The dissolution of cohesion is triggered by the Anaphase Promoting Complex 
(APC/C). In S. cerevisiae the APC/C is activated and targets a protein called securin 
(Pdsl) for degradation by uhiquitin-dependent proteolysis. The result of this 
degradation is the activation of securin's binding partner, a conserved enzyme referred 
to as separase (EspI). Its cysteine protease activity specifically cleaves Sccl/Mcdl at 
two sites and sister chromatids are separated (Ciosk et al., 1998; Uhlmann et al., 1999; 
Uhlmann et al., 2000). In addition, phosphorylation of Sec  by the Polo/cdc5 kinase 
enhances the cleavage reaction (Hirano, 2002). A similar mechanism occurs in S. 
pombe (Tomonaga et al., 2000). In contrast, dissolution of cohesion in higher 
eukaryotes occurs in two steps: a separase independent (or APC independent) step in 
prophase for dissolution of arm cohesion and a separase dependent step in anaphase for 
dissolution of centromeric cohesion (cleavage of the Scc I /Rad2 1 subunits). Recent 
studies in Xenopus propose that Polo-like kinase regulates the dissociation of cohesin 
from chromosome arms in prophase (Sumara et al., 2002). The nature of the molecular 
difference between arm and centromeric cohesion was not known until recently. MEl-
S332 in Drosophila (Kerrebrock et al., 1995; LeBlanc et al., 1999; Moore et al., 1998) 
and Sgol (Shugoshin) in yeast (Katis et al., 2004; Kitajima et al., 2004; Marston and 
Amon., 2004; Rabitsch et al., 2004) have been shown to protect centromeric cohesion 
during meiosis I. Similarly, it has been shown recently that Sgol is essential to prevent 
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premature sister centromere separation in mitosis (Salic et al., 2004), suggesting that this 
protein protects centromeric cohesin from cleavage during prophase. The difference in 
cohesin dissociation between lower and higher eukaryotes may have to do with the 
higher degree of condensation in higher eukaryotic chromosomes that takes place during 
prophase. 
Chromatin immunoprecipitation assays in S. cerevisiae have shown that cohesin 
has a preference for AT-rich sequences and is associated with specific regions near 
centromeres and along chromosome arms (Hirano, 2002). The association of cohesin 
with centromeres seems to require functional kinetochore proteins, suggesting that 
cohesin binding may be regulated in a different way to centromeres and chromosome 
arms. It has been shown in S. pombe that Swi6, a counterpart of heterochromatin protein 
HPI, enhances recruitment of cohesin to centromeres (Bernard et al., 2001). InS. 
cerevisiae, the HEAT protein Scc2 forms a complex with Scc4 and this complex is 
necessary for the stable association of cohesin with chromosomes during S phase but is 
not necessary for maintaining cohesion during G2 and M phases (Ciosk et al., 2000; 
Tóth et al., 1999). The homolog of Scc2 in S.poinbe, Mis4, appears to play a similar role 
(Tomonaga et al., 2000). The Ecolp/Ctf7p protein in S. cerevisiae is necessary for the 
establishment of cohesion during S phase but not for its maintenance (TOth et al., 1999). 
Eco 1 p  has also been shown to interact genetically with PCNA (Po130p), a known 
replication protein, and with Ctfl8, subunit of cohesin-loading replication factor C 
(Skibbens et al., 1999) confirming the link between DNA replication and sister 
chromatid cohesion. Additional evidence for this is provided from studies in budding 
yeast, where DNA polymerase Poky interacts with Trf4, a protein involved in cohesion 
(Hirano, 2002). Pds5, a HEAT-repeat containing protein which associates weakly with 
cohesin, has been shown to be required for the protection of cohesin during G2 phase 
(Hartman et al., 2000; Panizza et al., 2000; Tanaka et al., 2001). Finally recent studies 
suggest that chromatin-remodelling complexes might also have a role in sister chromatid 
cohesion, either in the recruitment of cohesin to particular sequences along the arms or 
in the establishment of cohesion during DNA replication (Riedel et al, 2004). 
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An important clue to how cohesin associates with replicated and unreplicated 
chromatin and holds DNAs together, is the recent discovery that cohesin forms a large 
tripartite ring structure within which DNA strands might be entrapped (Gruber et al., 
2003; Haering et al., 2002). The SMC1 and SMC3 subunits dimerise by interacting at 
the hinge domain, forming a V-shaped heterodimer, as previously described for SMC 
subunits. It has been shown that the N-terminal end of Sccl binds to SMC3, while its C-
terminus binds to SMC1 (Haering et al., 2002). Thus, the Sccl subunit of cohesin has 
been proposed to close a ring by connecting the two heads at the ends of the 
SMC1/SMC3 heterodirner, the arms of which comprise 50 nm-long coiled-coils. The 
diameter of the ring of close to 50 nm would be large enough to hold two sister DNA 
strands even when wrapped around histories (Uhlmann, 2004). Consequently, if sister 
DNAs were trapped within the same ring, it would explain how proteolytic cleavage of 
Scc 1 by separase liberates DNA from a ring, thereby destroying the connection between 
sister chromatids and triggering their disjunction at the metaphase to anaphase transition 
(Riedel et al., 2004). Nevertheless, if cohesin indeed traps DNA within the ring, how 
does the DNA gets inside? It was suggested that ATP hydrolysis by cohesin might be 
coupled to the active transport of DNA into the ring (Uhlmann, 2003). Experiments 
have shown that ATP hydrolysis is indeed required for DNA binding by cohesin 
(Arumugam et al., 2003; Weitzer et al., 2003), possibly by weakening the interaction 
between the SMC1 and SMC3 heads and thus opening a gap by which the DNA can 
enter. Furthermore, it was shown that SMC ATPase heads by themselves cannot bind to 
DNA but they only promote DNA binding when connected to a closed ring (Weitzer et 
al., 2003). DNA transport into the ring by the ATPase heads would explain both the 
requirement for ATP hydrolysis as well as an intact cohesin ring for DNA binding. 
However, there are still many questions that need to be addressed and this model still 
remains controversial. 
It has to be mentioned that for each organism or different cell cycles, a different 
mechanism may exist that ensures the correct balance between cohesion and 
condensation. Concerning the potential contribution of cohesin to chromosome 
condensation, experiments in S. cerevisiae suggest that cohesin is required not only for 
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the initiation of condensation, but also for the maintenance of a condensed state (Losada 
and Hirano, 2001). Also, the Trf4 and Pds5 proteins in S. cerevisiae and Mis4 protein in 
S. pombe were found to be involved in both cohesion and condensation. However, this 
observation does not seem to be hold in metazoans. So any structural or functional link 
between cohesion and condensation, remains to be determined. 
1.9. Why Drosophila melanogaster? 
The fruit fly Drosophila melanogaster has been selected as a model organism for the 
study of the biological function of individual condensin subunits. It offers numerous 
advantages as an experimental organism that provide an excellent system for the 
analysis of chromosome dynamics. 
Generally there is a high level of conservation of genes, pathways and cellular 
processes between Drosophila and other higher metazoa. Drosophila has proliferating 
tissues such as larval neuroblasts and imaginal discs, that display a conventional cell 
cycle consisting of G 1, 5, G2 and M phases. Furthermore, the fundamental cell cycle 
machinery (including cyclins and their cyclin-dependent kinases) is highly conserved. 
Drosophila is a good candidate for this particular study since its well-defined cytology 
and simple karyotype of only four pairs of chromosomes (of which three are relatively 
large) simplify the analysis of chromosome dynamics. Drosophila allows the study of 
proteins not only at the cellular level, but also during different developmental stages. 
Syncytial embryos provide a way to study synchronised rapid nuclear divisions. Later 
stages, such as larvae are useful for providing tissues rich in mitotic activity, such as 
third instar larval neuroblasts and imaginal discs. The Drosophila system also provides 
established protocols for the study of meiosis in germ-line tissues. Spermatogenesis 
offers an excellent system for genetic analysis of both the regulation of cellular 
differentiation and the structural basis of cellular and subcellular morphogenesis, while 
oogenesis is an excellent biological system for studying developmental programming. 
In addition, many cell lines are available, mainly from Drosophila embryonic tissues, 
which facilitate the study of several processes at the level of single cells. 
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However, the most powerful tool that makes Drosophila such an attractive model 
organism is its genetics. The advantages of Drosophila in genetic analysis include its 
short generation time and ease of culture. Furthermore, several types of mutations in 
Drosophila, especially those caused by transposon insertions, are very useful for the 
study of the biological function of the gene disrupted. The advantage of transposons 
(generally the P-element) versus chemically-induced mutations is that the flanking 
sequences of the disrupted gene can be identified by inverse-PCR and thus rapid 
identification of the affected gene can be obtained. P-elements can also be used for 
ectopic expression of a given sequence under the control of a wide range promoters 
allowing either temporally controlled expression (by heat-shock promoters) or tissue-
specific expression (IJAS/GAL4). Recessive lethal mutations can be maintained for 
several generations in Drosophila, thanks to the use of balancer chromosomes which 
have multiple inversions that effectively suppress recombination. 
The mapping and characterisation of new genes is greatly facilitated by many 
large collections of existing characterised mutations and deficiency stocks (in which a 
section of a chromosome is deleted). In addition, extensive libraries of partial or full 
cDNAs as well as the availability of a complete and annotated euchromatic genome 
sequence (by the Berkeley Drosophila Genome Project, BDGP) ensure that molecular 
understanding of a gene can be achieved rapidly. 
Finally the potential of combining genetic and molecular approaches to questions 
of gene expression, cell biology, development and neurobiology attract more and more 
scientists to work with Drosophila. In addition, of the close to 2000 disease genes 
identified in humans, roughly 75% have clear homologues in Drosophila melanogaster. 
1.9.1. The life cycle of Drosophila melanogaster 
The fly develops from the embryonic stage, through three larval stages (1St,  2nd and 3rd 
instars) and a pupal stage, into adult stage within approximately 9-10 days (Figure 1.5). 
Starting from the egg, fertilisation is followed by 13 rapid and synchronous cycles of 
nuclear divisions consisting of S and M phase, known as the syncytial divisions. These 
are completed within two hours. There after, cell membranes form around the nuclei to 
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form the cellular blastoderm. It is important to note that the syncytial cycles of the 
embryo are driven entirely by maternal deposition of mRNA and protein, while later 
cycles depend on zygotic contribution and what may be left of the maternal complement. 
After cellularisation, synchronisation of mitosis is lost and morphogenesis is initiated. 
Approximately 24 hours after fertilisation, the first instar larvae hatch. The first instar 
larva eats its way through food and then undergoes ecdysis (molting) 24 hours after 
hatching. The second instar larva similarly eats and grows for a day before it also 
undergoes ecdysis. The third instar larva eats for two days and the larva then emerges 
from the food medium and wanders on the vial wall until it pupates. Pupation lasts for 
about four days and terminates with eclosion, in which the adult fly emerges from the 
pupal case. Most of the growth in the three larval stages is caused by an increase in cell 
size with endoreduplication of the genome, rather that diploid cell proliferation, known 
as polyp] oidization. However, there are exceptions to this, such as brains and imaginal 
discs that will transform into adult structures during the ensuing pupal stage. These 
tissues continue to proliferate by a conventional mitotic cell cycle. Polyploidization 
results in structures such as the polytene chromosomes of the salivary glands of third 
instar larvae, in which replicated chromatids lie alongside each other with a 
characteristic banding pattern, reflecting differential packaging and transcriptional 
activity at various regions. These structures are very useful for analysing chromosome 
architecture in Drosophila. 
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Figure 1.5. The life cycle of Drosophila melanogaster.  . The fly develops 
from the embryonic stage, through three larval stages (Is', 2nd  and 3"-' 
instars) and a pupal stage, into adult stage within approximately 9-10 days 
at 25°C. 
1.10. Background of the Drosophila condensin complex 
The Drosophila Barren (CAP-H homologue) was first identified as a gene product 
required for sister chromatid segregation in Drosophila (Bhat et al., 1996). Mitotic 
defects in barr embryos resulted in a loss of peripheral and central nervous system (PNS 
and CNS respectively). In this mutant, centromeres moved apart at the metaphase to 
anaphase transition and Cyclin B was degraded, but sister chromatids failed to segregate 
properly. This phenotype was reminiscent of the one observed in topoisomerase II 
mutants and it was shown that Barren associates with topoisomerase II throughout 
mitosis and alters the activity of topoisomerase II. 
Mutations affecting the Drosophila SMC4 gene known as gluon were first 
identified through a screen of P-element mutations affecting embryonic peripheral 
nervous system development in Drosophila melanogaster (Kania et al., 1995). Further 
analysis of this mutant revealed that SMC4 is required for chromosome segregation 
during different developmental stages (Steffensen et al., 2001). However, it was shown 
that the SMC4 subunit was required for sister chromatid resolution rather than 
compaction along the longitudinal axis. Recently, depletion of SMC4 by RNA] showed 
that topoisomerase 11-dependent DNA decatanation activity in vitro was significantly 
reduced in the absence of SMC4 (Coelho et al., 2003). 
Mutations affecting the CAP-G non-SMC condensin subunit in Drosophila, 
displayed abnormal chromosome resolution and segregation (Dej et al., 2004). In this 
study the requirement of dCAP-G for condensation during prophase and prometaphase 
was illustrated, suggesting that an alternative mechanism ensures that chromosomes are 
condensed prior to metaphase. In addition, a role for dCAP-G in interphase in 
regulating heterochromatic gene expression was revealed. 
An EMS mutagenesis screen that took place in Dr. Jeff Sekelsky' s lab at the 
University of North Carolina, generated seven lethal lines which possibly were affecting 
the SMC2 gene in Drosophila. These lines were sent to our lab in order to be analysed. 
Initial characterisation of these lines by Hannah Townley, an honours student in the lab, 
revealed that one of these lines was a potential SMC2 mutation. Further characterisation 
of this mutant was performed by me. 
Initially, as a means of identifying condensin subunits in Drosophila 
melanogaster, available protein sequences of identified subunits in Xenopus were used 
as query sequences in TBLASTN searches of the Drosophila EST database (BDGP). 
This search resulted in the identification of DrnSMC2, DmSMC4, DmCAP-D2 and 
DmCAP-G. EST clones for each subunit were analysed further and antibodies were 
raised against these subunits. This work was done by Dr Margarete Heck and Soren 
Steffensen, a collaborator from Claudio Sunkel's laboratory in Portugal (Table 1). 
Antibodies against DmCAP-H/Barren were generated and described by Bhat et al. 
(1996). In this work further characterisation of the condensin subunits was performed 
using these antibodies. However, the main aim of this project was the characterisation 
of the CAP-D2 subunit and its potential role in chromosome condensation. 
Gene name Mutants 
Chromosome Polytene Antibodies Protein size CG 
arm location number 
SMC2 JSL2 2R 5ID1-2 R782 1179 aa 10212 
(134 kDa) 
SMC4 gluon 2L 36Al2-14 R688 1409 aa 11397 
(160 kDa) 
CAP-D2 - 3R 99137 R797 1381 aa 1911 
(158 kDa) 
CAP-H/ barren 2L 38B1-2 anti-Barren 736 aa 10726 
Barren (83 kDa) 
CAP-G red sea 2R 49E6-F8 attempted 1008 aa 17054 
(116 kDa) 
Table 1. General information of the Drosophila condensin subunits, including available 
mutants and antibodies that were used successfully in immonofluorescence or 
immunoblotting analysis. Antibodies generated against the CAP-G subunit did not give 
any specific signal either by immunofluorescence or by immunoblotting. CG number 
represents the identification number in Flybase. 
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1.11. Aims of the project 
When I started this project, most of the existing data for the contribution of the 
condensin complex to chromosome dynamics derived from yeast genetic studies and 
Xenopus biochemical data. Bearing in mind that each organism has differences in 
cytology and that yeast is a unicellular organism and Xenopus is multicellular (but not 
genetically tractable), it would be important to study chromosome condensation in a 
different organism. The fruit fly Drosophila melanogaster appears to be a good 
candidate for this study. As already mentioned previously, its well-defined cytology and 
the simple karyotype simplify the analysis of chromosome dynamics. Drosophila also 
allows the study of proteins during different developmental stages, while several types 
of mutations in Drosophila and especially those caused by transposon insertions are 
useful for the study of the function of the disrupted genes. In this study. I have 
attempted to analyse the role of different condensin subunits in chromosome dynamics. 
An advantage for this study was the fact that antibodies against all the subunits of the 
condensin complex were available as well as antibodies against other chromosomal 
proteins. Thereby, the subcellular distribution of proteins of the condensin complex 
could be examined, but also the behaviour of the rest of these subunits could be assessed 
in the absence of one or another component of the condensin complex. The main focus 
of this study was the analysis of the Drosophila CAP-D2 non-SMC condensin subunit. 
At the same time, analysis of an SMC2 mutant was performed. Finally, following the 
identification of a condensin complex II in vertebrate cells, I initiated the study of CAP-
D3, one of the non-SMC subunits of this complex in Drosophila. 
CHAPTER 2 
MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1. Drosophila melanogaster stocks 
Fly stock Information 
CaS (CantonS) Drosophila wild type stock 
B# 3365 Df(2L)c17, pr[i] cn[i]/CyO 
Deficiency uncovering the CAP-D3 gene 
with breakpoints at 25D7;26A7. Obtained 
from Bloomington Stock Centre. 
B# 6624 w[1118]; still e[i] 1(3)3450-M[H1]/TM6B, 
Tb[i] 
Deficiency uncovering the CAP-D3 gene 
with breakpoints at 25D2-4;25F2-4. 
Obtained from Bloomington Stock Centre. 
B# 25 Df(2L)cl-hl/CyO, amos[Roi-J] 
Deficiency uncovering the CAP-D3 gene 
with breakpoints at 25D4;25F12. 
Obtained from Bloomington Stock Centre. 
B#4187 al, dp, b, pr, cn, c, px, sp/CyO 
Second chromosome multiple marker used 
for the recombination of JSL2/CyO-GFP 
line. 
B#4347 al, dp, b, pr, Bl, cn, c,px, sp/CyO 
Second chromosome multiple marker used 
for the recombination of JSL2/CyO-GFP 
line. 
B#1150 wi/Dp(1;Y)y+; Df(2R)knSA3, 
Tp(i ,2) TE21F22A/CyO 
Deficiency uncovering the SMC2 gene 
with breakpoints at 51B05-1 1;51D07-E02, 
03C;03C;21F-22A08. Obtained from 
Bloomington Stock Centre. 
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B# 13964 yl, P{SUPor-P} CG 72 77KG03584/CyO; 
ry506 
P-element insertion in CG7277 gene. The 
insertion point is at 025-E06 chromosome 
region of the 2nd  chromosome. Obtained 
from Bloomington Stock Centre. 
B# 2386 Df(2L)DS6, b[1]pr[1] cn[1]/CyO 
Deficiency uncovering the cluster of 
histone H3 genes with breakpoints 
at 38F05;39E07-FO1. Obtained from 
Bloomington Stock Centre. 
Bc, Gla/CyO-GFP Stock used for balancing the 2 nd 
chromosome over the CyO-GFP balancer. 
P{EP}2415/CyO P-element insertion in CG14016 gene. 
EP(2)2415 synonym Obtained from Bloomington Stock Centre 
(Berkeley Drosophila Genome Project) 
1502614D P{EPgy2}/Cy0 
CAP-D3 mutation. P-element insertion in 
the CAP-D3 gene. Obtained from 
Bloomington Stock Centre (Berkeley 
Drosophila Genome Project). 
glu' 7C gluon' 7C/KrGFP 
Mutation affecting the SMC4 locus. 
Sequenced by Neville Cobbe 
barr' 305 barr' 305/Kr-GFP 
Null mutation of barren gene. Obtained 
from Hugo Bellen. 
JSL2/SM6a y, w /y J7. cn, JSL2, bw, sp /SM6a 
Mutation affecting the SMC2 gene. 
Obtained from Jeff Sekelsky. 
JSL2/CyO-GFP y,w /y Y; cn, JSL2, bw, sp /CyO-GFP 
Mutation affecting the SMC2 gene. 
Obtained from Jeff Sekeisky. 
JSL2/CyO-GFP b, pr, cn, JSL2, sp/CyO-GFP 
Mutation affecting the SMC2 gene. 
Recombinant line 58 obtained after 
recombination of the 2 d chromosome of 
the JSL2/CyO-GFP line. 
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2.1.2. Bacterial Strains 
Escherichia coil XL1 Blue (New England Biolabs) 
F' proAB iacFlacZAMl5 TNJO(Tet')/recAl endAl gyrA96(Nai') thil hsdRl 7frkmk 
supE44 re/Al lac 
Escherichia coil BL-21 (New England Biolabs) 
F- ompThsdSB (rB-mB-) gal dcm(DE3) 
Escherichia coil ER2566 (New England Biolabs) 
F-11-J7iuA2 [ion] ompTlacZ.: T7 gene] gal suiAll D(mcrC-mrr)114.'.ISlO R(mcr-
73.:miniTn]O-TetS)2 R(zgb-210.: TnlO) (TetS) endAl [dcm] 
Escherichia coil Ml 5 [pP4] (Qiagen) 
Derived from E. coil K12 
phenotype: Nai', StrS,  R Thf, Lac Ara, Gal, Mti F, RecAt Uvr, Lon 
2.1.3. Commonly used solutions 
Bovine serum albumin, 30% stock solution (Sigma). 
CLAP 
1 mg/ml chymostatin, 1 mg/lm leupeptin, 1 mg/ml antipain, 1 mg/ml pepstatin A 
(Sigma) in DMSO. 
Coomassie Blue stain 
0.5% Coomassie Blue in methanol. 
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Coomassie Blue stain diluent 
35% methanol, 14% acetic acid. 
Coomassie Blue fast destain 
35% methanol, 10% acetic acid. 
Coomassie Blue slow destain 
10% methanol, 7% acetic acid. 
Cytoskeletal Buffer (lx) 
137 mM NaCl, 5 mM KC1, 1.1 mM NaHPO4, 0.4 mM KH2PO4, 2 M MgCl2, 2 m 
EGTA, 5 mM PIPES, 5.5 mM Glucose, pH 6.1 with HC1. 
DAPI 
4',6-diamidino-2-phenylindole (Sigma), stock solution of 1 mg/ml in water, kept at 4°C 
or -20°C. 
DTT 
I M Dithiothreitol (Fisher) in ddH20. 
Dulbecco's PBS (I OX stock solution) 
1.37 M NaCl, 26.8 mM KC1, 14.7 mM KH2PO4, 64.6 mM Na2HPO4, pH 7.4 (filter 
sterilized). 
EBR (Ephrussi Beadle Ringer's Solution) (I OX stock solution) 
1.30 M NaCl, 47 mM KC1, 19 mM CaC12, 100 mM HEPES, pH6.9 (filter sterilized). 
EBR lysis buffer 
ix EBR, 10 mM EDTA, 10 mM DTT, 1:100 dilution of CLAP, PMSF and trasylol 
protease inhibitors. 
IPTG (stock solution) 
500mM Isopropyl-3-D-thiogalactopyranoside in ddH20. 
Laemmli gel buffer for stacking gel (Upper Buffer) 
0.5 M trizma base, pH 6.8 with HC1. 
Laemmli gel buffer for resolving gel (Lower Buffer) 
1.5 M trizma base, pH 8.8 with HC1. 
Laemmli gel running buffer (I OX stock solution) 
25 mM trizma base, 192 mM glycine, 1% SDS. 
LB (Luria-Bertrani broth) 
1% Bacto-tryptone, 0.5% Bacto-yeast extract, 1% NaCl, pH 7.4. 
MOPS SDS Running Buffer (20X stock solution) 
1 M 3-(N-morpholino) propane suiphonic acid, 1 M Tris base, 2% SDS, 20.5 mM 
EDTA, pH 7.7. 
Mowiol 
14% Mowiol, 28% glycerol in PBS. 
PBSTx 
1X PBS with 0.1% TritonX-100. 
PflcTw 
PBS with 0.1% Tween-20. 
PFA 
16% paraformaldehyde ampules from TAAB. 
MOM 
2% Bacto-tryptone, 0.5% Bacto-yeast extract, 8.6 mM NaCl, 50 mM MgC12, 2.5 mM 
KC1, pH 7.4. 
Soc 
SOB with 20 mM Glucose. 
Stripping Solution 
100 mM -mercaptoethano1, 2% SDS, 62.5 mM Tris, pH 6.7. 
TBS (Tris-buffered saline) (lx) 
137 mM NaCl, 20 mM Tris base, pH 7.6 with HC1. 
TAE (1X) 
40 mM Tris-acetate, 1 mM EDTA, pH 8.0. 
TBE(1X) 
45 mM Tris-borate, 1 mM EDTA, pH 8.0. 
TE (lx) 
10 mM Tris-HCJ, 1 mM EDTA, pH 7.6. 
Towbin buffer (protein transfer solution) 
25 mM Tris (Sigma 7-9), 20% methanol, 250 mM Glycine Sigma-Aldrich, 0.1% SDS. 
5X loading dye for DNA agarose gels 
17.5% Ficoll 400, 100 mM EDTA, pH 8.0, 2.5% SDS, 0.25% Bromophenol blue, 0.25% 
Xylene cyanol FF. 
3X loading dye for protein gels 
6% SDS, 150 mM Upper Buffer (0.5 M trizma-base, pH6.8), 30% Glycerol, 0.03% 
bromophenol blue, 6 mM EDTA. 
2.2 METHODS 
2.2.1. Preparation of electrocompetent cells 
2 ml overnight culture of appropriate bacterium (BL2 1 or XL- 1 Blue) was grown with 
shaking at 37 °C in SOB medium. 0.5 ml of the overnight culture was diluted into each 
of two 2 litre flasks containing 500 ml SOB. The larger cultures were grown with 
shaking at 37°C to an optical density OD600 of 0.8 (about four hours). The flasks were 
chilled in ice for about 15-30 minutes. All subsequent steps were performed on ice (it is 
important the bacterial cells remain cold, otherwise their competence is affected). 
The bacterial cells were harvested by centrifuging in sterile, chilled bottles for 15 
minutes at 2500 rpm in a Beckman JLA 10.500 rotor at 4°C. The supernatant was 
removed and the cell pellet for each culture was resuspended in 500 ml ice-cold 10% 
glycerol in distilled sterile water. The resuspended culture was centrifuged again at 
2500 rpm for 15 minutes at 4°C and the supernatant was removed. Each pellet was 
resuspended in 4.5 ml 10% glycerol and aliquots of 200 tl were snap-frozen in liquid 
nitrogen and stored at -80°C. 
2.2.2. Electroporation 
Electroporations were performed in appropriate cuvettes (0.2 cm, Invitrogen) by using a 
BioRad electroporator. Tubes of competent cells (aliquots of 200 tl) were thawed on 
ice. At the same time, an appropriate amount of 1.5 ml Eppendorf tubes and 0.2 cm 
disposable cuvettes were placed on ice to cool at 4°C. 80 tl of competent cells were 
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added to the 1.5 ml tubes and an appropriate amount of DNA (1-2 tl) was added as well 
and mixed. Cuvettes were tapped so that the sample went to the bottom and then 
electroporated at the following conditions: resistance set at 200 Ohms, capacitance set at 
25 	FD and volts set at 2.5 kV. After the electroporation, 1 ml of Soc medium was 
immediately added to each cuvette. The mixture was then transferred to 1.5 ml 
eppendorf tubes and incubated at 37°C for 30-60 minutes. Dilutions of the cultures were 
plated out on agar plates containing the appropriate antibiotic. 
2.2.3. Genomic DNA extraction 
20 flies or larvae (second or third instar) were frozen down in 1.5 ml tubes in -70°C for 5 
minutes (or at -20°C for longer) and then homogenised in 300 tl of Solution A (0.1mM 
Tris-HC1, pH 9.0, 0.1mM EDTA, pH 8.0, 0.1% SDS) by using a Polytron (Kinematica). 
The homogenised mixture was incubated at 70°C for 30 minutes and then 42 j.il of 8 M 
potassium acetate were added. The mix was centrifuged twice at 13,000 rpm, 4°C for 15 
minutes each, to obtain a clear supernatant. 150 tl of isopropanol was added to the 
supernatant and the DNA was precipitated for 1 hour at —70°C. The DNA was then 
pelleted at 13,000 rpm for 15 minutes at 4°C and washed with 70% ethanol (500 j.il) for 
15 min at 13,000 rpm. The pellet was air dried and the genomic DNA was resuspended 
in 100 tl of TE and then extracted once with equal volume of 
phenol: chloroform: isoamyl alcohol (PCI, 25:24:1) at 13,000 rpm for 5 minutes and once 
more with chloroform (13,000 rpm, 5 minutes) to remove any remaining phenol. The 
genomic DNA was then precipitated with 1/10 of the volume in sodium acetate and 2.5 
volumes of ethanol for at least 1 hour at -70°C, centrifuged at 13,000 rpm for 15 minutes 
at 4°C, washed in 70% ethanol as described above and resuspended in a final volume of 
30 1.11 TE. Genomic DNA was kept at 4°C. 
For the extraction of genomic DNA from a single larva, exactly the same 
procedure was followed with an adjustment to the volumes of Solution A (100 il), 8M 
potassium acetate (14l), isopropanol (50fl) and final TE (10tl). 
2.2.4. Plasmid DNA extraction 
For small scale plasmid DNA isolation, 3 ml E. coli (XL 1-Blue, DH5) culture was 
grown overnight at 37°C with shaking, 2 ml of which were used for plasmid DNA 
extraction and the remainder was used for making frozen glycerol stocks (700 il of 
culture and 300 tl of glycerol). All small scale plasmid DNA extractions (mini-preps) 
were performed using the UltraCleanTM  Plasmid Miniprep Kit from MoBio, according to 
manufacturer's instructions. Larger scale extractions of up to 50 ml were performed 
using either the UltraCleanTM Midiprep columns from MoBio or the Qiagen MidiPrep 
Kit, according to manufacturer's instructions. 
2.2.5. Restriction digestion of DNA plasmids 
Restriction digestion of DNA plasmids was performed in 1.5 ml Eppendorf tubes as 
follows: 
DNA (plasmid preps) 	 1-2 tl 
New England Biolabs enzyme(s) (20,000 uIml) 	1 .il 
Bovine serum albumin (10 mg/ml) 	 0.2 .tl 
New England Biolabs lox buffer 	 1 11 
Sterile deionised water 	 up to 20 p1 
Unless otherwise indicated, the i ox reaction buffer provided with the enzyme was used. 
Digestions were normally performed at 37°C for 3-4 hours. The size of the cloned insert 
was estimated by running an aliquot of the plasmid digest on a 1% agarose gel in TBE. 
2.2.6. Agarose gel electrophoresis 
Unless stated in the text, agarose gels were usually prepared in a concentration of 1 % 
SeaKem LE Agarose (BioWhittaker Molecular Applications) containing 0.3 jtg/ml of 
ethidium bromide. Gels were electrophoresed in electrophoresis tanks (Owl Scientific 
Plastics) in 1X TBE buffer. Different gel sizes were used according to the number of 
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samples and/or the degree of separation required. Gel size: mini (50 mis, run at 70-80 
V), midi (100 ml, run at 100 V) and maxi (300 ml, run at 150 V). 
2.2.7. Purification of DNA from agarose gels 
Electrophoresis was performed in low-melt agarose gels (MacroSieve low melting 
temperature agarose for separation of molecules <1 kb, Flowgen) containing 0.3 jtg/ml 
ethidium bromide. 1X TBE buffer was used and the desired bands were excised under 
UV irradiation using a razor blade and placed into 1.5 ml Eppendorf tubes. DNA was 
purified from agarose gel by using the Perfectprep Gel Cleanup Kit (Eppendorf). 
Samples were weighed and the appropriate volume of Binding Buffer was added. The 
gel was incubated for 5 to 10 minutes at 50°C and finally DNA was isolated by 
following the manufacturer's instructions (Perfectprep Gel Cleanup procedure). 
2.2.8. Amplification of genomic orpiasmid DNA by PCR 
Most PCR reactions were performed by using the Pfu DNA polymerase (with 
proofreading activity, Promega). The following basic protocol for a typical 50 t1 
reaction was used and the optimal Mg2 concentration for each primer pair had to be 
determined: 
Pfu DNA polymerase buffer with MgSO4  (I OX) 	5 tl 
dNTPs (1.25 mM each) 4 t1 
primer mix (2 	M each) 12.5 	tl 
Mg504 (25 mM) 0-4 jtl 
Pfu DNA polymerase (2-3 ulpi) 0.5 j.il 
DNA template (50-200 ng) variable 
Sterile deionised water up to 50 jtl 
PCR reactions were performed in a Biometra Personal Cycler or a Biometra Gradient 
Cycler according to the following protocol: 
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Initial Denaturation 95°C 2 minutes 
Denaturation 95°C 30 seconds 1 
Annealing 50-58°C 30 seconds 	x35 
Extension 75°C 2-5 minutes J cycles 
Final extension 75°C 10 minutes 
Hold 4°C 
Amplifications of large PCR targets (bigger than 1 kb) were usually performed using 
Herculase hotstart DNA polymerase (Stratagene) using the following protocol for a 
typical 50 pi reaction: 
lox Herculase buffer 5 p.1 
dNTPs (1.25 mM each) 4 p.1 
primer mix (2p.M each) 12.5 p.1 
Herculase (5 u!p.1) 0.25 p.1 
DNA template (50-200 ng) variable 
Sterile deionised water up to 50 p.1 
PCR reactions were performed in a Biometra Personal Cycler or a Biometra Gradient 
Cycler according to the following protocol: 
Initial Denaturation 94°C 2 minutes 
Denaturation 96°C 30 seconds 1 
Annealing 50-58°C 30 seconds 	x 30 
Extension 72°C 2-5 minutes J cycles 
Final extension 72°C 10 minutes 
Hold 4°C 
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2.2.9. Purification of DNA from PCR reactions 
DNA products from PCR reactions were usually purified by using the UltraCleanTM 
PCR Clean-upTM Kit (MoBio Laboratories). This method was preferred when only a 
single PCR product was amplified in a reaction. The entire PCR reaction was used and 
5 volumes of the SpinBind reagent were added. The DNA was finally purified using the 
Spin Filter columns by following the manufacturer's instructions and the DNA was 
eluted in 25 jl of elution buffer. 
2.2.10. Sequencing of DNA samples from plasmids or purified PCR products 
(a) Sequencing reactions were performed using 250-500 ng of template DNA in conjunction 
with 3.2 pmol of the appropriate primer and 8 tl of either dRhodamine or Big Dye 
terminator cycle sequencing kit (Perkin Elmer/Applied Biosystems), in a total reaction 
volume of 20 jil. The reactions were performed in a Biometra Personal Cycler according to 
the following protocol: 
Ramp 96°C 
Denaturation 96°C 	30 seconds 1 
Annealing 50°C 	15 seconds 	. x 25 cycles 
Extension 60°C 	4 minutes 	J 
Hold 4°C 
The completed sequencing reactions were precipitated as follows: 
2 p1 (1/10 of the volume) of 3M sodium acetate (pH 5.3) and 50 p1(2.5 of the volume) 
ethanol were added to each sequencing tube. The tubes were mixed by vortexing, 
placed on ice for 15 minutes, then spun at 13,000 rpm in a benchtop microfuge at 4°C 
for 30 minutes. The pellets were washed with 250 p1 of 70% ethanol and spun at 13,000 
rpm for 10 minutes at room temperature. The supernatant was removed and the pellets 
were air dried completely by placing the tubes in a 37 °C block with the lids open for 5- 
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10 minutes. The dried samples were then taken to the ICMB sequencing facility for 
loading onto an ABI prism sequencer. 
(b) A slightly different protocol had to be followed the last year since the protocol of the 
sequencing kit changed. Sequencing reactions were performed using 250-500 ng of template 
DNA in conjunction with 3.2 pmol of the appropriate primer and 4 p1 of Big Dye terminator 
cycle sequencing kit version 3.1 (Perkin Elmer, Applied Biosystems), in a total reaction 
volume of 20 p.1. The reactions were performed in a Biometra Personal Cycler according to 
the following protocol: 
95°C 5 minutes 
96°C 30 seconds 1 
55°C 15 seconds x25 cycles 
60°C 4 minutes 	J 
Hold 15°C 
The reactions were then transferred to 1.5 ml tubes and taken to the ICMB sequencing 
facility for loading onto an ABI prism sequencer. 
2.2.11. RNA extraction from larval tissues and whole or partial flies 
Total RNA from third instar larvae, brains, testes, ovaries, heads, carcasses and whole 
flies was prepared by using the RNeasy RNA extraction kit (Qiagen). Flies or tissues 
were disrupted and homogenised in appropriate volume of Buffer RLT (Lysis buffer) 
containing 10 t1/ml 3-Mercaptoethano1 using a motorised pestle. Total RNA was then 
purified by using the RNeasy columns according to manufacturer's instructions (RNeasy 
Mini Protocol for Isolation of Total RNA from Animal Tissues). RNA was finally 
eluted in 25 p.! of RNAase-free dH20 and stored at -20°C. 
2.2.12. DNase treatment of total RNA 
Total RNA was treated with DNAse I, Amplification Grade (Invitrogen) prior to reverse 
transcription as follows: 
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DNAase I, Amp Grade 1u/.tl 	 1t1 
lox DNaseI Reaction Buffer 	 lj.tl 
total RNA 	 ltg 
DEPC-treated Water 	 up to 10 p.1 
The reaction mixture was incubated for 15 minutes at room temperature and the DNAse 
I was inactivated by the addition of 1 p.1 of 25 mM EDTA solution. The reaction was 
heated at 65°C for 10 minutes and the RNA was ready to be used in reverse 
transcription, prior to amplification. 
2.2.13. RT-PCR from total RNA 
RT-PCR was performed on total RNA (DNase-treated) isolated from third instar larvae, 
brains, testes, ovaries, heads, carcasses and whole flies by using two different 
approaches. In the first one, the Sensiscript Reverse Transcriptase from Qiagen was 
used for first strand cDNA synthesis using low amounts of RNA (< 50 ng) 
The reaction was performed as follows: 
lOX Buffer RT 	 2p.l 
dNTPs (5 mM each dNTP) 	2p.I 
Oligo-dT primer (10 p.M) 	2 p.1 
RNase inhibitor (10 units/p.!) 	1 p.1 
Sensiscript Reverse Transcriptase 1 p.! 
RNase-free water 	 up to 20 p.1 
Template RNA (< 50 ng) 	variable 
The reaction was incubated at 37 °C for 1 hour and a small aliquot was used as template 
for PCR amplification with the standard PCR reaction, as described previously. The 
products were then visualised by electrophoreses on a 1% agarose gel. 
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In the second method the Access RT-PCR system (Promega) was used. In this 
procedure, cDNA synthesis and PCR amplification were taking place in the same tube 
(one step reaction). Specific primers to the gene of interest were used for the PCR 
amplification. The reaction was performed as follows: 
Nuclease-free water 	up to 50 t1 
AMV/Tf7 5X Reaction Buffer 	10 j.tl 
dNTP mix (10 mM each dNTP) 1 p1 
primer mix 50 pmol 	 25 t1 
25mM MgSO4 	 2 p1 
The reagents were mixed by pipetting and the remaining components were added as 
follows: 
AMV reverse transcriptase (5u/[x1) 	1 j.il 
Tfl DNA Polymerase (5uI..tl) 	1 p1 
The components were vortexed gently and the reactions were initiated by adding RNA 
template: 
RNA template 	 2-2.5 p1 
The reactions were performed in a Biometra Personal Cycler or a Biometra Gradient 
Cycler according to the following protocol: 
1. First strand DNA synthesis 
reverse transcription 	48°C 	45 minutes 
AMV/RT inactivation/ 	94°C 	2 minutes 
RNA!cDNA!primer denaturation 
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2. Second strand synthesis and PCR amplification: 
denaturation 94°C 30 seconds 
annealing 60°C 1 minute. x 40 cycles 
extension 68°C 2 minutes 	J 
final extension 68°C 7 minutes 
hold 4°C 
10 Vd of each reaction was analysed by agarose gel electrophoresis (1% agarose). 
2.2.14. Maintenance of Drosophila stocks 
Flies were cultured in bottles or vials containing 'Dundee" maize medium (14 litres 
water, 150g agar, ilOOg glucose, 620g brewer's yeast, l000g maize meal, 80g dried 
yeast, 38g nipagin (p-hydroxy benzoic acid methyl ester), 380 ml absolute alcohol, 45 
ml propionic acid). To fatten flies prior to embryo collection or larval dissection, yeast 
paste (dried yeast diluted with water) was placed into the vial. Yeast paste was also 
added to mutant fly stocks that were sick or difficult to maintain. Flies were usually 
kept at 25°C with tipping into a new vial once a week, or at 18°C with tipping into a new 
vial once every three weeks. Crosses were performed at room temperature using virgin 
female flies, collected as soon as possible after eclosion. 
2.2.15. Determination of hatching frequencies 
Male and female flies of the desired genotype were kept together for two days in vials of 
medium supplemented with yeast paste to allow the females to fatten. The fattened flies 
were then placed in 800 ml collection cages placed over red wine concentrate agar plates 
(25% red wine concentrate, 2.25% Difco Bacto agar, 2.5% sucrose, 0.15% Nipagin 
pH6.5) with yeast paste. The flies were left to mate for 6 hours and the eggs laid were 
collected and arranged in 10 rows of 20 on red wine agar plates. The collection plates 
were then kept in a humidified incubator at 25°C for 30 hours (wild type embryonic 
development usually requires 24 hours at 25°C) and the number of embryos that did not 
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hatch after this time were counted. The same procedure was followed with wild type 
flies, in order to estimate the number of embryos that were dying due to embryo 
manipulation. 
2.2.16. Lethality test of JSL2 homozygous animals 
In order to determine if the larvae homozygous for the JSL2 mutation were dying at 
second or third instar stage or if they were able to pupate, a lethality test was performed. 
Male and female flies of the desired genotype were kept together in vials of yeast-
glucose-agar medium supplemented with yeast paste. Second or third instar larvae 
homozygous for the mutation were collected under an epifluorescence microscope and 
placed on red wine agar plates. The collection plates were then kept in a humidified 
incubator at 25°C for 2-3 days (wild type larva development usually requires 2-3 days at 
25°C). The number of larvae that fail to pupate or to eclose into flies was counted. As a 
control, wild type larvae were treated in the same way and numbers were determined. 
2.2.17. Concanavalin A-treated coverslips 
Coverslips (22x22 mmIl .5 thick) were washed twice in deionised water for 15 minutes 
each time and then incubated in 0.5 M HCl for 30 minutes. The coverslips were washed 
twice in deionised water for 15 minutes each time and then placed in 100% ethanol for 
30 minutes. Excess ethanol was drained off and each coverslip was dipped in 
Concanavalin A solution (0.5 mg/ml in dH20), coated completely and drained of excess 
Con A solution. The coverslips were placed to dry on clean blotting paper and were 
sterilised for 1 hour by UV irradiation prior to use. 
2.2.18. Poly-L-lysine treated slides 
Microscope slides (76 x 26 x 1.0/1.2 mm thick, twin frosted one end, ground edges, 
Berliner Glass KG) were washed overnight in dH20 containing Decon (diluted 1:5 with 
dH20). The slides were rinsed with dH20, washed with 95% ethanol for 2-3 hours and 
rinsed again with dH20. The slides were then placed in poly-L-lysine solution (0.1% 
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w/v in water, Sigma-Aldrich) for at least 45 minutes, rinsed with dI-120 and left to dry 
overnight in a 65°C incubator. 
2.2.19. Cell Culture 
Drosophila embryonic S2 cells were maintained in serum free Schneider's Insect 
Medium (Sigma) supplemented with 10% Insect qualified Fetal Bovine Serum (FBS, 
Gibco). Cells were grown at 27°C in a humidified atmosphere (Hera Cell, Heareus) and 
were maintained by passaging the culture once a week (cells were usually diluted 1:30 
for maintaining the stock and 1:10 for use in RNAi or immunofluoresence). 
2.2.20. Double stranded RNA interference 
RNAi was performed in Drosophila S2 cells as previously described (Clemens et al., 
2000; Vass et al., 2003). Template DNA was prepared by PCR as described in Chapter 
2. The PCR primers were fused to T7 RNA polymerase promoter and the PCR product 
obtained was used as template for RNA synthesis using the Megascript T7 kit (Ambion) 
according to the manufacturer's instructions and as follows: 
2 tl of i OX Reaction buffer 
2 j.il of ATP, CTP, GTP, UTP 
2 jil of enzyme mix 
1 ptg of template DNA 
up to 20 j.il with nuclease-free dH20 
The reaction was incubated at 37°C for 4 hours followed by precipitation of the RNA 
with 3 M sodium acetate, pH 5.3 (1/10 th of the volume) and 100% ethanol (2.5 
volumes). The reactions were placed on ice for 15 minutes, centrifuged at 13,000 rpm 
for 30 minutes at 4°C, washed with 250 p1 of 70 % ethanol at 13,000 rpm for 10 minutes 
at room temperature and air dried at 37°C for 5-10 minutes. The pellets were 
resuspended in 30 p1 of nuclease-free dH20. To prepare dsRNA, the resuspended 
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pellets were heated to 65°C for 30 minutes and then placed in a 65°C water bath and 
allowed to cool slowly to room temperature. The concentration of dsRNA was obtained 
by determining the OD at 260 nm and the calculation that an 0D260 of 1= 45 pg/ml of 
dsRNA. An aliquot of the dsRNA was electrophoresed on a 1% agarose gel and it was 
finally stored at - 20°C until required. 
Particularly, two fragments from the 5' end of CAP-D2 (forward primer at 251-
270 bp of ORF and reverse primer at 873-892 bp of ORF) were fused to T7 RNA 
polymerase promoter and were used as PCR primers. The Drosophila EST clone 
LD404 12 was used as a template for the PCR reaction. The PCR product obtained 
(642bp) was used as template for dsRNA synthesis. A random human intronic 
sequence was used to generate control dsRNA, which was synthesized in the same way. 
Topo II dsRNA was obtained as described previously (Chang et al., 2003). For the 
CAP-D3 dsRNA, the EST clone RE18364 was used as a template for the PCR reactions. 
Two PCR products were obtained from two different regions of the ORF. The first one 
was obtained with a primer pair that included the start codon ( ri 639 bp) and the 
second one with a primer pair further inside the message (r2 723 bp). The two 
products were used in two independent experiments. 
For the RNAi experiment, 1x106 cells/ml were diluted in serum free Schneider's 
Insect Medium. 25 tg/ml of dsRNA was added to the cells (30 tg/ml for the CAP-D3 
RNAi). imi of these cells was placed into each well of a 6-well (35mm) plate and 
incubated for 60 to 90 min at room temperature. After the incubation 2mls of 
Schneider's Medium supplemented with 10% FBS was added to each well. The cells 
were placed in the 27°C humidified incubator and samples were processed for 
immunoblotting or for immunofluorescence at designated time points. In the double 
dsRNAi experiment, the two different dsRNAs were added to the cells at the same time 
and the procedure followed was the same as described above. 
For some experiments, cells were grown on sterilized Concanavalin A treated 
coverslips in a 35mm 6-well plate (Rogers, 2002), but only for the last 24 hours before 
being processed for immunofluorescence. The cell culture was usually dilute (1:5) 
before cells were allowed to grow on Concanavalin A-coverslips. 
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In some cases, S2 cells (RNAi treated or control) were exposed to 30 RM 
colchicine for 7 hours, 67 hours after the RNAi treatment. Cells were then processed for 
immunoblotting or immunofluorescence. 
2.2.21. Preparation of Cell Extracts 
Cells were counted under the microscope with a hematocytometer, centrifuged at 2,000 
rpm for 2 min and washed with 0.5 ml of PBS (phosphate-buffered saline: 137 mM 
NaCI, 2.7 mM KC1, 6.46 mM Na2HPO4, 1.47 mM KH2PO4 pH 7.4). The pellet was 
resuspended at a specific concentration in PBS and warm ( at 65°C) sample buffer [3X 
sample buffer: 2% SDS, 10% Glycerol, 0.01% Bromophenol Blue, 2 mM EDTA, 50 
mM trizma base p1-I 6.8] with 10 mM DTT (1/10 of final volume) was added. The cells 
were lysed by sonication and the extract was boiled at 100°C for 5 to 10 mm. The 
volume of PBS and sample buffer was calculated so that the final cell concentration was 
5x 1 04cells/tl. 
2.2.22. Preparation of Embryo Extracts 
To identify embryos homozygous for barr' 305 and glu17'' the mutant chromosomes were 
balanced over CyO, P {w+w=GAL4Kr.  CJDC3,  P{w+rnc=UASGFP.S65TJDC7  as 
described (Casso et al., 2000). One hour collections of embryos were aged for 12 hours, 
dechorionated with 50% bleach for 1 min and then sorted under a fluorescence 
dissecting microscope. Homozygous embryos (Kr-GFP negative) were homogenised 
with a motorised pestle in EBR lysis buffer [EBR (13 mM NaCl, 0.47 mM KC1, 0.19 
mM CaC12, 1 mM HEPES pH 6.9), 10 mM EDTA, 10 mM DTT, 1:100 dilution of 
CLAP, PMSF and trasylol] and warm (at 65°C) 3X Sample buffer with 100 mM DTT 
was added immediately. The embryo extract was boiled at 100°C for 10 mm. Usually 
100 embryos were homogenised in 50 tl of EBR lysis buffer and 25 l of warm 3X 
Sample buffer with DTT was added. Samples were kept at - 20°C. For preparation of 
extract from wild type embryos the procedure was exactly the same as described above 
except that no sorting under the microscope was necessary. 
2.2.23. Preparation of larval extracts 
30 second or third instar larvae were collected from vials and washed three times with 
1X EBR solution in a dissecting dish using a transfer pipette. Larvae were then 
transferred to a 2 ml Eppendorf tube and excess EBR was removed with a yellow tip. 
The larvae were homogenised by Polytron homogeniser (Kinematica, AG) for 
approximately 30 seconds in 300 tl EBR lysis buffer and 150 t1 warm (at 65°C) 3X 
Sample buffer with 100 mM DTT was added immediately. The extract was boiled at 
100°C for 10 mm. The sample was then centrifuged for 2 minutes at 13,000 rpm in a 
benchtop microfuge (Heraeus Instruments 'Biofuge 13') and the supernatant was 
removed to a fresh tube and kept at -20°C. 15tl of this preparation is equivalent to one 
larva. The same procedure was followed for extract preparation from flies. 
2.2.24. Preparation of larval brain extracts, pupal or adult testes and ovary extracts 
Male and female flies of the desired genotype were kept together in vials of yeast-
glucose agar medium supplemented with yeast paste, and they were left to mate. Second 
or third instar larvae were collected from vials and they were dissected under a 
dissecting microscope. 10-20 brains were homogenised with a motorised pestle in 50 tl 
EBR lysis buffer [EBR (13 mM NaCl, 0.47 mM KC1, 0.19 mM CaC12, 1 mM HEPES 
pH 6.9), 10 mM EDTA, 10 mM DTT, 1:100 dilution of CLAP, PMSF and trasylol] and 
25 pA of warm (at 65°C) 3X Sample buffer with 100 mM DTT was added immediately. 
The brain extract was boiled at 100°C for 10 mm. Samples were kept at -20°C. The 
same procedure was followed for extracts from testes or ovaries. Usually 20 testes or 
ovaries, dissected from late pupae or adult flies, were used for this purpose. 
2.2.25. SDS-PAGE ofproteins 
Two different types of gels and gel apparatus were used for electrophoresis of protein 
samples: Hoefer Scientific Instruments 'Vertical Slab Gel Unit' for large gels and Novex 
Mini Cell (Xcell SureLock, Invitrogen) for small pre-cast gels (Invitrogen). The Novex 
small pre-cast (ready-made) gels were used according to manufacturer's instructions and 
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electrophoreses was performed in 1X MOPS SDS Running Buffer (20X stock: 1 M 
MOPS free acid, 1 M Tris-base, 69.3 mM SDS, 20.5 mM EDTA dH20 up to 500 ml) at 
200 V. In this section, only the preparation of the larger SDS-PAGE gels will be 
described: 
Two glass plates (16 cm  18 cm) were washed with dH20, Decon (diluted 1:5 in dH20) 
again with dH20 and finally rinsed with 70% ethanol and wiped dry with a paper towel. 
The glass plates were placed one on top of the other but separated with 2 spacers (0.75 
mm or 1.5 mm), one at either end. The plates were clamped together and the bottom end 
was sealed with parafilm. The clamped plates were placed on the gel apparatus and the 
resolving (lower) acrylamide gel was poured in between the glass plates from the top 
first, followed by the stacking (upper) gel. The amount of solutions used are 
summarised in the following table according to different acrylamide percentages: 
Resolving (Lower) Gel 
Recipes for 1-1.5 mm thick gel (bold text) or 1-0.75 mm thick gel. The lower buffer 
consists of 1.5 M trizma-base, pH 8.8. Acrylamide refers to a stock of 30% acrylamide: 
0.8% Bis-acrylamide (Severn Biotech Ltd). AMPS is a 10% stock of Ammonium 
Persuiphate (Sigma). 
7.5% 10% 12.5% 
lower buffer 10 ml 	5 ml 10 ml 	5 ml 10 ml 	5 ml 
acrylamide 10 ml 	5 ml 13.3 ml 	6.65 ml 18.3 ml 	9.17 ml 
20% SDS 200 gl 	100 t1 200 .t1 	100 .tl 200 tl 	100 tl 
0.5 M EDTA 80 t1 	40tl 80 p1 	40 p1 80 p1 	40 p1 
dH20 19.72 ml 	9.86 ml 16.42 p1 	8.21 RI 11.39 p1 	5.69p1 
10% AMPS 400 pt 	200 p1 400p1 	200 p1 400p1 	200 p1 
TEMED 40 p1 	20 p1 40p1 	20 p1 40p1 	20 p1 
After pouring the resolving gel, butanol saturated with 0.25X lower buffer was layered 
over the top in order to create a sharp interface between resolving and stacking gels. 
Resolving gels were allowed to polymerise for 20-30 minutes at room temperature. The 
butanol layer was poured off, washed with dH20 and the stacking gel was poured on top. 
Stacking (Upper) gel 
The Upper buffer consists of 0.5 M trizma-base, pH 6.8. All stacking gels were made up 
in 10 ml containing: 
Upper buffer 	2.5 ml 
Acrylamide 1.33 ml 
20% SDS 50 p1 
0.5MEDTA 20p1 
UREA to8M 4.8g 
d1120 uptolOmi 
10% AMPS 100 p 
TEMED 10 jtl 
A plastic comb was placed on top of the stacking gel to form the wells and the gel was 
allowed to polymerise for 15 minutes at room temperature. The polymerised gel slab 
was then fixed in position in the buffer tank and 1X Running buffer (25 mM trizma-
base, 192 mM glycine, 1% SDS) was poured into the upper and lower chambers. 
Protein samples containing 1X Sample buffer and 100 mM DTT were boiled for 5 
minutes and then loaded into the wells using a Hamilton syringe. 30 .t1 of a molecular 
weight marker (SeeBlue Plus 2, Invitrogen) were loaded in the first well. Gels were run 
at 50-60 V overnight or at 15 mA during the day. 
For the RNAi experiment, 5x105 cells were loaded per lane while for the analysis 
of embryos, 5 embryos were loaded per lane for both the wild type (Canton 5) and 
mutant material. For extracts from other tissues the amount of tissue loaded is indicated 
in the text. 
2.2.26. Coomassie staining of gels 
To observe protein bands, gels were stained with Coomassie Blue (0.5% Coomassie 
Blue in methanol) diluted 1:5 in Stain diluent solution (35% methanol, 14% acetic acid 
in dH20) for 1 hour (or overnight) at room temperature. The gel was then destained 
with Fast Destain solution (35% methanol, 10% acetic acid in dH20) for 1 hour at room 
temperature and destained further with Slow Destain solution (10% methanol, 7% acetic 
acid in dH20) for 1 hour (or overnight) at room temperature. The gel was then placed 
between two cellophanes (IDEA Scientific company) which were clamped together 
using a plastic square box making sure that no bubbles were present. The gel was placed 
in a fan incubator (BioRad) to dry for three hours. 
2.2.27. Transfer of SDS-PA GE gels onto nitrocellulose 
After electrophoresis, the separated proteins were transferred to Protran nitrocellulose 
membrane (Schleicher and Schuell) by electroblotting, in preparation for probing with 
antibodies. 4 litres of Towbin Buffer were prepared (per litre: 800 ml dH20, 3.025 g 
Sigma 7-9 Tris, 14.425 g Sigma-Aldrich glycine, 200 ml methanol. Of these 4 litres, 
250 ml were decanted for soaking the Protran membrane and 18.5 ml 20% SDS were 
then added to give a final concentration of 0.1% SDS). The blot was then assembled in 
the transfer cassette, in the following order: 
(-pole)- sponge- Whatman blotting paper- gel- nitrocellulose- Whatman blotting paper-
sponge- (+pole). The cassette containing the gel and nitrocellulose were placed in the 
transfer tank (BioRad Trans-Blot) and the transfer was performed at 55 volts for 3.5 
hours at 4°C. After transfer, the membrane was rinsed with dH20 and stained with 
Ponceau-S (0.2% Ponceau-S in 3% trichioroacetic acid) for five minutes at room 
temperature with shaking. The membrane was rinsed with dH20 and the position of the 
molecular weight markers and the resolving/stacking interface were marked on the filter 
with a pencil. The membrane was stored at 4°C or washed once with PBS/Tw (PBS 
with 0.1% Tween 20) and used immediately for immunoblotting. 
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2.2.28. Immunoblotting 
Protein extracts were separated by SDS-PAGE and transferred onto nitrocellulose 
membranes in a Trans-Blot apparatus as described previously. Membranes were 
blocked in PBS+0.1% Tween 20 (PBSTw) and 5% semi-skimmed milk (less than 0.1% 
fat) for 1 hr at RT (or overnight at 4°C) and then incubated for 1-1.5 hours (or overnight 
at 4°C) with the primary antibody in PBSTw. After washing three times for 5, 15 and 
10 min with PBSTw, the membranes were incubated in a horseradish peroxidase-linked 
(HRP) secondary antibody for 1 hr in PBSTw at room temperature. Finally the 
membranes were washed as above in PBSTw and immunocomplexes were detected by 
enhanced chemi luminescence (ECL, Amersham Biosciences). The nitrocellulose was 
then exposed to Kodak XAR-5 film for autoradiography for 30 seconds, 60 seconds and 
5 minutes. Films were developed using a Konica SRX-1O1A developer and additional 
longer or shorter exposures were performed if necessary. 
2.2.29. Stripping of blotted nitrocellulose membrane 
Nitrocellulose membranes that were already used for immunoblotting were stripped of 
the primary antibodies in order to be used for further immunoblotting with different 
primary antibodies. The membrane was washed twice in PBSTw for 15 minutes each 
time and incubated in a Stripping Solution (100 mM 3-mercaptoethanol, 2% SDS, 62.5 
mM Tris, pH 6.7) for 30 minutes at 65°C. The membrane was then rinsed several times 
with PBSTw and washed twice for 10 minutes each time and then for 1-2 hours at room 
temperature (or overnight at 4°C) with PBSTw. The membrane was ready to be used for 
another immunoblotting. 
2.2.30. Phosphorimager Analysis 
Samples were processed as described for immunoblotting but instead of using an HRP 
secondary, a Cy5 conjugated secondary antibody (Jackson ImmunoResearch 
Laboratories) was used in a dilution of 1:200. The intensity of the signal was measured 
by using the STORM 860 scanning phosphorimager and calculated using the 
ImageQuant program (Amersham). The intensity was finally normalised by using a- 
tubulin as a loading control. Values were corrected by subtracting the background of the 
corresponding lane from each band. 
2.2.31. Generation of Antigens and Antibodies 
Polyhistidine (6His)-tagged fragments of DmSMC2 and DmCAP-D2 were produced 
using the residues 24-309 and 951-1162 respectively, by cloning a BamHl-1-TindIII 
fragment of the cDNA into a pQE30 (QlAexpress system, Qiagen) expression vector. 
The constructs were expressed in E. coil M15[pREP4] cells (Qiagen) and the proteins 
were purified on Ni-agarose columns (Qiagen) and subjected to SDS-PAGE. Individual 
protein bands were excised from the gel, ground under LN2, and injected into rabbits 
(Scottish Antibody Production Unit, Pentlands Science Park). This work has been 
performed by Soren Steffensen and Dr Margarete Heck and it is described in detail in 
Steffensen eta! (2001). The same procedure was followed for the generation of Topo II 
antibody, in which residues 1079-1333 were used and a BamHl-HindIII fragment of the 
genomic DNA was cloned into a pET23a (Novagen) expression vector. The construct 
was transformed into E. coil BL21 cells (Novagen) and the protein was purified as 
described above (this part was performed by Soren Steffensen). Individual gel bands 
were excised from the gel, ground under LN2, and injected into guinea pigs and rats 
(Scottish Antibody Production Unit, Pentlands Science Park). For CAP-D3 antibody, a 
peptide corresponding to the terminal 15 amino acids of the protein (residues 1253-1267, 
CDMLVTELTFQPPDW) was synthesised and injected into rabbits (Genosphere). 
2.2.32. 6xHis-tagged protein expression in E. coli 
Different types of cells for expression were used (BL21, ER 2566 cells and M15), 
depending on the expression vector. For BL21 and ER2566, the same procedure was 
followed for protein expression and is described below: 
BL21 or ER2566 cells were transformed with the desired expression construct as 
described previously. 3 ml of medium containing the 50 tg/ml ampicillin was 
inoculated with a single colony from the transformed cells and grown overnight at 37°C. 
The following morning, a 100 ml LB medium containing 50 j.tg /ml ampicillin was 
inoculated with 100-200 p1 of the overnight culture and then grown at 37°C for about 4 
hours until an 0D600 of 0.8 was obtained. 1 ml of the uninduced culture was kept at 4°C 
for further processing, while 0.5 mM IPTG (stock of 500 mM) was added to the 100 ml 
culture to induce expression of the recombinant protein. The cells were induced for 2-3 
hours at 37C. 1 ml of the induced culture was kept at 4°C for further processing. The 
induced 100 ml culture was pelleted by spinning at 4,000 rpm for 15 minutes at 4°C 
(Beckman JLA 10.500 rotor). The pellet from the whole culture was resuspended in 10 
ml of TEN (lx TE, 0.1 mM NaCl) and transferred to a 50 ml Falcon tube. The culture 
was centrifuged again at 4,000 rpm for 15 minutes at 4°C in a benchtop centrifuge. The 
supernatant was then discarded and the pellet were completely drained by inverting the 
tube on a paper towel. Pellets were frozen at - 80°C until required. 
The 1 ml uninduced and induced cultures that were kept at 4°C were centrifuged 
at 4,000 rpm for 5 minutes at 4°C in a benchtop microfuge, washed with 1 ml of TEN 
and spun again at 4,000 rpm for 5 minutes at 4°C. The pellet was resuspended in 60p1 
of 1X TE and 30p1 sample buffer containing DTT (2 p1) was added immediately. The 
mixture was boiled at 100°C for 5 minutes, then sonicated (approximately 1 second 
bursts for about 1 minute) and stored at -20°C. 10 p1 of the uninduced and induced 
samples were analysed on SDS-PAGE gel and stained with Coomassie blue as described 
previously in order to see if the recombinant protein was induced. To increase 
expression, different IPTG concentrations (0.2 mM - 1 mM) and induction temperatures 
(40°C, 25°C, 18°C) were attempted. 
M 1 [pREP4] cells (Qiagen) were ideal for the expression of recombinant 
proteins encoded by pQE vectors. These cells contained multiple copies of the low-copy 
pREP4 (kanamycin resistant), which express the lac repressor protein (encoded by the 
lac I gene) which binds to the operator sequences and tightly regulates recombinant 
protein expression. The transformation of these cells and the expression of the protein 
were performed according to the manufacturer's instructions (The QlAexpressionist, 
Qiagen). 
2.2.33. 6xHis-tagged protein purification using Ni-NTA beads (batch purification) 
Frozen pellets of bacteria containing induced recombinant protein were thawed on ice 
for 10-20 minutes, with occasional vortexing. The pellets were weighed and 20 ml of 
Lysis Buffer (8M urea, 5 mM immidazole, pH 8.0) per gram of pellet were used to lyse 
the cells for 1 hour at room temperature with moderate shaking. After lysis, the viscous 
solution was spun at 10,000 rpm for 20-30 minutes to pellet the cellular debris. The 
supernatant or 'cleared lysate' was collected and 100[d were kept for SD S-PAGE 
analysis. Ni-NTA beads (Qiagen) were added to the cleared lysate (1 ml of beads per 6-
7 ml of cleared lysate), and incubated for 1 hour at room temperature with shaking. The 
beads were pelleted at 2000 rpm for 5 minutes using a benchtop centrifuge and another 
100 	l aliquot of the flow through was taken. The remaining flow through was 
discarded and the beads were washed 3 tunes with Wash Buffer (8 M urea, 5 mM 
immidazole, pH 6.3) with shaking. The first two washes were performed with 10 ml 
Wash Buffer each and after the second wash the beads were spun down in a benchtop 
centrifuge at 2,000 rpm for 5 minutes and an aliquot of 100 tl was kept. The third wash 
was performed with 5 ml of Wash Buffer and the beads were poured into a BioRad 
chromatography column and spun at 2,000 rpm for 5 minutes. A 100 tl aliquot was 
taken from the third wash and rest was discarded. Bound proteins were eluted off the 
beads by adding 0.5 ml of Elution Buffer (either 8 urea, 5 mM immidazole, pH 4.5 OR 8 
M urea, 500 mM immidazole, pH 6.3) and spinning this through the BioRad column for 
5 minutes at 2000 rpm directly into 1.5 ml eppendorf tube. This was repeated for 5-6 
times and the elution fractions were stored at —20 °C. The beads were kept at 4°C for 
regeneration or were stripped of remaining bound protein by boiling in sample buffer. 
10 tl of uninduced, induced cleared lysate and flow-through, 30 l of each wash and 50 
tl of each elution fraction was analysed by SDS-PAGE. 
In some cases the BugBuster kit (His-Bind Purification kit, Novagen) for protein 
purification was used according to the manufacturer's instructions. Usually proteins 
were in inclusion bodies and thus an extra step for purification of inclusion bodies was 
performed according to the manufacturer's instructions. 
2.2.34. Preparation of antigen for injection 
Protein samples were electrophoresed on a large SDS-PAGE gel with one preparative 
well for sample and run overnight as described previously. The gel was rinsed 3 times, 
10 minutes each, with dH20 and stained with Aqueous Coomassie Blue (0.1% 
Coomassie Brilliant Blue R in 1X Laemmli Running Buffer without SIDS [25 mM trizma 
base, 192 mM glycine]) for 1 hour at room temperature with shaking. The gel was then 
destained for 3 times, 10 minutes each, with 1X Laernmli Running buffer until the band 
of interest was clearly visible. The desired band was excised using a fresh cover slip and 
ground to fine powder using a pre-chilled ceramic mortar and pestle (Philip Harris) and 
a small amount of liquid nitrogen. The ground protein was placed in a centrifuge tube 
using a small piece of weighing paper and it was stored at - 80°C or sent on dry ice to 
Scottish Antibody Production Unit (SAPU) for injections. 
2.2.35. Affinity purification of antibodies 
All subsequent steps were performed at 4°C. AffiGel® 10/15 Gel beads (BioRad) were 
used. AffiGel- 10 is best for binding proteins near or below their isoelectric point, while 
AffiGel- 15 is better for binding proteins near or above their isoelectric point. The 
following conditions refer to a mixture of the AffiGel- 10 and AffiGel- 15 for better yield 
of protein binding. 
Binding of antigen to AffiGel column: 
0.5 ml of each affigel-lO and affigel-15 beads were mixed and washed twice, with 10 ml 
of cold sterilised dH20 each time. The beads were centrifuged in between the washes 
for 2 minutes at 3,500 rpm at 4°C and they were finally diluted in 1 ml cold 100 mM 
MOPS, pH 7.5. 0.5 ml of the antigen (recombinant protein) was added to the beads and 
the mixture was incubated at 4°C for 6-7 hours with rotation. After the incubation, the 
mixture was centrifuged at 3,500 rpm at 4°C for 2 minutes and a sample was taken from 
the supernatant, while the rest was discarded. The beads were incubated with 1 ml of 1 
M Ethanolamine-HC1, pH 8.0 for 1 hour at 4°C with rotation (for blocking any free 
binding sites on the resin) and then transferred to a BioRad column. The beads were 
washed with each of the solutions that were going to be used later in the affinity 
purification to ensure that any material that would be eluted/removed by them would not 
do so during the purification. Thus the column was washed subsequently with: 
5 ml of TBS (20 mM tris pH 7.5, 150 mM NaC1) 
5 ml 20 mM tris pH 7.5, 500 mM NaCl 
5 ml of glycine (100 mM glycine, pH 2.5) 
5 ml of 50 mM tris, pH 8.8 
5 ml ethanolamine (100 mM ethanolamine, pH 8.0) 
2 x 5 ml TBS 
The column was allowed to drain in between the washes. Finally the column was used 
immediately for affinity purification of the antibody or it was stored in TBS at 4°C until 
required. The efficiency of antigen binding to the beads was tested by comparing 
protein samples that were not applied to the AffiGel column and protein samples after 
incubation with AffiGel beads. The samples were analysed side by side on an SDS-
PAGE gel and stained with Coomassie blue as described previously. 
Affinity purification 
Usually 1 ml of the immune serum was used for the purification and it was heated at 
56°C for 30 minutes to inactivate complement. The serum was placed on ice to cool and 
it then was centrifuged at 13,000 rpm for 2 minutes to remove debris and the supernatant 
was transferred into a fresh eppendorf tube. The serum was diluted 1:5 in TBS solution 
and applied to the column with the bound antigen. The serum was collected and re-
applied to the column for 5 times and finally was collected and stored at 4°C. The 
column was then washed subsequently with 5 ml of TBS twice and with 5 ml of 20 mM 
Tris pH 7.5, 500 mM NaCl twice. The antibody was eluted off the column using 0.5 ml 
of 100 mM glycine, pH 2.5. The elution step was repeated 10 times and each elution 
fraction was collected into an eppendorf tube containing 42 tl of 1 M Tris-Cl, pH 7.5 
and 50 l of 5 mg/ml BSA (for neutralisation). The column was finally washed with 10 
ml of TBS and stored in TBS at 4°C. The elution samples were stored at 4°C and they 
were tested, along with other samples kept during the affinity purification procedure, by 
immunoblotting against cell extract or against the recombinant protein (antigen) that was 
used for the affinity purification. Elution samples were usually used at 1:10 dilution for 
immunoblotting analysis. 
2.2.36. Identification of the Condensin Complex: Immunoprecipitation using protein 
A-seph arose 
Extract preparation: 0-5 hr Drosophila embryos were homogenised in one volume of 
buffer A (15 mM NaCl, 60 mM KC1, 2 mM EDTA, 0.34 M sucrose, 15 mM Hepes pH 
7.9) and complete protease inhibitors (Roche) using a loose pestle. The homogenate was 
centrifuged for 5 minutes at 5000 x g at 4°C in a benchtop centrifuge. The middle layer 
was collected, aliquoted and flash frozen in liquid nitrogen. Dimethyl pimelimidate 
cross-linking of CAP-D2 antibody to protein A-sepharose was performed according to 
Harlow and Lane (Harlow and Lane, 1999). For immunoprecipitation from crude 
extracts, antibody beads were incubated with the extract for 1 hr at 4°C. The beads were 
washed 10 times with 20 volumes of PBS, and then eluted and washed with PBS 
containing 250 and 500 mM NaCl. Protein interactions that were resistant to 500 mM 
NaCl were eluted using 2% SDS in PBS. 
2.2.3 7. Immunoprecipitations using the Dynabeds®M-280 Sheep anti-Rabbit IgG 
Immunoprecipitations were also performed by using magnetic beads with affinity 
purified Sheep anti-Rabbit IgG covalently bound to the surface (Dynabeds® M-280 
Sheep anti-Rabbit IgG, DYNAL Biotech). Extract preparation: 0-5 hr embryos were 
homogenised in one volume of PBS containing 0.2% Triton-X 100 and complete 
protease inhibitors (Sigma) using a motorised pestle. The homogenate was centrifuged 
through a mesh for 5 minutes at 5000 x g at 4°C in a benchtop centrifuge. The extract 
was collected, aliquoted, flash frozen in LN2 and kept at -80°C. 
The immunoprecipitation procedure was performed according to the manufacturer's 
instructions. 1-2 x 108  (6-7 x 108  beads/ml) beads were transferred in an 1.5 ml 
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Eppendorf tube and washed three times with the washing buffer (1X PBS) using a 
magnet. The antibody (usually diluted 1:2 or 1:3 in 1X PBS buffer) was added to the 
washed beads and incubated overnight at 4°C with slow tilt rotation mixing. The 
antibody was then removed and the beads were washed three times with the washing 
buffer. Crosslinking of the antibody with the beads was achieved by using Dimethyl 
pimelimidate dihydrochloride (DMP). Initially the beads were washed twice with 1 ml 
each time of 0.2 M triethanolamine, pH 8.2 and then 1 ml of 20 mM of DMP (diluted in 
0.2 M triethanolamine) was added to the beads. The mixture was incubated for 30 
minutes at 20°C with rotational mixing and the reaction was stopped with the addition of 
1 ml of 50 mM Tris, pH 7.5 and incubated for 15 minutes with rotational mixing. The 
crosslinked beads were washed three times with 1 ml each time of PBS/BSA (1X PBS 
and 0.2% BSA) and -300-600 tl of embryo extract were added and the mixture was 
incubated for 1-1.5 hours at 4°C with rotation. The embryo extract was then removed 
and the beads were washed three times with 1 ml washing buffer each time. The beads 
were eluted and washed with PBS containing 250 and 500 mM NaCl (diluted in 1X PBS 
and containing 0.05% Triton-X 100). Protein interactions that were resistant to 500 mM 
NaCl were eluted using 2% SDS in PBS. Finally the beads were boiled in 1X Sample 
buffer for 10 minutes and samples were analysed by SDS-PAGE. 
2.2.38. Preparing samples for Mass Spectrometry 
Protein samples from immunoprecipitations (washes and elutions) were electrophoresed 
on a large SDS-PAGE gel and run overnight to resolve the proteins. Immediately after 
the dye front left the gel, electrophoresis was terminated. The gel was disassembled and 
rinsed twice, for 10 minutes each, with sterilised deionised water. The gel was then 
stained overnight with the GelCode® Blue Stain Reagent (PIERCE) at room 
temperature and it was destained twice with sterilised deionised water for 2-3 hours until 
individual bands could be observed. If the signal was weak, the staining with the 
GelCode reagent was repeated once more overnight at room temperature. After 
destaining, the gel was photographed and individual bands were excised from the gel 
either with clean coverslips or with a clean razor blade that was washed with ethanol 
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before cutting a new band. The bands were placed in 1.5 ml eppendorf tubes and they 
were taken to the ICMB Mass Spectrometry Facility for further analysis. Samples from 
pre-immune serum were electrophoresed as well and protein bands were excised and 
sent for mass spectrometry analysis. 
2.2.39. Immunofluorescence of Drosophila Cultured Cells 
2x105 cells diluted in lx EBR were centrifuged onto poly-L-lysine-coated slides (500 tl 
of cells) for 2 min at 2000 rpm in a cytospin column (Cytospin 3, SHANDOI'T). The 
cells were immediately fixed for 4 min in 4% PFA in PBS at RT, washed for 5 min in 
PBS+0.1% Triton-X (PBSTx) and permeabilised in PBS +0.5% Tx for 5 mm. After the 
permeabilisation, cells were blocked for 1 hr at RT in 5% Bovine Serum Albumin (BSA, 
Sigma). Cells were washed in PBSTx for 5 min and incubated for 1 hr in the primary 
antibody in PBSTx+0.5% BSA. After three 5 min washes in PBSTx, cells were 
incubated in the secondary antibody (conjugated fluorochromes, Molecular Probes or 
Jackson ImmunoResearch Laboratories) in PBSTx+0.5% BSA and in 1 tg/ml DAPI for 
DNA staining. Cells were washed four times, 5 min each, in PBSTx and coverslips 
were mounted onto the slides with Mowiol (Calbiochem) and viewed under the 
fluorescent microscope. For some antibodies (DSA1, Drad2l/Sccl, SMC2, SMC4, 
guinea pig topo II and CAP-D3), 0.5% Triton-X was included in the fixative and the 
incubation in this solution was done for 10 mm. A permeabilisation step was performed 
as well as described above. 
For hypotonic treatment, cells were diluted in 0.25X EBR at a concentration of 
2x105 for 1-2 min at RT and then centrifuged onto poly-L-lysine slides and processed as 
described above. Cells that were grown on Concanavalin A-coated coverslips for 24hr 
in a 6-well (35mm) plate were then fixed and processed as described above. For 
immunofluorescence using INCENP antibody, the fixation step was performed in 4% 
PFA diluted in Cytoskeletal Buffer (137mM NaCl, 5 mM KCI, 1.1 mM NaHPO4, 0.4 
mM KH2PO4, 2 mM MgC12, 2 mM EGTA, 5 mM PIPES, 5.5 mM Glucose, pH 6.1 with 
HC1) instead of PBS for 4 minutes and the subsequent steps were the same as described 
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above. The Cytoskeletal Buffer was recommended for preservation of microtubules 
during immunofluorescence. 
2.2.40. BrdU Incorporation in Drosophila Cultured Cells 
Cells growing in flasks were incubated for 30 min in medium containing 6 [tg/ml BrdU 
(bromodeoxyuridine). 2x105 cells were centrifuged onto poly-L-lysine slides and 
processed as described for immunofluorescence except that DAPI was omitted. The 
primary antibody in this case was anti-CAP-D2 and the secondary was Alexa 594 goat 
anti-rabbit conjugate. After the anti-CAP-132 immunofluorescence was complete, the 
cells were post-fixed immediately in 4% PFA in PBS for 1 hr at RT, washed for 5 min in 
PBSTx and then incubated for 15 min in freshly prepared 2N HC1. After a 5 min wash 
in PBSTx, cells were blocked for 30 min in PBS 1-501'0 BSA and washed for 5 min in 
PBSTx and then incubated with the rat anti-BrdU antibody (1:2 dilution) in 
PBSTx+0.5% BSA at 4°C for 16 hrs. After three 5 min washes, the cells were incubated 
with Alexa 488 goat anti-rat conjugate (1:500 dilution) in PBSTx+0.5% BSA for 1 hr at 
RT. 1 [tg/ml DAPI was added during the last incubation. Finally cells were washed 
four times for 5 min each with PBSTx and coverslips were mounted onto the slides with 
Mowiol. 
2.2.41. Antibody staining of larval brains 
Third instar larvae were collected from vials and washed in EBR in a dissecting dish to 
remove excess food. Individual larvae were transferred to a new well containing EBR 
and brains were dissected under a dissecting microscope. 4-5 brains were processed on 
one slide and thus dissected brains were placed into a new well containing EBR until 
ready, but never for more than 10 minutes. The brains were hypotonically swollen for 3 
minutes in 0.25X EBR and fixed for 5 minutes in 4% paraformaldehyde (TAAB), 5% 
acetic acid, 0.1% Triton-X 100 in 0.16X EBR by placing them in a drop on a siliconised 
coverslip. A poly-L-lysine slide was inverted onto the coverslip and the brains were 
squashed during the fix repeatedly by pressing very hard on the slide. The slide was 
dipped in LN2 and the coverslip was breathed on to warm and flicked off with a razor 
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blade. The slide was placed immediately into a Coplin jar containing PBS for 2 minutes 
and it was then permeabilised for 3 times 10 minutes each in PBSTx (1X PBS + 0.1% 
Triton-X 100). Blocking was performed in 3% BSA in PBS for 1 hour at room 
temperature. After blocking, the slide was washed for 5 minutes in PBSTx and then 
incubated overnight at 4°C in the primary antibody diluted in PBS + 0.3 % BSA. The 
slide was washed 6 times for 5 minutes each in PBSTx and the appropriate secondary 
antibody diluted in 3% BSA in PBS was applied for 1-2 hours at room temperature. The 
slide was then washed 6 times, 5 minutes each, in PBSTx. The brains were also stained 
with DAPI (0.1 jtg/ml) that was included in the secondary antibody. Slides were finally 
drained and mounted in Mowiol, allowing 30 minutes for the Mowiol to set and 
examined under the fluorescence microscope. 
2.2.42. Bonaccorsi et alfixation of larval brains 
This protocol has been adapted from Bonaccorsi et al (2000) and is recommended for 
analysis of mitotic spindles in Drosophila neuroblasts. 
Brains were dissected from second or third instar larvae in EBR as described 
above and fixed in 4% paraformaldehyde (PFA) in PBS for 30 minutes at room 
temperature in a dissecting dish. Following this, the brains were transferred to a new 
well containing 45% acetic acid (in dH20) for 3 minutes, then transferred to a drop (10-
15 il) of 60% acetic acid on a siliconised coverslip and squashed gently onto a poly-L-
ysine slide. The slide was flash-frozen in liquid nitrogen and the coverslip was 
removed. The slide was placed in a coplin jar with 100% ethanol at - 20°C for 10 
minutes. The brains were then permeabilised in PBSTx for 10 minutes at room 
temperature, washed twice in PBS, 5 minutes each, and then blocked in 1X PBS + 3% 
BSA. Primary and secondary antibody incubations, washes and DAPI staining were 
performed as described above. 
2.2.43. DAPI staining of larval brains 
Brains were dissected from second or third instar larvae in EBR as described above and 
fixed twice in 45% acetic acid, 1.5 minutes each, in a dissecting dish. The brains were 
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then transferred to a drop of 45% acetic acid (5 t1 per drop) on a siliconised coverslip 
and a poly-L-lysine slide was inverted on top of the coverslip (total fixation should not 
exceed 3 minutes). The brains were squashed by pressing on the inverted slide (placed 
between folded Kim-wipe paper) and flash-frozen by dipping in liquid nitrogen. The 
coverslip was breathed on to warm and flicked off with a razor blade and immersed 
immediately in a Coplin jar containing PBS for 5 minutes to wash off acetic acid. The 
slide was transferred to ajar containing 0.1 tg/ml DAPI in PBSTx for 10 minutes and 
then washed 3 times, 5 minutes each, with PBSTx. Slides were finally drained and 
mounted in Mowiol, allowing 30 minutes for the Mowiol to set and examined under the 
fluorescence microscope. 
2.2.44. Embryo collection and preparation for immunofluorescence 
Flies of the appropriate stock were transferred to a collection cage and left to lay eggs on 
a red wine concentrate-agar dish with a dollop of thick yeast paste in the centre. The 
cage was left undisturbed for the desired laying period and the red wine agar dish was 
then exchanged for a fresh one in order to obtain subsequent embryo collections. 
Embryos were rinsed with water and brushed from the agar plate using a large 
paintbrush and transferred into a microsieve with a plastic pipette. The embryos were 
rinsed with water into the microsieve to remove yeast and then dechorionated in a 
freshly diluted 50% hypochiorite bleach solution (diluted with dH20) for 1-2 minutes. 
As soon as chorion fragments were observed floating on the sieve, the embryos were 
rinsed with water and then subsequently with EBR. Dechorionated embryos were 
transferred into a small glass vial, using heptane (heptane covered half the tube). The 
embryos were then fixed in equal volumes of heptane (to permeabilize the vitelline 
membrane) and 40% EM grade formaldehyde (Electron Microscopy Sciences, PA) with 
extremely gentle agitation for 3-5 minutes, ensuring that the embryos were spread in a 
monolayer at the interface between the two phases. The lower formaldehyde phase was 
then removed carefully using a glass Pasteur pipette and replaced with an equal volume 
of methanol (BDH ultrapure) to remove the vitelline membrane. The vial was shaken 
vigorously, vortexed for 15 seconds and then left to stand upright for one minute. The 
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devitellinised embryos which had sedimented to the bottom of the vial were removed 
using a glass Pasteur pipette and transferred into a 1.5 ml Eppendorf tube. The embryos 
were washed 5 times with fresh methanol and mixing in between to remove any 
remaining formaldehyde or heptane. Fixed embryos were stored in methanol at 4°C or - 
20°C until required for immunofluorescent labelling. Several fixation protocols were 
tested and the most successful staining for CAP-132 was obtained when a 
permeabilisation step (2% Triton X in PBS) was performed after the fixation for 10-15 
minutes. 
2.2.45. Antibody staining of Drosophila embryos 
Fixed embryos were rehydrated by performing five minute washes in a series of 
methanol solutions as follows: 
100% methanol 
90% methanol/10% PBS 
75% methanol/25% PBSTx (1X PBS + 0.05% Triton-X 100) 
50% methanol/50% PBSTx 
25% methanol/75% PBSTx 
100% PBSTx 
All subsequent washes and incubations were performed using a rotating wheel. The 
embryos were blocked in 10% BSA in PBSTx (PBS + 0.2% Triton-X 100) for 1.5 hours 
at room temperature and then washed in PBSTx two times for 15 minutes each. 
Embryos were then incubated in primary antibody overnight at 4°C (CAP-D2 antibody 
1:10,000 diluted in PBSTx + 0.5% BSA). Embryos were washed four times, 15 minutes 
each, with PBSTx and incubated for 2 hours at room temperature in the desired 
secondary antibody at a dilution of 1:1,000 in PBSTx + 0.5% BSA. The secondary 
antibody dilution also contained 0.1 [tg/ml DAPI, for DNA labelling. After the 
incubation, embryos were washed 4 times, 15 minutes each, with PBSTx, transferred on 
97 
a glass slide and mounted with 90% glycerol in PBS. Finally, a coverslip was placed 
over the sample and the edges were sealed with nail varnish. 
2.2.46. DAM staining of Drosophila testes 
Pupal testes were dissected in EBR solution in a dissecting dish. Testes were then fixed 
in 4% PFA in PBS for 15-20 minutes, permeabilised in 0.1% Triton-X 100 in PBS for 5 
minutes, stained with 0.1 jtg/ml DAPI in PBS for 15 minutes and washed in PBSTx 
(PBS + 0.1 % Triton-X 100) for 5 minutes. Testes were then transferred to a microscope 
slide, a coverslip was placed on top and the testes were squashed by pressing on the 
coverslip. Excess liquid was removed by a Kim Wipe paper tissue. The preparation was 
observed under a fluorescence microscope. 
2.2.47. Preparation of live testes squashes 
Testes from pupae or adults were dissected in EBR under a dissecting microscope. The 
testes were transferred on a clean slide and a coverslip (22 x 22 mm) was placed 
carefully on top without pressing. A very mild squashing was obtained by removing 
excessive buffer from the edges of the coverslip with a piece of blotting paper. 
Preparations were then analysed under phase-contrast optics usually with the 40X 
objective. Sperm motility assay was performed in the same way. Sperm were pulled out 
of the seminal vesicle before the coverslip was placed on top and if the sperm were 
motile, sinusoidal movement was observed. In general, excessive exposure to ether or 
CO2 should be avoided since sperm movement is sensitive to these reagents. 
2.2.48. Antibody injection in Drosophila embryos 
Embryo preparation: 
A 45 minute collection of wild type embryos expressing H2A-GFP was used for the 
CAP-D2 antibody injection. The embryos were collected in a sieve as described 
previously and they were dechorionated with 50% bleach in dH20 for 1-2 minutes. The 
sieve was rinsed thoroughly with water and dried with a paper towel. The embryos were 
transferred to an agar slice and lined up under a light microscope with their anterior ends 
to the right. Usually 20-30 embryos were lined up per agar slice and were then picked 
up using a coverslip with one side coated in heptane glue. The embryos stuck to the 
sticky surface and the coverslip was placed in a box containing silica gel for 
approximately 10 minutes to desiccate the embryos. After desiccation, the embryos 
were covered with halocarbon oil, series 700 (Halocarbon Products Company) and the 
coverslip was attached to a metal slide with some heptane glue. 
Antibody preparation and injection: 
10 t1 of the CAP-132 antibody was dialysed using 0.025 tm filters (MILLIPORE) 
against 3 litres of Injection buffer (I OX buffer: 0.1 M NaPi [NaH2PO4 + Na2HP041, 0.5 
M KC1). The antibody that was obtained (usually 30-40 tl) was concentrated using the 
Biomax 5K concentrator columns (MILLIPORE). The antibody was tested by 
immunoblotting and stored at 4°C or used immediately for injections. Pre-immune 
serum was dialysed in the same way. 
For the injections, a femtotip needle (Eppendorf) was loaded with approximately 
2 .tl of the dialysed CAP-D2 antibody, pre-immune serum or injection buffer using a 
microloader pipette tip (Eppendorf). Bubbles were avoided by loading the sample at the 
base of the needle. The needle was fixed to the injecting apparatus that was next to the 
Olympus Delta-Vision microscope (Applied Precision). The slide with the embryos was 
placed on the Delta-Vision microscope stage and the tip of the needle was focused so as 
to be at the same level with the prepared embryos. Only syncytial embryos that were 
undergoing mitotic divisions were injected. Immediately after injection, individual 
embryos were observed under the 40x objective using blue light and images were 
captured every 10 seconds (for 10 minutes in total) using the Delta-Vision microscope 
SoftwoRx programme. Finally at the end of the captures, a movie was created. 
2.2.49. Microscopy 
All preparations were examined with an Olympus Provis microscope, equipped with 
epifluorescence optics. Images were captured with an Orca II CCD camera 
(Hamamatsu) and Smart-Capture 2 software (Digital Scientific). All images were 
processed with Adobe Photoshop software. For examining the localisation and the 
presence of several proteins on the chromosomes in the RNAI experiment, all images 
were obtained with the same camera settings and the same exposure time was 
maintained between the controls and the CAP-D2 RNAi experiment. 
2.2.50. Antibodies 
The primary antibodies were used for immunofluorescence as follows: 
a-tubulin (mouse monoclonal antibody 135-1-2 used at 1:500, Sigma), 
y-tubulin (mouse monoclonal T 6557 used at 1:50, Sigma), 
P1-13 (mouse monoclonal used at 1:500, 9706L, New England Biolabs), 
BrdU (rat antibody used at 1:2, Harlan Sera Lab), 
CID (chicken polyclonal used at 1:200, (Blower and Karpen, 2001)), 
Topo II (rabbit polyclonal used at 1:500, and guinea pig polyclonal used at 
1:500), 
Barren (rabbit polyclonal used at 1:500 (Bhat et al., 1996)), 
SMC2 (rabbit polyclonal used at 1;500), 
SMC4 (rabbit and sheep polyclonals used at 1:500 (Steffensen et al., 2001), 
Drad2l/SCC1 (rabbit polyclonal used at 1:500 (Warren et al., 2000b)), 
DSA1 (rabbit polyclonal used at 1:500 (Valdeolmillos, 2004)), 
BubRi (rabbit polyclonal used at 1:1000), 
Bub3 (rabbit polyclonal used at 1:500), 
sheep Cyclin B (used at 1:500), 
INCENP (rabbit polyclonal used at 1:500, (Adams et al., 2001b)), 
CAP-D2 (rabbit polyclonal used at 1:1000 for immunofluorescence and 1:10,000 
for immunoblotting), 
CAP-D3 (rabbit polyclonal used at 1:200 for immunofluorescence and 1:500 for 
immunoblotting), 
PCNA (rabbit polyclonal used at 1:500), 
ASH1 (affinity purified rabbit polyclonal used at 1:500), 
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ORC-2 (rabbit polyclonal used at 1:2000), 
ORC-3 (mouse polyclonal used at 1:10,000), 
CP-190 (rabbit polyclonal used at 1:500), 
CNN (mouse polyclonal used at 1:500), 
HP1 (mouse polyclonal used at 1:250), 
Prod (rabbit polyclonal used at 1:500), 
ZW1O (rabbit polyclonal used at 1:500), 
BEAF-32 (rabbit polyclonal used at 1:1000), 
Histone H3 (rabbit polyclonal used at 1:5000), 
Tis-2 (affinity purified rabbit polyclonal used at 1:10). 
All fluorescently conjugated secondary antibodies (Molecular Probes, Jackson 
ImmunoResearch Laboratories) and Horseradish Reroxidase (HRP) conjugated 
antibodies (Amersham Biosciences) were used according to the manufacturer's 
instructions. 
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2.3. TABLES OF EST CLONES AND OLIGONUCLEOTIDES (PRIMERS) 
EST name Length Source Vector Host Restriction Antibiotic 
cells sites resistance 
LD40412 Full length embryo pOT2 XL-1 EcoRl- chioramphenicol 
(A1520293) cDNA blue XhoJ 12.5tg/mg 
LD10348 5' prime embryo pBluescript SOLR EcoRl- ampicillin 200 
(AA816786) SK XhoI 4g/mg 
LD41419 5' prime embryo pOT2 XL-1 EcoRl- chioramphenicol 
(A1515757) blue XhoI 12.51/mg 
LD08652 3' prime embryo pBluescript SOLR EcoRl- ampicillin 200 
(AA264983) SK XhoI Jtg/mg 
LD19049 5' prime embryo pBluescript SOLR EcoRl- ampicillin 200 
(AA539797) SK XhoI tg/mg 
LD17278 5' prime embryo pBluescript SOLR EcoRl- ampicillin 200 
(AA539174) SK XhoI tg/mg 
Table I. CAP-132 EST clones (ResGen, Invitrogen Corboration). 






RE18364 full length embryo pFlc-1 XL-1 XhoI- ampicillin 200 
(B1213051) cDNA blue BamHl pg/mg 
AT1 1671 full length adult pOTB7 XL-1 EcoRl- ampicillin 200 
(BF497492) cDNA testes blue XhoI tg/mg 
Table II. CAP-D3 EST clones (Drosophila Gene Collection). 
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Primer name Primer direction Primer sequence 
T7 primer forward 5'- AATACGACTCACTATAGG -3' 
T3 primer reverse 5'- AATTAACCCTCACTAAAGG -3' 
M13 forward primer forward 5'- TGTAAAACGACGGCCAGT -3' 
Ml 3 reverse primer reverse 5'- CAGGAAACAGCTATGAC -3' 
PM001 primer reverse 5'- CGTTAGAACGCGGCTACAAT -3' 
Table HI. Primers used for sequencing of inserts in several constructs. 
Vector Sequencing primers of inserts 
pBluescript and pOTB7 M13 forward and M13 reverse 
pOT2 T7 forward and PM0Olreverse 
pFLC- 1 T7 forward and T3 reverse 
Table IV. Primer pairs used for sequencing of inserts in different vectors. 
Primer name Start position Primer Primer sequence 
on coding direction T7 sequence TTAATACGACTCACTATACGC 
sequence  was added at the 5' end. 
CAP-D2 R1F 251 forward 5'- TTGACCTGCTCTACCTGACC -3' 
CAP-D2 R1R 873 reverse 5'- CCGAAGAGTCAGAACTGTCC -3' 
Table V. Primers used to deplete CAP-D2 by RNAi. 
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Primer name Primer Primer sequence 
direction T7 sequence TTA ATACG ACTCACTATAG CC was 
added at the 5' end 
Control F forward 5' GGGATCATCTGCAAGGAGCTC 3' 
Control R reverse 5' TCACAACGACCCTTTGAAGTG 3' 
Table VI. Primers used to amplify a product from a human intron that was used as 
control in the RNAi experiments. 






SMC2-pF 19 forward 5' CGGATCCACTAGGTTCCGTACT 3' 
SMC2-pRl 554 reverse 5' GAAAAGAACGCCAGGAATTAAA 3' 
SMC2-tF 4235 forward 5' TTGTACATTTTGGATGAGGTGGA 3' 
SMC2-tR 4906 reverse 5' GACTGCTTCAAAAGCTCACCAT 3' 









SMC2-1 375 forward 5' GAAGGTGCAAGAC'FTCTTCTGCTC 3' 
SMC2-2 919 forward 5' CGGGCACTAGAAGCTACCGCTA 3' 
SMC2-3 2,922 reverse 5' GAGAGTGCGTTCCATVFFGTCC 3' 
SMC24 3,219 forward 5' TGGCATATGGAAGGAGAGTCTCG 3' 
SMC2-5 1,398 forward 5' AAGTCTCGATTACGAGGGCGGTC 3' 
SMC2-6 2,568 reverse 5' GCGGCACTGGAGCTAT'FTACT 3' 
SMC2-7 1,905 forward 5' ACAAATCAGCTACGACCCCC 3' 
SMC2-8 2,706 forward 5' TTCTTCACCTCCAGCTCAATCTCC 3' 
SMC2-9 387 reverse 5' GCTGGATGGAGCAGAAGAAG 3' 
SMC2-10 2,041 reverse 5' CTCCCTGTACTCCTTTTCTAflTG 3' 
SMC2-I 1 2,070 forward 5' CTCTGAGATAGCCCAAGTG 3' 
SMC2-12 2,322 forward 5' CGAGGCGAAGTTGGCAGATG 3' 
SMC2-13 2,395 forward 5' ACCAAGCAAAGGGCGGAGAAATC 3' 
SMC2-14 2,818 forward 5' CCGGAGGAGAAGAACTGC 3' 
SMC2-15 3,016 forward 5' GTGGCGATGGACAAGGAG 3' 
SMC2-16 3,140 forward 5' TACCGGGTGCTGAAGCGAAACTC 3' - 
SMC2-17 814 reverse 5' GTTTTCAATGCTCTCGACCTCTGC 3' 
SMC2- 18 1,285 reverse 5' CTCACCCTCACGCTGUTCAATAC 3' 
SMC2- 19 1,620 reverse 5' AACTTCCGCCGGCTGTCTGG 3' 
SMC2-20 2,047 reverse 5' GTCGATCTCCCTGTACTCCTYTTC 3' 
SMC2-21 738 reverse 5' CATTAGCCTCCACCGTCTTG 3' 
SMC2-22 387 reverse 5' GCTGGATGGAGCAGAAGAAG 3' 
SMC2-23 2,392 reverse 5' CTCCGCCCTTTGCTTGGTCAC 3' 
SMC2-24 2,777 reverse 5' CTCAAGGGCTTCCATCCGYTTCT 3' 
SMC2-25 3,057 reverse 5' ATCCTGCTCTTCTTCGTCCATC 3' 
SMC2-26 3,417 reverse 5' ACCATCCTTGAGAGACACAATC 3' 
SMC2-27 49 forward 5' CGCACGGAGATAGAAGGATTC 3' 
SMC2-28 319 forward 5' GTGGTTGTCGGAGGCAAG 3' 
SMC2-29 528 reverse 5' TTGGTGGCATCTCGCTFG 3' 
SMC2-30 700 forward 5' CACATCTCCGCCAAGTATCTC 3' 
SMC2-3 1 738 forward 5' CAAGACGGTGGAGGCTAATG 3' 
SMC2-32 795 reverse 5' GAGGTTCTTGGCGTGAGTG 3' 
SMC2-33 1,923 forward 5' CCGTATTAATTGTCGTTCTGTG 3' 
SMC2-34 2,172 reverse 5' CCTGTTCTCGCACATGGTT 3' 
SMC2-35 2,287 reverse 5' CTTGCGAGGTCTTCTGCTT 3' 
SMC2-36 2,813 forward 5' GGAYFCCGGAGGAGAAGAAC 3' 
SMC2-37 2,854 forward 5' CGGTACGATTACAGCAAGGAG 3' 
SMC2-38 3,052 reverse 5' GCTC'TTCTTCGTCCATCTTCAC 3' 
SMC2-39 1,001 forward 5' CATCCAAAAACA'TTGAGGATGA 3" 
SMC2-40 1,588 reverse 5' GTGAAAGACATGCAAAACTCCA 3' 
SMC2-41 1,232 forward 5' AGGCACAGACCACCA1TAAGAC 3' 
SMC2-42 1,994 reverse 5' CTGCTCCTAAAGGTGCTAACGT 3' 
SMC2-43 2,209 reverse 5' CAACAGAATCAGGCTGAAA]TG 3' 
Table VIII. Primers used to sequence DmSMC2. 
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Table IX. Primer pairs that were used to amplify the DmSMC2 gene. 
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EPgy2F 1 9418 forward 5' GACATGCACTGCGCTCAAACTA 3' 
EPgy2F2 9378 forward 5' CGATCACTTCCCGCTTACAC 3' 
EPgy2F3 9132 forward 5' TGGCAGCCTGGACATTATCT 3' 
EPgy2R1 2041 reverse 5' TGACTTACATTTATCGTGGCAA 3' 
EPgy2R2 2202 reverse 5' GCATCTCATTAATATTCGCGA 3' 
EPgy2R3 2544 reverse 5' AACTGCTCCATATCCCGGGCTACT 3' 
P-stop R 12 reverse 5' CATGATGAAATAACATAA 3' 
EP-RI 393 reverse 5' GAACCAGAAAAGATAAAAGAAGGC 3' 
EP-R2 519 reverse 5' TGAAAATAAGAGCTTGAGGGAAAA 3' 
EP-171 9875 forward 5' TGACTCTGCGACGTATTTATCTTA 3' 
EP-172 10758 forward 5' TCACTCAGACTCAATACGACACTC 3' 
EPRT-F1 491 forward 5' TGTGCGTTAGGTCCTGTTCATTGT 3' 
EPRT-R1 1134 reverse 5' CGATTTTTGATGTAAGGTATGCA 3' 
EPRT-F2 1658 forward 5' GAAGCCGCCAAAGAGCAGGAATG 3' 
EPRT-R2 2282 reverse 5' ACTAAGAAGGGTGTGGTTTCAGGC 3' 
EPRT-F3 4247 forward 5' TTTCACACTTTCCCCTGCTTACCC 3' 
EPRT-R3 4918 reverse 5' TCTCAAGCGACCAGGCGATCTCA 3' 
EPRT-F4 6705 forward 5' CCAGCGGGGAACAGTGACGAATAA 3' 
EPRT-R4 7230 reverse 5' TCAGTGTTCGGGTAATCAGGTGGC 3' 
EPRT-F5 9249 forward 5' CAGCATTTTCCGTTTTGTGTTAT 3' 
EPRT-R5 9875 reverse 5' TGATCTGCGACGTATTTATCTTA 3' 
Table X. Primers designed to amplify regions of the P-element P{EPgy2} that is 
inserted in the CAP-D3 gene. 
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CAP-D3F1 7923 forward 5' GGAGTTGTGATTGATGGCGGATAC 3' 
CAP-D3F2 7785 forward 5' CACGTCGCTGGCAAAGTTATC 3' 
CAP-D3F3 7010 forward 5' CGAGCTTGAAACCGGCGTATGC 3' 
CAP-D3R1 9945 reverse 5' GCTACCGATGCCTGGGGATTG 3' 
CAP-D3R2 10489 reverse 5' ACTGGATGATTGTGATAGCCGGTC 3' 
CAP-D3R3 11206 reverse 5' TGCTCTTCATCATGCGCCG 3' 
CAPD3F1 159 forward 5' CAGCAGCGGGCGGAGAA 3' 
CAPD3172 439 forward 5' STATGCAGCTAGCCCTCAAT 3' 
CAPD3R1 995 reverse 5' CTTTTACATTGAGTGCGTGGTG 3' 
CAPD3R2 3038 reverse 5' TGACCAGGCTATTTTGAGGGGC 3' 
CAPD3R3 9353 reverse 5' CAACAAGCAGAGGAAGAGGGCGAAA 3' 
CAPD3 NP F 8709 forward 5' TACATTGAGTGCGTGGTGTCCAAAT 3' 
CAPD3 NP R 9001 reverse 5' GCCACGAGGTGTCCGACGTGC 3' 







tetF 115 forward 5' CAGCAGCGGGCGGAGAAGT 3' 
tetR 863 reverse 5' GTGGAGCGATGCAAAGTGGGG 3' 
3'ORF F 3190 forward 5' CCCGACGCCCTGATTGTGGTT 3' 
3' ORF R 3714 reverse 5' GACCACGCCGACTGCCTCCCGT 3' 
Table XI. Primers designed to amplify regions of the CAP-D3 gene. 







T7 sequence TTAATACGACTCACTATAGGG was 
added at the 5' end 
D3RF1 1 forward 5' ATGTCGGATTTCCATCGTAT 3' 
D3RR1 639 reverse 5' CGACAGGATCATTCGTTGTCT 3' 
D3RF2 1418 forward 5' ACGAGCTGCGTTTCGAGAAGC 3' 
D3RR2 1 2141 1 reverse 5' CGCTGCAGCTGATCACTGGCT 3' 
Table XII. Primers used to deplete CAP-D3 by RNAi. 







31648F1 41 forward 5' ACAAACAAGTGCTAAAATAAATGA 3' 
31648F2 173 forward 5' CGCCCTCAAAACTCAGTCCATAAG 3' 
31648R1 674 reverse 5' GAGGTGGACATGCCCGT 3' 
31648R2 798 reverse 5' ACTTCCCCAGCTATGCAAAACCTC 3' 
7277F1 35 forward 5' TGAAATTTCGGAAGATGTTGGG 3' 
7277F2 198 forward 5' TATAATCATCGGAGGCGGCGGACT 3' 
7277R1 1544 reverse 5' TTGTGAGCGGAATAAAGTC 3' 
7277R2 1382 reverse 5' GTTCAGTCCGGTGGTCTTGCT 3' 
31915171 205 forward 5' CATTTTGGTGTGCATTTCAGGAC 3' 
31915F2 450 forward 5' ACGAATTTAAGCCGGAGGAGCAGAG 3' 
31915R1 2009 reverse 5' TCTACCGAACAAAAACCATGC 3' 
31915R2 2228 reverse 5' AAGATAACACAAGTAGTAGTAATC 3' 
14016F1 1 forward 5' ATGCCATCGCCCAAGAAA 3' 
14016F2 137 forward 5' TGGCCATCTGCACCAAGTT 3' 
14016R1 690 reverse 5' GGAGAAAATATGCGAGTACAGC 3' 
14016R2 594 reverse 5' CATGCTCATCCAAGGCCACG 3' 
14015F1 49 forward 5' CGCTTGCGAAAATGCTGCTAAAAA 3' 
14015172 288 forward 5' CAGCGGGAGAACGGAGTGATT 3' 
14015R1 1986 reverse 5' ACACCAAAGGAAATTATCTATG 3' 
14015R2 1724 reverse 5' CGCACTTCATTCCAATTACATAAG 3' 
Table XIII. Primers used to sequence the five genes that are located within the CAP-D3 
gene. 
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Name of primer pair Primers 
Si CAP-133F1 + EPgy2R1 
S2 CAP-D3F1 + EPgy2R2 
S3 CAP-D3F1 + EPgy2R3 
S4 CAP-D3F3 + EPgy2R1 
S5 CAP-D3R2 + EPgy2F1 
S6 CAP-D3R2 + EPgy2F2 
S7 CAP-D3R2 + EPgy2F3 
31648 31648F1 +31648R1 
7277 7277F1 + 7277R1 
31915 31915F1 +31915R1 
14016 14016F2 +14016R2 
14015 14015F1 +14015R1 
D5' tetF + tetR 
D3'  3'ORFF+3'ORFR 
ri D3RF1+D3RR1 
r2 D3RF2+D3RR2 
P1 EPRT-F1 + EPRT-R1 
P2 EPRT-F2 + EPRT-R2 
P3 EPRT-F3 + EPRT-R3 
P4 EPRT-F4 + EPRT-R4 
P5 EPRT-F5 + EPRT-R5 
P6 EPRT-F4 + EPRT-R5 
Fla CAPD3 NP F + EP-RI 
Fib CAPD3 NP F + EP-R2 
F2 EP-F2 + CAPD3 NP R 
F3 CAPD3 NP F + EPRT-RI 
F4 EPRT-Fi + CAPD3 NP R 
Wi CAPD3 NP F + CAPD3 NP R 
Table XIV. Primer pairs used to amplify regions of the CAP-D3 gene and the P-
element for several purposes as indicated in Chapter 6. 
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CHAPTER 3 
CHARACTERISATION OF THE DROSOPHILA CAP-D2 
CONDENSIN SUBUNIT 
3.1. 	Introduction 
The main focus of this study is the characterisation of the biological function of 
condensin subunits and particularly of the CAP-132 non-SMC subunit. An antibody 
against this protein was raised by Margarete Heck in collaboration with Claudio Sunkel's 
laboratory in Portugal, but it was not characterised further. Before attempting to unravel 
the functional contribution of this protein to chromosome assembly and organisation, 
further analysis of its subcellular distribution during the cell cycle was necessary. 
Thereby, general characterisation of the CAP-132 condensin subunit was performed using 
the CAP-D2 antibody and this work will be described in this chapter. 
3.2. Characterisation of the CAP-D2 condensin subunit 
3.2.1. The Drosophila CAP-D2 gene 
The CAP-D2 gene (CG 1911) is located on the right arm of the third chromosome of 
Drosophila melanogaster in 99B7 (nucleotides: 25430764-25555351) (Figure 3.1 A). A 
4281 bp cDNA encodes a protein of 1381 amino acid residues (Mr 158 kDa, p1 5.67). 
The gene consists of 5 small introns and 6 exons (Figure 3.1 B). Searching the PROSITE 
protein motif library, some putative motifs were detected on CAP-D2 protein such as N-
glycosylation sites, cAMP- and cGMP- dependent protein kinase C phosphorylation sites, 
caseine kinase II phosphorylation sites, tyrosine kinase phosphorylation sites, a bipartite 
nuclear targeting sequence (1347-1363 aa, Figure 3.1 B) and several other sites. A 
SMART search gave a coiled-coil region (intimately associated regions of long alpha 
helices) by using the method of Lupas et al (Lupas et al., 1991) and several regions with 
low residue complexity by using Wootton's and Federhen's method. These sites could be 
useful for indicating putative molecular functions of CAP-D2 protein. Neuwald and 
Hirano (Neuwald and Hirano, 2000) found that Xenopus CAP-D2 protein contains HEAT 
repeats (tandemly arranged bihelical structures that appear to function as flexible joints 
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Figure 3.1. A. Overview of the right arm of the third chromosome. The CAP-D2 gene 
(red square) is located in 99B7 chromosome locus (nucleotides: 25430764-2555535 1). A 
P-element has been reported recently, which locates about 100,000 bp away from the 
CAP-132 gene (indicated by an arrowhead). The map was adapted from Flybase. 
B. The CAP-D2 gene consists of 5 small introns and 6 exons. A 4281 bp cDNA encodes 
a protein of 1381 amino acid residues. The four HEAT repeats (green boxes, 362-398aa, 
402-438aa, 652-688aa and 1050-1068aa) and the nuclear bipartite signal (yellow box, 
1347-1363aa) are indicated on the protein sequence. 
 
 
that can wrap around target substrates and act as scaffolding on which other molecular 
components may assemble) by using iterative search and Gibbs sampling alignment 
procedures. A simple search was attempted for DmCAP-D2, which resulted in the 
finding of four HEAT repeats and seven ARM repeats (Armadillo repeats) (Figure 3.1 B). 
ARM and HEAT repeats are considered to be evolutionarily related and to share a 
common phylogenetic origin even though they have diverged significantly (Andrade et 
al., 2001). However, there is no experimental evidence for the function of these repeats. 
Antibodies that recognise individual subunits of the condensin complex are 
necessary for the localisation and characterisation of this complex during the cell cycle. 
As already mentioned, polyclonal antibodies against SMC2, SMC4, Barren (CAP-H 
homologue), CAP-G and CAP-D2 were available. The SMC4, SMC2 and CAP-G 
antibodies were already characterised by Soren Steffensen (Steffensen, 2001; Steffensen 
et al., 200 1) and Neville Cobbe (Cobbe, 2003), while the Barren antibody was 
characterised by Bhat eta! (Bhat et al., 1996). My work includes the characterisation of 
the CAP-D2 antibody. The antibody was raised against the C-terminal 211 aa of the 
CAP-D2 protein (951-1162 aa) (Figure 3.2 A). This fragment was cloned into a pQE30 
vector and tagged with 6 histidine residues in the N-terminus to enable purification by 
Ni-affinity chromatography (QlAexpress, Qiagen). The protein fragment, with a 
molecular weight of approximately 26 kDa, was expressed in a QlAexpress system and 
excised from SDS-PAGE gel. This purified fragment was then used to immunise two 
rabbits (R797 and R796) each producing 3 bleeds after three injections. As mentioned 
previously, the generation of the antibody was done by Dr M. Heck and S. Steffensen, 
however the characterisation of the antibody by Western immunoblotting and indirect 
immunofluorescence was performed by me. 
3.2.2. Immunoblotting with the CAP-D2 antibody 
Optimisation of the western blotting conditions for this antibody was necessary. For this 
purpose, Drosophila cultured cell (S2 or Dme12 cells) extract was analysed by 
immunoblotting with the CAP-D2 antibody. Different blocking agents, antibody 
dilutions and incubation conditions were attempted with the best results obtained when 
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the membrane was blocked with 5% milk and incubated with the CAP-D2 antibody in a 
dilution of 1:10,000. All incubations were performed for 1 hour at room temperature in 
PBS-Tween solution. All three bleeds of the CAP-D2 immunised sera were tested and a 
prominent band of about 137 kDa was detected. Pre-immune serum of the rabbit that was 
immunised against the CAP-D2 protein was available and used as a control in the western 
blot in different dilutions. None of the pre-immune dilutions could detect the 137 kDa 
band indicating that the CAP-D2 antibody specifically detects this protein (Figure 3.2 B). 
The difference between the predicted (158 kDa) and the detected 137 kDa band of CAP-
D2 protein could be due to the electrophoresis conditions, to the precision of the 
molecular weight marker or to post-translational modifications. The results that are 
shown in Figure 3.2(B) are from one of the two rabbits (R797) that were immunised 
against the CAP-D2 protein. The serum of the second rabbit (R796) could detect the 137 
kDa band, but the signal was fainter (data not shown). Finally the CAP-D2 antibody 
could detect the protein from as few as of 4 x 104  cells (Figure 3.2 D). 
3.2.3. Protein Expression and Purification of CAP-D2 
In order to confirm that the antibody was specifically detecting the CAP-D2 protein, 
immunoblot analysis was performed against the protein fragment that was used to 
generate the antibody. The protein fragment was expressed in bacteria by using the IPTG 
inducible QlAexpress system (using the pQE30 vector), which is repressed without 
induction. The expressed fragment was recovered in inclusion bodies (insoluble 
aggregates containing the protein), that were solubilised under denaturing conditions and 
purified by Ni-affinity chromatography through its 6-His tag (QlAexpress, Qiagen). An 
expression level of 0.4 gIL of the protein was obtained. Different combinations of 
IPTG concentrations and induction periods were attempted in order to increase the yield, 
unfortunately with no success. The quantitation of the protein was performed by 
comparing amounts of the CAP-D2 protein with specific amounts of purified BSA 
protein (0.1-50 pg4tl) on an SDS-PAGE gel after staining with Coomasie blue. 
Immunoblot analysis against the purified CAP-132 protein and against cell extract from 
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Figure 3.2. A. Schematic representation of the CAP-132 protein region that was used for the 
generation of the CAP-D2 antibody. 951 to 1162 amino acid residues were used (indicated by 
red diagonal lines). 
Immunoblot analysis of Dmel2 cell extract (8.5x 106  cells/gel) by using three different 
serum bleeds immunised against CAP-D2 protein fraction, in 1:10,000 dilution. The serum 
recognises a prominent band of 137 kDa which corresponds to CAP-D2 protein. Available 
preimmune serum from the same animal was tested in different dilutions (1:1000, 1:5000, 
1:10000) but no band of the expected size was detected. 
Western blot analysis against the purified CAP-132 protein and against cell extract from 
the induced (+IPTG) and uninduced (-IPTG) cultures by using the CAP-132 antibody. A 
prominent band of about the estimated size (- 26 Kda) was detected in the induced culture 
and in the purified protein fraction. This band was almost undetectable in the uninduced 
culture. 
Titration of the number of S2 cells, in which the CAP-D2 antibody can detect the CAP-D2 
protein. The antibody could detect the protein from as few as of 4x 101  of cells, in a dilution 
of 1:10,000. 
(- 26 kDa) in both the induced and purified protein fractions (Figure 3.2 Q. This 
suggested that the antibody could detect the protein specifically but further 
characterisation was still necessary (i.e. immunofluorescence). From the immunoblot it 
was evident that the protein was expressed after induction with IPTG but the purification 
yield was low suggesting that a different purification protocol should be used. One 
possibility is to use 3-mercaptoethanol in the Denaturing buffer, thereby reducing 
disulfide bonds. The existence of disulfide bonds between the polypeptide chains might 
be the cause of the formation of inclusion bodies. The expression and purification of the 
fusion protein could also be useful for affinity purifying the CAP-D2 antibody but higher 
yield of the protein purification should be obtained first. Nevertheless, affinity 
purification of the antibody was not necessary for analysis by immunoblotting or 
immunofluorescence (see 3.2.4) since the background staining caused by the antibody 
was very low. 
3.2.4. Immunolocalisation of CAP-D2 
The subcellular localisation of the CAP-D2 protein during the cell cycle could be very 
important for understanding the protein's function. This was analysed by indirect 
immunofluoresence. The most successful chromosomal staining was obtained in cultured 
cells that had been centrifuged onto poly-L-lysine slides (cytospin), thereby adhering and 
flattening the cells and making the chromosomal epitopes more accessible. To examine 
the localisation of CAP-D2 during mitosis, S2 cultured cells (Drosophila embryonic 
cells) were cytospun onto poly-L-lysine slides and stained for CAP-D2, phosphoiylated 
histone 3 (P1-13) and DNA. In prophase, during early stages of chromosome 
condensation, the CAP-D2 protein accumulated in the condensing chromatin. In 
prometaphase, the protein showed a localisation along the condensed chromosome arms, 
with more intense labeling of the centromeric regions (Figure 3.3 A). That was 
confirmed by using CID (centromere identifier) as a marker. CID is the Drosophila 
homolog of CENP-A, a variant of histone H3, which localises exclusively to centromeres 
and plays a key role in assembling the kinetochore during mitosis (Henikoff, 2000). The 
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Figure 3.3. Characterisation of CAP-D2 during mitosis. 
CAP-132 localises to a central axis in chromatids and shows accumulation at the 
centromeres from prometaphase until telophase. P-1-13 was used as a mitotic marker. 
During late anaphase and telophase, where chromosomes decondense, CAP-132 still 
associates with chromosomes. CAP-132 (red), P-H3 (green), and DNA (blue). 
Accumulation of CAP-132 at centromeres during metaphase. CID was used as a 
centromere marker. CAP-132 (red), CID (green), and DNA (blue). 
CAP-132 is still strong in the daughter nuclei of a cell undergoing cytokinesis (arrow). 
CAP-132 (red), a-tubulin (green), and DNA (blue). 
The scale bar represents 10im. 
accumulation of CAP-D2 at centromeres can be clearly observed in both the merged and 
CAP-132 image of a cell stained with CID and CAP-132 (Figure 3.3 B). In metaphase and 
early anaphase when chromosomes are fully condensed, the labeling was more intense 
throughout the core of the chromatids. During telophase CAP-D2 protein was still tightly 
associated to chromosomes, even as chromosomes start to decondense (Figure 3.3 A). 
The nuclear staining for CAP-D2 protein was still intense during late telophase but it was 
decreased during cytokinesis. The two phases could be partially distinguished by using 
an antibody against a-tubulin, since a-tubulin is present at the midbody (Figure 3.3 Q. 
During cytokinesis the midbody is thinner than in telophase so these two phases can be 
partially distinguished. These results suggest that CAP-D2 associates with chromosomes 
in prophase, distributes axially on the chromosome arms with enrichment at the 
centromeres during prometaphase, is present throughout anaphase and telophase and even 
remains tightly associated with chromosomes as they start to decondense. 
Immunofluorescence revealed that CAP-D2 is mainly nuclear and present at 
different levels during interphase. Therefore several markers were utilized to further 
characterise the levels of the protein during interphase (Figure 3.4). An antibody to y-
tubulin, a centrosomal component, was used to denote cells that were in G 1 phase, prior 
to centrosome duplication. G  cells (single centrosome) showed the level of CAP-D2 in 
the cytoplasm to be almost as high as in the nucleus (Figure 3.4 A, top). Cells with 2 
centrosomes (in S or G2 phase) (Loupart et al., 2000) had much higher levels of nuclear 
CAP-D2 (Figure 3.4 A, bottom). For the discrimination of S phase, BrdU, a thymidine 
analog was used. BrdU (Bromo-deoxyuridine) is incorporated into DNA in place of 
dTTP during DNA replication (S phase). Cells positive for BrdU showed nuclear 
staining of CAP-D2 (Figure 3.4 B). While the intensity of the CAP-D2 signal varied 
among BrdU positive cells (compare 3.4 B, top and bottom), analysis of replication 
patterns with 2 thymidine analogues (Chloro-deoxyuridine and Iodo-deoxyuridine) 
(Manders et al., 1992) demonstrated that the nuclear level of CAP-D2 increased as cells 
progressed through S phase (demonstrated by Dr M-L Loupart, data not shown). Cyclin 
B was used to identify cells that were in late G2/early prophase. Cyclin B forms a 
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Figure 3.4. CAP-D2 localisation during interphase. 
S2 cultured cells were cytospun onto poly-L-lysine slides, then fixed and stained with 
various antibodies as described. 
CAP-132 localises in the nucleus during interphase. G  cells (using y-tubulin as a marker) 
show nuclear staining for CAP-132 with a diffuse cytoplasmic staining. Cells in G  phase 
(single centrosome, arrow in upper panel) have less nuclear CAP-132 than cells with two 
centrosomes (cells in S or G2 phase, arrow in lower panel). y-tubulin (red), CAP-132 (green), 
and DNA (blue). 
S phase cells (detected after BrdU incorporation) show strong nuclear staining for CAP-
D2, but at differing levels. BrdU (green), CAP-132 (red), and DNA (blue). 
Cells in late G2/early prophase (arrow) show an intense staining for CAP-D2. Cyclin B 
(nuclear during late G2/early prophase) was used as a marker for this stage. Cyclin B 
(green), CAP-132 (red), and DNA (blue). 
The scale bar represents 1 Oim. 
complex with Cdk I kinase, which considers to be one of the major mitotic kinases. This 
protein complex moves from the cytoplasm into the nucleus at late G2/early prophase, 
associates with condensed chromosomes during prophase and prometaphase and 
subsequently associates with the mitotic spindle during metaphase (Huang and Raff, 
1999; Raffet al., 2002). Cells that had nuclear Cyclin B showed an intense nuclear 
staining for CAP-D2 (Figure 3.4 Q. Taken together, these results suggest that 
Drosophila CAP-132 is nuclear during interphase, with low levels in G  that increase 
during S and are highest in late G2/early prophase. Bearing in mind that the major 
fraction of Drosophila SMC4 and Barren is mainly cytoplasmic during telophase and 
interphase (Steffensen et al., 2001), it could be suggested that CAP-D2 is responsible for 
a function other than mitotic chromosome condensation during interphase or may be 
sequestered away from SMCs to regulate activity of the condensin complex. 
3.2.5. Localisation of CAP-D2 in third instar larval brains and early Drosophila 
embryos 
As described above for S2 cells, CAP-D2 associates with chromosomes in prophase, 
distributes axially on the chromosome arms during prometaphase, is present throughout 
anaphase and telophase and even remains tightly associated with chromosomes as they 
start to decondense. To observe if a similar localisation occurs in vivo, third instar larval 
brains and syncytial embryos were stained for CAP-D2 and P1-13. The CAP-132 
antibody did not work very well in either the larval brains or the syncytial embryos and 
thus different conditions needed to be tested in order to obtain good staining. Even with 
different conditions, the quality of the results was not as good as in tissue culture cells. 
In third instar larval brains, CAP-D2 localised on condensed chromosomes during 
prometaphase and metaphase and even remained tightly associated on chromosomes as 
they decondensed during anaphase and telophase. The protein was still present on 
chromatin during late telophase and cytokinesis (Figure 3.5 A). Interphase cells showed 
mainly nuclear staining of CAP-132 with some protein localised in the cytoplasm (Figure 
3.5 B). In early syncytial embryos, CAP-D2 showed a slightly different pattern of 
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Figure 3.5. CAP-D2 localisation in third instar larval brains. 
Brain squashes were performed according to "Antibody staining of larval brains" 
protocol and stained for CAP-D2 (red), P-H3 (green) and DAPI (blue). 
CAP-132 localised along the chromatids during prometaphase and remained 
tightly associated with chromosomes as they decondense during anaphase and late 
telophase/cytokinesis. 
Interphase cells showed mainly nuclear staining of CAP-132, while some protein 
localises in the cytoplasm. 
The scale bar represents 1Otm. 
localisation. In very early embryogenesis (syncytial embryo), CAP-D2 was dispersed in 
the nucleus and not restricted to chromosomes during mitosis. This pattern of 
localisation was more obvious during prophase/prometaphase (Figure 3.6 A). The 
abundance of CAP-D2 in the nucleus during this stage could be a consequence of the 
maternal contribution to early embryos or possibly CAP-132 is required for another 
function beyond the condensin complex during this developmental stage. In later stages 
of embryogenesis, CAP-D2 was mainly restricted on condensed chromosomes from 
prometaphase to metaphase and remained tightly associated with chromosomes as they 
began to decondense during anaphase (Figure 3.6 B). Finally CAP-132 was found to 
dissociate from chromosomes during late telophase. No signal could be detected on 
chromosomes with the pre-immune serum (Figure 3.6 Q. Taking these results into 
consideration, it seems that CAP-D2 has similar localisation patterns both in vivo and in 
vitro, with the exception of early stages of embryogenesis. Beyond this exception, the 
protein associates with chromosomes in early stages of mitosis and even remains tightly 
associated with chromosomes as they decondense during anaphase and telophase. 
3.2.6. Developmental expression of CAP-D2 
To determine the developmental expression pattern of CAP-132 an immunoblot analysis 
was performed against total extracts from syncytial embryos (0-4 hours after egg 
deposition), cellularised embryos (4-24 hours after egg deposition), first-, second- and 
third instar larvae, early and late pupae, male and female adults, by using the CAP-132 
antibody. This analysis showed that CAP-D2 is present throughout development with 
high amounts of protein in embryos and female adults (Figure 3.7 A, the amount of 
protein loaded in female flies lane is 2-3 fold less compared to the rest, according to a-
tubulin loading control. Thus, the amount of CAP-D2 protein should be considered to be 
at least 2-3 fold more from what is shown). This distribution is consistent with the level 
of cell proliferation in these tissues: embryos are mitotically active while female flies are 
meiotically active and contain a stockpile of proteins in their eggs used in early stages of 
embryogenesis. Thus CAP-132 is needed in high amounts in tissues that are mitotically or 
meiotically active. 
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Figure 3.6. CAP-D2 localisation in syncytial Drosophila embryos. Embryos were prepared 
as described in materials and methods and stained for CAP-132 (red) and P--'1-13 (green). 
A. Early stage syncytial embryo. CAP-132 was dispersed in the nucleus and was not restricted 
onto chromosomes during mitosis. This pattern of localisation was more obvious during 
prophase/prometaphase. The bottom panel is a higher magnification (1 OOx) of an area from the 
top panel (40x) indicated by a box. B. Late stage syncytial embryo. CAP-132 was mainly 
restricted on condensed chromosomes from prometaphase to metaphase and even remained 
tightly associated with chromosomes as they start to decondense during anaphase (arrow). The 
three bottom panels are higher magnifications (lOOx) of different areas from the top panel (40x) 
indicated by a box and a number. C. The pre-immune serum could not detect any specific 
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Figure 3.7. A. Immunoblot analysis against protein extracts from different Drosophila 
developmental stages by using the CAP-D2 antibody. CAP-D2 is present throughout 
development with high amounts of protein in embryos and female adults. a-tubulin was 
used as a loading control. 
Immunoblot analysis against S2 cell extract (125x i0 cell/gel) by using the elution 
fractions (8 sequential elutions performed with 100 mM glycine pH 2.5) of the affinity 
purified SMC4 antibody. All the elution fractions (1-8) were recognising a band of the 
right size (160 kDa), which corresponds to the SMC4 protein. The background bands could 
possibly be degradation products of SMC4 protein. 
Immunoblot analysis of S2 cell extract (5x 105  cells/lane) by using two different 
Topoisomerase II antibodies raised in guinea pig (GP1 and GP2). Two different dilutions 
were used (1:250 and 1:500) and both antibodies recognised a prominent band of the right 
size (170 kDa), which corresponds to Topoisomerase II. Available pre-immune serum from 
the two guinea pigs was tested in a dilution of 1:250 but no band of the expected size was 
detected. 
3.3. Co-imniunolocalisation of CAP-D2 and SMC4 
Drosophila SMC4 and Barren have been shown to associate with chromosomes during 
prophase and to dissociate during anaphase as chromosomes start to decondense. Also 
the major fraction of these proteins is mainly cytoplasmic during telophase and interphase 
(Steffensen et al., 2001). This localisation is different from what has been described 
above for CAP-D2. In order to assess if that is the case, co-immunolocalisation studies 
were performed with the CAP-D2 (raised in rabbit) and SMC4 (raised in sheep) 
antibodies. The co-localisation of Barren or SMC2 with CAP-D2 was not possible since 
all antibodies were raised in rabbits. To observe the localisation of these proteins during 
mitosis, S2 tissue culture cells were cytospun onto poly-L-lysine slides, extracted during 
fixation and stained for CAP-D2, SMC4 and DAPI. The two condensin subunits were 
found to co-localise to the chromosome axes during prometaphase and metaphase. 
Nevertheless, some parts of the chromosomes were more strongly labelled with CAP-D2 
i.e. centromeres, while SMC4 was less restricted to the chromosomes axes compared to 
CAP-D2. During anaphase, as chromosomes decondensed, SMC4 dissociated from 
chromosomes with a fainter signal near the centromeric regions and quite high at the end 
of chromosome arms. In contrast CAP-D2 was still present throughout the chromatids 
(Figure 3.8 A). The differences in the localisation between the two proteins could be due 
to the quality of the antibodies, since both of them are members of the same complex and 
they are expected to dissociate from chromosomes at the same time. Nevertheless, the 
distinct timing of dissociation of the different condensin subunits could be due to a CAP-
D2 function performed beyond that required of condensin, or to regulate activity of 
condensin complex. Evidence for this comes from human cells where it has been shown 
that the C terminal-end of CAP-D2 possesses a mitotic chromosome-targeting domain 
that does not require the other condensin subunits (Ball et al., 2002). It is possible that a 
similar regulation occurs in Drosophila and that CAP-D2 binds independently of the 
other subunits to chromosomes. 
To observe the co-localisation of these two subunits during interphase two 
different approaches were followed. In the first approach S2 cells were treated as 
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Figure 3.8. A. Co-immunolocalisation of CAP-132 and SMC4 during mitosis. Cells 
were cytospun onto poly-L-lysine slides, extracted during fixation and stained for 
CAP-132 (green), SMC4 (red) and DAPI (blue). The two proteins co-localise at the 
chromosome axes during prometaphase. SMC4 comes off the chromosomes as they 
start to decondense during anaphase, while CAP-132 persists throughout the length of 
the chromosomes. In telophase SMC4 is diffuse in the cytoplasm and the nucleus, 
while CAP-132 is still tightly associated to chromosomes. The scale bar is 10 [tm. 
B. Co-immunolocalisation of CAP-132 and SMC4 during interphase. Cells were 
cytospun onto poly-L-lysine slides, fixed and permeabilised and stained for CAP-132 
(green), SMC4 (red) and DAPI (blue). The two proteins localise mainly in the 
nucleus. The nuclear levels of CAP-132 appear higher compared to SMC4, while 
SMC4 signal is more disperse in the cytoplasm and the nucleus. The scale bar is 10 
Jim 
fixed and then permeabilised in order to maintain the cytoplasmic structure that is lost 
when cells are extracted during fixation. By both approaches it appeared that SMC4 was 
mainly nuclear with a high cytoplasmic staining and co-localised with CAP-132. The 
only observable difference, was that nuclear levels of CAP-132 were higher compared to 
SMC4, while SMC4 signal was more disperse in the cytoplasm and the nucleus (Figure 
3.8 B). As already mentioned, it was previously shown that SMC4 is mainly cytoplasmic 
during interphase (Steffensen et al., 2001). The two different results could be due to the 
fact that the antibody used in Steffensen et al (Steffensen et al., 2001) was affinity 
purified. In this case the affinity purified antibody was presumably recognising only 
specific epitopes, while the non-affinity purified antibody (used in this study), could bind 
to additional unspecific epitopes. An attempt to affinity purify the antibody was 
successful by immunoblotting (Figure 3.7 B) but failed by immunofluorescence and thus 
this issue was not clarified. 
3.4. Characterisation of a DNA topoisomerase II (Topo If) antibody and co-
immunolocailsation with CAP-D2 
Localisation studies revealed that topoisomerase IT (Topo II), a major protein of the 
chromosome scaffold, is distributed axially in the chromosome arms with some 
concentration at the centromeres, in a manner similar to condensin subunits (Maeshima 
and Laemmli, 2003; Steffensen et al., 2001). Colocalization and biochemical studies in 
Drosophila indicated that Barren associates and alters the activity of topoisomerase II 
throughout mitosis (Bhat et al., 1996), while cell extracts from DmSMC4 dsRNA-treated 
cells show significantly reduced topoisomerase TI-dependent DNA decatenation activity 
in vitro (Coelho et al., 2003). Furthermore, yeast mutations in Topo II exhibit 
segregation defects similar to those observed in condensin mutations (Holm et al., 1985). 
For this reason, colocalisation and functional (see Chapter 4) studies between 
Topoisomerase II and CAP-132 could be informative for the elucidation of the 
interrelation of these proteins. 
In order to be able to perform colocalisation studies between topoisomerase II and 
CAP-D2, antibodies recognising these proteins that were raised in different animals were 
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necessary. In collaboration with Soren Steffensen, we were able to raise an antibody 
against topoisomerase II in guinea pig. Two animals were injected with the 
topoisomerase II protein [guinea pig I (GPI) and guinea pig 2 (GP2)]. Immunoblot 
analyis against cell extract with the immunised sera revealed that the antibodies could 
detect specifically a prominent band of the estimated size (-170 kDa) in a dilution of 
1:500. This band corresponds to topoisomerase II and was not detected with the pre-
immune sera (Figure 3.7 Q. 
To examine the localisation of topoisomerase II with these antibodies and its 
colocalisation with CAP-D2, cells were cytospun onto poly-L-lysine slides and stained 
for topoisomerase II, CAP-D2 and DAPI. The two proteins colocalised at the 
chromosome axes in prometaphase, metaphase and anaphase and remained tightly 
associated with chromatin until late telophase (Figure 3.9 A). When metaphase 
chromosome spreads were performed, after cells were arrested in metaphase with 
colchicine, individual chromosomes could be observed. From this preparation it was 
obvious that CAP-D2 and topoisomerase II colocalised along the chromosomes but 
topoisomerase II was less restricted to the chromosome axes and was less abundant at the 
centrorneres compared to CAP-D2 (Figure 3.9 B). The colocalisation of the two proteins 
at the chromosome axes may suggest that they collaborate to organize mitotic 
chromosomes. However, their distinct localisation at the centromeres combined with the 
fact that topoisomerase II is not strictly restricted to the chromosome axes, may suggest 
that the two proteins also have distinct roles. 
3.5. Biochemical identification of a condensin complex in Drosop hi/a-
Immunoprecipitations with the CAP-D2 antibody 
Even though a five member condensin complex has been shown to exist in other 
organisms (Freeman et al., 2000; Hirano et al., 1997; Kimura, 2001; Sutani et al., 1999), 
no biochemical data exist to support this in Drosophila. For this reason, 
immunoprecipitations with the Drosophila CAP-D2 antibody were performed by Sue 
Cotterill (St. George's University in London), using 0-5 hour embryo extracts. Bound 
proteins were eluted sequentially with 0.5 M NaCI and 2% SDS in PBS. I analysed the 
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Figure 3.9. Co-immunolocalisation of CAP-D2 and Topoisomerase H. S2 cells were 
cytospun onto poly-L-lysine slides, extracted during fixation and stained for CAP-132 
(green), Topo II (red) and DAPI (blue). 
The two proteins colocalised at the chromosome axes in prometaphase, metaphase 
and anaphase and remained tightly associated to chromatin until late telophase. The scale 
bar represents 10im. 
Metaphase chromosome spreads after cells were treated with coichicine. An 
individual chromosome is shown in the bottom panel in a higher magnification. The two 
proteins colocalise partially. Note that Topo II is less restricted to the chromosome axes 
and is less abundant at the centromeres compared to CAP-132. The scale bar represents 
lOim. 
fractions by immunoblotting with SMC2, SMC4, CAP-D2, and CAP-H/Barren 
antibodies. All four proteins were present suggesting that they participate in the same 
complex. SMC2 and SMC4 proteins were eluted with both NaCl and SDS solutions, 
while CAP-D2 and CAP-H were only eluted with the SDS (Figure 3.10). This result 
suggests two possibilities. First, the CAP-D2 and CAP-H non-SMC subunits may be 
more tightly associated with each other than they are with the SMC subunits of the 
condensin complex (a similar observation was made for the cohesin complex (Vass et al., 
2003)). Second, the SMCs eluting with NaCl may be participating in another complex, 
such as the condensin II complex (Ono et al., 2003). As the antibody generated to the 
CAP-G protein was not working by immunoblotting, the presence of this protein in the 
complex could not be assessed by immunoblotting. 
Additional evidence for a condensin complex came from mass spectrometric 
analysis This was performed firstly, to confirm that CAP-U protein was a member of the 
condensin complex, since it could not be identified by immunoblotting, and secondly, to 
find novel proteins that interact with CAP-D2. The different samples were 
electrophoresed onto an SDS-PAGE gel and bands were isolated from both the pre-
immune and CAP-D2 fractions (Figure 3.10). After these bands were analysed by mass 
spectrometry all five condensin subunits, including CAP-U, were specifically identified 
in the CAP-D2 fractions. In addition, some other proteins were identified as possible 
interactors with CAP-D2. One such protein was ASH!, a Drosophila trithorax group 
protein, required for methylation of lysine 4 residues on historic 113. Methylation of 
lysine 4 is believed to activate transcription by relaxing chromatin (Beisel et al., 2002), a 
process that could also involve members of the condensin complex (PEV analysis, 
Neville Cobbe, personal communication). To confirm this interaction, the elution 
fractions were analysed by immunoblotting with an antibody against ASH! protein. 
Unfortunately, no band could be detected in the CAP-D2 elution fractions suggesting that 
no interaction exists between the two proteins. The rest of the proteins that were 
identified as possible interactors of CAP-D2 were considered contaminants (such as heat-
shock proteins, etc). For this reason a different approach was followed in order to 
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Figure 3.10. Identification of a condensin complex in 0-5 hr embryo extracts following 
immunoprecipitation with an antibody recognizing Drosophila CAP-D2. Three 0.5M 
NaCl washes and three 2% SDS elutions are shown for preimmune and immune 
precipitations. 
The samples were analysed by immunoblotting with SMC2, SMC4 and CAP-
H/Barren antibodies. A fraction of SMC2 and SMC4 eluted already in the washes, but 
more so with the elutions, while CAP-H/Barren appeared more tightly bound to one 
another as they only eluted with 2% SDS. 
The immunoprecipitation samples were electrophoresed on a 7.5% poly-acrylamide 
gel and stained with BlueCode Coomasie. Bands, indicated by boxes, from both the pre-
immune and CAP-D2 fractions were isolated and sent for mass spectrometry. CAP-G 
was identified in the CS8 band, CAP-D2 in CS2, Barren in CS7 and SMC2 in CS3. 
SMC4 was identified in another preparation. 
identify novel interactors of CAP-D2 protein. The immunoprecipitation fractions were 
analysed by immunoblotting, by using antibodies against known proteins that are 
involved in the cell cycle and chromatin organization. Such proteins were INCENP 
(chromosomal passenger), PCNA (DNA replication), Tis2 (a centromeric protein 
currently being characterized in the lab), ORC-2 and-3 (origin recognition complex), 
CP 190 (centrosomal protein), centrosomin (CNN), HP 1 (heterochromatin protein), Bub3 
(mitotic checkpoint protein), BubRl (mitotic checkpoint protein), Cyclin B, Prod 
(PROliferation Disrupter, heterochromatin binding), CID (centromere identifier), ZW 10 
(mitotic spindle checkpoint), BEAF-32 (DNA binding) and topoisomerase II. 
Unfortunately, none of these proteins was found by immunoblotting to interact with 
CAP-132 immunoprecipitations. 
In order to identify novel proteins that interact with CAP-D2, 
immunoprecipitations were repeated by following another procedure (as my supervision 
of honours student). Immunoprecipitations were performed by using magnetic 
Dynabeads thereby avoiding undesirable contaminants that may precipitate with the 
Sepharose beads during centrifugation. 0-4 hour embryo extracts were used and bound 
proteins were eluted sequentially with 0.25 M NaCl, 0.5 M NaC1 and 2% SDS in PBS. In 
order to confirm that the immunoprecipitations were successful, an immunoblot analysis 
was performed on the eluates with CAP-D2, SMC2, SMC4 and Barren antibodies. All 
four proteins were present in the CAP-132 fractions, suggesting that the 
immunoprecipitations were successful (Figure 3.11 A). 
In the next step, the different eluates were electrophoresed onto an SDS gel and 
bands were excised from both the pre-immune and CAP-D2 fractions (Figure 3.11 B and 
Q. These bands were analysed by mass spectrometry and several proteins were 
identified as possible interactors with the CAP-132 protein. For each band, a list of 25 
putative interactors was obtained after blasting the resulting peptides against the 
Drosophila database. Each resulting protein had a MOWSE score, a number that 
indicates how likely the identified protein is to be "real". The function of these proteins 
was found by using the Drosophila Genome Database (www.flybase.net). Proteins that 
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Figure 3.11. Identification of possible CAP-132 interactors in 0-4 hr embryo extracts following 
immunoprecipitation with an antibody recognizing Drosophila CAP-132. 0.25M MCI, 0.5M 
NaCl washes, 2% SDS elution and elution after boiling the beads in 1X sample buffer are 
shown for preimmune and immune precipitations. 
A. The samples were analysed by immunoblotting with SMC2, SMC4 and CAP-H/Barren 
antibodies. All four proteins were present at the elution fractions of immune precipitation. 
B and C. The immunoprecipitation samples were electrophoresed on a 7.5% poly-acrylamide 
gel and stained with BlueCode Coomassie. Bands, indicated by numbers, from both the pre-
immune and CAP-D2 fractions were isolated and sent for mass spectrometry. (B) and (C) 
represent two independent immunoprecipitation experiments. 
different groups by using several criteria. The first group contained proteins that were 
involved in the cell cycle, in mitosis and in cell communication (Table 1) due to the 
putative role of CAP-132 in interphase as well as mitosis. Proteins that were involved in 
cell communication were also selected since CAP-D2 was found to interact with proteins 
that are involved in cell communication (CG13502 and CG1313 1) in a Drosophila 
protein-protein interaction database (www.ihubiomed.org/perl/flynet.pl). These 
interactions were detected experimentally or mapped cross-species from Saccharomyces 
cerevisiae orthologs. The second group contained the four first proteins that had the 
highest MOWSE score from each band whose function did not fall into the first group 
(Table 2). 
The immunoprecipitation procedure was performed twice (Figure 3.11 B and C) 
and the two sets of results were compared in order to find proteins that were present in 
both experiments. These proteins are highlighted in red and likely represent true 
interactors since they were identified in two independent experiments. However, all 25 
proteins that were identified for each band and that were neither present in the pre-
immune nor in the two categories mentioned above, could be still true interactors of the 
CAP-D2 protein. Nevertheless, the possibility for this is low since their MOWSE score 
was quite low. 
The interactions between these proteins and CAP-D2 are preliminary and further 
experimental data are necessary to show which of these proteins truly interact with CAP-
D2. This screen could be a start for a new project. 
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Protein Name Band MOWSE Molecular Molecular Function Biological process 
Name Score weightlkDa 
CG15824 B! 1.6e+006 227.587 Unknown Putatively involved in 
cell comunication 
CG 11371 B4 1.34e+05 110.582 Unknown Putatively involved in 
cell comunication 
CG31510 B4 9.88e+04 129.29 Putatively involved in cell Unknown 
communication  
CG9277 B9 1.39e+12 50.148 Structural constituent of Cell motility; 
cytoskeleton ; GTP- chromosome 








CG5270 BI 1.05e+004 253.676 Putative actin binding Putatively involved in 
cell cycle 
CG 16742 BI 9.73e+003 160.899 Putative actin binding Unknown 
CG30 132 B8 44e+004 78.312 DNA topoisomerase Early meiotic 







CG 1618 138 1.61e+04 82.556 ATPase activity Intracellular protein 
tranport; mitosis 
CG9356 B8 1.3Ee+04 49.990 Putative chromatin binding Putatively involved in 
cell cycle 
CG1 1248 B8 8044 96.073 Structural constituent of Cell cycle; 
cytoskeleton; microtubule intracellular protein 
binding transport; mitosis; 
protein tergeting 
CG2512 139 1.14e+1 1 49.891 GTP-binding; structural Cell motility; 
constituent of cytoskeleton; chromosome 
tubulin binding segregation; 
intracellular protein 
transport; mitosis 
CG 1913 B9 1.149e+1 1 49.909 GTP-binding; structural Cell motility; 
constituent of cytoskeleton; chromosome 






CG 16940 B6 426 116.842 Exoribonuclease II RNA catabolism; 
activity; nucleic acid mitosis 
binding  
Table 3.1. Possible CAP-D2 interactors that are involved in cell communication, cell 
cycle and mitosis. 
Protein Name Band MOWSE Molecular Molecular Function Biological process 
Name Score weightlkDa  
CG6349 BI 2.72e+004 169.9 Alpha DNA polymerase Involved in DNA 
activity, nucleic acid strand 
binding; elongation;DNA 
3-5 exodeoxy- recombination 
ribonuclease activity  
CG13930 133 1.459e+04 77.626 Motor activity; putatively Unknown 
involved in microtubule 
—based movement which is 
a component of the 
microtubule associated 
complex  
CG6743 134 1.008e+05 97.383 Transporter activity Protein targeting 
135 5094  
CG3836 135 3.297e+04 112.874 RNA polymerase II Oocyte cell fate 
transcription factor activity determination; 
protein localisation 
CG32940 li5 1.514e+04 149.069 Unkown Unkown 
(aka Pif)  1.49e+05  
CG1571 137 8208 75.816 Motor activity; Microtubule based 
138 2.15e+04 Structural constituent of movement 
cytoskeleton; ATPase 
activity coupled  
CG15695 138 5.79e+04 83.096 Unknown Unknown 
CG 14870 C9 1.009e+05 26.866 Unknown Unknown 
CG 18102 CIO 3.736e+05 93.760 Actin binding; microtubule Defence response; 
(aka Dynamin, binding; intracellular protein 
Shibire) Microtubule motor activity; transport 
structural constituent of 
cytoskeleton; GTPase 
activity; small GTPase 
activity; dynamin GTPase 
activity  
CG13 127 C9 5.693e+04 52.372 Unknown Unknown 
Table 3.2. Possible CAP-D2 interactors that their MOWSE score was in the top four for 
each band that was sent for mass spectrometry. 
CHAPTER 4 
FUNCTIONAL ANALYSIS OF CAP-D2 
4.1. 	Introduction 
The condensin complex is known to be involved in chromosome condensation 
and segregation. However, exact roles for individual proteins within the complex 
remain to be determined. Mutations are useful tools for the elucidation of roles of 
proteins and thus a search was carried out in the Gadfly database in order to find a 
putative CAP-D2 mutation. Unfortunately no mutations that disrupt the CAP-D2 gene 
were identified. A P-element insertion located approximately 100,000 bp downstream 
of the CAP-D2 gene (Figure 3.1) and a deficiency (deletion of a whole chromosomal 
region [Df(3R) Dr-rvl, bc: 2538400-25500982)] that uncovers the region between 
99136-1 1), were identified. The deficiency also uncovers the bub3 gene (locus 99137) 
located next to the CAP-D2 gene (CAP-D2 is located at the 3' UTR of bub3 gene). 
Bub3 is involved in the mitotic checkpoint and thus interpretation of the analysis of a 
deficiency uncovering both CAP-D2 and bub3 genes would be very difficult and 
complicated, therefore no attempt to study this deficiency was undertaken. As for the P 
element insertion, P hopping could have been attempted however due to its large 
distance from the region, the possibility to get the P-element in the CAP-D2 gene was 
low. Thus, P hopping was not attempted either. 
As no CAP-D2 mutations were available, double stranded RNA mediated 
interference (dsRNAi) on S2 cells was used to elucidate the role of CAP-D2. This 
method, originally pioneered in C. elegans, has been widely used in different organisms 
including Drosophila (Sharp, 2001). 
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4.2. CAP-D2 dsRNA -mediated interference (RNAi) in Drosophila cultured cells 
results in abnormal chromosome morphology and behaviour 
In order to perform double stranded RNA mediated interference on CAP-D2, 
several Drosophila EST clones showing homology with the CAP-D2 gene were 
obtained and sequenced to confirm they contained the CAP-D2 cDNA (Chapter 2, Table 
I). The EST clone LD40412, contained the 5' end of the CAP-D2 cDNA and was used 
as a template for the PCR reaction to produce a 642 bp fragment of CAP-D2 dsRNA as 
described in Chapter 2 (Figure 4.1). S2 cultured cells were incubated with the dsRNA 
and samples were collected subsequently at 24 hr time points. Two negative controls 
were performed at the same time: cells that were incubated with dsRNA synthesized 
from a human intron (C) and cells with no dsRNA (-). Protein extracts from each time 
point were analysed by immunoblotting (Figure 4.2 A). A decrease in CAP-D2 levels 
was already apparent at 48 hrs and the protein was greatly depleted by 72 hrs and nearly 
undetectable by 96 hrs (the final depletion was estimated to be 94% based on 
quantitation of known cell numbers, Figure 3.2 D). The levels of the protein were 
unaffected in control cells, and chromosomes appeared normal through mitosis (Figure 
4.2 A and B). Immunofluorescence of the CAP-D2 RNAi cells confirmed that these 
cells had no CAP-D2 on their chromosomes. 48 hrs after the RNAi treatment, CAP-D2 
signal was decreased (data not shown) and by 72 hrs no CAP-D2 protein could be 
detected on the chromosomes of cells exhibiting abnormal chromosome morphology 
(Figure 4.2 Q. However these cells appeared to have some cytoplasmic staining which 
was also present in control cells and was therefore considered to be background staining. 
The cytoplasm was maintained in this preparation since the cells were fixed and then 
permeabilised. 
After counting the number of viable cells it was apparent that CAP-D2 RNAi 
cells grew more slowly than control cells. Cell number reached a plateau 72 hrs after 
treatment, and it did not change significantly afterwards (Figure 4.3 A). 
Different time points were assessed for mitotic index and the distribution of mitotic 
phases. The percentage of cells positive for histone H3 phosphorylated on Serine 10 
(P1-13), indicative for mitotic cells, was increased 2-3 fold in the CAP-D2 RNAi 
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Figure 4.1. 
Diagram showing the position of the primer pair that was used to amplify a 642 bp 
product for CAP-D2 dsRNA (red diagonal lines). The sequence of these primers is 
shown in Table V. 
PCR products after amplification of a region of a human intron (control) and a region 
of the 5' prime end of CAP-D2 eDNA. Ml is OX174 phage digested with ETaeIII 
molecular weight marker. 
Control and CAP-D2 dsRNA products. The PCR products shown in (B) were used as 
a template for the dsRNA synthesis of control and CAP-D2, respectively. 
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Figure 4.2. CAP-D2 dsRNA-interference in Drosophila S2 cells results in abnormal 
chromosome morphology and segregation. 
A. Immunoblot showing the depletion of CAP-132 after treatment with dsRNA. 5x105 cells 
were loaded per lane. CAP-D2 levels start to decrease as early as 48 hours and the protein 
becomes undetectable at 96 and 120 hours. a-tubulin was used as a loading control. Key: 
C (control dsRNA), - (no dsRNA), D (CAP-132 dsRNA). B and C. Immunofluorescence 
analysis of control and CAP-132 RNAi cells. Cells were cytospun 72 hours after treatment 
onto poly-L-lysine slides and stained for CAP-132 (red), Cyclin B (green), and DNA (blue). 
C. CAP-132 depleted cells have no CAP-132 on condensed chromosomes and exhibit an 
abnormal chromosome morphology. Cells also show severe segregation defects and 
unequal daughter nuclei. The scale bar represents 10tm. 
between 36 and 72 hours (6.7% of RNAi treated cells versus 2.2% of control cells, at 48 
hours) (Figure 4.3 B). At 24 hrs, 25% of the mitotic cells were abnormal while 
approximately 97% of mitotic cells displayed abnormal chromosome morphology 
between 48 hrs and 72 hrs (only 4-11% of control mitotic cells appeared abnormal) 
(Figure 4.3 Q. Therefore, most of the phenotypic analysis was carried out 65 or 72 hrs 
after treatment with dsRNA. Analysis by immunofluorescence showed dramatic 
chromosome defects after treatment with CAP-D2 dsRNA including failures in 
chromatid resolution, chromosome alignment, and segregation. Chromosomes were not 
properly aligned on the metaphase plate and they appeared fuzzy with ill-defined sister 
chromatids. In anaphase, chromosomes failed to resolve and segregate properly to the 
two poles with chromosome bridges forming between the two daughter nuclei (Figure 
4.2 Q. 
A consequence of the abnormal chromosome morphology was that the mitotic 
stage of the CAP-D2 depleted cells could not be easily determined. Particularly, it was 
not trivial to distinguish if cells were in prometaphase or anaphase. Thus the stage of the 
mitotic cells could only be distinguished after staining for mitotic proteins that are 
degraded naturally during anaphase, such as Cyclin B and members of the cohesin 
complex. Initially cells were stained for Cyclin B, a cofactor for the mitotic CDC2 
kinase that moves from the cytoplasm into the nucleus in late G2/early prophase, 
associates with condensed chromosomes during prophase and prometaphase, and 
subsequently associates with mitotic spindle and spindle poles during metaphase and 
finally is degraded during anaphase (Huang, 1999; Raff, 2002). It was obvious that the 
majority of CAP-D2 depleted cells were positive for Cyclin B as they had Cyclin B on 
the spindle and spindle poles (Figure 4.2 C, top two), and were therefore considered to 
be in prometaphase with unaligned chromosomes. Cells were grouped into the different 
phases of mitosis by using PH3/u-tubulin/Cyclin B triple staining (Figure 4.4 A). 
Between 36 hours and 72 hours, 67-88% of RNAi mitotic cells were in prometaphase 
compared to only 19-51% of control cells, suggesting a pronounced prometaphase delay 
(Figure 4.4 B). The anaphase index for the same period was very low: only 4% of 
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Figure 4.3. 
Growth curve showing the number of cells at different time points after dsRlNAi 
treatment. CAP-132 RNAi cells grew more slowly than control cells. Cell number 
reached a plateau 72 hrs after treatment, and cell number did not change significantly 
after that time. 
Graph showing the percentage of mitotic cells in control and CAP-D2 RNAi cells. 
The percentage of mitotic cells was increased 2-3 fold in the CAP-D2 RNAi between 36 
and 72 hours. 
Graph showing the percentage of abnormal mitotic cells in control and CAP-132 
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Figure 4.4. 
Graph showing the distribution of mitotic cells in the different mitotic phases after staining 
with Cyclin B/PH3/cL-tubulin, in control and CAP-D2 depleted cells. 
Graph showing the percentage of prometaphase cells after staining with Cyclin B/PH3/a-
tubulin, in control and CAP-D2 RNAi cells. There was a pronounced prometaphase delay 
between 36 and 72 hours in the CAP-D2 depleted cells. 67-88% of mitotic cells were in 
prometaphase during this period compared to only 19-51% of control cells. 
Graph showing the percentage of anaphase cells after staining with Cyclin B/PH3/a-
tubulin, in control and CAP-D2 RNAi cells. The anaphase index between 36 and 72 hours was 
very low in the CAP-D2 depleted cells. Only 4% of mitotic cells were in anaphase compared 
to 10-30% of control cells. 
compared to 10-30% of control cells (Figure 4.4 Q. The rest of the mitotic cells were 
distributed in the other mitotic phases without any noticeable delay (Figure 4.4 A). 
However, it was observed in control cells, that Cyclin B was not degraded from 
spindle poles in a minority of anaphase cells, as it normally is (Figure 4.2 B, bottom). In order 
to exclude any overinterpretation of the results by using Cyclin B, the stage of the mitotic cells 
(prometaphase or anaphase) was also estimated after staining for DSA 1, a subunit of the 
cohesin complex. DSA1 localises along the condensed chromosomes during prometaphase, 
with more intense labelling in the centromeric regions and a fainter labelling between sister 
chromatid arms. In metaphase, it is highly concentrated at centromeres and persists there until 
sister chromatids separate at the onset of anaphase (no DSAI can be detected on 
chromosomes). DSA 1 also stains the spindle poles and the spindle microtubules. During 
anaphase, the spindle poles are the most intensely stained structures (Valdeolmillos et al., 
2004). The protein levels of DSAI appeared unaffected in the CAP-D2 RNAi cells (Figure 
4.5 A). Cells were categorised in the different phases of mitosis by using DSA1/C[D double 
staining (Figure 4.5 B and C and 4.6 A). At 48 hours, the majority of cells were positive for 
DSA I and were therefore considered to be in prometaphase with unaligned chromosomes 
(67% of mitotic RNAi cells compared to 35% of control cells), suggesting a pronounced 
prometaphase delay (Figure 4.5 Cl and 4.6 B). The anaphase index for the same period was 
very similar to control cells (17% of mitotic RNAi cells compared to 20% of control cells) 
(Figure 4.6 B). At 72 hours, the prometaphase index of the RNAi cells was not significantly 
higher compared to control cells (66% of RNAi mitotic cells compared to 63% of control 
cells), while the anaphase index was higher in the RNAi cells (23% in the RNAi cells 
compared to 16% of control cells) (Figure 4.6 B). These results are similar to those found 
after Cyclin B staining. However, the peak in prometaphase index appeared to be different in 
the DSA1 and Cyclin B experiments: when stained for DSA1 the prometaphase index was 
slightly higher, but very similar to control cells at 72 hours, while in the Cyclin B staining the 
reduction of the prometaphase index happened sometime after 72 hours. One possibility is 
that this event could be dependent upon the particular stage of the culture when subjected to 
RNAi at 0 time. Another difference 
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Figure 4.5. A. Immunoblotting showing that the levels of DSA 1 were not affected 
72 hours after CAP-D2 RNA1 treatment. - (no dsRNA), C (control dsRNA), D 
(CAP-D2 dsRNA). x-tubulin was used as a loading control. B and C. Centromere 
resolution is disrupted in the CAP-132 depleted cells. Control (B) and CAP-D2 
depleted (C) cells were cytospun onto poly-L-lysine slides 72 hours after dsRNAi 
treatment, fixed and stained for DSA1 (green), CID (red) and DNA (blue). The 
majority of prometaphase/metaphase cells had normal CID staining between sister 
chromatids (Cl and higher magnification), while a small percentage showed CID 
slightly stretched (C2 and higher magnification). Cells in anaphase showed severe 
centromere stretching on chromosomes (C3, C4 and C5 and higher magnification). 
The DSA1 staining indicates the mitotic phase of the cells. The white boxes indicate 
the region from where the higher magnifications were taken. The scale bar 
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Figure 4.6. 
Graph showing the distribution of mitotic cells in the different mitotic phases after 
staining with DSA1/CID at 48 and 72 hours, in control and CAP-132 depleted cells. 
Graph showing the percentage of prometaphase and anaphase cells at 48 and 72 hours 
after staining with DSA1/CID, in control and CAP-D2 depleted cells. Cells are delayed 
in prometaphase at 48h (67% of mitotic RNAi cells compared to 35% of control) but 
they finally progress into anaphase, 72 hours after CAP-132 depletion (23% of RNAi 
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Graph showing the percentage of cells in cytokinesis in control and CAP-132 depleted 
cells. The percentage of cells in cytokinesis is very low in the CAP-132 depleted cells at all 
time points. 
Graph showing the percentage of bi- and tn- nucleate cells in control and CAP-D2 
depleted cells. The percentage of bi- and tn- nucleate cells increases by time in the CAP-D2 
depleted cells while is almost undetectable in control cells. 
between stainings was the anaphase index which was estimated to be higher at both 48 and 72 
hours after staining for DSA 1 compared to Cyclin B staining. However, this is consistent with 
the observation that Cyclin B persists on the spindle poles of some cells that entered anaphase. 
The mitotic phase of the cells that were in anaphase, with Cyclin B still present on the spindle 
poles, could be easily distinguished in control cells from their overall chromosome 
morphology. In the RNAi treated cells however, cells positive for Cyclin B were considered 
to be in prometaphase, since their chromosome morphology was compromised and 
subsequently no conclusion could be made for their mitotic stage. It is possible that some of 
these cells were in anaphase. 
Nevertheless, it was obvious from both approaches that CAP-132 RNAi cells 
were delayed in prometaphase before progressing into anaphase, albeit with evident 
failures in segregation that resulted in chromosome bridges forming bi-nucleate or even 
tn-nucleate cells (Figure 4.2 C, 4.9 B4 and 4.7 B). Frequently, daughter nuclei of 
unequal size were also observed, suggesting that chromosomes had not been equally 
distributed to the two poles during anaphase. Intriguingly, chromosomes were 
compacted relative to an interphase state in the CAP-D2 RNAi cells, though the 
resulting chromosomes appeared fuzzy, unresolved and hypercondensed. The 
hypercondensation is possibly a result of prometaphase delay. 
4.3. Chromosome and centromere resolution are compromised after CAP-D2 
depletion 
In order to confirm that chromatid resolution was defective, cells were treated with a 
hypotonic buffer that results in better chromosome spreading and improved observation 
of individual chromatids. The control cells appeared to have normal chromosome 
resolution and individual chromatid arms could be easily distinguished (Figure 4.8 A). 
In hypotonically treated CAP-D2 RNAi cells, individual chromatids were not visible and 
chromosomes appeared as balls of chromatin distinct from one another, albeit with usual 
levels of phospho-histone 113 (Figure 4.8 B). 
Immunolabeling for CID showed that centromeres were often stretched in the 
CAP-D2 RNAi cells (Figure 4.5 C and 4.9 B), while in control cells, centromeres were 
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Figure 4.8. Chromosome resolution is compromised after CAP-D2 depletion. 
A and B. Hypotonic treatment of control (A) and CAP-132 depleted (B) cells 65 
hours after dsRNA treatment shows that chromatid resolution is defective in the 
CAP-132 depleted cells. Cells were hypotonically treated, centrifuged onto poly-L-
lysine slides, fixed and stained for CAP-132 (red), PH3 (green) and DNA (blue). 
Note that individual chromatids are not readily apparent after depletion of CAP-132. 
The scale bar represents 10m. 
always distinct double dots in metaphase or cleanly separated from one another during 
anaphase (Figure 4.5 B and 4.9 A). The CID stretching was more obvious on 
chromosomes that were aligned on the metaphase plate and on chromosomes that were 
undergoing anaphase (Figure 4.9 B 1 and B3, and higher magnification), while distinct 
double CID spots were only detected on individual unaligned chromosomes (Figure 4.9 
B2, and higher magnification). Also, daughter nuclei connected with chromosome 
bridges still had centromeres extending between them (Figure 4.5 C5 and 4.9 B4, and 
higher magnification). In order to quantify these results, cells were stained for CID and 
DSA1 and categorised into different groups. 95% of the cells that displayed CID 
stretching between sister centromeres had no DSA1 on their chromosomes and were 
thus considered to be in anaphase (Figure 4.5 C3, 4.5 C4 and 4.5 CS, and higher 
magnification). 60% of these anaphase figures were in early anaphase, as concluded 
from the short distance between the centromeres of sister chromatids (Figure 4.5 C3 and 
4.5 C4, and higher magnification). The remaining 5% of cells that displayed CID 
stretching were positive for DSA1 and thus were considered to be in 
prometaphase/metaphase (Figure 4.5 C2, and higher magnification), dependent upon 
chromosome alignment on the metaphase plate. The CID stretching in these cells was 
not as extreme as in anaphase cells. The rest of the prometaphase/metaphase cells had 
no obvious CID stretching between their sister chromatids (Figure 4.5 Cl, and higher 
magnification). This suggests that tension applied upon bipolar alignment accentuates 
the defect in resolution, and therefore in anaphase, the most extreme stretching of CID 
stained regions was detected (Figure 4.5 C5, and higher magnification). These results 
suggest that CAP-D2, and likely the entire condensin complex, is primarily required for 
resolution of sister chromatids (of arms and centromeres) and in the establishment of 
mitotic chromosome architecture rather than chromosome compaction in Drosophila. 
4.4. Topoisomerase II localisation is affected in the CAP-D2 depleted cells 
DNA topoisomerase II (Topo II) has long been implicated in chromosome 
structure and dynamics, since its discovery as a chromosome 'scaffold' protein, and its 
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Figure 4.10. Effect on DNA topoisomerase IL in CAP-D2 depleted cells. 
A. Immunoblotting of control and CAP-132 depleted extracts with an antibody to 
Topo II shows that depletion of CAP-132 does not affect the level of Topo H. a-
tubulin was used as a loading control. C (control dsRNA), - (no RNA), D (CAP-132 
dsRNA). B and C. limmunolocalization of Topo II in control (B) and CAP-132 
depleted (C) cells after 65 hours of RNA] treatment. Cells were grown on 
Concanavalin A treated coverslips for the last 24 hrs, fixed and stained for Topo H 
(red), a-tubulin (green) and DNA (blue). In the CAP-132 depleted cells, Topo II 
localises to chromatin but any axial localisation is lost. Also the protein is slightly 
less and diffuse. The scale bar represents 10im 
localization at the base of chromatin loops (Earnshaw et al., 1985; Earnshaw and Heck, 
1985)(Gasser et al., 1986). Biochemical and localisation studies in Drosophila showed 
that CAP-H/Barren associated with Topo II throughout mitosis, while SMC4 appeared 
to be responsible for the axial localisation of Topo II on the chromosomes and for its 
decatenation activity (Bhat et al., 1996; Coelho et al., 2003). However, in S. pombe, the 
localisation but not the activity of Topo II was affected in condensin mutations, while 
Topo II localization to well-defined axial structures in Xenopus was independent of 
condensin (Bhalla et al., 2002; Cuvier and Hirano, 2003). Furthermore, in this study 
(Chapter 3), it has been shown that CAP-D2 and Topo 11 colocalise partially along the 
chromosomes axes during mitosis. For these reasons I decided to investigate whether 
the stability and localisation of Topo II were affected in the CAP-D2 depleted cells. By 
immunoblotting, the level of Topo IT appeared to be unaffected (Figure 4.10 A). 
However, the localisation of Topo 11 was altered in the CAP-132 depleted cells. Cells 
grown on Concanavalin A coverslips were stained for Topo II and c-tubulin. In control 
cells, Topo II associated with chromosomes in an axial pattern (Figure 4.10 B). In the 
CAP-132 depleted cells, Topo II still localized to chromatin, even though chromosome 
morphology was abnormal (Figure 4.10 Q. However, distribution was not restricted to 
an axial core and the protein was slightly less and more diffuse compared to control 
cells. This suggests that Topo II localisation is dependent upon CAP-D2. 
4.5. CAP-H/Barren is unstable in cells depleted of CAP-D2 
As CAP-D2 is one subunit of a complex, it is possible that associated proteins may be 
affected by its depletion. For this reason, the stability and localisation of the other 
subunits of the complex were analysed upon depletion of CAP-132. Immunoblotting of 
RNAi cell extracts for CAP-H/Barren, revealed that the levels of this protein were 
affected by the depletion of CAP-D2 (Figure 4.11 A). CAP-H/Barren may be more 
tightly associated with CAP-D2 compared to the SMC subunits, as suggested in the 
immunoprecipitations presented in Chapter 3. As no sequence similarity exists between 
the two proteins, the depletion by RNAi should be specifically directed only against 
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Figure 4.11. Effect on condensin subunits. 
A. Immunoblotting of control and CAP-132 depleted extracts with Barren, SMC4 and 
SMC2 antibodies demonstrates that Barren levels are reduced while SMC4 and SMC2 
levels appear largely unaffected after loss of CAP-132. a-tubulin was used as a loading 
control. Key: C (control dsRNA), - (no RNA), D (CAP-132 dsRNA). B and C. Cells 
from both control (B) and CAP-132 RNAi (C) experiments were cytospun onto poly-L-
lysine slides 72 hours after treatment and stained for Barren (red), Cyclin B (green) and 
DNA (blue). Barren is absent from mitotic chromosomes and it appears to localise 
diffusely in the cytoplasm after CAP-132 RNAi. The scale bar represents 10pm. 
CAP-D2. In contrast, when the same analysis of SMC2 and SMC4 was done, no 
substantial change was observed in their protein levels (Figure 4.11 A). 
4.6. Inzrnunolocalisation of Barren, SMC4 and SMC2 in CAP-D2 depleted cells 
Although the levels of CAP-H, SMC2 and SMC4 were not similarly affected, it was 
possible that localisation could still be influenced after the depletion of CAP-D2. To 
examine this, cells were cytospun onto poly-L-lysine slides after dsRNA treatment and 
immuno fluorescence for CAP-H, SMC4 and SMC2 was performed. In control cells, 
CAP-H associated with chromosomes and localised to sister chromatid cores (Figure 
4.11 B). In the CAP-D2 depleted cells, CAP-H protein appeared to localise diffusely in 
the cytoplasm and no CAP-H could be detected on the chromosomes (Figure 4.11 Q. 
To examine the localisation of the SMC4 subunit, double staining with CAP-D2 
(rabbit) and SMC4 (sheep) antibodies was performed 65 hrs after dsRNA treatment. It 
was thus possible to observe the localisation of SMC4 in cells that were clearly negative 
for CAP-132. Cells were extracted during fixation and thus no cytoplasmic staining was 
observed for CAP-D2. In both control and CAP-D2 depleted cells, SMC4 was localised 
on the chromosomes (Figure 4.12 A), even though chromosome morphology was 
abnormal in the CAP-132 depleted cells (Figure 4.12 B). However, distribution was not 
restricted to an axial core in the CAP-132 depleted cells, presumably because of the 
abnormal chromosome organisation. In approximately 40% of the abnormal cells, the 
SMC4 signal was more severely reduced (Figure 4.12 B 1 and 134) than in other CAP-D2 
depleted cells (Figure 4.12 B2 and 133), which may reflect an uneven RNAi efficiency 
across the cell population. 
SMC2 stability and localisation was also examined. As for SMC4, the levels of 
SMC2 appeared largely unaffected as CAP-D2 was depleted (Figure 4.11 A). Because 
both CAP-D2 and SMC2 antibodies were raised in rabbits, double immunolabeling was 
not possible. Therefore, cells were double-labelled for SMC2 and topoisomerase II 
(using the guinea pig antibody), as a marker for the chromosome scaffold. In control 
cells, both SMC2 and topoisomerase II associated with chromosomes in a striking axial 
pattern (Figure 4.13 A). After CAP-D2 depletion, SMC2 localized to chromatin masses, 
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Figure 4.12. Control (A) and CAP-132 RNAi (B) cells were cytospun onto poly-
L-lysme slides 65 hours after treatment, extracted during fixation, and stained for 
SMC4 (red), CAP-132 (green) and DNA (blue). While cells have varying levels of 
SMC4 on chromatin (compare B  and B4 with B2 and B3), any axial localisation 
of SMC4 is lost in the CAP-132 depleted cells. The scale bar is 10 .tm. 
albeit in an unrestricted manner reflecting aberrant chromosome organisation, similar to 
SMC4 behaviour. Approximately half of these cells (43%) had what appeared to be 
reduced levels of SMC2 (Figure 4.13 B 1) while 47% had higher levels of SMC2 (Figure 
4.13 132). Cells with reduced levels of SMC2 also had decreased levels of 
topoisomerase II, suggesting that these cells may be overall more severely affected. The 
remaining 10% had SMC2 localise diffusely on chromosomes and mitotic spindle 
(Figure 4.13 133). In these cells, Topo II was also slightly diffuse but not to the same 
extent as SMC2. Taken together, these results suggest that the axial localisation of 
SMC4, SMC2, and Topoisomerase II is dependent on proper chromosome resolution 
which requires CAP-D2, and CAP-H/Barren (as it is also depleted). 
4.7. Cohesin dissociates normally from chromosomes at the onset of anaphase in 
CAP-D2 depleted cells 
It is possible that chromosome bridges formed during anaphase in CAP-D2 depleted 
cells are a consequence of an abnormal dissociation of cohesin during anaphase. 
However, as described above for DSA I, both its levels and its localisation were similar 
to those observed for control cells (Figure 4.5). DSA1 dissociated from chromosomes at 
the onset of anaphase as normal. Similarly, when the stability and localisation of 
Drad21/Sccl, another subunit of the cohesin complex was assessed, no difference was 
observed between control and RNAi treated cells (Figure 4.14). The Drad2 l/Sccl 
subunit had a similar localisation pattern as that described for DSA 1. From these 
observations it can be concluded that the dissociation of cohesin from chromosomes 
during anaphase is not dependent on CAP-D2. 
4.8. Compromise in mitotic coordination after loss of condensin function: 
4.8.1. Effect on chromosome passengers 
The chromosome is not an isolated entity, but rather must be considered in the context of 
the rest of the cell. INCENP is a member of the chromosomal passenger complex along 
with Aurora B kinase, Survivin, Borealin, and TD-60 (Adams et al., 2001a; Gassmann et 
al., 2004; Sampath et al., 2004). Chromosome passengers localise to centromeres at 
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Figure 4.14. Cohesin dissociates normally from chromosomes at the onset of anaphase 
A. Immunoblotting showing that the levels ofDrad2l/Sccl were not affected after CAP-D2 
RNA1 treatment. - (no dsRNA), C (control dsRNA), D (CAP-D2 dsRNA). a-tubulin was 
used as a loading control. B and C. Dad2l dissociates normally from chromosomes at the 
onset of anaphase in the CAP-D2 depleted cells. Control (B) and CAP-D2 depleted (C) cells 
were cytospun onto poly-L-lysine slides 72 hours after dsRNAi treatment, fixed and stained 
for Drad2l/Sccl (green), CD (red) and DNA (blue). Drad2lis present at the centromeres 
during prometaphase/metaphase and it dissociates during anaphase in both control (B) and 
CAP-D2 (C) depleted cells. The scale bar represents I Oim. 
prometaphase and metaphase, associate with the central spindle at the onset of anaphase 
and finally localise to the midbody in cytokinesis. INCENP is required for the correct 
targeting of Aurora B at all times in mitosis and Aurora B has been shown to 
phosphorylate histone H3 during mitosis, an event that coincides with the initiation of 
chromosome condensation. 
The stability and localisation of INCENP was examined to assess whether 
chromosome passenger dynamics were affected when condensin function was 
compromised. While immunoblotting for INCENP revealed that protein level was 
unaffected in CAP-D2 dsRNA treated cells (Figure 4.15 A), the localisation of this 
protein was clearly affected (Figure 4.15 Q. Cells grown on Concanavalin A-coverslips 
were stained for INCENP and c-tubulin. In CAP-D2 RNAi prometaphase cells, 
INCENP localized to chromatin but occupied a more extensive area compared to the 
restricted centromeric localisation in control cells (compare Figure 4.15 B with 4.15 Cl). 
This may be a result of the stretched centromeric regions in CAP-D2 depleted cells, as 
shown by CID staining. In 60% of anaphase cells (generally 'early' anaphases), 
INCENP was abnormally present on chromatin and dispersed throughout the spindle, 
with failure to concentrate on the spindle midzone (compare Figure 4.15 B with 4.15 
C2). The remaining 40% of the anaphase cells (generally 'later' anaphases) showed the 
expected association of INCENP with the central spindle even though these cells had 
severe segregation problems (Figure 4.15 C3). In 50% of cells undergoing cytokinesis, 
INCENP was unexpectedly still on chromatin as well as localised to the midbody 
(Figure 4.15 C4). In the remaining dividing cells, INCENP localised to the midbody, 
albeit in a more dispersed fashion (Figure 4.15 CS). From these observations, it can be 
concluded that proper chromosome resolution and segregation is requisite for the 
appropriate timing of passenger transfer. However, by the end of mitosis, the majority 
of INCENP localizes appropriately with the midbody. 
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Figure 4.15. INCENP exhibits temporal mislocalization in cells depleted of CAP-
02. 
A. Immunoblotting of control and CAP-D2 depleted extracts with the INCENP 
antibody at 72 and 96 hours showed that the protein level has not been affected by the 
depletion of CAP-D2. a-tubulin was used as a loading control. - (no dsRNA), C 
(control dsRNA), D (CAP-D2 dsRNA). 
B and C. Immunolocalisation of INCENP in control (B) and CAP-132 depleted (C) 
cells 65 hours after dsRNA treatment. Cells were grown on Concanavalin A coverslips 
for the last 24 hrs, fixed and stained for INCENP (red), o-tubulin (green), and DNA 
(blue). In comparison to control prometaphase cells, INCENP occupies a more 
extensive area on prometaphase chromosomes (Cl) after CAP-D2 depletion. In 
anaphase, IICENP is dispersed throughout the spindle and on the chromosomes (C2), 
or associates with the central spindle normally (0). In cytokinesis, INCENP can be 
found abnormally on the chromosomes as well as the midbody (C4), or just at the 
midbody as expected (CS). The scale bar represents lOtm 
A) 72h 	96h 
F# 	Aio Ass 1NCENP 
a-tubulin 















4.8.2. Metaphase checkpoint 
BubRi is a metaphase checkpoint protein kinase that 'senses' the completion of 
chromosome alignment at the metaphase plate. It associates with kinetochores during 
prophase and dissociates from kinetochores that have made stable attachments to the 
spindle (Chen et al., 2002; Jablonski et al., 1998; Taylor et al., 2001). To examine the 
status of the metaphase checkpoint in CAP-D2 depleted cells, cells grown on 
Concanavalin A coverslips were analysed for BubRi and u-tubulin 65 hours after 
dsRNA treatment. In control cells, BubRi associated with chromosomes that were not 
yet aligned to the metaphase plate while BubRi signal was greatly reduced in 
chromosomes that had satisfied the metaphase checkpoint by achieving alignment on the 
metaphase plate (Figure 4.16 A, upper). As expected during anaphase, BubRi was 
undetectable at kinetochores (Figure 4.16 A, middle). Chromosomes in 
prometaphase/metaphase RNAi cells were normal with regard to appearance of BubR 1 
staining (Figure 4.16 B, upper two). However, there was still detectable BubRl on 
anaphase and telophase chromosomes in CAP-132 RNAi cells (Figure 4.16 B, lower 
two). Though these cells had proceeded into anaphase, paradoxically they behaved as 
though the checkpoint was still operative, exhibiting evident BubRl localization. These 
cells apparently were not satisfied for the metaphase checkpoint but they nevertheless 
proceeded into anaphase. It is also possible that cells never entered metaphase and that 
they proceeded from prometaphase directly into anaphase with unaligned chromosomes 
never progressing onto the metaphase plate. This could explain the fact that spindle 
poles have an intense BubRl signal (Figure 4.16 B, arrows). Also this possibility is 
consistent with what was observed after staining for DSA1/CID. CAP-132 depleted cells 
in early anaphase (negative for DSA 1) had unaligned chromosomes with two CID spots, 
which failed to bi-orient properly on the metaphase plate and individual chromatids 
never separated during anaphase (Figure 4.5 C3 and C4). However, it could be possible 
that BubRi epitopes were more accessible to the antibody, since the chromatin was not 
organised properly, and thus a BubRi signal is still detected on chromosomes. As 
observed for CID, the BubRi signal was also stretched along chromatin, suggesting that 
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Figure 4.16. Aberrant behaviour of BubRi, a metaphase checkpoint protein, 
after CAP-D2 depletion. 
Control (A) and CAP-D2 depleted (B) cells were processed 65 hours after dsRNAi 
treatment, grown on Concanavalin A coverslips for the last 24 hrs, fixed and stained 
for BubRi (red), u-tubulin (green), and DNA (blue). CAP-D2 depleted cells that are 
in anaphase or telophase (arrows), as determined from chromosome morphology and 
from comparison with cells that were stained with Cyclin B or DSA1, have BubRi 
on their centromeres, while it is undetectable on centromeres of aligned and 
separated chromosomes in wild type cells. The scale bar is 10 im. 
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Figure 4.17. Bub3 levels are unaffected in the CAP-D2 depleted cells 
Immunoblot analysis of control (C) and CAP-D2 (D) depleted cells with the Bub3 
antibody. Bub3 protein levels are unaffected in the CAP-D2 depleted cells. C (control 
dsRNA), D (CAP-D2 dsRNA). 
defective centromere resolution may have had additional consequences on the 
localization of at least one metaphase checkpoint component. Intriguingly, aberrant 
metaphase checkpoint behaviour after the depletion of CAP-D2 may be causal to the 
observed prometaphase delay. 
As already mentioned previously, the CAP-D2 gene is located in the 3' UTR of 
the bub3 gene. Despite the fact that depletion by RNAi should be specifically directed 
only against CAP-D2, I decided to check that Bub3 protein levels were not 
affected after CAP-D2 depletion. Immunoblot analysis of control and CAP-D2 depleted 
cells revealed that the levels of Bub3 were unaffected (Figure 4.17). Thus the 
checkpoint defects described above were not a consequence of indirect depletion of 
Bub3. 
4.9. Depletion of both CAP-D2 and Topo II results in chromosome morphology no 
more severe than that observed in cells depleted for CAP-D2 alone 
Since the resolution of sister chromatids was compromised in CAP-D2 depleted cells 
and Topo II is important for decatenating DNA strands, it seems likely that the 
condensin complex and Topo II collaborate to organise mitotic chromosomes. 
Furthermore, the phenotype observed in this study when CAP-D2 was depleted by 
RNAi, was very similar to the phenotype obtained after depletion of Topo II (Chang et 
al., 2003) (Figure 4.18 C and D). In order to determine if these proteins have similar or 
distinct roles in organising mitotic chromosomes, CAP-D2/Topo II double RNAi was 
performed. Immunoblotting showed that both proteins were greatly depleted 72 hours 
after treatment (Figure 4.18 A). Immunofluorescence analysis at 96 hours revealed that 
cells depleted for both proteins (Figure 4.19 B) exhibited an abnormal chromosome 
morphology and behaviour no more severe than in either of the single depletions (Figure 
4.18 C and D). Surprisingly, the ability of chromosomes to compact appeared as it did 
in either single RNAi (compare Figure 4.18 C and D with 4.19 B). In addition, 
chromosomes in the double RNAi failed to resolve, and formed bridges during anaphase 
(Figure 4.19 B). Chromosome congression defects, observed previously after Topo II 
depletion (Chang et al., 2003) were also noted (Figure 4.18 D, top two and 4.19 B, top). 
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Figure 4.18. Depletion of CAP-D2 and DNA topoisomerase II results in a similar 
phenotype. A. The depletion of CAP-132 and Topo H after treatment with two dsRNAs was 
assessed at 72 and 96 hours by immunoblot analysis. Both proteins were depleted with similar 
kinetics and they are almost undetectable by 96 hrs. a-tubulin was used as a loading control. - 
(no dsRNA), C (control dsRNA), D (CAP-D2 dsRNA), T (Topo H dsRNA), D/T (CAP-D2/Topo 
II dsRNA). B, C and D. Analysis of the chromosome morphology in control (B) CAP-D2 (C) 
and Topo 11(D) depleted cells. Cells were cytospun onto poly-L-lysine slides, extracted during 
fixation and stained for Topo II (red), CAP-132 (green), and DNA (blue), 96 hours after the 
dsRNA treatment. Chromosome morphology was abnormal and remarkably similar between 
the two experiments. Note the chromosome congression defect after Topo II depletion. The 
scale bar is 10 urn. 
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Figure 4.19. Analysis of the chromosome morphology in control (A) and CAP-
D2/Topo II doubly-depleted (B) cells. Cells were cytospun onto poly-L-lysine slides, 
extracted during fixation and stained for Topo II (red), CAP-132 (green), CID (white) 
and DNA (blue), 96 hours after the dsRNA treatment. Chromosome morphology was 
abnormal and remarkably similar to that observed after single CAP-132 and Topo II 
RNAI. Centromeres were stretched along the chromatin in anaphase as observed 
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Figure 4.20. 
Growth curve showing the number of cells at different time points after CAP-132 
and Topo II single depletions and CAP-D2/Topo II double depletion. Cells grow with 
similar kinetics in controls and single and double depletions. 
Graph showing the percentage of mitotic cells in control and RNAi cells. The 
percentage of mitotic cells was increased 2-3 fold in the CAP-D2 RNAi single 
depletion and CAP-D2/Topo II double depletion at 72 and 96 hours. The mitotic index 
was mainly increased at 96 hours in the single Topo 11 depletion. 
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Figure 4.21. 
Graph showing the percentage of abnormal mitotic cells in control, CAP-D2 and Topo 
II RNAi single depletions and CAP-D2/Topo II double depletions. The majority of cells are 
abnormal, 72 hours after dsRNAi treatment in both single and double depletion. 
Graph showing the distribution of mitotic cells in the different mitotic phases after 
staining with Cyclin B/P—H3/a-tubulin, in control and RNAi cells 
Graph showing the percentage of prometaphase cells after staining with Cyclin 
B/P1-13/c-tubulin, in control and RNAi cells. There was a pronounced prometaphase delay 
between 48 and 96 hours in the CAP-132 depleted and CAP-D2/Topo II depleted cells. In 
the Topo II depleted cells there was a prometaphase delay but not as significant as in the 
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Figure 4.22 
Graph showing the percentage of cells in cytokinesis in control, CAP-D2 and Topo H 
RNAi single depletions and CAP-D2/Topo II double depletion. 
The percentage of cells in cytokinesis is very low in the CAP-132 single and CAP-D2/Topo 
II double depletions 48 hours after dsRNAi. The percentage in the Topo II single depletion 
is very similar to the controls. 
Graph showing the percentage of bi- and tn- nucleate cells in control and RNAi cells. 
The percentage of bi- and tn- nucleate cells increases by time in both the single and double 
depletions. 
After counting the number of viable cells it was obvious that RNAi cells grew 
with similar kinetics as control cells (Figure 4.20 A). Different time points were 
assessed for mitotic index and the distribution of mitotic phases. The percentage of cells 
positive for histone H3 phosphorylated on Serine 10 (P—H3) was increased 2-3 fold in 
the double RNAi compare to the single CAP-132 RNAi between 72 and 96 hours (7.7% 
versus 3.1% at 72 hours) (Figure 4.20 B). In the Topo II single depletion the mitotic 
index was similar to controls at 72 hours but was slightly higher at 96 hours (4.6% 
versus 2.5%). The number of abnormal mitotic cells was similar between the single and 
double depletions and increased over time (Figure 4.21 A). Cells were categorised into 
the different phases of mitosis by using PFI3/a-tubulin/Cyclin B triple staining (Figure 
4.21 B). There was a pronounced prometaphase delay between 48 hours and 96 hours in 
the CAP-D2 single and the CAP-D2/Topo II double depletions (about 2-fold increase), 
while no significant prometaphase delay could be seen in the Topo II single depletion 
(Figure 4.21 Q. Finally bi- and tn- nucleate cells were observed in equal levels in both 
the double and single depletions (Figure 4.22 B). 
In order to better assess the different phenotypes of the single and double 
depletions, metaphase chromosome spreads were performed after cells were treated with 
colchicine. RNAi treated and control cells were cytospun onto poly-L-lysine slides and 
stained for CAP-D2, Topoll and DNA. The control cells displayed the typical X-shaped 
structure and sister chromatids were properly resolved. Both CAP-D2 and Topo II 
localised axially along the length of the chromosomes and the two proteins partially co-
localised. (Figure 4.23 Al, A2 and 4.23 B, control). In both Topo II and CAP-D2 single 
depletions and in the TopoII/CAP-D2 double depletion chromosome morphology was 
very abnormal. The structural integrity of these chromosomes was compromised with 
chromatin appearing torn and stretched. No axial staining could be observed in either 
experiment (Figure 4.23 A3, A4 and AS). However Topo II levels were not significantly 
affected in the CAP-D2 RNAi, as previously mentioned (Figure 4.23 A3). Similarly, 
levels of CAP-D2 were not affected in the Topo II depleted cells (Figure 4.23 A4), 
which is consistent with previous observations for Barren localisation (Chang et al., 
2003). When individual chromosomes were observed it was apparent that sister 
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Figure 4.23. Depletion of CAP-D2 and DNA Topoisomerase H in coichicine 
treated S2 cells 
A and B. Metaphase chromosome spreads of control, Topo II depleted cells, CAP-132 
depleted cells and CAP-D2/Topo II doubly-depleted cells, after cells were treated with 
colchicine. Cells were cytospun onto poly-L-lysine slides, extracted during fixation 
and stained for Topo II (red), CAP-132 (green) and DNA (blue), 74 hours after dsRNA 
treatment. A. Control cells displayed the typical X-shaped structure and sister 
chromatids could be easily distinguished. Both CAP-132 and Topoli localised axially 
along the length of the chromosomes and the two proteins were partially colocalised 
(Al, A2 and B, Control). In Topo II (A3) and CAP-132 (A4) single depletions and in 
the CAP-D2/Topo II double depletion (A5) no sister chromatid resolution could be 
observed and chromosomes appeared fuzzy. The scale bar is 10 pm. 
B. Individual chromosomes observed in chromosome spreads. The phenotype was 
similar between the two single (CAP-D2 RNAi and Topo TI RNAi) and the double 
(CAP-D2/Topo II RNAi) experiments. Chromosomes appeared unresolved and fuzzy. 
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chromatids were not resolved and chromosomes appeared fuzzy and diffuse (Figure 4.23 
B). The phenotype was similar between the single and double depletion experiments as 
chromosomes appeared well compacted but unresolved. Since no difference in 
phenotype was observed at this level between the CAP-D2, Topo II and CAP-D2/Topo 
II doubly depleted cells, it appears most likely that Topo II and the condensin complex 
participate in the same pathway to resolve sister chromatids. It is therefore suggested 
that additional, as yet unidentified, factors are required for to bring about appropriate 
chromosome compaction during mitosis. 
4.10. Reciprocal dependence on stability: CAP-D2 is unstable in a barren mutant 
Depletion of the CAP-D2 protein by dsRNAi affected the stability of the CAP-H/Barren 
protein. To test if reciprocal stability was true (i.e. the levels of CAP-D2 protein were 
affected by the absence of CAP-H/Barren), a barren mutant, barr' 305, was examined. 
barrL3O5 is a null mutation which causes lethality late in embryogenesis (Bhat et al., 
1996). Analysis by immunoblotting of embryonic extract from barr homozygous 
embryos ('-12-13 hours old) showed that when the level of Barren was decreased, CAP-
D2 was greatly reduced as well (Figure 4.24 A). Quantitation of protein levels using 
phosphorimaging revealed that Barren was decreased 8-fold compared to wild type 
embryos while the level of CAP-D2 was 6-fold lower. The fact that both proteins were 
decreased to nearly the same extent strongly suggests that the two proteins are tightly 
associated with each other and that they very likely depend on each other for stability. 
The residual Barren protein on the blot was a maternal contribution to the embryos. 
When the same membrane was reprobed with antibodies to SMC2 and SMC4 subunits, 
it was obvious that their levels were also reduced but not to the same extent (Figure 4.24 
A). Quantitative analysis showed that SMC2 was reduced 4-fold and SMC4 3.5-fold, 
consistent with participation of some of the two SMC proteins in a second complex. It is 
possible, of course, that some of the remaining SMC proteins are maternal components 
that are quite stable (see gluon 17C  mutant). Quantitations were repeated twice in two 
independent experiments. The presence and stability of Scc 1 /Drad2 1, a member of the 
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Figure 4.24. Instability of additional condensin subunits after mutation of only one 
in Drosophila. A. CAP-D2 is unstable when Barren is absent in a barr'-305 mutant. 
Immunoblot of embryonic extract from 12-1 3hours wild type (Canton S) and ban-L 305  
homozygous embryos shows that Barren is almost undetectable in homozygous mutant 
embryos. The remaining protein is the maternal contribution to the embryos. The 
membrane was probed for Barren, CAP-D2, SMC2, SMC4 and Sccl and the decrease in 
protein level was calculated using phosphorimaging. 5 embryos were loaded per lane. 
Barren levels decreased 8-fold, CAP-D2 levels decreased 6-fold and SMC2 and SMC4 
levels decreased 4-fold and 3.5-fold respectively. o-tubulin was used as a loading 
control. B. Stability of other condensin subunits in an SMC4 (gluonh7C)  mutation. 
Immunoblot of embryonic extract from 12-13 hours wild type (Canton 5) and gluon 17C 
homozygous embryos with the SMC4, SMC2, CAP-D2 and Barren antibodies. The 
levels of the four proteins were calculated using phosphorimaging. 5 embryos were 
loaded per lane. SMC4 shows a 5.9-fold decrease in protein levels, SMC2 shows a 5.6-
fold decrease, while Barren and CAP-D2 show a 4.7-fold decrease. a-tubulin was used 
as a loading control. 
cohesin complex (Vass et al., 2003), was analyzed as well. This protein appeared to be 
unaffected, as was the level of a-tubulin, by mutation of CAP-H/Barren (Figure 4.24 A). 
The stability of the condensin subunits was also examined in an SMC4 mutant, 
gluon17'. This is an embryonic lethal null mutation for SMC4, that removes 
approximately 31 kb including the SMC4 gene (accession AJ543 652). Analysis by 
quantitative immunoblotting of  gluon  h?C  embryonic extract (12-13 hours old) showed 
that the SMC4 protein was decreased 5.9-fold compared to wild type embryos (Figure 
4.24 B). The existence of residual protein suggested that the maternal component was 
possibly quite stable, or that the remaining protein may be required later in development 
for another function. When the levels of the rest of the subunits were assessed, it was 
observed that the SMC2 subunit was decreased to the same extent as SMC4 (5.6 fold), 
while CAP-D2 and CAP-H/Barren were reduced 4.7-fold (Figure 4.24 B). These results 
revealed that in the absence of one of the condensin subunits in Drosophila, the 
abundance and stability of the rest were affected. Furthermore, the strength of the 
interactions between the four examined members of the condensin complex appears to 
vary as the non-SMC subunits, CAP-D2 and CAP-H/Barren, show similar tight 
dependencies on one another for stability in the animal and in cultured cells. 
4.11. In vivo analysis of CA P-D2 function 
The functional analysis of CAP-D2 described above was carried out in tissue culture 
cells. It would be interesting to assess the CAP-D2 function in an in vivo system. For 
this reason I attempted to inject syncytial Drosophila embryos that were expressing 
I-12A-GFP with the CAP-D2 antibody. Therefore, it was able to observe the phenotype 
caused in the absence of CAP-D2 and also to calculate the time of the delay in each 
mitotic phase. For this reason the CAP-D2 antibody was dialysed in a specific buffer as 
described in Chapter 2 and it was injected into embryos. Unfortunately, no phenotype 
was observed. At the same time the buffer alone was injected as a control. Even though 
the antibody was concentrated before the injections, it is possible that it was not 
concentrated enough in order to cause loss of CAP-D2 function. Nevertheless, no 
further attempts were carried out with this analysis. 
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CHAPTER 5 
Characterisation of JSL2 - an SMC2 mutation 
5.1. 	Introduction 
An EMS mutagenesis screen that took place in Dr. Jeff Sekeisky's lab at the University 
of North Carolina, generated seven lethal lines named JSL-2,-6,-10,-1 1,-12,-13,-14. His 
lab was interested in the Erccl (excision repair endonuclease) protein, which maps close 
to the SMC2 locus (CG 10212), a subunit of the condensin complex. The seven lines 
were not disrupting the erccl gene, thus they were sent to our lab in order to be analysed 
as potential SMC2 mutations. An honours student in the lab in 2001, Hannah Townley, 
crossed each line to the others in order to characterise which of these lines were allelic. 
JSL-6 and —10 were allelic and JSL-10 and -11 as well. Also she found that JSL- 6, 10, 
13, 14 were embryonic lethal and JSL-2, 11, and 12 were larval lethal. By analysing the 
larval lethal lines by immunoblotting with an antibody against SMC2, she found that 
only the JSL2 line lacked the 136 kDa band that was present in the wild type and 
corresponded to the SMC2 protein. Also a smaller protein of about 57 kDA was present 
in the mutant extracts, but it was absent from the wild type. Homozygous mutant larvae 
could reach the point of third instar before dying. The mutation was carried over the 
CyO-GFP balancer and homozygous larvae could be easily selected under the 
fluorescence microscope. The next step was to sequence the mutation in order to 
confirm that the mutation was affecting the SMC2 gene. My contribution to this project 
involves the sequencing of the mutation and its further characterisation. 
5.2. Sequencing of the JSL2 mutation 
The SMC2 gene maps to the right arm of the second chromosome in the 5105 region. A 
4456 bp cDNA encodes a protein of 1179 amino acids (Mr=136 kDa). The gene consists 
of six introns and seven exons (Figure 5.1 A). In order to sequence the .JSL2 mutation, 
primers were designed to cover the whole gene including 500bp upstream and 
downstream of the SMC2 gene (Figure 5.2) (Table VII and VIII. Primers SMC2-1 to -36 
were designed by Neville Cobbe, a PhD student in the lab before I arrived). 
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Figure 5.1. A. Representation of the DrnSMC2 gene. The gene consists of 6 introns 
and 7 exons. A 4456 bp cDNA encodes for a protein of 1180 amino acid residues. 
B. Sequencing of JSL2, an SMC2 mutation, revealed that cytidine was substituted by 
thymidine at the position 2482 of the coding sequence, causing a stop codon in the 
place of glutamine and the production of a truncated protein of 827 amino acid 
residues. The truncated protein lacks the carboxyl globular domain and a part of the 
coiled coil sequence, which are necessary for the function of the SMC2 protein. 
Amino acids 24-309 (green box with diagonal lines on wild type SMC2 protein) 
represent the protein region that was used for the generation of the SMC2 antibody. 
Genomic DNA was extracted from homozygous second instar JSL2 larvae. The size of 
the homozygous JSL2 larvae was almost one third of the wild type and that made the 
work difficult. The reason that second instar larvae were selected was that the JSL2 
homozygous flies were dying as second instar larvae instead of third instar, a year after 
the mutation arrived in the lab, probably because additional mutations were introduced 
into the stock during its maintenance. The gene was amplified by PCR by using different 
combinations of primers (Table IX, Figure 5,4 and 5.5). The PCR products covered the 
whole gene and were usually overlapping in order to confirm the sequencing results 
(Figure 5.2). PFU, a proofreading polymerase (3'-5' exonuclease activity, Promega), 
was used for PCR amplification in order to minimise any mistakes introduced by the 
enzyme. As a control, the wild type SMC2 gene was amplified from wild type CaS third 
instar larval DNA using the same primer-pairs (Figure 5.3). The PCR products were then 
sequenced and the results were analysed by the Lasergene Navigator EditSeq alignment 
program. In the mutant sequence, a base was substituted (cytidine to thymidine) in the 
position 2482 of the coding sequence. This caused the change of the codon that encodes 
for the amino acid Glutamine (Q) to a stop codon (CAG codon to TAG codon) which 
should result in the synthesis of a truncated protein of about 827 amino acid residues 
(predicted Mr 94 kDa). The truncated protein lacks the carboxyl globular domain and a 
part of the coiled-coil sequence, which presumably are necessary for the function of the 
SMC2 protein (Figure 5.1 B). In an immunoblot analysis, a band of about 52 kDa was 
recognised in the extract from homozygous mutant larvae, which was absent from the 
wild type (Figure 5.8). The size of this band was smaller than the estimated size. This 
could be due to the fact that the truncated protein is not stable and it gets degraded or that 
it runs anomalously on gels. 
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Figure 5.2. Strategy used for the amplification of SMC2 gene. Primer pairs Al-36 
are shown. The position of the primer pairs is shown relative to the SMC2 gene 
regions. The numbers I-VII correspond to the seven exons of the SMC2 gene. The 
5' and 3'UTR'sof the SMC2 gene are shown as well. The primers used are 


















Figure 5.3. PCR products after amplification of the SMC2 gene from wild type GaS 
third instar larval genomic DNA. The primer pairs that were used to amplify each 
product are shown (Al -43). Ml and M2 are the X phage digested with Hindll and 
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M 	 M2 
Ml 	 M2 
Figure 5.4. PCR products after amplification of the SMC2 gene from genomic 
DNA of JSL2 homozygous second instar larvae. The primer pairs that were used 
to amplify each product are shown (A 1-43). Ml and M2 are the X phage digested 
with HIndlI and OX 174 phage digested with HaeIII, molecular weight markers 
respectively. 
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Figure 5.5. PCR products after amplification of the SMC2 gene from homozygous for 
the JSL2 mutation second instar larval genomic DNA. The primer pairs that were used 
to amplify each product are shown (A 1-43). Ml and M2 are the X phage digested 
with FlindIl and OX 174 phage digested with HaeIII, molecular weight markers 
respectively. 
5.3. Genetic recombination of the JSL2 mutation 
The homozygous JSL2 flies were originally dying as third instar larvae, but a year after 
as second instar larvae, suggesting that possible modifiers or mutations were introduced 
into the stock during its maintenance. An additional mutation could cause several 
problems and could complicate the interpretation of the results during the 
characterisation of the JSL2 mutant. Furthermore, due to smaller size, it is very difficult 
to dissect tissues, such as brains, from second instar larvae. Thus, a genetic 
recombination was necessary in order to clean the stock of any additional mutations 
beyond the JSL2 mutation. 
As mentioned above the SMC2 gene is located on the second chromosome. There 
was a possibility that the additional mutation was in one of the other chromosomes and 
not on the second. Since the third chromosome is bigger than the second, and the fourth 
chromosome does not carry many genes it was possible that the background mutation 
was on the third chromosome. In this case genetic recombination of the second 
chromosome would not be necessary. In order to test this possibility, virgin females 
from the JSL2 mutation were crossed with males from the Bc, Gla/CyO-GFP stock as 
follows: 
JSL2 	x Bc Gla _______ 
CyO - GFP 	CyO - GFP 
4,  
Re Clii 	Re Clii 	Ci,!) - CPP 
CyO - (JEP 	CyO - GFP 	JSL2 	CyO - GFP 
where Gla is a marker on the second chromosome, which gives a dark, smaller and 
smoother eye phenotype and CyO is a balancer chromosome which precludes 
recombination of the second chromosome and it carries the dominant marker Curly (Cy) 
which gives curly wings, and a recessive lethal mutation causing embryonic lethality. 
183 
Virgin female JSL2/CyO-GFP progeny were selected and crossed again with male 
Be, Gla/CyO-GFP. This cross was repeated three times and finally JSL2/CyO-GFP 
progeny were selected and the stock was expanded. The JSL2/CyO-GFP progeny were 
distinguished as they had normal eyes (absence of Bc, Gla). The CyO-GFP/CyO-GFP 
progeny do not make it to adults. By following this procedure all chromosomes except 
for the second could swap or even recombine with their homologs between the 
JSL2/CyO-GFP and Be, Gla/CyO-GFP stocks and thus the JSL2/CyO-GFP could be 
cleaned up from the background mutation. Recombination events though would mostly 
happen between the homologs of the third chromosome since recombination does not 
occur on the fourth chromosome and the X or Y chromosomes. 
In order to test if the additional mutation was lost after chromosomes were 
'cleaned up' as described above, JSL2/CyO-GFP progeny were crossed between them. 
Homozygous progeny for the JSL2 mutation (JSL2/JSL2) were selected under a 
fluorescence microscope as they were negative for GFP. After a lethality test was 
performed on these progeny, it was obvious that the homozygotes for the JSL2 mutation 
were still dying at second instar larvae and no improvement was observed on their size. 
This result suggested that the additional mutation was probably on the second 
chromosome and thus genetic recombination of this chromosome was necessary. 
5.4. Genetic recombination of the second chromosome of the JSL2 line 
For the genetic recombination of the second chromosome two stocks with multiple 
markers on the second chromosome were used. The first one was the 4187/CyO (a!, dp, 
b, pr, en, c, px, sp/CyO) and the second was the 434 7/CyO (a!, do, b, pr, B!, en, c, px, 
sp/CyO). The SMC2 gene is mapped at the 5105 chromosome locus and is located 
between the cinnabar (cn) and curved (c) markers (Figure.5.6). The original JSL2 line 
had the en (cinnabar), br (brown) and sp (speck) markers on the second chromosome as 
well. 
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Figure 5.6. Map of the second chromosome 
Initially the following cross was performed: 
	
en' JSL2, sp 	 4187 
x 
CyO-GFP 	 CyO 
4,  
en, JSL2, sp 
	





CyO-GFP 	 4187 
	
CyO 
The en, JSL2, sp/4187 virgin females were selected. These flies were easily 
distinguished as they had straight wings (absence of CyO marker). The selection of 
female flies was necessary at this point since meiotic recombination occurs only in 
females. At the second step of the recombination en, JSL2, sp/4187 virgin females were 
crossed to male 434 7/CyO as follows: 
185 
x, cn, JSL2, sp 
4347 
cn, JSL2, sp 	 4347 
x 
4187 	 CvO 
x, cn, JSL2, sp 	4347 	 4187 
CyO 	 4187 	 CyO 
x=any markers that were introduced on the chromosome that contains the JSL2 mutation 
after recombination took place in the oocytes of the cn, JSL2, sp/4187 female flies. 
From this cross male x, cn, JSL2, sp/4347 flies were selected. These flies were 
distinguished as they had straight wings. Most of the 4347/4187 flies that also had 
straight wings were dying before they eclosed into flies. Some escapers were easily 
distinguished as they had all the markers present and they were very sick. Male x, cn, 
.JSL2, sp/4347 flies were selected as recombination does not occur in male flies and thus 
a stock from recombinant flies could be maintained. 
Since the SMC2 gene (and thus the JSL2 mutation) is located between cinnabar 
and curved markers, it was desirable for this region not to be recombined so that the 
mutation would not be lost. For this reason x, cn, .JSL2, sp/4347 flies that did not have 
cinnabar and curved present should be selected. The fact that cinnabar was already 
present on the second chromosome of the JSL2 line could not permit the selection of flies 
that did not have the region around cinnabar recombined. Thus, only x, cn, JSL2, 
sp/4347 flies that did not have curved could be selected as possible carriers of the JSL2 
mutation. The phenotype of these flies could be al or do orb orpr or cn, orpx or sp or 
any combination of these markers depending on how many recombination events took 
place. The desired line would be the one with the most markers present, since that would 
be an indication that most of the second chromosome was recombined. Fly lines, with 
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several combinations of these markers were obtained that lacked curved and these flies 
were then crossed to Bc, Gla/CyO-GFP as follows: 
xl, cn, JSL2, sp 	Bc, Gla 
X 
4347 	 CyO-GFP 
xl, cn, JSL2, sp 	xl, cn, JSL2, sp 	Bc, Gla 
	
4347 





where xl=- any markers, except from curved (c), that were introduced on the chromosome 
that contains the JSL2 mutation, after recombination took place. 
This cross was necessary in order to obtain a stock that had the recombined chromosome 
over a balancer. The xl, cn, JSL2, sp/CyO-GFP progeny were selected and crossed 
between them in order to obtain a stock. These flies were easily distinguished as they 
had normal eyes. The 434 7/CyO-GFP also had normal eyes but the dominant BI marker 
on the 4347 chromosome could distinguish these flies from the desirable xl, cn, .JSL2, 
sp/CyO-GFP progeny. To test which of the recombinant lines retained the JSL2 
mutation a complementation test was performed between the xl, cn, JSL2, sp/CyO-GFP 
flies and the original cn, JSL2, sp/CyO-GFP stock as follows: 
187 
xl, en, JSL2, sp 	en, JSL2, sp 
KI 
CyO-GFP 	 CyO-GFP 
I 





en' JSL2, sp 	CyO-GFP 
	
CyO-GFP 
If the xl, cn, .JSL2, sp/cn, JSL2, sp progeny were viable and flies emerged it meant that 
the JSL2 mutation was lost from the recombined chromosome since the homozygotes for 
the JSL2 mutation are expected to die as third instar larvae. The xl ,en, JSL2, sp/cn, 
JSL2, sp flies were distinguished by their straight wings. After a complementation test 
was performed with the recombined lines, a line with the JSL2 mutation was obtained 
(line 58). This JSL2 allele, b, pr, en, JSL2, sp/CyO-GFP, had a significant part of the 
second chromosome recombined since most of the markers were present. The line was 
expanded and used for further characterisation of the mutant. 
5.5. Lethality test and hatching frequency of the recombinant JSL2 allele 
The main reason that the recombination was performed was to clean the JSL2/CyO-GFP 
stock of any additional mutations and to improve the health of the homozygous 
individuals. To test if this succeeded, recombinant b, pr, en, JSL2, sp/CyO-GFP flies 
were crossed inter se and a lethality test was performed on the homozygous progeny. 
The progeny homozygous for JSL2 were selected under a fluorescence microscope as 
being negative for GFP. It was obvious that these progeny were dying at early pupae. A 
more detailed characterisation of the lethal phase revealed that 90.4% were dying as early 
pupae while 9.6% were dying as third instar larvae, compared to 100% of GaS flies that 
pupated and eclosed into flies. The third instar homozygous larvae were clearly bigger 
and healthier compared to the second instar homozygous larvae before the 
recombination. Their size though was slightly smaller compared to wild type CaS third 
instar larvae. 
Another hypothesis to test was if any homozygotes for the .JSL2 mutation were 
dying during embryogenesis. To test this, a hatching frequency was performed with the 
progeny when b, pr, cn, JSL2, sp/CyO-GFP flies were crossed with each other. 30% of 
embryos were dying before they hatched into larvae. The expected ratio for embryonic 
lethality was 25%, which corresponds to the CyO-GFP/CyO-GFP progeny. The 
resulting ratio was slightly higher than expected (about 5%) but this is probably due to 
the way that the embryos were handled during the experiment. That was confirmed 
when the hatching frequency was tested in wild type CaS progeny. The resulting ratio 
was 7% of embryonic lethality while the expected ratio was 0%. Similarly the 
embryonic lethality in the control (CaS) was probably due to the way that the embryos 
were handled. 
5.6. Sequencing of the recombinant JSL2 allele 
In order to confirm that the mutation was present in the recombinant JSL2 allele, the 
region of the SMC2 gene that contained the JSL2 mutation was sequenced. Genomic 
DNA from single JSL2 homozygous larvae was used as a template for the PCR reactions. 
The primer pairs A26, A27 and A43 were used to amplify the region around the mutation 
and the resulting PCR products were sequenced (Figure 5.7). A base substitution 
(cytidine to thymidine) was observed at the position 2482 of the coding sequence, a 
mutation that was identical with the one in the original JSL2/CyO-GFP stock (CAG - 
TAG, premature stop codon). This suggests that the recombinant JSL2/CyO-GFP allele 
was an SMC2 mutant which could be further characterised. Originally 20 homozygous 
larvae (GFP negative) were used for genomic DNA isolation. When the above procedure 
was followed and the PCR products were sequenced the results revealed that there was a 
mixture of mutant and wild type genomic DNA. This suggests that probably some 
heterozygous flies (JSL2/Cy0-GFP) may not express GFP and thus they were selected as 
mutant homozygotes or that the selection of the homozygotes was not carefully done. 
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Figure 5.7. PCR products after amplification of the region of the SMC2 gene that 
contained the JSL2 mutation. Genomic DNA from single homozygous third 
instar larvae from the recombinant JSL2 allele was used. Primer pairs A26, A27 
and A43 were used for the amplification. M2 is the OX 174 phage digested with 
flaeIII, molecular weight marker. 
For this reason single larvae were used for genomic DNA isolation and further 
sequencing of the mutation. 
5.7. Phenotypic and biochemical characterisation of larval JSL2 mutants 
The existence of the JSL2 mutation allows the in vivo study of the function of the protein. 
In this mutation, the homozygous animals die as early pupae allowing the phenotypic and 
biochemical characterisation of larval tissues that are rich in mitotic activity. Such 
tissues are third instar larval brains which can be used in order to assess the role of 
SMC2 firstly in chromosome morphology and architecture (phenotypic characterisation) 
and secondly in the stability of the condensin complex and of other mitotic proteins 
(biochemical characterisation). 
5.7.1. Biochemical characterisation 
The sequencing of the JSL2 mutation revealed that a premature stop codon causes the 
production of a truncated protein of 827 aa. To confirm that and also to show that the 
full length SMC2 protein was absent from the homozygous JSL2 animals, an 
immunoblot analysis was performed. Third instar brain extracts from wild type (CaS), 
heterozygous (JSL2/CyO-GFP) and homozygous (JSL2/JSL2) larvae were probed with 
the SMC2 antibody. The antibody was generated against the N-terminal region of the 
SMC2 protein (amino acids 24-309) (Figure 5.1 B). In the homozygous extract, it was 
obvious that the full length SMC2 protein was absent, while a smaller protein of about 52 
kDa was present (Figure 5.8 A, arrow). The smaller protein probably corresponds to the 
truncated protein of which the size is estimated to be around 94 kDa. The difference 
between the size of the 52 kDa band and the predicted size could be due to the fact that 
the truncated protein is not stable and it gets degraded or that the conformation of the 
truncated protein is such that allows the protein to run faster. Furthermore in the 
heterozygous lane, a similarly sized band appeared to be present (absent from the wild 
type), strongly suggesting that this band corresponds to the truncated protein. 
In the absence of SMC2 it was reasonable to test if the stability of the rest of the 
condensin components and of other proteins that are involved in chromosome dynamics 
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Figure 5.8. A. Immunoblot analysis of wild type CaS, heterozygous JSL2/CyO-GFP 
(JSL2 +/-) and homozygous JSL2/JSL2 (JSL2 -/-) third instar larval brains by using the 
SMC2 antibody. The full length SMC2 protein (13 6kDa) is absent from homozygous 
brain extracts. A truncated protein of approximately 52 kDa is present in the homozygous 
and heterozygous brain extracts while it is absent from the wild type (black arrow). 
Approximately two third instar larval brains were loaded from the wild type and 
heterozygous brain extracts and four brains from the homozygous brain extracts. a-
tubulin was used as a loading control. 
B. Immunoblot analysis of third instar larval brain extracts of wild type CaS, 
heterozygous JSL2/CyO-GFP (JSL2 +/-) and homozygous JSL2/JSL2 (JSL2 -/-) larvae. 
By using antibodies against condensin subunits it was obvious that the protein levels of 
CAP-D2, Barren and SMC4 were greatly reduced in the absence of SMC2 in the 
homozygous brain extracts. Quantitation with the phosphorimager revealed that SMC4 
was reduced 6.5-fold, CAP-D2 8.2-fold and Barren 14-fold compared to wild type CaS 
brain extracts. INCENP levels were also greatly reduced in the absence of SMC2 protein 
while Drad21/Sccl levels appeared unaffected. Approximately two third instar 
larval brains were loaded from the wild type and heterozygous brain extracts and four 
brains from the homozygous brain extracts. a-tubulin was used as a loading control. 
(Figure 5.8 B). Quantitation of protein levels using phosphorimaging revealed that 
SMC4 was decreased 6.5-fold, CAP-D2 8.2-fold and Barren 14-fold compared to wild 
type brain extracts, suggesting that the stability of these proteins is greatly affected by the 
absence of SMC2. 
In order to investigate if the stability of chromosomal passengers was affected by 
the absence of SMC2, an antibody against INCENP was used. As already mentioned in a 
previous chapter, INCENP is required for the correct targeting of Aurora B at all times in 
mitosis and Aurora B has been shown to phosphorylate histone H3 during mitosis, an 
event that coincides with the initiation of chromosome condensation (Adams et al., 
2001b). When immunoblotting of larval brain extracts was performed with the INCENP 
antibody, it was obvious that the protein levels were greatly reduced in the homozygotes 
compared to wild type and heterozygous extracts (Figure 5.8 B). This result was 
surprising, bearing in mind that INCENP levels were not affected when condensin 
function was compromised after depletion of CAP-D2 (Chapter 4.8.1). 
In Drosophila, most of the cohesin complex dissociates from chromosomes in 
prophase and only a small amount remains associated at centromeric regions (Warren et 
al., 2000b). To assess if the cohesin complex is affected by the absence of SMC2, an 
antibody against the Drad2 I /Scc 1 cohesin component was used. Analysis by 
immunoblotting showed that no significant change was observed in the protein levels 
(Figure 5.8 B) suggesting that probably cohesin and condensin complexes are not 
interacting directly. Also to ensure that wild type, heterozygous and homozygous 
extracts were equally loaded, o-tubulin was used as a loading control. 
5.7.2. Phenotypic characterisation of the JSL2 mutant 
The phenotypic characterisation of the JSL2 mutant was very important in order to 
understand the role of the SMC2 protein in chromosome organisation. The overall size 
of the homozygous brains was smaller than both the heterozygous and wild type brains 
(Figure 5.9), suggesting that proliferation was affected. When third instar larval brains 
from heterozygous (control) and homozygous larvae were squashed and stained for 





Figure 5.9. Wild type CaS, heterozygous JSL2/CyO-GFP and homozygous 
JSL2/JSL2 whole third instar larval brains. The homozygous brain is almost half the 
size compared to wild type and is certainly smaller compared to heterozygous 
brains. Scale bar is 20p-m. 
(Bonaccorsi et al., 2000)), the first major defect observed in the homozygous mutant 
brains, was the overall lack of mitotic cells. Indeed, when the mitotic index was 
determined, based on chromosome morphology, it was obvious that the percentage of 
mitotic cells was significantly lower compared to the control (0.26% in the mutant versus 
1.62% in the control) (Figure 5.10 A). That was also confirmed, when an immunoblot 
analysis against third instar larval brains using an antibody against the phosphorylated 
histone H3 was performed. This analysis showed that the level of phosphorylated 
histone H3 was greatly reduced in the homozygous brain extract while it was normal in 
the heterozygous and wild type brain extracts (Figure 5.10 B). Both of these approaches 
strongly suggest that the mitotic index is greatly reduced in the JSL2 mutant. This 
observation could explain the unexpected reduction of INCENP levels and the fact that 
the levels of all the condensin subunits were more severely affected compared to the 
gluon 17C  mutant, which is a null for SMC4. 
As an additional control, an immunoblot analysis using an antibody against 
histone H3 was performed. The levels of this protein should be unaffected by the 
absence of SMC2. However, after the experiment was performed it was obvious that the 
level of histone H3 was also reduced in the homozygous brain extract (Figure 5.10 Q. A 
small reduction was observed in the heterozygous extract. As already mentioned 
previously, the reduction of mitotic proteins in the homozygous brain extracts was 
perhaps not suprising since the mitotic index was significantly low. The reduction of 
histone H3 was unexpected, since this protein is not a mitotic protein and its levels 
should not be affected by the absence of SMC2. For this reason, I decided to look if 
there was an additional mutation in the JSL2 line that affects the histone H3 gene. For 
this reason, a deficiency 2386/CyO (DJ(2L)DS6, b[l] pr[1] cn[1]/CyO) that uncovers the 
cluster of histone H3 genes on the second chromosome was used to do a 
complementation test with the JSL2/CyO-GFP line. 
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Figure 5.10. A. Histogram showing the mitotic index in control (JSL2 +1-) and 
homozygous JSL2/JSL2 (JSL2 -I-) third instar larval brains. The percentage of mitotic 
cells is significantly lower in the homozygous brains compared to control brains. 20 
brains were scored for each sample. 
B and C. Immunoblot analysis of wild type CaS, heterozygous JSL2/CyO-GFP (JSL2 
+1-) and homozygous JSL2/JSL2 (JSL2 -I-) third instar larval brains, using antibodies 
against phosphorylated histone H3 (P—H3) and histone H3. The level of PH3 is 
greatly reduced in the homozygous mutant extracts compared to wilt type and 
heterozygous extracts (B). The level of histone H3 is also reduced in the homozygous 
brain extract compared to wild type. Suprisingly a slight reduction is also observed in 
the heterozygous extract (C). o-tubulin was used as a loading control. 
The following cross was performed: 
JSL2 	 2386 
CyO - GFP 	CyO 
'r4r 
JSL2 2386 2386 CyO 
CyO CyO - GFP JSL2 CyO - GFP 
expected I 33% 33% die 
ratio I 
observed I 
40% I 40% 20% die ratio 
If the 2386/JSL2 progeny are viable and flies emerge, it means that the JSL2 line does 
not have a lethal mutation in the H3 genes. This is because progeny homozygous for 
histone H3 mutations would be expected to die early in development since histone H3 is 
an essential gene. 2386/JSL2 flies were distinguished by their straight wings. From this 
cross, 20% of the viable progeny were 2386/JSL2. The expected ratio that corresponds 
to these progeny if they are all equally viable is 33% since CyO/CyO-GFP progeny die 
during embryogenesis. The fact that the resulting ratio is lower than the expected (semi-
lethal phenotype), could be because several genes are missing in the deficiency stock and 
in combination with the JSL2 mutation could cause lethality before flies enclose. The 
20% of viable 2386/JSL2 flies though suggests that most likely additional mutation exists 
in the JSL2 line that affects the histone H3 gene. The reason that histone 113 levels were 
reduced in the JSL2 homozygous brain extract remains a mystery. 
Analysis of the few mitotic cells that were present in the homozygous brains 
showed several defects in chromosome morphology (Figure 5.11 B and 5.12 B). 
Chromosomes appeared fuzzy with almost no sister chromatid resolution. Prometaphase 
and metaphase chromosomes appeared as unresolved chromatin masses with unaligned 
chromosomes (Figure 5.11 B). 12% of cells in prometaphase and metaphase displayed 
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defects in chromosome condensation (Figure 5.11 B (c)). These defects refer to mitotic 
chromosomes that contained regions of undercompacted chromatin connected by 
normally compacted chromatin (irregularly condensed chromosomes), a defect that was 
also observed in ORC mutants affecting the normal pattern of chromosomal replication 
(Loupart et al., 2000). Furthermore, cells in anaphase and telophase showed extensive 
chromatin bridges and had unequal nuclei probably as a result of defective chromosome 
segregation during mitosis (Figure 5.12 B). However, the stage of many mitotic cells 
(56%) could not be easily determined as the chromosome structure was so abnormal 
(Figure 5.13 A). On the other hand, control cells from heterozygous brains showed 
normal chromosome morphology and chromosomes were segregating normally during 
anaphase (Figure 5.11 A and 5.12 A). 
As mentioned previously, INCENP through interaction with Aurora B, is 
involved in histone H3 phosphorylation during mitosis. Bearing in mind that INCENP 
levels were greatly reduced in the homozygous larval brain extracts, as well as the levels 
of phosphorylated H3, it was necessary to test if individual mutant mitotic cells had 
normal levels of phosphorylated histone H3. To assess that, the same exposure time for 
P1-13 was used to capture images of both control and mutant mitotic cells. In most of 
the mutant mitotic cells, the level of P1-13 appeared similar to the control cells and no 
significant change was observed. Interestingly though, 28% of mutant cells, which 
looked mitotic, as judged by their chromosome morphology, were negative for 
phosphorylated histone H3 (Figure 5.13 B (b) and (c)). Nevertheless it was not 
determined if these cells were definitely mitotic cells, interphase cells with abnormal 
morphology, or apoptotic. A way to test this, was to look for the presence of the mitotic 
spindle. Usually though, no mitotic spindle or any microtubule structure could be 
observed in these P1-13 negative cells, even though the protocol that was used for brain 
squashes was able to preserve microtubule organisation. This suggests that probably 
these cells are in interphase or that mitotic spindle organisation is defective in the mutant 
cells. Indeed mitotic spindles were not usually observed in 92% of mutant mitotic cells 
suggesting that mitotic spindle organisation was defective. In contrast to the mutant 
cells, in control cells a mitotic spindle could usually be observed (in 80% of mitotic 
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Figure 5.11. Control (A) and homozygous JSL2/JSL2 (B) third mstar larval 
neuroblasts. Brains were squashed and stained for P--1-13 (red), a-tubulin (green) and 
DNA (DAPI, blue) according to the Bonaccorsi protocol. Prophase and prometaphase 
figures are shown in control panel (A). Individual chromatids can be easily observed 
(A) and chromosome organisation and compaction appears normal. Also a mitotic 
spindle can be easily observed in panel (A). In homozygous brains (B), prometaphase 
cells appeared as unresolved chromatin masses with unaligned chromosomes (red 
arrows). In some cells, chromosome condensation was irregular, since some parts of 
a chromosome appeared undercompacted (yellow arrow) compared to other regions 
within the same chromosome (green arrow). Also a well organised mitotic spindle 
could not be observed in these cells. Scale bar is lOun. 
cells). It is important to mention though, that P1-13 negative cells that looked like 
mitotic cells were present in the control brains but not in the same ratio as in mutant cells 
(2% in control brains versus 28% in mutant brains) (Figure 5.13 B (a)). 
5.7.3. Quantification of mitotic phenotypes in third instar larval brains 
No delay was observed in prometaphase/metaphase in mutant brains since the percentage 
of cells in these phases was lower (32%) compared to control (54%) (Figure 5.14 A). 
Also no anaphase figures could be observed in the mutant brains (compared to 16.6% in 
control) while the percentage of telophase cells was still lower (8%) compared to control 
(12.5%) (Figure 5.14 A). Furthermore the mitotic index was significantly lower in the 
mutant as mentioned above (0.26 versus 1.62 in the control). Taken together, these 
results suggest that progression through mitosis was not delayed in mutant larval brains. 
In contrast it seems that cells were not entering mitosis probably as a consequence of 
accumulated chromosome abnormalities or activation of the DNA structure checkpoint. 
Even though 56% of mitotics could not be categorised to any of the mitotic phases, due 
to the lack of particular chromosome morphology, the overall reduction of the mitotic 
index in the mutant indicates that the above conclusion is still valid. All telophase cells 
in the mutant had chromosome bridges. Also a high percentage of interphase cells were 
joined with chromosome bridges (bi-nucleate cells, 2.66% compare to 0.06% in control 
cells) (Figure 5.14 B). Chromosome bridges probably result from the lack of sister 
chromatid resolution affecting chromosome segregation. In general all mitotic cells were 
abnormal in the mutant (100% compared to 4% in the control) (Figure 5.14 Q. 
5.7.4. Phenotypic characterisation of second instar JSL2 mutant brains 
As discussed above, the mitotic index was reduced in the JSL2 homozygous third instar 
brains and the chromosome morphology was highly abnormal, two features that were 
making the characterisation of the mutant very difficult. In order to bypass these two 
disadvantages, second instar larval brain squashes were performed and stained for a-
tubulin, P1-13 and DNA. In this way it was possible that in second instar larval brains, 
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Figure 5.14. A. Graph showing the distribution of mitotic cells in the different 
mitotic phases in control (JSL2 +1-) and homozygous (JSL2 -I-) third instar larval 
brains. The mitotic stage of 56% of mutant mitotic neuroblasts could not be 
determined (unknown). 
Histogram showing the percentage of bi-nucleate cells in control (JSL2 
+1-) and homozygous (JSL2-/-) third instar larval brains. The percentage of bi-
nucleate cells is significantly higher in the homozygous larval brains compared to 
control larval brains. 20 brains were scored for each sample. 
Histogram showing the percentage of abnormal mitotic cells in control (JSL2 
+1-) and homozygous (JSL2-I-) third instar larval brains. All mitotics are 
abnormal in the homozygous brains while only a small percentage is abnormal in 
control brains. 20 brains were scored for each sample. 
 
 
chromosome morphology would be better and more mitotic cells may be present than in 
third instar larvae. Indeed, in homozygous second instar larval brains both the mitotic 
index and chromosome morphology were improved compared to third instar. The reason 
for that, was probably the fact that fewer chromosome defects had accumulated in second 
instar larvae than in third and thus more cells were still undergoing mitosis. Particularly, 
the mitotic index in homozygous second instar larval brains was almost double compared 
to third instar brains (0.4% in second instar compared to 0.26% of third instar), but still, 
it was significantly lower compared to the control (0.4% in the mutant versus 1.3% in the 
control) (Figure 5.15 A). The calculation of the mitotic index was based on chromosome 
morphology. 
Chromosome morphology was not as severe as in third instar larvae but the 
defects observed were very similar. Chromosomes appeared fuzzy throughout mitosis. 
Prometaphase and metaphase chromosomes appeared as unresolved chromatin masses 
with unaligned chromosomes (Figure 5.15 C), while cells in anaphase and telophase 
showed extensive chromatin bridges (Figure 5.16 B). Ill-defined sister chromatids were 
observed and chromosome condensation was quite abnormal. Usually two (bi-nucleate) 
or even three (tn-nucleate) nuclei were joined with chromosome bridges, probably as a 
result of defective chromosome segregation and failed cytokinesis (Figure 5.16 B). In 
some cells though chromosome morphology was very abnormal and the stage of many 
mitotic cells could not be easily determined (29.2%) (Figure 5.17). On the other hand, 
chromosome morphology appeared normal in the heterozygous control (Figure 5.15 B, 
5.16 A). 
No significant delay was observed in the mitotic progression. The 
prometaphase/metaphase index was slightly higher in the mutant (56%) compared to 
control (45%) (Figure 5.18 A). Similarly to third instar brains, no anaphases were 
observed in the second instar mutant brains (in control 22% of mitotic cells were in 
anaphase) while the percentage of cells in telophase was similar between the mutant and 
the control (12.1% in mutant versus 13% in control) (Figure 5.18 A). All mitotic cells 
were abnormal in the mutant brains and all telophases had chromosome bridges. 
Furthermore a significant amount of interphase cells were joined with chromosome 
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Figure 5.15. A. Histogram showing the mitotic index in control and homozygous 
JSL2/JSL2 second instar larval brains. The percentage of mitotic cells is noticeably lower in 
the homozygous brains compared to control brains. 20 brains were scored for each sample. 
B and C. Brains were squashed and stained for P-H3 (red), a-tubulin (green) and DNA 
(DAPI, blue) according to the Bonaccorsi protocol. In control prometaphase and metaphase 
cells (B), chromosomes are properly condensed and organised with well defined 
chromosomes and sister chromatids (Bb and Bc). Mitotic spindle organisation appears 
normal (Ba and Bb). In homozygous JSL2/JSL2 mutant cells (C), chromosomes are fuzzy 
and chromosome condensation appears quite abnormal. No well-defined chromatids could 
be observed. Chromosomes appeared as unresolved chromatid masses with unaligned 
chromosomes (red arrows). Mitotic spindle structure looks normal in C(a) but is 
disorganised in C(b). Scale bar is lOum. 
bridges (2.4% bi-nucleates versus 0.02% in control and 0.14% tn-nucleate versus 0% in 
control) (Figure 5.18 B). 
5.7.5. Spindle morphology in second instar larval neuroblasts 
A mitotic spindle was usually present in mutant cells, in contrast to third instar larvae. 
Its morphology though was usually abnormal compared to heterozygous controls (Figure 
5.19 A). Usually monopolar spindles were observed and the overall structure of the 
spindle was defective. These abnormalities were categorised as follows: 17.7% of the 
mutant mitotic cells had normal mitotic spindle (Figure 5.15 C (a) and 5.19 B) while 
46.34% had no spindle (28% of control cells had no mitotic spindle) (Figure 5.15 C (b) 
and 5.19 B). Of the rest of the mitotics, 6.7% had a partially disorganised spindle (Figure 
5.19 A(a) and 5.19 B), 14.63°/ had microtubules growing from only one pole 
(monopolar spindles) (Figure 5.19 A(b) and 5.19 B), 4.87% had microtubules emanating 
from three different chromosome regions (tnipolar spindles) (Figure 5.19 A(e) and 5.19 
B) and 9.75% had microtubules emanating from chromosomes but they were not focused 
to a pole (Figure 5.19 A(c) and (d) and 5.19 B). As previously mentioned, these defects 
could be an indirect effect of accumulated chromosome abnormalities 
5.8. Brief discussion 
In conclusion, JSL2 mutation is an SMC2 mutation that causes lethality in early pupae. 
The fact that individuals homozygous for the JSL2 mutation live up to this point is 
surprising, but is possible that the remaining truncated protein is functional in a way and 
it can partially rescue the loss of SMC2 protein. The overall morphology of brain cells is 
highly abnormal and chromosome organisation is definitely compromised. The main 
phenotype observed is the loss of sister chromatid resolution and the failure of 
chromosome segregation during anaphase, defects that were also observed after the 
depletion of other condensin subunits in Drosophila (Bhat et al., 1996; Coelho et al., 
2003; Savvidou et al., In Press; Steffensen et al., 2001). Chromosome condensation is 
compromised and in some cases some parts of the chromosomes are less condensed than 
others (irregularly condensed chromosomes). A large number of mitotic cells could not 
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Figure 5.19. A. Homozygous JSL2/JSL2 second instar larval neuroblasts. Brains 
were squashed and stained for PH3 (red), a-tubulin (green) and DNA (DAPI, blue) 
according to the Bonaccorsi protocol. Several spindle abnormalities were observed in 
mitotic cells and cells were categorised according to their spindle defects. These groups 
contain cells with partially disorganised spindle (Aa), cells with a monopolar spindle 
(Ab), cells with a spindle that does not focus on a pole (Ac and Ad) and cells that their 
spindle looks like tripolar (Ae). Scale bar is lOym. 
B. Bar chart showing the percentage of mitotic cells, in control (JSL2 +1-) and 
homozygous (JSL2-/-) second instar larval brains, that display a certain type of mitotic 
spindle abnormality as described in (A). 
be categorised into definitive mitotic stages thus making the interpretation of the results 
difficult. Also the reduction in the levels of histone H3 is very difficult to interpret and 
no logical explanation could be found to explain it. The protein levels of the rest of the 
condensin subunits and INCENP are greatly reduced by the absence of SMC2. The 
reduction in INCENP levels is probably a consequence of the low mitotic index that is 
observed in JSL2 mutant brains. Furthermore, mitotic spindle organisation is 
compromised in the mutant cells and only a small fraction of the mitotic population had 
normal spindles. The severity of the phenotype though, makes the characterisation of the 
mutant very difficult. Second instar larvae are very difficult to work with due to small 
size and the overall percentage of mitotic cells is very low. Thereby, it was not possible 
to get a lot of information from the characterisation of this mutant and thus, no further 
analysis was performed. 
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CHAPTER 6 
CHARACTERISATION OF CAP-D3, A CONDENSIN II SUBUNIT 
6.1. 	Introduction 
The condensin complex plays an essential role in mitotic chromosome assembly and 
segregation from yeast to humans. Recently a second condensin complex (condensin 
complex II) has been identified in vertebrate cells. The two complexes, condensin I (the 
first identified condensin complex) and condensin II, share the same pair of the two 
SMC subunits, SMC2 and SMC4, but contain different sets of the non-SMC subunits, 
CAP-H2, CAP-G2 and CAP-D3 (Ono et al., 2003). It has been shown that the two 
complexes make distinct contributions to chromosome architecture and are differentially 
regulated during the cell cycle (Ono et al., 2004). Sequence analysis suggests the 
existence in Drosophila of CAP-D3 and CAP-H2, but not CAP-G2. A search in the 
database for any putative Drosophila mutations in CAP-H2 and CAP-D3 resulted in the 
identification of a CAP-D3 mutation. Therefore, an examination of condensin II in 
Drosophila, was initiated. 
6.1.1. Spermatogenesis in Drosophila 
Analysis of the CAP-D3 mutation revealed mainly defects in spermatogenesis. Thereby, 
to be able to understand the phenotype caused from this mutation, a brief description of 
spermatogenesis will be given here. 
Male meiosis occurs in the context of a complex developmental process, called 
spermatogenesis, that leads to the formation of 64 spermatids from each primary gonial 
cell (Figure 6.1). The Drosophila testis is a long tube with a straight apical and coiled 
basal end. Spermatogenesis begins in the germinal proliferation centre, an area located 
at the apical tip of the testes which is comprised of 5-9 germ-line stem cells (in adult 
flies) and 9-17 somatically derived, cyst progenitor cells, that flank the germ-line stem 
cells. The germ-line stem cells are arranged around a compact group of specialised 
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somatic cells known as the "hub". The asymmetric division of a stem cell generates a 
primary spermatogonium (gonial cell or goniablast) and another stem cell, which 
remains anchored at the apex of the testis. Concomitant with the formation of this 
primary gonial cell, the asymmetric division of two neighbouring cyst progenitor cells 
generates two cyst cells, which encyst the primary spermatogonium and its progeny until 
completion of spermatogenesis. The packet of the two cyst cells and the gonial cell is 
termed a cyst and is the basic unit of spermatogenic differentiation. Germ cells are 
displaced away from the tip as new cells form so that cysts of primary spermatocytes 
move down the testis and enter meiosis near the start of the coil. 
The primary gonial cell undergoes four rounds of synchronous mitotic divisions, 
giving rise to a cyst of 16 primary spermatocytes. Cytokinesis is incomplete during 
these specialised divisions, leaving the cells connected by stable intercellular bridges 
called ring canals. These cells, after pre-meiotic DNA synthesis, enter a growth phase 
that lasts approximately 3.5 days, during which time the nuclear volume increases 25-
fold. Nuclear growth is accompanied by extensive gene expression which results in the 
formation of the Y-chromosome lampbrush-like loops generated by several fertility 
factors. 
At the end of the growth period, the Y-loops degenerate, and primary 
spermatocytes undergo meiosis I and meiosis H in rnetasynchrony, resulting in a cyst of 
64 interconnected haploid spermatids. During the meiotic divisions, a very prominent 
spindle forms which is particularly amenable to cytological analysis. During the two 
meiotic divisions, the mitochondria in each spermatocyte line up along the pole-to-
equator microtubules of the spindle and are separated equally to the daughter cells by 
cytokinesis. After telophase II, all the mitochondria in each early spermatid aggregate 
together and fuse into two giant mitochondria, which wrap around each other to form a 
phase dark, spherical structure termed the "Nebenkern" or mitochondria derivative. This 
stage is called the onion-stage, as in a cross section the concentric layers of 
mitochondrial membrane make this structure resemble an onion slice, and is used to 





Figure 6.1. Spermatogenesis in 
Drosophila melanogaster. 
Male germ-line stem cells (S) lie 
next to the apical hub (H) at the tip 
of the testis. Each germ line stem 
cell is flanked by a pair of cyst 
progenitor cells (CP). When either 
a germ-stem cell or a cyst 
progenitor cell divides, the 
daughter that maintains contact 
with the hub retains stem cell 
character, whereas the daughter 
displaced away from the hub 
initiates differentiation-in the case 
of the germ line as a gonialblast 
(G), and in the case of the cyst 
progenitor as a cyst cell (C). Two 
cyst cells enclose the gonialblast 
and they never divide again, but 
enclose all progeny of the 
gonialblast throughout the 
remainder of spermatogenesis. 
The gonialblast and its 
spermatogonial daughter cells 
undergo four rounds of mitotic 
divisions with incomplete 
cytokinesis. The resulting 16 
interconnected cells switch to the 
meiotic program and enter a 
period of growth and gene 
expression. For simplicity only 
one of the 16 primary 
spermatocytes in a cyst is shown. 
All 16 primary spermatocytes exit 
the cell growth stage and undergo 
two meiotic divisions resulting in 
a cyst of 64 interconnected, onion 
stage, haploid round spermatids. 
All the spermatids in an onion-
stage cyst have the same-sized 
nucleus and mitochondrial 
derivative (Nebenkern). The 
haploid spermatids remain 
interconnected and proceed 
through the morphological change 
of spermiogenesis in synchrony. 
Finally, the fully elongated 
spermatids are individualised, coil 
to the base of the testis and are 
transferred to the seminal vesicle. 
The drawing has been adapted 
from Fuller (1998). 
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contains a single, phase-light, spherical nucleus paired with the phase dark, spherical 
Nebenkern. If all steps were normal in the preceding meiotic divisions, all the spermatid 
nuclei and Nebenkern in a cyst have a highly regular appearance and consistently exhibit 
similar sizes. This regular array of nuclei and Nebenkern allows easy identification of 
mutants that affect the meiotic divisions by examining onion-stage cysts with phase 
contrast light microscopy. 
Spermiogenesis or spermatid differentiation in Drosophila proceeds by a 
dramatic series of morphological changes in which most, if not all, subcellular 
components are remodelled. Spermatids grow a long flagellum containing the axoneme, 
a complex microtubule-based organelle for motility. The wrapped layers of the 
mitochondrial derivative unfurl and mitochondria elongate along the flagellum. The 
ring canals are gathered to the elongating end of the flagellar bundle opposite the nuclei. 
The spermatid DNA becomes highly condensed and the nucleus is shaped along a 
microtubule scaffold. The mature spermadits are individualised by an actin-based 
structure called the "investment cone" and finally the sperm bundle coils to the base of 
the testis and is released into the seminal vesicle (Fuller, 1998). 
The regular appearance of onion stage early spermatid cysts serves as a 
convenient diagnostic for identification of mutants that cause several different types of 
meiotic defects (Bate, 1993). Mutants that fail to undergo chromosome segregation and 
cytokinesis during meiosis commonly result in cysts with 16 onion-stage spermatids 
with 4N nuclei and large Nebenkern. Mutants that cause defects in spindle assembly 
and function often cause failure of cytokinesis as well as defects in chromosome 
segregation, resulting in onion-stage spermatid cysts with large or variable Nebenkern 
associated with variable numbers of differently sized nuclei. Mutants that cause defects 
in cytokinesis but not chromosome segregation should produce large Nebenkern 
associated with nuclei that are uniform and normal in size. Some mutations produce 
onion-stage spermatids that have Nebenkern but no nucleus visible by phase contrast 
optics, probably due to failure of chromatin to decondense at the end of meiotic 
divisions. Finally, some mutants produce onion-stage spermatids with normal sized 
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nuclei but no apparent Nebenkem, as a result of the loss of mitochondria between the 
gonial cell and mature primary spermatocyte stages (Bate, 1993). 
6.2. The Drosophila CAP-D3 gene 
The CAP-D3 gene (CG3 1989) is located on the left arm of the second chromosome of 
Drosophila melanogaster in 25E5 (nucleotides: 5458120-5589325) (Figure 6.2 A). The 
CAP-D3 gene is 11.2 kb long and it consists of 6 introns and 7 exons. A 5201 bp cDNA 
(380 Ibp coding sequence) encodes a protein of 1267 amino acid residues (Mr: 145 kDa, 
p1: 7.22) (Figure 6.2 B). The first intron of the gene is about 6 kb long and three other 
genes are located in it (Figure 6.3 A). These genes CG31648, CG3 1915 and CG7277, 
are involved in cytochrome c oxidase biogenesis and complex assembly, in carbohydrate 
metabolism and in ubiquinone biosynthesis, respectively. There are an additional two 
genes, CG14016 and CG14015 in the 3' UTR of the CAP-D3 gene (Figure 6.3 A). 
These genes are involved in nucleotide/nucleic acid metabolism and transcription 
regulation and in mannosidase activity, respectively. None of these genes overlaps with 
the others. The orientation of CG7277, CG14016 and CG14015 genes is from right to 
left which is opposite from the orientation of transcription of the CAP-D3 gene (Figure 
6.3 A). Finally there are two mutations that interrupt the CG7277 and CG14016 genes, 
which will be discussed later. 
6.3. The CAP-D3 mutation 
A search in the Drosophila database resulted in the identification of a CAP-D3 mutation 
(15026/4D). This mutation is caused from a P-element insertion P{EPgy2} at the 
beginning of the third exon of the CAP-D3 gene (1095 bp of ORF) (Figure 6.3 A). The 
P-element is 10,872 kb long and it contains two functional transgenes, the mini-white 
and the intronless-yellow, which can be used to follow the transposon (P-element) on the 
appropriate genetic background. The promoter of the P-element is at the 3' end of the P 
and the orientation is from left to right. This P-element also has a GAL4/UAS enhancer 
that allows the mis-expression of an adjacent gene downstream of the P-element 
promoter under the control of GAL4 (Bellen et al., 2004) (Figure 6.3 B). 
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Figure 6.2. A. Overview of the left arm of the second chromosome. The CAP-D3 
gene (red square) is located in 25E5 chromosome locus (nucleotides: 5458120-
5589325). The map was adapted from Flybase. 
B. The CAP-D3 gene is 11.2 kb long and it consists of 6 introns and 7 exons. A 
5201 bp cDNA encodes a protein of 1267 amino acid residues. The numbers on 
the CAP-D3 gene indicate the start and the end of the exons. Exons are indicated 
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Figure 6.3. A. The first intron of the CAP-D3 gene is about 6kb long and three 
other genes CG31648, CG31915 and CG7277 are located there. Two more 
genes, CG14016 and CG14015 are located in the 3' UTR of the CAP-D3 gene. 
The orientation of CG7277, CG14016 and CG14015 genes is from right to left 
which is opposite to the transcription orientation of CAP-D3 gene. A P-element, 
P{EPgy2}, insertion at the beginning of the third exon of the CAP-D3 gene (1095 
bp of ORF) interrupts the function of the gene, causing a mutation. 
B. The P-element P{EPgy2} is 10,872 bp long and it contains two functional 
transgenes, the mini-white and the intronless-yellow, which can be used to follow 
the transposon (P-element) on the appropriate genetic background. The promoter 
of the P-element is at the 3' of the P and the orientation is from left to right. This 
P-element also has a GAL4/UAS enhancer that allows the mis-expression of an 
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Figure 6.4. A. Strategy used to determine the exact position of P-element in the 
CAP-D3 gene (5' and 3' flanking sequences of P-element). Primer pairs S1-7 were 
used (Table XIV). The position of the primer pairs is shown relative to the CAP-
D3 gene and the P-element. The exact position of the primers is summarised in 
Tables X and XI. The size of each PCR product is indicated next to each primer 
pair. 
B. PCR products after amplification of the regions shown by the primer pairs in 
(A) (S 1-S7). Ml molecular weight marker is the X phage digested with Hindu. 
The exact position of the P-element insertion in the CAP-D3 gene was reported in 
Flybase, however it was necessary to confirm it. Therefore, primer pairs at the 5' and 3' 
ends of the P-element and at the CAP-D3 sequence flanking the P-element were 
designed (Figure 6.4 A). The region around the 5' and 3' of the P-element including 
CAP-D3 sequence was amplified by PCR and the reactions were sequenced (Figure 6.4 
B). The P-element was indeed inserted at 1095 bp of the CAP-D3 ORF. Eight base 
pairs were duplicated at the insertion point as generally happens with P-element 
insertions (O'Hare, 1983) Thus, the last eight base pairs of the CAP-D3 sequence 
flanking the 5' end of the P-element were also present at the end of the 3' end of the P-
element. 
The CAP-D3 mutation was carried over the CyO balancer. In order to test if 
homozygous flies were dying and in which developmental stage, heterozygous flies for 
the CAP-D3 mutation were crossed inter se as follows: 
P{EPgy2} >< P{EPgy2} 
CyO 	 CyO 
P{EPgy2} 	P{EPgy2} 	CyO 
CyO 	P{EPgy2} 	CyO 
expected ratio 33% 67% die 
observed ratio 33% 67% die 
It was obvious that the homozygous progeny P{EPgy2)/P{EPgy2} were viable and 
healthy since flies with straight wings were present in the population in the expected 
ratio (33%). The CyO/CyO were dying in early embryogenesis. To test if the 
homozygous flies for the CAP-D3 mutation were fertile, male and female homozygous 
flies for the mutation were crossed simultaneously to female and male wild type (GaS) 
flies respectively, as follows: 
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A. Check female fertility 
and 
















When male homozygous flies P{EPgy2}/P{EPgy2} were crossed with female wild type 
flies (B) no progeny eclosed (x), suggesting that male homozygous for the CAP-D3 
mutation were sterile. Therefore, it could be possible that CAP-D3 is involved in male 
meiosis. However, the fact that other genes are located in the CAP-D3 gene it was 
possible that they were also affected by the P-element insertion. The disruption of these 
genes could be the causal of male sterility and for this reason several tests were 
performed in order to investigate this hypothesis (see 6.4). 
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6.4. The genes located in the CAP-D3 gene are not affected by the CAP-D3 mutation 
Several tests were performed in order to investigate if the function of the 5 other genes 
that are located in the CAP-D3 gene were affected by the P-element insertion in the 
CAP-D3 mutation. Initially, RT-PCR was performed to test if the transcription of the 
genes was affected by the P-element insertion. mRNA from flies homozygous for the 
CAP-D3 mutation was used to generate cDNA, while mRNA from wild type flies was 
used as a control. Primers were designed to cover the majority of the message RNA of 
each of the 5 genes and finally RT-PCR products of the expected size were obtained 
(Figure 6.5 A and 6.5 B). It was apparent that all five genes were normally transcribed 
in the CAP-D3 homozygous flies and their levels were similar to wild type controls 
(Figure 6.5 B). 
As mentioned previously, two P-element mutations interrupting the CG7277 
(13964/CyO) and CG14016 (EP(2)2415/CyO) genes were available from the 
Bloomington Stock Centre. These mutations could be very useful for assessing if the 
interrupted genes (CG7277 and CG14016) were affected by the P-element insertion in 
the CAP-D3 mutant (demonstrated later on). When these fly lines were tested for the 
state of their homozygous flies, it was obvious that they were viable but the ratio was 
lower than expected, suggesting that they are semi lethal. This was concluded after 
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Figure 6.5. A. Strategy showing the amplification of the majority of the mRNA of each 
one of the 5 genes that locate in the CAP-D3 gene (CG31915, CG31648, CG7277, 
CG14016, CG14015). The position of the primers is shown relative to the five genes and 
the CAP-D3 gene. The exact position of the primers is summarised in Tables XIII and 
XIV. The size of each PCR product is indicated next to each primer pair. 
B. RT-PCR products showing that the transcription levels of the five genes located in the 
CAP-D3 gene are not affected by the P-element insertion. mRNA from wild type (wt) 
flies and flies homozygous for the CAP-D3 mutation (D3 -I-) was used as template for 
the cDNA library. RT-PCR reactions without reverse transcriptase (-RT) were done as 
control. Ml is the X phage digested with Hindll molecular weight marker and M is the I 
kb DNA ladder. 
13964 	13964 
CyO CyO 




expected ratio 33% 67% die 
observed ratio 7% 93% die 
and 
EP(2)2415 >< EP(2)2415 
CyO 	 CyO 
EP(2)2415 	EP(2)2415 	CYO 
EP(2)2415 CyO CyO 
expected ratio 33% 67% die 
observed ratio 16% 84% die 
From the first cross (A), homozygous flies 13964/13964 were present in the population 
in a ratio of 7%, while the expected ratio was 33% since CyO/CyO progeny die during 
embryogenesis. Similarly, the EP(2)2415/EP(2)2415 homozygous flies (B) were 
present in 16% while the expected ratio was 33%. These results suggest that the 
homozygotes for these two mutations are semi-lethal. Furthermore, when the fertility of 
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the homozygous 13964/13964 and EP(2)2415/EP(2)2415 flies was tested as follows, it 
was obvious that they were both male sterile (x) (A2 and B2 respectively). 
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check female fertility 
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(2) check male fertility 
	
©% EP(2)2415 	 GaS 
EP(2)2415 	 CaS 
EP(2)2415 
GaS 
This could suggest that CAP-D3 gene is affected in these two mutations since the P-
element insertion in CG7277 interrupts the first intron of the CAP-D3 gene, while the 
mutation in CG14016 interrupts the 3' UTR of the CAP-D3 gene. 
To test if the CAP-D3 mutation was affecting the CG7277 and CG14016 genes, a 
complementation test was performed between the two mutations and the CAP-D3 
mutation as follows: 
13964 	CAP-D3 
X 
CyO 	 CyO 
13964 	13964 	CAP-D3 	CyO 
CAP-D3 	CyO 	CyO 	CyO 
expected ratio 33% 33% 33% die 
observed ratio 33% 33% 33% die 
and 
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EP(2)2415 >< CAP-D3 
CyO 	 CyO 
EP(2)2415 EP(2)2415 CAP-D3 CyO 
CAP-D3 	CyO 	CyO 	CyO 
expected ratio 33% 33% 33% die 
observed ratio 31% 34% 34% die 
The trans-heterozygous flies for each case, 13964/GAP-D3 and EP'2)2415/cAP-D3, 
were easily distinguished as they had straight wings. The ratio of these flies was 33% 
for 13964/CAP-D3 and 31% for the EP(2)2415/CAP-D3, which was very close to the 
expected ratio of 33% in both cases, since CyO/CyO flies die during embryogenesis. 
Thus, it was obvious that the presence of CAP-D3 gene (and subsequently the presence 
of the other genes) rescues the phenotype of the other two mutations, confirming that 
CG7277 and CG14016 genes are not affected in the CAP-D3 mutation and thus they 
were able to rescue the phenotype of the 13964 and EP(2)2415 mutations respectively. 
However, when the fertility of the trans-heterozygotes 13964/CAP-D3 and 
EP(2)2415/CAP-D3 was assessed, it was apparent that they were both male sterile, 
suggesting that the P-element insertions in CG7277 and CG14016 genes may affect the 
CAP-D3 gene or that these genes may also be important for fertility. Nevertheless, this 
observation has to be confirmed by RT-PCR from mRNA derived from 13964/13964 
and EP(2)2415/EP(2)2415 homozygous flies. If the levels of CAP-D3 mRNA are 
affected in these mutations it means that the P-element insertions affect the CAP-D3 
gene. 
Additional data that supports the idea that the other genes are not affected by the 
CAP-D3 P-element insertion came from CAP-D3 mutant crosses to three deficiencies 
that uncover the CAP-D3 region (deficiency 6624/CyO [breakpoints: 25D2-4;25F2-4], 
227 
deficiency 25/CyO [breakpoints: 25D4;25F1 -2], and deficiency 3365/CyO [breakpoints: 
25D7;26A7]). Only the 3365/CyO deficiency was molecularly mapped. The CAP-D3 





6624 	6624 	CAP-D3 	CyO 
CAP-D3 	CyO 	CyO 	CyO 
expected ratio 33% 33% 33% die 






3365 	3365 	CAP-D3 
CAP-D3 	CyO 	CyO 
expected ratio 33% 33% 33% die 
observed ratio 28% 36% 36% die 
228 
C) 
25 	 CAP-D3 
CyO 	 CyO 
25 	 25 	CAP-D3 	CyO 
CAP-D3 	CyO 	CyO 	çvO 
expected ratio 33% 33% 33% die 
observed ratio 32% 34% 34% die 
The 6624/CAP-D3, 3365/CAP-D3 and 25/CAP-D3 progeny were all viable. The ratio 
for these progeny were 29%, 28% and 32% respectively, which were very close to the 
expected ratio of 33% since the CyO/CyO progeny die during embryogenesis. This 
suggests that the CAP-D3 mutation was rescuing the loss of the neighbouring genes in 
the deficiency including the other genes located within the CAP-D3 gene. Furthermore 
when a fertility test was performed on the 6624/CAP-D3, 3365/CAP-D3 and 25/CAP-D3 
progeny, it was apparent that the male progeny were sterile (x) (A2, B2 and C2), 
confirming that CAP-D3 gene is probably involved in male meiosis. 
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6.5. Developmental and tissue-specific expression of CAP-D3 
Since the only observed defect in the CAP-D3 mutation was male sterility, it was 
anticipated the CAP-D3 gene would be expressed in testes. For this reason a search was 
carried out in Flybase to find any putative CAP-D3 EST clones. This search resulted in 
the finding of 5 ESTs, of which 4 derived from embryos and one from testes (Chapter 
2.3, Table II). Two of the embryonic ESTs, RE18364 and RE74832, appear to contain 
full length eDNA (Figure 6.6 A). The testes EST, AT1167 1,  was reported as full length, 
but it was missing the first 706 nucleotides of the CAP-D3 ORF, which corresponds to 
the first exon (706 bp), while it contained the 5' UTR of the cDNA (45 bp) (Figure 6.6 
B). The testis clone could possibly be an alternatively spliced form that is necessary in 
testes. The predicted protein sequence for the testis clone was the same as the full length 
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II RE18364 
1 aa 	 1267 aa 
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••AT 11671 
I aa 	 1001 aa 
Figure 6.6. Alternatively possible spliced forms of the CAP-D3 gene. The 
RE183 64  EST from embryos contains the full length cDNA of the CAP-D3 gene 
which encodes for the CAP-D3 protein of 1267 amino acids (A), while the 
AT1 1671 EST from testes is missing the first exon and it encodes for a protein of 
1001 amino acids (B). Exons are marked with numbers I-Vu. 
 
 
CAP-133 protein but it was missing the first 266 aa (Figure 6.6 B), suggesting that an 
alternative ATG start codon may exist at the beginning of the second exon. In order to 
confirm that these differences exist between the embryonic and testes ESTs, the 
RE 18364 and AT 11671 clones were obtained and sequenced. The embryonic clone 
contained the full length ORF and a part of the 5' and 3' UTR, while the testis clone was 
missing the first exon of the CAP-D3 gene, which was in agreement with the Flybase 
data. Also the testis clone appeared to contained 30 bp from the first intron and 62 bp 
that did not match the CAP-D3 genomic sequence. This 62 bp could be an artefact from 
the cloning, as it did not match any other genomic sequences after searching against 
sequences of different species. These results suggest that AT 11671 EST clone could 
represent an alternatively spliced form of the CAP-D3 gene that is required in testes or 
an artefactual chimera. 
In order to test if alternatively spliced forms exist in testes and embryos, RT-
PCR was performed from different fly tissues and developmental stages. For this 
purpose RNA was extracted from male and female brains, male and female 3rd instar 
larvae, adult testes and carcass (what was left from the male fly after testes were 
removed), adult ovaries and carcass (what was left from the female fly after ovaries were 
removed), testes from CAP-D3 homozygous flies and carcass. Primers to cover the 5' 
and 3' of the CAP-D3 mRNA were designed (Figure 6.7 A). The primers for the 5' were 
designed to cover the majority of the first exon (that was absent from the EST clone 
found in testes), and a part of the second exon. The primers from the 3' were covering 
the last three exons of the message which were present in both the embryonic and testes 
EST clones. RT-PCR revealed a band of the expected size for both 5' and 3' of the 
mRNA in all tissues and developmental stages that were examined (Figure 6.7 B). In 
some tissues (CAP-D3 carcass, female larvae, female brains and female carcass) the 5' of 
the mRNA was not present (Figure 6.7 B), but when the RT-PCR was repeated for these 
tissues, with higher amount of template, the expected product was obtained (Figure 6.8 
B). These results suggest that the first exon is also transcribed in testes and it could be 
possible that two alternatively spliced forms exist in this tissue. The first form would 
include the first 
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Figure 6.7. A. Diagram of the position of the primer pairs that were used to amplify the 5' 
(D5', 748bp) and 3' (D3', 524bp) of the CAP-D3 ORF (Tables XI and XIV). The D5' product 
corresponds to the first two exons while the D3' product to the last three exons of the CAP-D3 
gene. 
B. RT-PCR products after amplification of the 5' (D5', red asterisk) and 3' (D3', arrow) of 
the CAP-D3 ORE, in different tissues and developmental stages of Drosophila melanogaster. 
The 3' is present in all tissues and developmental stages while the 5' is present in brains, larvae, 
testes and carcass of male flies. Control primers were used to amplify a region of the SMC2 
gene (control). RT-PCR reactions without reverse transcriptase (-RT) were done as controls. 
Ml and M2 are molecular weight markers: 2. phage digested with Hindll and OX174 phage 
digested with HaeIII respectively. áV=males, ? =females 
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Figure 6.8. A. RT-PCR products after amplification of the 5' (D5', red asterisk) and 3' 
(133', arrow) of the CAP-133 ORE in the testes and male carcass of flies homozygous for 
the CAP-D3 mutation. The 3' is present in both the testes and carcass, while the 5' is 
only present in the testes. 
B. RT-PCR products after amplification of the 5' of the CAP-D3 ORE in tissues that the 
5' failed to amplify by RT-PCR as shown in figure 6.6(B) and 6.7(A). The experiment 
was repeated with higher amount of template (cDNA) compared to figure 6.7(B) and 
6.8(A). All tissues appear to include the 5' of the CAP-133 ORF in the message RNA. 
Control primers were used to amplify a region of the SMC2 gene (control). RT-PCR 
reactions without reverse transcriptase (-RT) were done as controls. 
Ml and M2 are molecular weight markers: X phage digested with Hindll and OX1 74 
phage digested with HaeIII respectively. #=males, ? =females 
exon while the second would not. However, further investigation is necessary in order 
to confirm if and which different forms of the CAP-D3 protein exist. 
6.6. CAP-D3 antibody generation and characterisation 
6.6.1. Antibody characterisation by immunoblotting 
In order to analyse the role of condensin II in Drosophila, antibodies against the non-
SMC subunits were necessary. Thus, peptide antibodies in two rabbits were generated 
against the 15 last amino acid residues of the C-terminus of CAP-D3 protein (Figure 6.9 
A) (rabbits A2922 and A2923). Optimisation of immunoblotting conditions for these 
antibodies was necessary. For this purpose, extract from Drosophila cultured cells (S2 
cells) was analysed by using the CAP-D3 antibodies (Figure 6.9 B). A prominent band 
of about 80 kDa was detected by both antibodies. Pre-immune sera of the rabbits that 
were immunised against the CAP-D3 peptide were used as a control in the 
immunoblotting. The pre-immune sera did not detect the 80 kDa band or any other band 
indicating that the CAP-D3 antibodies specifically detected this protein (Figure 6.9 B). 
The difference between the predicted (145 kDa) and the detected 80 kDa band of CAP-
D3 protein could be because a different form exists in these cells or that the CAP-D3 
protein is cleaved. Smaller products were also detected by the antibodies which 
probably represent degradation products of the CAP-D3 protein or unspecific proteins 
recognised by the antibody. A similar pattern of bands was detected by the two CAP-D3 
antibodies but the signal from the A2922 serum was stronger and thus was considered to 
be better for immunoblotting analysis. 
Since mutation of the CAP-D3 gene results in male sterility, immunoblot 
analysis was performed against testis extract from wild type, heterozygous and 
homozygous flies by using the CAP-D3 antibody (A2922) (Figure 6.9 Q. A prominent 
band of approximately the predicted size ( 145 kDa) was present in all testes extracts. 
Smaller but less prominent bands were also present in these extracts. These bands could 
correspond to degradation products, alternatively spliced forms or post-translational 
modifications of the full length CAP-D3 protein. In the same analysis, carcass extract 
from wild type, heterozygous and homozygous flies was analysed and showed 
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Figure 6.9. A. Schematic representation of the protein region that was used to generate 
the CAP-D3 peptide antibody. The 15 terminal amino acid residues were used (1253-
1267). 
Immunoblot analysis against cell extract (S2 cells, 5x105 cells/lane) with the CAP-
D3 antibodies revealed a prominent band of about 80 kDa (asterisk). The band was 
absent from the pre-immune lanes. Two CAP-133 antibodies were used (A2922 and 
A2923) and a similar pattern of bands was detected by both. The A2922 gave stronger 
signal and thus was considered to be better for immunoblotting. 
Immunoblot analysis against testes and male carcass extracts from wild type, 
heterozygous (+/-) and homozygous (-/-) flies. The A2922 antibody was used. 
Approximately four testes/lane were loaded, while an equivalent amount of protein from 
carcass extract was loaded (the protein extracts were compared by coomassie staining). 
The CAP-133 antibody recognises a band of approximately the estimated size (145 kDa, 
asterisk) in all testes extracts including the homozygous mutant (-I-) lane. Smaller 
bands that are labelled in testes lanes are probably degradation products. In the carcass 
lane the '-145 kDa band is not detected, but a prominent band of'-491 kDa (block 
arrow) is recognised. Also a smaller band of —64 kDa (arrow) is present as well. M is 
the SeeBlue Plus2 (Invitrogene) molecular weight marker. 
prominent bands, of approximately 191 kDa and 64 kDa (Figure 6.9 Q. These results 
strongly suggest that full length CAP-D3 protein is expressed in testes. However, it is 
very difficult to explain why the CAP-133 protein is still present in homozygous flies. 
One possible explanation is that the P-element is not transcribed and only wild type full 
length CAP-133 protein is produced. Another remote possibility is that part of the P-
element is transcribed, which compensates for the upstream part of the CAP-D3 gene 
that is not expressed and thus a protein of a size similar to the wild type protein is 
produced. Nevertheless, to be able to answer this question, further experiments would 
need to be performed (see 6.6.2). 
To test if the full length CAP-D3 protein was present in tissues other than testes 
or in different developmental stages, a developmental and tissue-specific 
immunoblotting was performed. Extracts from male and female brains, male and female 
third instar larvae, testes, male head and male carcass (what was left from the fly after 
testes and head were removed), ovaries, female head and female carcass (what was left 
from the fly after ovaries and head were removed) were analysed by using the CAP-133 
antibody (Figure 6.10). Several banding patterns were revealed which were usually 
different for each extract and thus no conclusions could be easily made. A prominent 
band of approximately the predicted size for full length CAP-D3 protein (145 kDa) was 
present in brain, testis and ovary extracts (Figure 6.10, asterisk). In the remaining 
extracts prominent bands of the predicted size were not recognised by the antibody. 
However, many bands were identified in all extracts suggesting that alternatively spliced 
forms might exist in different tissues and developmental stages. Some of these bands 
could be non-specific background proteins or degradation products of the CAP-D3 
protein. Some of these products could correspond to post-translational modifications of 
the CAP-D3 protein. Nevertheless, it would be appropriate to affinity purify the CAP-

















Figure 6.10. Developmental and tissue-specific immunoblot. 
Immunoblot analysis against extracts from male and female brains, male and female 
third instar larvae, testes, male head and carcass, ovaries, female head and carcass 
were analysed by using the CAP-D3 antibody (A2922). A different banding pattern 
was revealed for each extract. A prominent band of approximately the estimated 
size for full length CAP-D3 (145 kDa) is present in brain, testis and ovary extracts 
(asterisk). In the remaining extracts no prominent band of the predicted size is 
recognised by the antibody. However, many bands are identified in all extracts 
suggesting that alternatively spliced forms may exist in different tissues and 
developmental stages. M is the SeeBlue Plus2 (Invitrogene) molecular weight 
marker. 
6.6.2. Transcription of the P-element in the CAP-D3 mutant 
As previously mentioned, the CAP-133 antibody recognises a band of the predicted size 
in both the wild type and CAP-D3 homozygous mutant testes. One possibility is that the 
P-element is not transcribed along with the CAP-D3 gene and thus a product of the 
predicted wild type size is produced. For this reason RT-PCR was performed in order to 
see if and how much of the P-element was transcribed along with the CAP-D3 gene. As 
mentioned previously the P-element is 10,872 bp long and it contains two functional 
transgenes, the mini-white (white gene missing the first intron) and the intronless-
yellow (yellow gene missing its intron), which can be used to follow the transposon on 
the appropriate genetic background (white and yellow are genes of the Drosophila 
genome and thus are also present in wild type flies). The orientation of these genes is 
from right to left which is opposite to the orientation of the CAP-D3 gene. The promoter 
of the P-element is at the 3' end of the P-element and the orientation is from left to right. 
This P-element also has a GAL4/UAS enhancer. All the different regions of the P-
element are linked between them with unspecific DNA sequences (Bellen, 2004; Geyer, 
1992; Patton, 1992)(Figure 6.11 A). 
For the RT-PCR reactions, primers along the P-element were designed (Figure 
6.11) and mRNA from male flies homozygous for the CAP-D3 mutation was used as a 
template for eDNA library. mRNA from male wild type flies was used as a control. At 
the same time, PCR reactions (as an additional control) were set up with genomic DNA 
as a template from wild type flies and flies homozygous for the CAP-D3 mutation using 
the same primer pairs (Figure 6.12 B). The position of the primer pairs is indicated in 
Figure 6.11 while the presence or absence of the products as expected and as eventually 
obtained are shown in Figure 6.12(A). RT-PCR reactions with primer pairs 1, 3 and 5 
were in agreement with what was expected (Figure 6.12 A and 6.12 B). In addition, 
when combinations between the fourth and fifth primer pairs (primer pair 6) were 
attempted, no RT-PCR products were amplified suggesting that this region was not 
transcribed. In this reaction, a product was expected from CAP-D3 (-/-) genomic DNA 
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Figure 6.11. Diagram showing the position of several primer pairs relative to the 
different regions of the P-element P{EPgy2} and the CAP-D3 flanking sequence. The 
primer pairs (P1 -P6, Fl -174 and W 1) were designed to investigate which parts of the P-
element are transcribed and their exact position is summarised in tables X, XI and XIV. 
The numbers on the P-element indicate the start and end of the different parts of the P-
element. The white and yellow genes are shown. The mRNA of the yellow gene 
corresponds to the 5069-7106 bp of the P-element, while the rest of the indicated 
yellow gene (7106-9973 bp) is 5' genomic sequence flanking theyellow ± gene. The 
size of each PCR product is indicated on each primer pair. 
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Figure 6.12. A. Table showing which products were expected (exp) to be amplified (J) 
or not (x) by RT-PCR and which products were amplified (obs) ("1) or not (x) with the 
primer pairs P1 -P6 (their position relative to P-element is shown in figure 6.11). 
B. PCR (gen, genomic) and RT-PCR products amplified with the primer pairs P1-P6. 
Genomic DNA (gen) from wild type (wt) and CAP-D3 homozygous mutant (D3 -I-) flies 
and cDNA from mRNA from wild type (wt) and CAP-D3 homozygous mutant (D3 -I-) 
flies were used as a template. P1, P3 and P5 primer pairs amplified products as expected 
and are shown in 6.11(A). The products revealed from primer pairs P2, P4 and P6 
disagree with the expected results. Reactions without reverse transcriptase were 
performed as controls (-RT). Ml and M2 are molecular weight markers: A. phage digested 
with Hindll and OX 174 phage digested with HaeIIT respectively. 
 
 
In primer pairs 2, 4 and 6 the results were unexpected, making the interpretation 
of the results very difficult. In primer pair 4, unexpected products were present in wild 
type and mutant CAP-D3 RT-PCR reactions (Figure 6.12 B). In this case, no products 
were expected in either the wild type or the CAP-D3 since the reverse primer was 
located in the 5' flanking DNA of the yellow gene and thus no product should be 
amplified (yellow gene corresponds to 5069-7106 bp of P-element). The resulted 
products were smaller than expected, suggesting that they may be unspecific products. 
It could also be possible that a region of the 5' flanking DNA of the yellow gene is 
transcribed and thus these products were amplified. Furthermore, in the same reaction a 
bigger band was present in the CAP-D3(-/-) RT-PCR which was absent from the wild 
type. The presence of this band could not be explained either. Sequencing of these 
products would show if they are regions of the yellow gene or unspecific products. 
Primer pair 2 was amplifying a region of the white gene which is also present in wild 
type flies (Figure 6.12 A). This product though was not amplified in the RT-PCR 
reaction from wild type flies, while it was expected to be present (Figure 6.12 B). The 
reason for this was not clear. 
The experiment was repeated three times with different PCR conditions and the 
results were reproducible. In conclusion, these results suggest that the yellow and white 
genes are transcribed independently of the CAP-D3 gene but that the majority of the P-
element is not transcribed along with the CAP-D3 gene. This is supported by the 
observation that sequences linking different parts of the P-element are not transcribed 
(pair 1, pair 3 and pair 5). Furthermore, when RT-PCR was performed with primers that 
were covering the 5' and 3' ends of the P-element including the flankingCAP-D3 region, 
it was obvious that these regions were transcribed (Figure 6.13 A). When the same was 
repeated with primers further inside the P-element (Figure 6.11), no products of the 
expected size were produced (Figure 6.13 B), suggesting that only a small part of the P-
element (from the 5' and 3' ends) is transcribed. It also seems that the 5' of the CAP-D3 
gene (first, second and the start of the third exon) with a part of the 5' of the P-element 
are transcribed since an RT-PCR product of the expected size was obtained (Figure 6.8 
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Figure 6.13. A. RT-PCR products amplified with the primer pairs Fla-F2. mRNA 
from testes and carcass of male flies homozygous for the CAP-D3 (D3 -I-) mutation 
was used as a template for cDNA production. The position of the primers relative to 
the CAP-D3 gene and the P-element is shown in figure 6.11. Fla and Fib primer 
pairs are amplifying a region between the 5' of the P-element and the CAP-D3 gene 
(asterisk, Fla, 554 bp and block arrow, Fib, 680 bp) while the F2 primer pair is 
amplifying a region between the 3' of the P-element and the CAP-D3 gene (F2, arrow, 
220 bp). Reactions without reverse transcriptase were performed as controls (-RT). 
B. PCR (gen, genomic) and RT-PCR products amplified with the primer pairs F3 and 
F4. Genomic DNA (gen) from CAP-D3 homozygous mutant (D3 -I-) flies and cDNA 
from mRNA from wild type (wt) and CAP-D3 homozygous mutant (D3 -I-) flies were 
used as a template. The position of the primers is shown in Figure 6.11. No RT-PCR 
products of the expected size (arrows) were amplified. The bands that were amplified 
are probably unspecific products since they are also present in wild type lanes. 
Reactions without reverse transcriptase were performed as controls (-RT). Ml and 
M2 are molecular weight markers: X phage digested with Hindlil and 4X 174 phage 
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Figure 6.14 A. RT-PCR products amplified with the primer pair WI. mRNA from 
testes, ovaries and carcasses of wild type flies and flies homozygous for the CAP-D3 
(D3 -I-) mutation was used as a template for cDNA production. The primers are 
located on the CAP-D3 sequence flanking the P-element (Figure 6.11) and a product 
of —257 bp is amplified in wild type tissues (asterisk). This product is absent from 
CAP-D3 homozygous flies and no prominent band is amplified that would 
correspond to the part of the P-element that is transcribed. Reactions without reverse 
transcriptase were performed as controls (-RT). Control primers were used to amplify 
a region of the SMC2 gene (control). 
B. The same as in (A). All the reactions from (A) were loaded side by side to 
compare the products that were revealed from the reactions (only +RT). No product 
is amplified in testes and carcass homozygous for the CAP-D3 mutation. Some 
bands that were revealed are also present in wild type tissues suggesting that they are 
unspecific products (arrows). 	= males, ? = females 
M (molecular weight marker) is OX 174 phage digested with HaeIII. 
CAP-D3 message since no RT-PCR product was obtained with primers that were 
designed to cover the entire P-element message (primers were located on the CAP-D3 
DNA sequence flanking the P-element) (Figure 6.11, 6.14 A and 6.14 B). 
Unfortunately the antibody recognises only the C-terminus of the CAP-D3 ORE 
and thus it could not be determined if the N-terminus of the CAP-D3 is expressed as a 
separate stable protein or if the N-terminus is somehow linked to the rest of the CAP-D3 
message. The best way to examine this is by Northern analysis. By this procedure it 
would also be possible to investigate if the CAP-D3 protein is indeed present in the 
mutant and if a part of the P-element is included in the CAP-D3 message by using 
probes from different parts of the CAP-D3 coding sequence and from the P-element. I 
did not attempt this due to lack of time. 
6.6.3. CAP-D3 localisation in S2 tissue culture cells 
Even though CAP-D3 is most probably involved in male meiosis, the existence of the 
embryonic ESTs and the observation that the antibody recognises a prominent band by 
immunoblotting S2 tissue culture cells, suggest that CAP-D3 may be more generally 
expressed. Therefore, the subcellular localisation of CAP-D3 was analysed by 
immunofluorescence in S2 tissue culture cells that were cytospun on poly-L-lysine slides 
(Figure 6.15). Immunolabeling revealed that the protein localised diffusely in the 
cytoplasm and the nucleus during interphase (Figure 6.15 A). During mitosis, CAP-D3 
localised at the centromeres, partially overlapping with CID at prometaphase, metaphase 
and anaphase, while at telophase the signal was reduced and less restricted to the 
centromeres (Figure 6.15 B). The CAP-D3 was partially overlapping with CID since it 
was only localised in one side of CID (Figure 6.15 Q. Both CAP-D3 antibodies were 
tested and both of them showed the same localisation. The A2923 antibody was slightly 
better since it gave a stronger signal and thus was considered to be better for 
immunofluorescence analysis. Nevertheless, since the CAP-D3 mutant phenotype 
suggests a role for CAP-D3 in male meiosis, an extensive localisation study of CAP-D3 
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Figure 6.15. Immunolocalisation of CAP-D3 in S2 cells. 
Cells were cytospun onto poly-L-lysine slides, extracted during fixation and 
stained for CAP-133 (green, A2923), CID (red), and DNA (blue). 
CAP-133 is disperse in the cytoplasm and the nucleus during interphase. 
CAP-D3 localises to the centromeres and partially overlaps with CID at 
prometaphase, metaphase and anaphase. The signal is slightly reduced during 
anaphase and is diffuse and less restricted to the centromeres at telophase. The 
antibody gives a non-specific centrosomal staining as well. 
Higher magnification of a prometaphase cell showing that CAP-D3 is on one 
side of CID, since overlapping (yellow) and distinction (pure red, CID) of the two 
proteins can be observed. 
6.7. CAP-D3 dsRNA mediated interference in Drosophila S2 cultured cells 
To analyse the possible function of CAP-D3 on chromosome architecture and to 
investigate if CAP-D3 has a mitotic function, a double stranded RNA mediated 
interference on CAP-D3 was performed in S2 cells. For this reason the full length 
Drosophila EST clone RE 18364 was used. Two different primer pairs were designed, 
the first was covering the majority of the first exon including the ATG (r I= 639bp) and 
the second was covering a part of the fifth exon (r2= 723 bp) (Figure 6.16 A). In this 
way, two different dsRNAs targeting different regions of the CAP-D3 mRNA were 
available, in order to target two any possible different splice forms (Figure 6.16 B). 
Also, even though depletion by RNAi should be specifically directed only against CAP-
D3, the RNAi primers were carefully designed to be far away from the other genes 
located in the CAP-D3 gene so that their function would not be disrupted. S2 cultured 
cells were incubated with the two different dsRNAs independently and samples were 
collected subsequently at 24 hr time points. Two negative controls were performed at 
the same time: cells that were incubated with dsRNA synthesized from a human intTon 
(C) and cells with no dsRNA (-). Protein extracts from each time point were analysed 
by immunoblotting (Figure 6.16 Q. No decrease in CAP-D3 levels was observed in the 
cells treated with CAP-D3 dsRNA and the protein levels remained unchanged even after 
120 hrs. Furthermore, immunofluorescence analysis revealed that chromosome 
morphology and chromosome segregation appeared normal in the dsRNAi treated cells 
and CAP-D3 localisation was unaffected (Figure 6.16 D). These results were the same 
after treatment with the two different dsRNAs, suggesting that CAP-D3 protein is very 
stable, alternatively it has no mitotic function or, the antibodies recognise another 
protein. 
6.8. Immunoprecipitation with the CAP-D3 antibody 
Since CAP-D3 has been proposed to be a member of the condensin complex II along 
with CAP-G2 (so far not identified in flies) CAP-1-12, SMC2 and SMC4, 
immunoprecipitations were performed with the CAP-D3 antibody in order to confirm 
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Figure 6.16. A. Diagram showing the position of the two primer pairs (rI and r2) that were 
used to amplify products for CAP-133 dsRNA. The primers are summarised in Tables XII 
and XIV. B. PCR products after amplification of two regions (ri and r2) of CAP-133 ORF by 
using the primer pairs shown in 6.15(A). These products were used as template for dsRNA 
production. C. Inimunoblotting of control and CAP-D3 dsRNA treated cell extracts with an 
antibody to CAP-133 shows that the protein levels are unaffected after treatment with dsRNA 
from different regions of the message. a-tubulin was used as a loading control. C (control 
dsRNA), - (no RNA), rl and r2 (CAP-133 dsRNA from two different regions of the message). 
D. CAP-133 dsRNA treated cells 96 hours after treatment (r2 dsRNAi). Cells were cytospun 
onto poly-L-lysine slides, extracted during fixation and stained for CAP-133 (green, A2923), 
CID (red), and DNA (blue). Chromosome morphology is normal and CAP-133 protein still 
localises at the centromeres as in control cells. The scale bar is 10 Utm. 
II exists in Drosophila. For this reason, immunoprecipitations with both Drosophila 
CAP-133 antibodies were performed independently by using magnetic dynabeads and 0-
24 hour embryo extracts. Pre-immune serum was used as a control. Bound proteins 
were eluted sequentially with 0.25 M NaCl, 0.5 M NaCl and 2% SDS in PBS and the 
fractions were analysed by immunoblotting with CAP-133, SMC2 and SMC4 antibodies. 
However, no protein could be detected with any of the CAP-133 antibodies (or with pre-
immune sera) (data not shown). Similarly, the SMC2 and SMC4 antibodies were not 
detecting the expected bands in the CAP-133 immonoprecipitations as were detected 
with CAP-132 immunoprecipitations (data not shown). The background banding pattern 
was similar to the one observed with the pre-immune sera. These results could suggest 
that either the two antibodies are not recognising the CAP-133 protein or that CAP-D3 is 
not present/abundant in embryos. For this reason, extracts from testes should be used in 
order to test if the CAP-133 antibody can pull down CAP-133 protein and the rest of the 
condensin II complex. The problem with this procedure is that a large amount of testes 
material is needed which would be difficult to obtain. Furthermore, affinity purification 
of the CAP-D3 antibody is necessary so as to ensure that the antibody is recognising the 
appropriate protein. 
6.9. CAP-D3 function is independent of CAP-D2 
Since CAP-132 and CAP-133 are proposed to be subunits of two different complexes, it 
would be expected that they do not interact with each other. To assess if this is true, the 
fractions immunoprecipitated using the CAP-D2 antibody (Chapter 3, Figure 3.10) were 
probed with the CAP-D3 antibody and no interaction was detected between the two 
proteins (data not shown). In addition to this no difference in the level of CAP-D3 was 
observed in either the CAP-D2 or Topo II single depletions or CAP-D2/Topo II double 
depletion, suggesting that CAP-D3 was not affected (Figure 6.17 A). Also, the overall 
localisation of CAP-133 was not affected in the CAP-132 depleted cells. CAP-D3 was 
present at the centromeres in the CAP-132 depleted cells and when CID was stretched, 
CAP-133 was also stretched (Figure 6.17 B). These results suggest that functions of 
CAP-132 and CAP-D3 are probably independent of one another. 
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Figure 6.17. A. Immunoblotting of control, CAP-132 depleted, Topo II depleted 
and CAP-D2/Topo II doubly depleted cell extracts with the CAP-133 antibody 
(A2922). The CAP-133 levels are unaffected in either the single or the double 
depletions. a-tubulin was used as a loading control. C (control dsRNA), - (no 
RNA), D (CAP-132 dsRNA), T (Topo H dsRNA) and D/T (CAP-D2/Topo II double 
dsRNA). 
B. CAP-D2 dsRNA treated cells 72 hours after treatment. Cells were cytospun onto 
poly-L-lysine slides, extracted during fixation and stained for CAP-133 (green, 
A2923), CID (red), and DNA (blue). CAP-133 protein still localises at the 
centromeres in the CAP-132 depleted cells and is stretched when CID is stretched 
(white arrow). The scale bar is 10 Itm. 
6.10. Phenotypic analysis of CAP-D3 mutant testes 
The only phenotype observed in the CAP-D3 mutant was male sterility and thus, 
phenotypic analysis of homozygous testes for the CAP-D3 mutation was attempted. 
Two different avenues were followed to investigate the reason(s) behind male sterility. 
Firstly, whole testes from late pupae were observed after staining for DNA (Figure 
6.18). The morphology of the mutant pupal testes was normal as their width and length 
appeared similar to control (Figure 6.18 A and B). The only possible defect observed 
was that the tips of the mutant testes were more pointed suggesting that they may have 
reduced germ cell content (Figure 6.18 B). This appearance is usually more common in 
older testes, where germ cells have proceeded into mitosis and meiosis and mature 
sperm has been produced repeatedly. Bearing in mind that the testes were dissected 
from late pupae, they would be expected to have a rich germ cell content and thus more 
rounded tips as observed in control testes. At the base of testes, in both wild type and 
mutant preparations, mature cysts with elongated sperm were present (Figure 6.18 A and 
B). When these cysts were more carefully observed, it was obvious that in wild type 
most of the spermatid nuclei were clustered in cysts while some were scattered (Figure 
6.19 A). In the mutant testes, spermatid nuclei were clustered and individual cysts could 
be recognised but a significantly higher fraction of spermatid nuclei were scattered 
compared to controls (Figure 6.19 B). While spermatid nuclei were elongated from 
mutant testes, this was not as extreme as in wild type (compare Figure 6.19 A( 1-3) and 
6.19 B( 1-3)). This could be because the mutant testes were slightly younger compared 
to wild type (even though wild type and mutant testes were dissected from the same late 
pupa stage) or that the mutant spennatids differentiate and mature slower compared to 
control. The second assumption could be more possible bearing in mind that testes from 
mutant mature adults have a white/transparent colour compared to a yellow colour of 
wild type testes. The yellow colour is a consequence of spermatid maturation and aging. 




CA P-D 3/CA P-D3 
Figure 6.18. A. Testes from wild type pupae. Testes were fixed and stained 
for DNA (DAPI). Pupal testes (T) with accessory glands (G) are shown in 
(1) and a single testis is shown in (2). The red arrow (2) at the base of the 
testis indicates junction between testis and seminal vesicle (S). The tip of the 
pupal testis (t) is round. Mature spermatid cysts are obvious at the base of the 
testis (white block arrows). 
B. Testes from CAP-D3 homozygous pupae. Testes were fixed and stained 
for DNA (DAPI). Pupal testis (T) are shown in (1) and a single testis is 
shown in (2). The red arrow (1) at the base of the testis indicates junction 
between testis and seminal vesicle (S). The tip of the pupal testis (t) is 
pointed in contrast to wild type which is rounded. Mature spermatid cysts are 
obvious at the base of the testis (white block arrows). 
The scale bar is lOtm. 
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Figure 6.19. A. Elongated spermatid nuclei morphology from wild type 
pupae. Testes were fixed and stained for DNA (DAPI). Several clusters of 
threadlike spermatid nuclei are visible. Although most nuclei are clustered into 
cysts (1, 2 and 3) some are scattered (4, 5 and 6), possibly as a result of testes 
handling. 
B. Elongated spermatid nuclei morphology from CAP-D3 homozygous pupae. 
Testes were fixed and stained for DNA (DAPI). Although individual cysts can 
be recognised (arrowheads) most of the spermatid nuclei are scattered (white 
arrows). Notice that the spermatid nuclei are elongated but are not fully 
condensed (wider and shorter) compared to control. 
The scale bar is lOj.im. 
condensation defect, which persists during spermatid differentiation, may impact on 
final sperm function. 
In the second approach, unfixed testes were observed by phase contrast 
microscopy. In this way it was possible to observe stages that were not visible by DAPI 
staining such as 'onion-stage' early spermatid cysts. The regular appearance of onion-
stage early spermatid cyst serves as a diagnostic for identification of mutants that caused 
defects during the meiotic divisions. Thus, onion-stage early spermatid cysts were 
observed by phase contrast microscopy from both wild type and CAP-D3 homozygous 
mutant flies (Figure 6.20 and 6.2 1, respectively). In wild type, each spermatid nucleus 
appeared as a pale sphere (white) and next to it was a dark, equal in size, spherical 
"Nebenkern" or mitochondria derivative (Figure 6.20). In the CAP-D3 mutant, most of 
the nuclei and Nebenkern appeared normal and equal in size but abnormalities were also 
observed (Figure 6.21). These defects include onion-stage spermatid cysts with large or 
variable Nebenkern associated with variable numbers of differently sized nuclei. 
Particularly, these defects are grouped in several categories such as: one big Nebenkern 
associated with two smaller nuclei of uniform size (Figure 6.21 A(1)), one small 
Nebenkern associated with a bigger and a smaller nucleus (Figure 6.21 A(2)), two 
unequal Nebenkern associated with a smaller nucleus (Figure 6.21 A(3)), two 
Nebenkern associated with one nucleus (Figure 6.21 A(4)), one big Nebenkern 
associated with smaller nucleus (Figure 6.21 A(5) and 6.21 B(2)), one Nebenkern 
associated with a smaller nucleus and a micronucleus (abnormally small nucleus) 
(Figure 6.21 B(1)) and two big Nebenkern associated with four smaller nuclei of 
uniform size (Figure 6.21 B(3)). These abnormalities are probably a consequence of 
abnormal chromosome segregation and cytokinesis. Nevertheless, all these phenotypes 
should be quantified in order to draw any significant conclusions about the role of CAP-
D3 in male meiosis. Despite the defects in chromosome segregation and cytokinesis, 
spermatid differentiation proceeded nonetheless and elongated cysts were produced in 
the CAP-D3 mutant testes, an observation that is also mentioned in the literature for 








Figure 6.20. A. Morphology of onion-stage early spermatid cysts 
visualised by phase contrast microscopy of unfixed wild type testes. Each 
spermatid contains a single nucleus (white circle) and a single Nebenkem 
(black circle) of uniform size, which can be easily observed in higher 










Figure 6.21. A. Morphology of onion-stage early spermatid cysts visualised by phase 
contrast microscopy of unfixed homozygous CAP-D3 mutant testes. Most of the 
spermatids appear normal and they contain a single nucleus (white circle) and a single 
Nebenkern (black circle) of uniform size. However, meiotic division defects were also 
observed:(1) one large Nebenkern is associated with two nuclei of smaller size, (2) one 
small Nebenkern is associated with a bigger and a smaller nucleus, (3) one nucleus is 
associated with a bigger and a smaller Nebenkern, (4) two equal Nebenkern are 
associated with one nucleus, (5) one Nebenkern is associated with a nucleus smaller in 
size. 
B. Parts of an onion-stage early spermatid cyst visualised by phase contrast 
microscopy of unfixed homozygous CAP-D3 mutant testes. Meiotic division defects 
can be easily recognised:(l) one Nebenkern and an equal in size nucleus are associated 
with a micronucleus, (2) a large Nebenkern is associated with a smaller in size nucleus, 
(3) two large Nebenkern are associated with four smaller but equal in size nuclei. 
the mature spermatids of CAP-D3 homozygous male flies were motile as judged by a 
motility assay that was performed on sperm from seminal vesicles (Tim Karr, personal 
communication), suggesting that the male sterility is not a consequence of immotile 
sperm but probably a result of aneuploidy that occurred during the mitotic and/or 
meiotic stages. 
In conclusion, there are several defects observed in the CAP-D3 homozygous 
testes. The testes tips are pointed instead of round in late pupae, the colour of the testes 
is white instead of yellow in mature adults, the spermatid nuclei are more scattered, 
shorter and wider compared to wild type and a fraction of the onion-stage early 
spermatids are defective. The most suggestive phenotype of all are the abnormalities 
observed in the onion-stage early spermatid cysts. As already mentioned, these 
abnormalities are probably a consequence of defective chromosome segregation and 
cytokinesis during the meiotic stages. The defects in the colour of the testes, the 
scattering of spermatid nuclei and the size of spermatid nuclei in mutant preparations 
could be a secondary consequence from the defects observed in the onion-stage. 
Nevertheless, a more detailed phenotypic analysis of different developmental stages of 
the testes, along with quantification of the defects observed is necessary to fully 
understand the consequences of CAP-D3 loss. In general the defects observed in the 
CAP-D3 mutant testes were very mild and possibly analysis of testes from CAP-D3/Df 
(CAP-D3 over the deficiency) flies could be more informative. In this way, one of the 
two alleles will be completely absent and thus the phenotype could be more severe. 
Eventually further investigation will highlight the role of CAP-D3 in male meiosis. I 
was not able to perform this analysis due to lack of time. 
6.11. Brief discussion 
Preliminary functional analysis of the CAP-D3 protein revealed a putative role in 
spermatogenesis and most probably in male meiosis. However during this study many 
of the results could not be interpreted and many questions still need to be answered. The 
major boundary in this analysis is the quality of the CAP-D3 antibody. In tissue culture 
cells, the antibody recognises a band that is significantly smaller than the predicted size, 
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while in the testes, where a full length protein of the estimated size is detected, a protein 
of similar size is also present in the testes of the homozygous CAP-D3 flies. 
Even though several possible explanations have been given in order to justify the 
presence of the full length protein in the homozygous mutant flies, the fact that 8 base 
pairs are duplicated in the insertion point of the P-element, definitely excludes the 
possibility that a full length wild type protein could be produced. The 8 base pair 
duplication would destroy the ORF downstream of the P-element insertion and even if 
the P-element is somehow not transcribed along with the rest of the CAP-133 message, 
the message downstream of the transposon will not be in frame. Thus no wild type 
and/or full length protein should be produced. These data strongly support the idea that 
the CAP-133 antibody does not recognise the CAP-133 protein and that probably the 
antibody detects a non-specific epitope. 
Further data that support the non-specificity of the CAP-D3 antibody, is the 
failure to detect a reduction in the level of CAP-D3 protein after RNAi treatment. 
However, the attempt to deplete CAP-D3 by RNAi in S2 cells also had no effect on 
either mitotic chromosome organisation or mitotic progression. The lack of a mitotic 
phenotype supports the idea that CAP-133 probably has no mitotic role. An experiment 
to test if the RNAi disrupts CAP-D3, is to perform an RT-PCR with primers that cover 
CAP-133 mRNA. If the level of the CAP-D3 mRNA is reduced after RNAi treatment, 
two possibilities emerge. Either the CAP-133 protein is very stable and it can function 
for a long time after its expression and thus the protein can be still detected (by 
immunoblotting) and no phenotype can be observed (by immunofluorescence). 
Alternatively, the CAP-D3 antibody may not recognise the right protein and CAP-D3 
has no mitotic role. However, at this point there is no evidence if CAP-133 protein is 
expressed in S2 cells. 
If we assume that the CAP-133 antibody does not recognise CAP-D3, then the 
centromeric staining observed after immunofluorescence would be non-specific. Not 
infrequently, antibodies unspecifically recognise subcellular structures such as 
centrosomes - but centromeres are not commonly detected unspecifically. A good way 
to analyse the subcellular localisation of the CAP-D3 protein during the cell cycle, is to 
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tag the protein with GFP. This strategy would allow live imaging of the CAP-D3 
protein and its localisation during the cell cycle, and it would permit comparison of the 
localisation of the protein after antibody staining and GFP-tagging. Furthermore, extract 
from cells that express CAP-D3 protein tagged with GFP could be used for further 
analysis by immunoblotting (using an anti-GFP antibody), thus allowing the detection of 
the full length CAP-D3 protein and a shifted size (with CAP-133 antibody). 
Furthermore, an antigen competition experiment could be performed as additional 
control in order to test if the antibody recognises the CAP-D3 protein. In this 
experiment, the peptide (antigen) that was used for the generation of the CAP-133 
antibody will be incubated with the antibody and this mixture will then be used to detect 
the CAP-D3 protein on tissue culture or testes extract, by immunoblotting. If the 
expected protein does not appear or the strength of the signal is significantly reduced, it 
suggests that the antibody recognises the "right" protein. If no change occurs, it is most 
probable that the antibody detects a non-specific epitope. 
However, a few more assumptions could be made of what the CAP-D3 antibody 
could be recognising. If alternatively spliced forms of the CAP-D3 gene exist, and the 
third exon is completely removed in one of these splice variants then the P-element 
insertion might not affect the expression of the protein. Nevertheless, exclusion of the 
third exon would imply a change of the protein size ('27 kDa). Alternatively, it could 
be possible that the CAP-D3 protein is produced by a splice variant lacking the last 
exon. The CAP-D3 antibody would not recognise this protein, as the CAP-133 antibody 
was generated against the predicted final 15 amino acids of the CAP-D3 protein. The 
last exon is relatively small and the size difference after its removal would not be 
significant (lO kDa). Unfortunately, no EST data exist so far to support the existence 
of the two splice variants proposed above. 
In conclusion, generation of several antibodies against different regions of the 
CAP-D3 protein should be pursued. Also Northern and RT-PCR analysis using different 




7.1. The role of Drosophila CAP-D2 
In my thesis research, I have shown that CAP-D2 is part of a complex containing other 
condensin subunits (SMC2, SMC4, CAP-H/Barren and CAP-G) in Drosophila. 
Interestingly, the non-SMC subunits, CAP-D2 and Barren, appear to be more tightly 
associated with each other than they are with the SMC subunits. This finding is 
reminiscent of studies in the Heck lab of the cohesin complex in Drosophila where it 
was shown that Scc 1 /Drad2 I and Scc3/SA I appeared to have a higher affinity for one 
another than for SMC1 and SMC3 (Vass et al., 2003). 
The subcellular localisation of CAP-132 revealed that the protein was nuclear 
throughout interphase with levels increasing during S phase, and peaking in late 
G2/early prophase. This result was particularly intriguing as Drosophila SMC4 and 
Barren appear cytoplasmic during interphase and associate with chromatin only during 
prophase (Steffensen et al., 2001). In human cells the majority of CAP-D2 (and SMC2 
and SMC4) localises in the cytoplasm during interphase, finally becoming nuclear 
during prophase, suggesting that the subcellular distribution of the entire condensin 
complex in human cells may be regulated in a cell cycle-dependent manner (Ball et al., 
2002; Schmiesing et al., 2000). Differential localisation of condensin subunits during 
interphase in Drosophila suggests that CAP-D2 may be sequestered away from SMCs to 
regulate activity or may be utilized for a function other than that required of other 
condensin subunits during interphase. it has recently been shown in Xenopus that CAP-
D2 (pEg7) along with SMC2 (XCAP-E) localise in the granular compartment of the 
nucleolus suggesting that these subunits may be involved in nucleolar organisation and 
/or ribosome biogenesis (Uzbekov et al., 2003). Furthermore in S. cerevisiae, the CAP-
D2 homolog Ycs4 is nuclear during interphase, implicated in suppressing inter-repeat 
rDNA recombination and believed to be required for silencing at the silent mating loci 
(Bhalla et al., 2002). Thus, it is possible that Drosophila CAP-D2 is responsible for a 
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non-mitotic function during interphase, possibly during S phase when its level increases. 
Alternatively, expression during S phase may be important to template the protein 
appropriately for its mitotic role (Loupart et al., 2000; Shelby et al., 1997). The increase 
of nuclear CAP-D2 levels during S phase could be either because protein expression is 
up-regulated or because the protein is imported into the nucleus from the cytoplasm. A 
potential nuclear bipartite targeting signal between amino acids 1347 and 1363 was 
identified on the Drosophila CAP-132 protein (this study). Similarly human CAP-132 
(CNAP1) has been shown to have a functional bipartite nuclear localisation signal 
responsible for the localisation of CAP-D2 to the nucleus (Ball et al., 2002). During 
mitosis, CAP-D2 localises to the chromatid cores and remains tightly associated with 
chromosomes until late telophase/cytokinesis, even as chromosomes are decondensing. 
DmSMC4 and Barren proteins are loaded onto chromosomes in early prophase but they 
dissociate from chromosomes late in anaphase/telophase when decondensation begins 
(Steffensen et al., 2001). This distinct timing of dissociation of the different condensin 
subunits could be because CAP-D2 performs a function beyond that required of 
condensin, or to regulate activity of condensin. In human cells it has been shown that 
the C terminal-end of CAP-D2 possesses a mitotic chromosome-targeting domain that 
does not require the other condensin subunits (Ball et al., 2002). It is possible that a 
similar regulation occurs in Drosophila and that CAP-D2 binds to chromosomes 
independently of the other subunits. Beyond the axial localisation of CAP-D2 on 
mitotic chromosomes, a specific accumulation of this protein has been observed at 
centromeres during mitosis and especially during metaphase. A similar localisation has 
been also reported for Barren and SMC4 in Drosophila (Steffensen et al., 2001), while 
an interaction between CAP-G and CID has been recently reported suggesting a role for 
the condensin complex in kinetochore structure (Jager, 2005). 
I have shown that depletion of CAP-132 by RNAi in Drosophila cultured cells 
results in an abnormal mitotic phenotype. The major defect is the loss of sister 
chromatid (arm and centromere) resolution and the resulting failure of chromosomes to 
segregate normally during anaphase, a phenotype similar to that observed in barren, 
DmSMC4 and dCAP-G (red sea) mutant alleles (Bhat et al., 1996; Dej et al., 2004; 
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Steffensen et al., 2001) and DmSMC4 RNAi (Coelho et al., 2003). No complete loss of 
compaction defect per se has been observed, consistent with the existence of additional 
essential factors in Drosophila, as in chicken cells (Hudson et al., 2003). Although loss 
of Barren in Drosophila appears not to have an effect on cell cycle progression (Bhat et 
al., 1996), loss of SMC4 causes a metaphase delay in embryos (Steffensen et al., 2001) 
and even more pronounced prometaphase delay (unpublished data), similarly, loss of 
dCAP-G causes a prometaphase delay in embryos (Dej et al., 2004). Depletion of CAP-
D2 in S2 cells results in a temporal prometaphase delay, though cells do eventually 
undergo aberrant anaphase and cytokinesis. 
The delay is possibly a consequence of checkpoint activation, since 
chromosomes have not aligned properly on the metaphase plate, and exhibit elevated 
levels of BubRI labeling (which persists during anaphase and cytokinesis). The mis-
alignment of chromosomes in the metaphase plate could be a consequence of the loss of 
interaction between the condensin complex and chromokinesisn KIF4A. It has been 
shown recently, that human chromokinesin KIF4A interacts with the condensin I and 
condensin Ii complexes, while depletion of this protein by RNAi results in defective 
prometaphase organisation and chromosome mis-alignment at metaphase (Mazumdar et 
al., 2004). Thus, the interaction between condensin and chromokinesin KIF4A could be 
essential for the alignment of chromosomes on the metaphase plate. 
Furthermore, centromere organisation seems to be affected by the depletion of 
CAP-132 since centromeres appear stretched during anaphase. Similar results have been 
observed in DmSMC4 RNAi (Coelho et al., 2003) where kinetochores associated with 
spindle microtubules were stretched polewards, sometimes well beyond the chromatin 
mass. However, when microtubules were depolymerised by colchicine, centromere 
stretching was not observed, suggesting that the observed defect was microtubule and 
tension dependent. In C. elegans, the condensin complex is required for the restricted 
orientation of centromeres towards spindle poles (Hagstrom et al., 2002), while in an S. 
cerevisiae BRN 1 mutant, centromere function is defective and centromeres do not 
segregate normally (Ouspenski et al., 2000). Recently it has been shown that depletion 
of condensin I or condensin IT in vertebrate cells results in structural distortions of the 
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centromere/kinetochore region which affects the opposing orientation of sister 
kinetochores and interaction with the mitotic spindle (Ono et al., 2004). Moreover, an 
interaction between the Drosophila CAP-G and CID, the centromere-specific histone H3 
variant CENP-A, has been reported (Jager et al., 2005). CID has been shown to play a 
role in kinetochore specification and assembly (Blower and Karpen, 2001; Howman et 
al., 2000; Oegema et al., 2001). 
Taken together, these results suggest that the condensin complex may have a role 
in centromere organization and ensuing kinetochore-spindle interactions. This defect in 
turn could impact the localization of chromosome passenger proteins as shown in this 
study. INCENP showed temporal disruption of localisation in the CAP-D2 depleted 
cells. Very similar defects in INCENP localization were observed when the Sccl/Rad2l 
cohesin subunit was depleted in cultured cells (Vass ct al., 2003). These results argue 
that proper chromosome organisation is necessary for the correct temporal localisation 
of at least one chromosome passenger protein. 
Different subunits of the condensin complex appear to behave differently 
following the depletion of CAP-D2. Barren is unstable when CAP-D2 is depleted and 
any residual protein is cytoplasmic. Similarly, in the DrnSMC4 RNAi, Barren 
localisation was dependent on SMC4 (Coelho et al., 2003). In a Barren mutant, CAP-
D2 was unstable to a similar level as Barren, corroborating the interdependence of the 
two proteins on one another for stability. On the other hand, levels of SMC2 and SMC4 
were not greatly affected by the CAP-D2 depletion and the two proteins were still 
localised to chromatin, albeit in a non-axial fashion. This is likely a reflection of 
compromised structural integrity of mitotic chromosomes as observed in chicken DT40 
cells depleted of SMC2 (Hudson et al., 2003). Nevertheless, a number of CAP-D2 
RNAi cells have reduced levels of SMC4 and SMC2 on their chromosomes, and are 
possibly more severely affected by the CAP-D2 RNAi. 
In S. cerevisiae and S. pombe, the condensin SMCs can bind chromatin only 
when the non-SMC subunits are present (Freeman et al., 2000; Lavoie et al., 2002). The 
question that arises then is whether the SMCs remaining on chromosomes are in any 
way functional? Recently, a condensin II complex was found in vertebrate cells which 
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shares the same two SMC subunits as the 'original' condensin I complex but contains 
different non-SMC subunits (two of three have been identified in Drosophila (Ono et al., 
2003)). Should a functional condensin II complex exist, then the remaining 
chromosomal SMCs (after CAP-D2 depletion) may be members of the condensin TI 
complex. Consistent with this is the observation that SMC2 and SMC4 are similarly 
reduced in a Barren mutant, but not as severely as Barren and CAP-132. Attempts to 
deplete the CAP-133 subunit of the Drosophila condensin II complex by RNAi in S2 
cells failed to present a mitotic phenotype while mutation by P-element insertion in the 
CAP-133 gene caused male sterility. It therefore remains to be determined if the 
condensin complex II has a meiotic, but not a mitotic role in Drosophila. If so, then 
SMCs remaining on chromosomes after depletion of CAP-132 and Barren may be 
involved in yet another complex, distinct from condensin I and II complexes. 
In this study, the first disruption in Drosophila of two components (condensin 
and topo II) known to be involved in chromosome organisation was performed. When a 
double depletion of CAP-D2/Topo II was performed, abnormal chromosome appearance 
and behaviour similar to that observed in the individual Topo IT and CAP-D2 RNAi 
experiments was seen. Chromosomes were fuzzy and unresolved, inadequately aligned 
on the metaphase plate, and formed chromosome bridges during anaphase and 
cytokinesis. Surprisingly, the double depletion phenotype was no more severe than in 
either of the single depletions. This result suggests not only that topo II and the 
condensin complex participate in the same pathway required to organise mitotic 
chromosomes into well-defined structures, but also that factors other than these proteins 
still remain to be identified for their essential roles in chromosome condensation. 
7.2. Characterisation of JSL2 - an SMC2 mutation 
A point mutation affecting the SMC2 gene causes lethality in early pupae. The fact that 
homozygous individuals for the JSL2 mutation live up to this point is surprising, 
bearing in mind the importance of this protein for chromosome dynamics as well as the 
fact that mutants affecting SMC4 (gluon' 7C  and gluon 8882) and Barren (barr1305) 
condensin subunits die during embryogenesis. The maternal contribution to the embryo 
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would be expected to maintain the function of the condensin complex up to 
cellularisation or even until the end of embryogenesis, but possibly no further than this 
stage. However, this protein and generally the condensin complex are also necessary 
after embryogenesis, for the development of larval tissues that are mitotically active, 
such as brains and imaginal discs. 
Several hypotheses could be made for the reason that JSL2 mutant live up to 
pupation. One possibility is that the SMC2 truncated protein is functional in a way and 
it can partially rescue the loss of SMC2 protein. The fact that SMCs are dimerised by 
hinge-hinge interactions (Hirano and Hirano, 2002) and that only the C-terminal region 
of the SMC2 protein is missing it could be suggested that the truncated SMC2 protein 
participates in the formation of a "condensin" complex. However, this complex is not 
expected to function properly since one of the catalytic domains is missing. A second 
scenario is that the SMC4 subunit forms homodimer in the JSL2 mutant and thus a 
substitute "condensin" complex is assembled. The second assumption is supported by 
the observation that eukaryotic SMCs were able to form homodimers when fusion 
proteins were highly overexpressed, thereby titrating out the natural SMC partner 
(Strunnikov et al., 1995). Nevertheless, a condensin complex containing a homodimer 
of SMCs should not be functional as the in vitro activity of the complex depends on the 
combined presence of both subunits (Kimura and Hirano, 1997; Kimura et al., 1999; 
Schmiesing et al., 1998; Sutani and Yanagida, 1997) while mutation of only one SMC 
partner produces defects in vivo (Chuang et al., 1994; Dej, 2004; Lieb et al., 1998; 
Michaelis et al., 1997; Saka et al., 1994; Steffensen et al., 2001; Strunnikov et al., 1995; 
Strunnikov et al., 1993). Indeed, whatever is responsible for the surprisingly 'long life' 
of the homozygous animals can not certainly replace the contribution of SMC2 in 
chromosome organisation. 
The absence of a functional SMC2 protein results in abnormal mitotic 
phenotype. The major defect observed is the loss of sister chromatid resolution and the 
failure of chromosome segregation during anaphase, defects that were also observed 
after the depletion of other condensin subunits in Drosophila (Bhat et al., 1996; Coelho 
et al., 2003; Dej, 2004; Savvidou et al., In Press; Steffensen et al., 2001). However, no 
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complete loss of compaction defect per se has been observed. The fact that 
undercondensed chromosome regions were observed in a minority of mitotic cells in the 
JSL2 mutation, could be an indirect effect of accumulated chromosome defects from the 
failure of previous mitotic divisions. This is supported by the observation that these 
defects are only observed in a minority of cells in third instar larval brains but not in 
second instar larvae. Loss of SMC2 results in a slightly higher 
prometaphase/metaphase index in the mutant compared to control, suggesting that 
progression through mitosis may be somewhat delayed in mutant larval brains, it has 
been reported that loss of Barren in Drosophila appears not to have an effect on cell 
cycle progression (Bhat et al., 1996), while loss of SMC4, dCAP-G and CAP-D2 cause 
metaphase or prometaphase delay (Coelho et al., 2003; Dej et al., 2004; Savvidou et al., 
In Press; Steffensen et al., 2001). 
The protein levels of the rest of the condensin subunits were reduced by the 
absence of SMC2. This reduction in level was more severe than that observed in the 
gluon' 7C  allele of SMC4. Moreover, INCENP levels, were significantly decreased in 
homozygous JSL2 third instar larvae brains. Nevertheless, as INCENP is responsible 
for the correct targeting of Aurora B during mitosis and that Aurora B phosphorylates 
histone H3 at the onset of mitosis (Adams et al., 200 Ia), it would be expected the levels 
of phosphorylated histone H3 might be affected in mutant JSL2 cells. Interestingly, H3 
was normally phosphorylated in the mitotic cells of the homozygous JSL2 larval brains 
as judged by immunofluorescence analysis. Therefore, the reduction observed in the 
levels of INCENP is possibly a consequence of the low mitotic index of the 
homozygous JSL2 third instar larvae brains. However, the levels ofDrad2l/Sccl were 
largely unaffected in the homozygous brain extracts. Drosophila Drad2 1 /Scc 1 
dissociates from chromosomes in prophase and only a small population remains 
associated with centromeres until the metaphase to anaphase transition (Warren et al., 
2000b). I would suggest, the low mitotic index observed in second and even more so in 
third instar larval brains is a consequence of accumulated chromosome abnormalities or 
activation of the DNA structure checkpoint. So as to test if the distribution of condensin 
subunits and INCENP is affected in mitotic cells lacking SMC2, immunofluorescence 
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for these proteins should be performed on larval brains. However, previous attempts to 
use these antibodies on neuroblast squashes was unsuccessful. 
Strikingly, loss of SMC2 appears to affect the organisation of the mitotic 
spindle. Interestingly, a recent analysis has shown that the condensin complex is 
required for mitotic spindle assembly and function in Xenopus laevis egg extract 
(Wignal et al., 2003). In this study, immunodepletion of condensin inhibited 
microtubule growth and organisation around chromosomes, and eliminated the 
formation of mitotic spindles. However, in Drosophila, depletion of CAP-D2 or SMC4 
by RNAi or loss of SMC4 and dCAP-G by mutation, did not display any abnormalities 
in mitotic spindle formation (Coelho et al., 2003; Dej et al., 2004; Steffensen et al., 
2001). Thus, it is possible, that the spindle defects observed in the JSL2 mutant were 
specific to this subunit or may be an indirect effect, caused by the overall chromosome 
abnormalities accumulated in previous cell cycles. 
Surprisingly, level of H3 was reduced in JSL2 homozygous third instar larval 
brains. This observation does not appear to be a consequence of second site mutations 
in any of the histone H3 genes. Whether other histones are affected is unknown. The 
fact that the mitotic index is significantly reduced, make the analysis of chromosome 
dynamics very difficult in this mutant. Furthermore, the major part of this analysis has 
to be performed in second instar larvae, which are extremely difficult to handle, while 
immunofluorescence using antibodies against condensin subunits and INCENP was not 
highly successful in larval neuroblasts. For these reasons, further analysis of this 
mutant was not performed. However, the phenotypic analysis of the JSL2 mutant 
confirmed that SMC2 and likely the entire condensin complex is primarily required for 
sister chromatid resolution and segregation in Drosophila and that the stability of the 
other subunits of the complex is compromised after loss of SMC2. 
7.3. Characterisation of CAP-D3, a condensin II subunit 
Recently, a condensin II complex was found in vertebrate cells. This complex shares the 
same two SMC subunits as the 'original' condensin I complex but contains different 
non-SMC subunits, CAP-D3, CAP-G2 and CAP-1-12 (Ono et al., 2003). In Drosophila 
only two of the three non-SMC subunits have been identified, CAP-1-12 and CAP-D3 
(not CAP-G2). In this study analysis of the CAP-D3 subunit was performed. CAP-D3 
localises to the centromeres and partially colocalises with CID in mitotic Drosophila S2 
cells. Attempts to coimmunoprecipitate proteins interacting with CAP-D3 were 
unsuccessful and thus it is not yet clear if this protein interacts with SMC4, SMC2 and 
CAP-1-12 to form a condensin complex II in Drosophila. Furthermore, attempts to 
deplete CAP-D3 by RNAi in S2 cells failed to present a mitotic phenotype, suggesting 
that either this protein does not have a role in mitotic chromosome dynamics or that the 
protein is quite stable and it can not be depleted by RNAi. Interestingly, a P-element 
insertion in the CAP-D3 gene causes male sterility, indicating a role for this protein in 
spermatogenesis. Mature spermatids of CAP-D3 homozygous male flies were motile, 
suggesting that male sterility was not a consequence of decreased motility. In contrast, 
several defects were mainly observed in the onion stage spermatids. These 
abnormalities are probably a consequence of abnormal chromosome segregation and 
cytokinesis, which occurred in the meiotic stages (Bate and Martinez, 1993; Castrillon et 
al., 1993). Despite the defects in chromosome segregation and cytokinesis, spermatid 
differentiation proceeded nonetheless and elongated cysts were produced in the CAP-D3 
mutant testes, an observation that is also mentioned for mutations with similar 
phenotypes (Castrillon et al., 1993; Fuller, 1993). Nevertheless, further and detailed 
analysis of this mutation is necessary to draw any significant conclusions about the role 
of CAP-D3, and possibly for the whole condensin complex II, in male meiosis in 
Drosophila. 
7.4. 	Conclusions and fluture perspectives 
The precise mechanism of chromosome condensation and decondensation remains a 
mystery, despite progress over the last 25 years aimed at identifying components 
essential to the compaction of the genome during mitosis. However, modern 
experimental approaches are now providing novel insights into the old questions. 
Indeed, recent studies of condensin have resolved one old controversy by showing that 
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non-histone proteins (and not just the histories) play an essential role in mitotic 
chromosome structure. 
In this study, it has been demonstrated for the first time that a condensin complex 
exists in Drosophila embryos. This complex contains CAP-132, the anticipated SMC2 
and SMC4 proteins, the CAP-H/Barren and CAP-G (non-SMC) subunits. Analysis of 
the localisation of CAP-D2 showed that this protein is nuclear throughout interphase, 
increasing in level during S phase, present on chromosome axes in mitosis, and still 
present on chromosomes as they start to decondense late in mitosis. In vitro and in vivo 
analyses of different Drosophila condensin subunits, have shown that condensin is 
required mainly for chromosome resolution rather than chromosome compaction per se, 
in this organism. Particularly, when the consequences of CAP-D2 loss after dsRNA-
mediated interference were analysed, it was discovered that the protein was essential for 
chromosome arm and centromere resolution. The loss of CAP-D2 after RNAi has 
additional downstream consequences on the stability of CAP-H, the localization of DNA 
topoisomerase II and other condensin subunits, chromosome segregation, and the 
dynamics of chromosome passenger proteins. Similarly, loss of SMC2 subunit by 
mutation, confirmed the requirement of this protein, and probably of the entire 
condensin complex, in chromosome resolution and segregation. Furthermore, in this 
mutant, the stability of other condensin subunits and chromosome passenger proteins 
was compromised. However, while loss of CAP-132 only affects the stability of the 
Barren subunit, loss of SMC2 affects the stability of all the examined condensin 
subunits, suggesting that the strength of the interactions between the four examined 
members of the condensin complex may vary or that phenotypes in cultured cells may 
differ from those in the animal. 
In contrast to vertebrates, analysis of the Drosophila condensin complex II 
revealed so far that this complex is more likely to be involved in male meiosis rather 
than mitosis. If this is true, it would then be tempting to suggest that different 
mechanisms may exist between Drosophila and vertebrates, that regulate the 
organisation of mitotic and meiotic chromosomes. Drosophila offers a good system for 
the analysis of male meiosis and thus detailed analysis of the condensin complex II in 
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CHROMOSOME CONDENSATION 
Ellada Savvidou and Margarete M. S. Heck 
Wellcome Trust Centre for Cell Biology, University of Edinburgh 
INTRODUCTION 
Chromosomal DNA, if stretched end-to-end, measures about 2 metres in any one cell of the human 
body and therefore it must be highly folded to fit into a nucleus of only 5 tm diameter. In addition 
to this, DNA has to condense even more prior to cell division in order to form the highly compacted 
metaphase chromosome. Several levels of packing enable DNA to achieve this packaging and a 
number of structural proteins are involved. The simplest level of packing involves the winding of 
DNA around octamers of core histories in a structure called the nucleosome. This shortens DNA 
about 7-fold relative to naked DNA. The folding of regularly spaced nucleosomes forms a shorter, 
thicker filament, called the 30 nm chromatin fiber, in which the DNA is about 40-fold more 
compact than when naked. The most highly condensed and least understood stage takes place prior 
to chromosome segregation when the DNA in metaphase chromosomes of higher eukaryotic cells is 
compacted nearly 10,000-fold in length. The way that chromatin organizes into this higher-order 
structure of mitotic chromosomes is not well understood and the different models that have been 
proposed remain controversial. 
FIRST LEVEL OF COMPACTION: THE NUCLEOSOME 
Interphase nucleosomal chromatin under low salt conditions appears (by electron microscopy) as 
beads on a string with a diameter of about 10 nm. This packaging results when 166 bp of DNA 
winds around an octamer of core histories in a left-handed superhelix following a helical path along 
the surface of the octamer. The histone octamer consists of an [H3]2:[H4]2 tetramer, flanked on 
either side by an H2A:H2B heterodimer. Each core histone has a compact domain of 70 to 80 
amino acid residues and a flexible N-terminal tail of approximately 30 amino acids outside the 
nucleosome. These N-terminal tails allow the nucleosomes to pack into a 30 nm fiber, while 
specific modifications of the tails are crucial for modulation of chromatin structure. Histone Hi, or 
other linker histones, binds to a variable amount of linker DNA that extends between adjacent 
nucleosomes. The N-terminal tails of the histories are also important for extra-nucleosomal 
interactions. The variants of linker histone differ from the core histories in that the globular central 
domain is flanked by unstructured basic domains at both the N- and C-termini. Histone Hi resides 
at the side of nucleosome where DNA enters and exits the nucleosome. The master cell cycle 
regulatory kinase, CDK1 (cdc2:cyclinB), phosphorylates serine and threonine residues on the 
histone Hi tails during mitosis. Hyperphosphorylation of histone HI was originally thought to be 
important for mitotic chromosome condensation but recent studies show that it is not required for 
this process. Mitosis-specific phosphorylation of histone 113 at serine-10 (by aurora B kinase) is 
also not necessary for mitotic chromosome condensation. The N-terminal tails of histories may also 
be acetylated or methylated, resulting in an epigenetic historic code important for gene expression 
or assembly of heterochromatin. 
ABOVE AND BEYOND THE NUCLEOSOME 
Chromatin isolated from interphase nuclei has a diameter of 30 nm. This fibre has been variously 
modelled as either a solenoidal coiling, random or organized folding of the nucleosomal fibre 	its 
actual structure remains undetermined. Fragility of the 30 nm fibre during preparation is likely 
responsible for the inability to unambiguously ascertain its architecture. However, the 40-fold 
length compaction within the 30 nm fibre is not nearly enough to account for the compaction of the 
genome in interphase nuclei or mitotic chromosomes. 
MITOTIC CHROMOSOME CONDENSATION 
The mechanism for packaging the 30 nm fibre into the highly compact, characteristc rod-shaped 
mitotic chromosomes remains a fundamental question for modem cell biologists. The shortening of 
DNA by roughly 10,000-fold is essential for the proper physical separation of sister chromatids to 
opposite poles, e.g. in order to avoid cleavage of the genome by an ingressing cleavage furrow. In 
addition, chromosomes must be properly aligned via their kinetochores to ensure that one of each 
chromatid pair ends up in each new daughter cell. However, early approaches utilizing electron 
microscopy to examine isolated native mitotic chromosomes only served to confirm that the DNA 
is indeed very densely packed within chromosomes. 
Several approaches have been utilized in an attempt to expose the factors underlying higher order 
chromosome structure. By depleting core histories from highly purified mitotic chromosomes 
(either with a high salt concentration or polyanions which compete with histories by charge) under 
conditions that maintain residual non-histone proteins, some of the first hints about large scale 
chromatin folding were obtained. Long extended loops of DNA (about 15-100 kb) surrounded a 
protein core that retained the general size and shape of a native chromosome. These striking 
images led to a model known as the radial loop model in which the folding of the chromatin fiber 
into loops is mediated by proteins of an insoluble chromosome scaffold that is essential for the 
final size and shape of a chromosome. Others though considered the scaffold to be an artifact, a 
result of inappropriate protein interactions created during preparation of this fraction. Nonetheless, 
this model was first proposed more than 25 years ago, and there is a significant amount of data 
supporting it. A:T-rich DNA sequences (SAR5 scaffold attachment regions, or MARS matrix 
attachment regions) have been identified as the cis-sequences interacting with the proteinaceous 
component. The DNA intervening between two SAR sequences bound to the scaffold, separated 
by up to 100 kb of DNA, would form a chromatin loop. 
PROTEIN COMPONENTS: TOPOISOMERASE II AND CONDENSINA biochemical 
analysis of scaffolds showed there were two major components: Sc I and Sc2, which later were 
identified as DNA topoisomerase II and SMC2 (a subunit of the condensin complex), respectively. 
In addition to this, characterization of chromosomes remodelled from sperm chromatin in Xenopus 
egg extracts, resulted in the identification of several protein components of these in vitro assembled 
structures. The mitotic chromosome fraction contained histories and linker histones, topo ha, 
chromokinesin, the chromatin remodeling ATPase ISW1, and a complex subsequently named 
condensin. These studies demonstrated that mitotic chromosomes are rich in ATPases, which are 
likely important to induce conformational changes of chromosomes and to support microtubule-
dependent movement of chromosomes. 
Topoisomerase II is an ATP-dependent enzyme that can alter DNA topology by passing one 
double-strand helix through another via a transient double-strand break, an activity necessary for 
the resolution of catenated sister DNA strands. Topo II is located both at the centromeres and 
axially along mitotic chromosome arms at the base of loops. All eukaryotic organisms have at least 
one topo II. Higher eukaryotes though, have two isoforms (topo ha and topo 1113) that have similar 
catalytic activities in vitro but different localization in vivo. Topo II activity is required for the 
resolution of the catenated strands of DNA so that each chromatid of a pair becomes an individual 
unit, facilitating successful separation during anaphase. Indeed, mutations in topo II in both 
Saccharomyces cerevisiae and Schizosaccharomycespombe were lethal in mitosis, with sister 
chromatids failing to segregate properly. Further analysis in S. pombe revealed that topo II was also 
required for the final stages of chromosome condensation, possibly in collaboration with the 
condensin complex, but its exact role in this process is not yet clear. In Drosophila, depletion of 
topo II by RNAi resulted in a 2.5-fold decrease in the level of chromatin compaction but overall 
chromosome condensation occurred without topo II. in the same study, chromosome morphology 
was abnormal and one or more chromosome arms frequently stretched out from the metaphase 
plate, suggesting an unexpected role for topo II in chromosome arm congression to the metaphase 
plate. Even though topo II seems to be important for the establishment of chromosome 
condensation in many different organisms, in Xenopus egg extracts it seems not to be essential for 
the maintenance of chromosome condensation, suggesting that topo 11 might contribute to the early 
stages of this process. Interestingly, as chromosomes decondense at the end of mitosis, topo IIo 
undergoes specific degradation, only to be resynthesized at the start of S phase if cells are actively 
cycling 
ScIl was identified as SMC2, a Structural Maintenance of Chromosomes protein, and a member of 
the condensin complex. This complex consists of two SMC proteins (SMC2 and SMC4) and three 
non-SMC subunits (CAP-D2, CAP-G and CAP-H). SMC2 and SMC4 form a heterodimer, and the 
non-SMC subunits presumably play regulatory roles. The SMCs are present in all species 
examined and they constitute a family of highly conserved and ubiquitous proteins. All members 
are large polypeptides with a molecular mass of 115-165 kDa and a similar structural organization. 
The proteins have two extended coiled-coil domains, which are separated by a central globular 
hinge region. The N- and C- termini flanking the coiled-coil domains are highly conserved among 
SMC proteins. The N-terminal domain contains a Walker A box (an ATP-binding motif). The C-
terminal domain contains a DA box resembling a Walker B site (ATP hydrolysis motif) and it has 
been shown to bind DNA. Eukaryotic SMCs comprise at least six distinct subfamilies (SMC 1-
SMC6), which form 3 different heterodimers: SMC1/SMC3 (chromatid cohesion), SMC2/SMC4 
(chromosome condensation), and SMC5/SMC6 (DNA repair). Recent data suggests that each of 
the SMC subunits of the cohesin and condensin complex folds intramolecularly and their 
heterodimerisation is mediated by a hinge-hinge interaction. The intramolecular folding of an SMC 
molecule allows the association of the N- and C- terminal domains and the formation of an ATP 
catalytic domain at each end of the heterodimer. The non-SMC subunits bind to one or both of the 
catalytic domains. 
Much of the current understanding of condensin activity comes from the biochemical 
characterization of the complex from Xenopus egg extract. In this system it has been shown that all 
five subunits are necessary for DNA-stimulated ATPase activity, which reconfigures DNA in an 
ATP-dependent manner. Condensin introduces positive supercoils into relaxed circular DNA in the 
presence of topoisomerase I and converts nicked circular DNA into positively knotted forms in the 
presence of topoisomerase II in vitro. Recent observations of the condensin complex by 
spectroscopic imaging, suggest that a single condensin complex organizes two oriented supercoils, 
thus inducing superhelical tension. A model that emerges from these observations is that each of 
the two end domains wraps DNA into nearly one superhelical turn allowing a single condensin 
complex to create two supercoils. Although the way that DNA interacts with the two-armed 
structure of condensin is unknown, a recent study showed that the region that binds DNA may be in 
the coiled-coil arms and not in the catalytic domains. A similar model has been recently proposed 
for the action of cohesin. Another study suggests that condensin may form a DNA loop by holding 
two distantly located DNA segments. 
Two models have been proposed to explain how condensin may act on chromatin but both models 
are highly speculative. The first model proposes that local positive supercoiling driven by 
condensin introduces a compensatory superhelical tension into the neighbouring region of DNA, 
which in turn acts as a driving force for the compaction of a chromatin fiber. The problem with this 
model is that there is no evidence for superhelical tension in metaphase chromosomes. The second 
model is based on the prediction that a single condensin complex introduces two positive supercoils 
by a trapping mechanism and forms a topological link between the condensin clamp and the 
trapped DNA strands. If a free translocation of the DNA strands is allowed without disrupting the 
topological link, a positive loop of DNA would be created. A continuing creation of positive loops 
by the action of condensin might contribute to mitotic chromosome organization. 
Even though condensin was originally thought to be responsible for chromosome condensation 
(hence the name), recent genetic studies in different organisms suggest that this complex is required 
for the proper organization and segregation of mitotic chromosomes, and not condensation per se. 
Yeast mutations in the condensin complex increased the average distance between two loci on a 
mitotic chromosome arm in the same way depletion of condensin from Xenopus mitotic egg 
extracts resulted in less compact chromosomes. Condensin however seems to be more than a 
simple compactor and is essential for resolution between sister chromatids in vivo. In Drosophila 
SMC4 mutants, shortening of the longitudinal axis of the chromosomes was unaffected, but 
chromosomes failed to resolve into two distinct chromatids at prophase, and then showed 
chromosome bridging in anaphase. Similarly depletion of SMC4 by RNAi in Caenorhabditis 
elegans caused dramatic abnormalities in chromosome morphology at prometaphase, yet a high 
degree of compaction still occurred by metaphase. Mutation or RNAi of non-SMC condensin 
subunits also resulted in aberrant chromosome segregation (but apparently normal condensation). 
In Drosophila, depletion of the condensin subunit SMC4 disrupted the localization of topo II in a 
central axial structure and furthermore to led a reduction of topoisomerase IT-dependent DNA 
decatenation activity in vitro. Condensin appears to be required for proper chromosome 
organisation, this facilitating the action of topo II in sister chromatid resolution. Recently in an 
ScII/SMC2 knockout in chicken cells, it was found that chromosome condensation was delayed but 
it could finally reach its normal levels. In this study, mitotic chromosomes were missing a number 
of scaffold proteins and they lacked structural integrity indicating that condensin was necessary for 
the establishment of a robust chromosome structure. One of the most important results to date is 
the observation that when both topo II and condensin are disrupted by RNAi, that chromosomes are 
still able to condense. There are clearly more components essential for mitotic chromosome 
condensation to be identified. 
The supercoiling activity of the condensin complex has been shown in vertebrates to require mitosis 
specific phosphorylation of the three non-SMC subunits by CDKI, the major mitotic kinase. CAP-
D2 is phosphorylated at its C-tenninus probably directly by CDK 1, while CAP-H is phosphorylated 
probably by CDK1 or other kinases. The hyperphosphorylation of the non-SMC subunits is 
proposed to have two dual roles. The first one is to activate the ATPase activity of SMCs and the 
second to allow the condensin complex to be associated with chromatin in a mitosis-specific 
manner. 
Recently a second condensin (II) complex was identified in vertebrate cells. Both complexes share 
SMC2/SMC4, but contain different sets of non-SMC subunits. The two complexes may have 
distinct distributions along chromosome axes, but show a similar distribution at the centromere 
region. It has been proposed that the two complexes make distinct mechanistic contributions to 
mitotic chromosome architecture in vertebrate cells. Depletion of condensin I or condensin II 
produces weaker defect in chromosome morphology, while simultaneous depletion of both 
complexes causes the severest defect. Furthermore, the centromeric regions were structurally 
disorganised after the depletion of either condensin I or II subunits suggesting a role for both 
complexes in centromere organization. Sequence comparisons suggest that condensin II should 
exist in other organisms, but experimental data will confirm if that is the case. 
Along with the phosphorylation of condensin subunits by the master mitotic kinase CDK 1, the 
phosphorylation of histone H3 at the onset of mitosis has been proposed to play a role in condensin 
recruitment and chromosome condensation. Histone H3 mutations in Tetrahymena therm op hila 
show abnormal chromosome condensation and extensive chromosome loss. In C. elegans, 
Drosophila and human cells, Aurora B, a chromosome-bound kinase, is targeted to chromosomes 
along their length during prophase, becomes concentrated at the centromeric regions during 
metaphase and is transferred to the spindle midzone when sister chromatids are separated in 
anaphase. This kinase is thought to interact with two other molecules, the inner centromere protein 
(INCENP) and survivin, which together are referred to as chromosomal passengers. Aurora B has 
been proposed to be the physiological kinase that phosphorylates histone H3 during mitosis. A 
model that connects the phosphorylation of historic H3 and chromosome condensation is that the 
modification of the histone may send a signal to initiate chromosome condensation. The 
phosphorylation could function as a receptor for the recruitment of proteins such as the condensin 
complex. Experiments in several organisms though, suggest that the phosphorylation of histone H3 
is not responsible for the direct recruitment of condensin onto chromosomes and chromosome 
condensation is not affected when histone H3 phosphorylation is diminished by depletion of Aurora 
B. Future work will clarify the role of H3 phosphorylation in mitotic chromosome dynamics. 
DEPENDENCE ON APPROPRIATE DNA REPLICATION AND REPAIR 
The final condensation of mitotic chromosomes is dependent not only on mitotic events, but also on 
appropriate timing of DNA replication and the satisfaction of DNA-structure checkpoints. In 
Drosophila, mutations of 0RC213/5, subunits of the Origin Recognition Complex, result in the 
formation of irregularly condensed chromosomes in mitosis. Regions of euchromatin that were 
replicated abnormally late in these mutations showed a severe condensation defect in contrast to 
other regions of the chromosome. Mutations in RFC4 (subunit 4 of Replication Factor C) resulted 
in DNA-structure checkpoint defects, chromosome pulverization (mitotic catastrophe), and also 
prematurely separated chromosomes in mitosis 	as a result of interfering with different functions 
of RFC. Whether the condensation defect observed in these mutants is a direct effect on topo II or 
condensin, is currently unknown. 
A YIN-YANG BALANCE WITH COHESION? 
Sister chromatid cohesion is established between the two replicated sister chromatids during S 
phase by an evolutionary conserved complex called cohesin. The cohesin complex (a heterodimer 
of SMC 1 and SMC3 and two additional non-SMC subunits Scc 1 and Scc3) is essential for 
holding sister chromatids together until the onset of anaphase, ensuring the accurate 1:1 partitioning 
of chromatids. In yeast all cohesin dissociates from chromosomes at the beginning of anaphase 
when the Sccl subunits is cleaved. In higher eukaryotes, most of the cohesin complex dissociates 
from chromosome arms already in prophase after phosphorylation by the polo kinase with only a 
small amount of cohesin left at centromeric regions. Residual cohesion is lost at the onset of 
anaphase by the cleavage of the Scc 1 non-SMC subunit. The dissociation of cohesin from 
chromosome arms in prophase could facilitate either the condensation or resolution of chromatids. 
Alternatively, condensation may help to release cohesion between chromatids. However, loss of 
Sccl (and cohesion) by RNAi has no apparent effect on condensation. However it is plausible that 
a mechanism ensuring the correct balance between cohesin and condensin may exist. A structural 
and functional link between cohesion and condensation, if it exists, remains to be determined. 
We have attempted to highlight some of the most important issues surrounding chromosome 
organization and condensation throughout the cell cycle. The organization of a scaffold and its 
association with specific DNA sequences, along with the mechanism by which chromosomes 
condense prior to mitosis, or decondense after mitosis are poorly understood. Nevertheless, 
exciting progress is being made through diverse approaches. We also believe there are as yet, 
uncharacterized factors that play crucial roles in these events, which may even result in the proposal 
of new models for the dynamics of higher order chromosome architecture. 
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Glossary 
Chromosome: Each chromosome consists of a single, long DNA molecule with a telomere at each 
end, and a centromere mediating attachment to the mitotic spindle. Every species has a 
characteristic number of chromosomes that are visualized as separate entities only during mitosis 
(e.g. humans have 46 chromosomes). After replication, each chromosome is composed of 2 
identical chromatids. 
Chromosome passengers: Proteins that are associated with chromosomes during the early stages 
of mitosis, then with the spindle midzone during anaphase and telophase, and finally with the 
midbody at the exit from mitosis. So far there are 5 known members: INCENP, survivin, Aurora B, 
TD-60, and borealin. 
Cohesin: a multiprotein protein complex that is required to hold together the sister chromatids of 
replicated chromosomes. It consists of two SMC proteins (SMCI and SMC3), and two non-SMC 
subunits(Sccl and Scc3). In higher eukaryotes, cohesin dissociates from chromosome arms in 
prophase and from the centromeres at the onset of anaphase, while in yeast, it dissociates from 
chromosomes at the onset of anaphase. 
Condensin: a multiprotein complex that consists of two SMC subunits (SMC2 and SMC4), and 
three non-SMC subunits (CAP-D2, CAP-G and CAP-H). Condensin is required for chromosome 
organization and segregation and it only associates with chromosomes at prophase, when 
chromosomes condense and dissociates in anaphase when chromosomes start to decondense 
though individual subunits show different behaviour. 
SMC proteins: Abbreviation for Structural Maintenance of Chromosomes. The SMCs are known 
to be present in species from mycoplasma to mammals and they constitute a family of conserved 
and ubiquitous proteins, called the SMC family (with 6 subfamilies). The proteins have two 
extended coiled-coil domains, which are separated by a central globular hinge region. These 
proteins, when dimerised, have ATPase activity by bringing together the N- (ATP binding) and C-
(ATP hydrolysis) termini. 
Topoisomerase II (topo II): An ATP-dependent enzyme that can alter DNA topology by passing 
one double helix strand through another via a transient double helix break, an activity necessary for 
the resolution of catenated sister DNA strands. It is located both at centromeres and along mitotic 
chromosome arms at the base of loops. 
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Summary 
The precise mechanism of chromosome condensation and decondensation remains a mystery, despite 
progress over the last 20 years aimed at identifying components essential to the mitotic compaction of 
the genome. In this study, we analyze the localization and role of the CAP-132 non-SMC condensin 
subunit and its effect on the stability of the condensin complex. We demonstrate that a condensin 
complex exists in Drosophila embryos, containing CAP-132, the anticipated SMC2 and SMC4 proteins, 
the CAP-H/Barren and CAP-G (non-SMC) subunits. We show that CAP-D2 is a nuclear protein 
throughout interphase, increasing in level during S phase, present on chromosome axes in mitosis, and 
still present on chromosomes as they start to decondense late in mitosis. We analyzed the 
consequences of CAP-132 loss after dsRNA-mediated interference, and discovered that the protein is 
essential for chromosome arm and centromere resolution. The loss of CAP-132 after RNAi has 
additional downstream consequences on the stability of CAP-H, the localization of DNA 
topoisomerase II and other condensin subunits, and chromosome segregation. Finally, we discovered 
that even after interfering with two components important for chromosome architecture (DNA 
topoisomerase II and condensin), chromosomes were still able to compact, paving the way for the 
identification of further components or activities required for this essential process. 
Savvidou, et al. 
Introduction 
Chromosomal DNA, if stretched end to end, measures about 2 metres in any one cell of the 
human body and therefore must be highly folded to fit into a nucleus of only 5 pm diameter. DNA has 
to condense even further prior to cell division in order to form the highly compact metaphase 
chromosome comprising two sister chromatids, capable of withstanding anaphase segregation (Heck, 
1997; McHugh, 2003; Swedlow and Hirano, 2003). Thus, mitotic chromosome condensation consists 
of a process in which interphase chromatin is 1) compacted, and 2) resolved into two distinct rod-
shaped sister chromatids. Recent studies have contributed to the unraveling of this process. A five 
subunit "condensin" complex was initially identified biochemically in Xenopus (Hirano et al., 1997; 
Hirano and Mitchison, 1994), and is comprised of two SMC (Structural Maintenance of Chromosomes) 
proteins (SMC2 and SMC4) and three non-SMC proteins (CAP-D2, CAP-G or CAP-H [Barren in 
Drosophila]). All five subunits have been identified in the eukaryotes examined to date (Cobbe and 
Heck, 2000). The SMC proteins belong to a superfamily of highly conserved and ubiquitous 
chromosomal ATPases (Cobbe and Heck, 2004). The non-SMC subunits have been proposed to have 
dual roles in the regulation of condensin function: one is to activate the SMC ATPases to perform 
ATP-dependent supercoiling activity, and the other is to allow the holocomplex to associate with 
chromatin in a mitosis-specific manner (Kimura and Hirano, 2000). Each of the condensin subunits is 
essential and required for proper organisation and segregation of mitotic chromosomes, but exactly 
how the complex contributes to these processes is still unclear. Recently a second condensin complex 
has been identified, with a different complement of non-SMC subunits (Ono et al., 2003). 
Studies of condensin function have resulted in conflicting hypotheses as to the role of this 
complex. Mutants in Cut3 and Cutl4 (the SMC4 and SMC2 subunits respectively) of 
Schizosaccharomycespombe exhibited chromosome condensation defects and displayed a 'cut' 
phenotype where septation (cell division) occurred with incompletely separated chromosomes (Saka et 
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al., 1994). Fluorescence in situ hybridization in these mutants demonstrated that the length of mitotic 
chromosome arms increased while the centromeric DNA could separate and move to the opposite poles 
normally. In S. poinbe and Saccharoinyces cerevisiae, studies have shown that all members of the 
condensin complex are required for proper chromosome condensation and segregation (Lavoie et al., 
2000; Ouspenski et al., 2000; Strunnikov et al., 1995; Sutani et al., 1999). InXenopus, when condensin 
was depleted from mitotic extracts before or after condensation, unreplicated chromatin failed to 
assemble into individual chromatids or became completely disorganised, suggesting that the complex 
was required both for assembly and maintenance of mitotic chromosomes (Hirano et al., 1997; Hirano 
and Mitchison, 1994). In contrast, genetic studies in Drosophila and Cuenorhabditis elegans showed 
that resolution between the sister chromatids rather than condensation of the chromosomes was 
compromised when the condensin complex was disrupted (Bhat et al., 1996; Hagstrom et al., 2002; 
Steffensen et al., 2001). In both organisms, a high degree of compaction relative to interphase and a 
bipolar metaphase plate formed. However, severe chromosome segregation defects and chromosome 
breakage were observed in anaphase and telophase. DmSMC4 RNAi in Drosophila cultured cells 
confirmed the requirement of this protein for chromosome organisation and segregation (Coelho et al., 
2003). A common phenotype of the absence of condensin subunits in most organisms is the formation 
of chromosome bridges due to incomplete resolution and ensuing failure of sister chromatids to 
separate completely during anaphase (Hagstrom and Meyer, 2003). Particular insight was gleaned 
when the robustness of chromosome architecture was assessed after SMC2 knock-out in chicken DT40 
cells - while chromosomes still reached normal levels of condensation, clear defects in association of 
other non-histone chromosomal proteins was observed (Hudson et al., 2003). 
Recently, a second condensin complex, called condensin II, was identified in vertebrates (Ono 
et al., 2003). This complex shares the same two SMC subunits as the original complex, now named 
condensin I, but appears to contain different non-SMC subunits (named CAP-133, CAP-G2, and CAP-
1-12). The two complexes appear to alternate along the axis of metaphase chromatids but are both 
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present at the centromere, albeit in distinct regions (Ono et al., 2004). Depletion of these complexes in 
Xenopus and HeLa cells produced distinct defects in chromosome morphology, suggesting that the 
complexes may contribute differently to mitotic chromosome architecture (Ono et al., 2003). 
Furthermore, the centromere/kinetochore regions were structurally disorganised from the depletion of 
either condensin I or II subunits suggesting a specific role for both complexes in centromere 
organisation (Ono et al., 2004). 
DNA topoisornerase II (topo II) has long been implicated in chromosome structure and 
dynamics, since its discovery as a chromosome 'scaffold' protein, and its localization at the base of 
chromatin loops (Earnshaw et al., 1985; Earnshaw and Heck, 1985; Gasser et al., 1986). SMC2 has 
also been shown to be a component of the chromosome 'scaffold' fraction (Saitoh et al., 1994). Yeast 
mutants in topo II exhibit segregation defects similar to those observed in condensin mutants (Holm et 
al., 1985). The decatenation activity of topo II facilitates the resolution of sister chromatids and the 
complete separation of chromosomes in anaphase. Topo II has also been shown to be required for 
chromosome condensation but its role in this process has been controversial since disruption of its 
function resulted in different chromosome morphologies (Swedlow and Hirano, 2003; Warburton and 
Earnshaw, 1997). Recently, an unexpected role for topo II in chromosome arm congression emerged 
after RNAi depletion in Drosophila cells (Chang et al., 2003). Localisation studies revealed that Topo 
II was axially distributed in the chromosome arms with some concentration at the centromeres, a 
distribution that was also observed for condensin subunits (Maeshima and Laemmli, 2003; Steffensen 
et al., 2001). The localisation pattern and the phenotype after the depletion of either the condensin 
complex or topo II suggested that these two components of the chromosome scaffold may collaborate 
to bring about chromosome compaction and organisation. Biochemical and localisation studies in 
Drosophila showed that CAP-H/Barren associated with topo II throughout mitosis, while SMC4 
appeared to be responsible for the axial localisation of topo II on the chromosomes and for its 
decatenation activity (Bhat et al., 1996; Coelho et al., 2003). However, in S. pombe, the localisation 
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but not the activity of topo II was affected in condensin mutants, while topo II localization to well-
defined axial structures inXenopus was independent of condensin (Bhalla et al., 2002; Cuvier and 
Hirano, 2003). Given that chromosomes experience different constraints depending on the cell, 
organism, or time in development, it is perhaps not surprising that a 'unified' hypothesis regarding 
these two components has not emerged. 
In this study, we demonstrate that a condensin I complex exists in Drosophila. We 
subsequently examined the cell cycle localization and role of the Drosophila CAP-132 subunit in 
chromosome dynamics during mitosis. We show that depletion of CAP-132 by RNAi in Drosophila 
cultured cells results in a compromised mitotic chromosome architecture with defective sister 
chromatid resolution and subsequent chromosome bridges in anaphase. We demonstrate here for the 
first time, that the fate of other members of the condensin complex and other chromosomal proteins 
essential for chromosome dynamics during mitosis is altered when a condensin subunit is disrupted 
either by depletion or mutation. We additionally examine Drosophila mutations of condensin subunits 
to assess the stability of the complex in the context of the organism. We also show that mitotic 
coordination with regard to chromosome passengers is compromised when condensin function is 
affected. Finally we demonstrate that when both condensin and topo II are disrupted by RNAi, 
chromosomes are surprisingly still able to compact, intimating the existence of additional, currently 
unknown, factors essential to the assembly of mitotic chromosomes. 
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Materials and Methods 
Identification of the Condensin Complex 
Extract preparation: 0-5 hr Drosophila embryos were homogenised in one volume of buffer A (15 mM 
NaCl, 60 mM KC1, 2 mM EDTA, 0.34 M sucrose, 15 mM Hepes pH 7.9) and complete protease 
inhibitors (Roche) using a loose pestle. The homogenate was centrifuged for 5 minutes at 5000 x g at 
4°C in a benchtop centrifuge. The middle layer was collected, aliquoted and flash frozen in liquid 
nitrogen. Dimethyl pimelimidate cross-linking of CAP-D2 antibody to protein A-sepharose was 
performed according to Harlow and Lane (Harlow and Lane, 1999). For immunoprecipitation from 
crude extracts, antibody beads were incubated with the extract for 1 hr at 4°C. The beads were washed 
10 times with 20 volumes of PBS, and then eluted and washed with PBS containing 250 and 500 mM 
NaCl. Protein interactions that were resistant to 500 mM NaCl were eluted using 2% SDS in PBS. 
Generation of Antigens and Antibodies 
Polyhistidine (6His)-tagged fragments of DmSMC2 and DmCAP-D2 were produced using the residues 
24-309 and 951-1162 respectively, by cloning a BamHl-HindIII fragment of the cDNA into a pQE30 
(QlAexpress system, Qiagen) expression vector. The constructs were expressed in E. coli 
M15[pREP4] cells (Qiagen) and the proteins were purified on Ni-agarose columns (Qiagen) and 
subjected to SDS-PAGE. Individual gel bands were excised from the gel, ground under LN2, and 
injected into rabbits (Scottish Antibody Production Unit, Pentlands Science Park). The same procedure 
was followed for the generation of topo IT antibody. Residues 1079-1333 were used and a BamHl-
Hindill fragment of the genomic DNA was cloned into a pET23a (Novagen) expression vector. The 
construct was transformed into E.coli BL21 cells (Novagen) and the protein was purified as described 
above. For CAP-133 antibody, a peptide corresponding to the terminal 15 amino acids of the protein 
(residues 1253-1267, CDMLVTELIFQPPDW) was synthesised and injected into rabbits (Genosphere). 
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Cell Culture and RNAi 
Drosophila embryonic S2 cells were maintained in serum free Schneider's Insect Medium 
supplemented with 10% Insect qualified Fetal Bovine Serum (FBS). Cells were grown at 27°C in a 
humidified atmosphere. RNAi was performed in Drosophila S2 cells as previously described (Clemens 
et al., 2000; Vass et al., 2003). Two fragments from the 5' end of CAP-132 (forward primer at 251-270 
bp of ORF and reverse primer at 873-892 bp of ORF) were fused to T7 RNA polymerase promoter and 
were used as PCR primers. The Drosophila EST clone LD404 12 was used as a template for the PCR 
reaction. The PCR product obtained ('642bp) was used as template for RNA synthesis using the 
Megascript kit (Ambion). A random human intronic sequence was used to generate control dsRNA, 
which was synthesized in the same way. Topo II dsRNA was obtained as described previously (Chang 
et al., 2003). For the CAP-D3 dsRNA the EST clone RE18364 was used as a template for the PCR 
reactions. Two PCR products were obtained from two different regions of the ORF. The first one was 
obtained with a primer pair that includes the start codon (ri 639 bp) and the second one with a 
primer pair further inside the message (r2723 bp). The two products were used in two independent 
experiments. For the RNAi experiment, 1x106 cells/ml were diluted in serum free Schneider's Insect 
Medium. 20-25 ig/ml of dsRNA was added to the cells (30 ig/ml for the CAP-D3 RNAi). lml of 
these cells was placed into each well of a 35mm 6-well plate and incubated for 60 to 90 mm. After the 
incubation 2mIs of Schneider's Media supplemented with 10% FBS was added to each well. The cells 
were placed in the 27°C humidified incubator and samples were processed for immunoblotting or for 
immunofluorescence at certain time points. For some experiments, cells were grown on sterilized 
Concanavalin A treated coverslips in a 35mm 6-well plate (Rogers, 2002), but only for the last 24hr 
before being processed for immunofluorescence. In some cases S2 tissue culture cells (RNAi treated or 
control cells) were exposed to 30 jiM colchicine for 7 hours, 67 hours after the RNAi treatment. Cells 
were then processed for immunoblotting or immunofluorescence. 
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Preparation of Cell Extracts 
Cells were counted under the microscope with a hematocytometer, centrifuged at 2000 rpm for 2 mm 
and washed with 0.5 ml of PBS (phosphate-buffered saline: 137 mM NaCl, 2.7 mM KCI, 6.46 mM 
Na2HPO4, 1.47 mlvi K1-12PO4 pH 7.4). The pellet was resuspended in a certain amount of PBS and 
warm sample buffer [3X sample buffer: 2% SDS, 10% Glycerol, 0.01% Bromophenol Blue, 2 mM 
EDTA,, 50 mlvi trizma base pH 6.8] with 10 mM DTT (1/10 of final volume). The cells were lysed by 
sonication and the extract was boiled at 100°C for 5 to 10 mm. The volume of PBS and sample buffer 
was calculated so that the final cell concentration was 5x104cells/lil. 
Preparation of Embryo Extracts 
To identify homozygous embryos for barr' 305 and gluJ7C  the mutant chromosomes were balanced over 
CyO, P {wfhC=GAL4Kr.C}DC3,  P{w'=UAS-GFP.S65T}DC7 as described (Casso et al., 2000). 
One hour collections of embryos were aged for 12 hours, dechorionated with 50% bleach for 1 min and 
then sorted under a fluorescence dissecting microscope. Homozygous embryos were homogenised 
with a motorised pestle in EBR lysis buffer [EBR (13 mM NaCl, 0.47 mM KC1, 0.19 mlvi CaC12, 1 mM 
HEPES pH 6.9), 10 mM EDTA, 10 mM DTT, 1:100 dilution of CLAP, PMSF and trasylol] and warm 
sample buffer with DTT (1/10) was added immediately. The embryo extract was boiled at 100°C for 
10 mm. 
Immunoblotting 
Protein extracts were separated by SDS-PAGE and transferred onto nitrocellulose membranes in a 
Trans-Blot apparatus. Membranes were blocked in PBS+0. 1% Tween 20 (PBSTw) and 5% semi-
skimmed milk for 1 hr at RT and then incubated for 1-1.5 hours with the primary antibody in PBSTw. 
After washing three times for 5, 15 and 10 min with PBSTw, the membranes were incubated in a 
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horseradish peroxidase-linked (HRP) secondary antibody for 1 hr in PBSTw at RT. Finally the 
membranes were washed as above in PBSTw and immunocomplexes were detected by enhanced 
chemi luminescence (ECL, Amersham Biosciences). For the RNAi experiment, 5x105 cells were 
loaded per lane while for the analysis of embryos, 5 embryos were loaded per lane for both the wild 
type (Canton S) and mutant material. 
Phosphorimager Analysis 
Samples were processed as described for immunoblotting but instead of using an HRP secondary, a 
Cy5 conjugated secondary antibody (Jackson lmmunoResearch Laboratories) was used in a dilution of 
1:200. The intensity of the signal was measured by using the STORM 860 scanning phosphorimager 
and calculated using the ImageQuant program (Amersham). The intensity was finally normalised by 
using o-tubulin as a loading control. Values were corrected by substracting the background of the 
corresponding lane from each band. 
Immunofluorescence of Drosophila Cultured Cells 
2x 1 05 cells diluted in EBR were centrifuged onto poly-L-lysine-coated slides for 2 min at 2000 rpm in 
a cytospin column. The cells were immediately fixed for 4 min in 4% PFA in PBS at RT, washed for 5 
min in PBS+0.1% Triton-X (PBSTx) and permeabilised in PBS +0.5% Tx for 5 mm. After the 
permeabilisation, cells were blocked for 1 hr at RT in 0.5% Bovine Serum Albumin (BSA, Sigma). 
Cells were washed in PBSTx for 5 min and incubated for 1 hr in the primary antibody in PBSTx+0.5% 
BSA. After three 5 mill washes in PBSTx, cells were incubated in the secondary antibody (conjugated 
fluorochromes, Molecular Probes or Jackson ImmunoResearch Laboratories) in PBSTx+0.5% BSA 
and in 1jig/ml DAPI for DNA staining. Cells were washed four times, 5 min each, in PBSTx and 
coverslips were mounted onto the slides with Mowiol (Calbiochem) and viewed under the fluorescent 
microscope. For some antibodies (SMC2, SMC4, guinea pig topo II and CAP-133), 0.5% Triton-X was 
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included in the fixative and the incubation in this solution was done for 10 mm. A permeabilisation 
step was performed as well as described above. For hypotonic treatment, cells were diluted in 0.25X 
EBR at a concentration of 2x 105  for 2 min at RT and then centrifuged onto poly-L-lysine slides and 
processed as described above. Cells that were grown on Concanavalin A coated coverslips for 24hr in 
a 35mm 6-well plate were then fixed and processed as described above. 
BrdU Incorporation in Drosophila Cultured Cells 
Cells growing in flasks were incubated for 30 min in medium containing 6 ig/ml BrdU 
(bromodeoxyuridine). 2x 1 ü cells were centrifuged onto poly-L-lysine slides and processed as 
described for immunofluorescence except that DAPI was omitted. The primary antibody in this case 
was anti-CAP-D2 and the secondary was Alexa 594 goat anti-rabbit conjugate. After the anti-CAP-132 
immunofluorescence was complete, the cells were post-fixed immediately in 4% PFA in PBS for 1 hr 
at RT, washed for 5 min in PBSTx and then incubated for 15 min in freshly prepared 2N HC1. After a 
5 min wash in PBSTx, cells were blocked for 30 min in PBS+5% BSA and washed for 5 min in PBSTx 
and then incubated with the rat anti-BrdU antibody (1:2 dilution) in PBSTx+0.5% BSA at 4°C for 16 
hrs. After three 5 min washes, the cells were incubated with Alexa 488 goat anti-rat conjugate (1:500 
dilution) in PBSTx+0.5% BSA for 1 hr at RT. 1 ig/ml DAPI was added during the last incubation. 
Finally cells were washed four times for 5 min each with PBSTx and coverslips were mounted onto the 
slides with Mowiol. 
Microscopy 
All preparations were examined with an Olympus Provis microscope, equipped with epifluorescence 
optics. Images were captured with an Orca II CCD camera (Hamamatsu) and Smart Capture 2 
software (Digital Scientific). All images were processed with Adobe Photoshop software. For 
examining the localisation and the presence of several proteins on the chromosomes in the RNAi 
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experiment, all images were obtained with the same camera settings and the same exposure time was 
maintained between the controls and the CAP-D2 RNA] experiment. 
Antibodies 
The primary antibodies were used for immunofluorescence as follows: a-tubulin (mouse monoclonal 
antibody 135-1-2 used at 1:500, Sigma), y-tubulin (mouse monoclonal T 6557 used at 1:50, Sigma), 
P'-'H3 (mouse monoclonal used at 1:500, 9706L, New England Biolabs), BrdU (rat antibody used at 
1:2, Harlan Sera Lab), CID (chicken polyclonal used at 1:200, (Blower and Karpen, 2001)), topo II 
(rabbit polyclonal used at 1:500, and guinea pig polyclonal used at 1:500), Barren (rabbit polyclonal 
used at 1:500 (Bhat et al., 1996)), SMC2 (rabbit polyclonal used at 1;500), SMC4 (rabbit and sheep 
polyclonals used at 1:500 (Steffensen et al., 2001), SCCI (rabbit polyclonal used at 1:500 (Warren et 
al., 2000)), DSA1 (rabbit polyclonal used at 1:500 (Valdeolmillos, 2004)), BubRl (rabbit polyclonal 
used at 1:1000). Sheep Cyclin B, INCENP (rabbit polyclonal used at 1:500, (Adams et al., 2001b)), 
CAP-D2 (rabbit polyclonal used at 1:1000 for immunofluorescence and 1:10,000 for immunoblotting), 
CAP-D3 (rabbit polyclonal used at 1:200 for immunofluorescence and 1:500 for immunoblotting). All 
fluorescently conjugated secondary antibodies (Molecular Probes, Jackson IrnmunoResearch 
Laboratories and Amersham Biosciences) were used according to the manufacturer's instructions. 
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Results 
Biochemical identification of a condensin complex in Drosophila 
In this study we demonstrate for the first time that SMC2, SMC4 and the CAP-D2, CAP-G and 
CAP-H/Barren proteins exist as a complex in Drosophila. Immunoprecipitations with an antibody 
generated to DmCAP-D2 (Supp Figure 1 A) were performed using 0-5 hour embryo extracts. Bound 
proteins were eluted sequentially with 0.5M NaCI and 2% SDS in PBS. The fractions were analysed 
by immunoblotting with SMC2, SMC4, CAP-D2, and CAP-H/Barren antibodies. All four proteins 
were present suggesting that they participate in the same complex. SMC2 and SMC4 proteins were 
eluted with both NaC1 and SDS solutions, while CAP-D2 and CAP-H were only eluted with the SDS 
(Figure 1A). This result suggests two possibilities. First, the CAP-D2 and CAP-H non-SMC subunits 
may be more tightly associated with each other than they are with the SMC subunits of the condensin 
complex (we made a similar observation for the cohesin complex (Vass et al., 2003)). Second, the 
SMCs eluting with NaCl may be participating in another complex, such as condensin II. As no 
antibody was available to the CAP-G protein, the presence of this protein in the complex could not be 
assessed by immunoblotting. However, we were able to identify CAP-G by mass spectrometric 
analysis of proteins interacting with CAP-D2 (data not shown). 
Characterisation of CAP-132 during the cell cycle 
To determine the subcellular localization of the CAP-D2 protein during the cell cycle, S2 
cultured cells were centrifuged onto poly-L-lysine slides and processed for indirect 
immunofluorescence using the CAP-D2 antibody. Immunofluorescence revealed that CAP-D2 was 
mainly nuclear with varying levels during interphase. Several markers were utilized to further 
characterise these levels. An antibody to 'y-tubulin, a centrosomal component, was used to denote cells 
that were in G  phase prior to centrosome duplication. G  cells showed the level of CAP-D2 in the 
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cytoplasm was nearly the same as in the nucleus (Figure 1 B, top). Cells with 2 centrosomes (in S or 
G2 phase) (Loupart et al., 2000) had much higher levels of nuclear CAP-D2 (Figure 1B, bottom). S 
phase cells were identified following BrdU (a thymidine analogue) incorporation. All S phase cells 
showed nuclear staining of CAP-132 (Figure 1C). While the intensity of the CAP-132 signal varied 
among S phase cells, analysis of replication patterns with 2 thymidine analogues, CIdU and IdU 
(Manders et al., 1992), demonstrated that the nuclear level of CAP-D2 increased as cells progressed 
through S phase (data not shown). Cyclin B, a cofactor for the mitotic CDC2 kinase, moves from the 
cytoplasm into the nucleus in late G2/early prophase (Huang, 1999). Cells with nuclear Cyclin B 
showed an intense nuclear staining for CAP-132 (Figure 1 D). These results suggest that Drosophila 
CAP-132 is nuclear during interphase, with low levels in G  that increase during S and are highest in 
late G2/early prophase. 
The localisation of CAP-132 during mitosis was also examined. In prometaphase, the protein 
localised along the condensed chromosome arms with more intense labelling of the centromeric regions 
(Figure 2A and B). The accumulation of CAP-D2 at centromeres can be clearly observed when cells 
are immunostained for both CAP-132 and CID, the Drosophila homologue of CENP-A, a histone H3 
isoform (Henikoff, 2000) (Figure 213). In metaphase and early anaphase, when chromosomes were 
fully condensed, the CAP-D2 signal was most intense throughout the core of the chromatids. In 
telophase, even as historic H3 becomes dephosphorylated and chromosomes start to decondense, CAP-
D2 was still tightly associated with chromatin (Figure 2A). The CAP-D2 staining was still intense 
during late telophase and cytokinesis (Figure 2C). Our results suggest that CAP-D2 associates with 
chromosomes in prophase, distributes axially on the chromosome arms with enrichment at the 
centromeres during prometaphase, is present throughout anaphase and telophase and even remains 
tightly associated with chromosomes as decondensation ensues. 
SMC4 and Barren proteins are loaded onto chromosomes in early prophase but they dissociate 
from chromosomes late in anaphase/telophase when decondensation begins (Steffensen et al., 2001). 
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Since CAP-132 appears to persist on chromosomes late in mitosis, we performed co-localisation studies 
with SMC4 in order to observe if the two subunits dissociate independently from chromatin late in 
mitosis. During anaphase, SMC4 started to dissociate from chromosomes as they start to decondense. 
Like P-1-13, the SMC4 signal was fainter near the centromeric regions but was quite high at the end of 
chromosome arms, while CAP-132 was still present throughout the chromatids (Supp Figure 1C). In 
telophase, while CAP-132 was still associated with chromatin, SMC4 was diffuse and the chromosomal 
staining reduced (Supplemental Figure IC). 
CAP-D2 dsRNA-mediated interference in Drosophila cultured cells results in abnormal 
chromosome morphology and behaviour 
As no CAP-D2 mutants were available, dsRNA-mediated interference (RNAi) on S2 cells was 
used to assess CAP-132 function. S2 cultured cells were incubated with a 642 bp dsRNA fragment of 
CAP-132 and samples were subsequently collected at 24 hr time points. Two negative controls were 
performed at the same time: cells that were incubated with dsRNA synthesized from a human intron 
(C) and cells with no dsRNA (-). Protein extracts from each time point were analysed by 
immunoblotting (Figure 3A). A decrease in CAP-132 level was apparent at 48 hr with the protein 
greatly depleted by 72 hr and nearly undetectable by 96 hr (lanes labeled D - the final depletion was 
estimated to be 94% based on titration of signal from known cell numbers). The level of the protein 
was unaffected in control cells, and chromosomes appeared normal through mitosis (Figure 313). 
Immunofluorescence of the CAP-132 RNAi cells confirmed that these cells had much diminished CAP-
D2 chromatin staining. 48 hr after RNAi, CAP-D2 signal was decreased (data not shown) and by 72 hr 
CAP-D2 protein was hardly detectable on the chromosomes of cells exhibiting abnormal chromosome 
morphology (Figure 3C). Chromosomes condensed relative to interphase but appeared fuzzy, 
unresolved and hypercondensed (a possible consequence of prometaphase delay). Dramatic failures in 
segregation resulted in chromosome bridges forming bi-nucleate or even tn-nucleate cells (Figure 
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3C4). We also frequently observed daughter nuclei of unequal size, suggesting that chromosomes had 
not been equally distributed during anaphase. 
In order to better examine chromosome morphology, we treated cells with a hypotonic buffer 
that results in better chromosome spreading and improved observation of individual chromatids. 
Control cells appeared to have normal chromosome resolution and individual chromatid arms could be 
easily distinguished (Figure 3D). Individual chromatids were not visible in hypotonically treated CAP-
D2 RNAi cells, and chromosomes appeared as condensed balls of chromatin distinct from one another, 
with usual levels of phospho"-histone 1-13 (Figure 3E). 
The quantitation of numerous mitotic parameters is presented in Supplemental Figure 2. CAP-
D2 RNAi cells grew more slowly than control cells and cell number plateaued 72 hrs after treatment 
(Supp Figure 2A). Different time points were assessed for mitotic index, phenotype, and the 
distribution of mitotic phases. The percentage of mitotic cells (those positive for phospho'histone 1-13) 
after CAP-D2 RNAi increased 3-fold between 36 hrs and 72 hrs (Supp Figure 213). 25% of the CAP-
D2 RNAi mitotic cells were abnormal at 24 hrs, while 95-100% were abnormal after 48 hrs (Supp 
Figure 2C). After staining for cyclin B, it appeared that CAP-D2 RNAi cells were delaying in 
prometaphase (cyclin B positive) - this was corroborated by scoring the anaphase index (cyclin B 
negative, Supp Figure 2D and E). While the dsRNAi experiment was repeated several times, 
quantification of the phenotypes was performed three times with insignificant deviation between the 
results. Most of the phenotypic analysis was therefore carried out at 65 or 72 hrs after treatment with 
dsRNA. 
As shown in Figure 3, dramatic chromosome defects were observed after treatment with CAP-
D2 dsRNA - apparent failures in chromatid resolution, alignment, and segregation. We therefore 
asked whether centromere resolution was compromised after staining for two centromeric proteins - 
CID, and Scc3/DSA 1, a subunit of the cohesin complex. The levels of DSA 1 (and CID, not shown) 
appeared largely unaffected in the CAP-D2 RNAi cells (Figure 4A). DSA1 was highly concentrated at 
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centromeres during prometaphase and metaphase, and localized between CID spots (Figure 413). 
DSA1 persisted at centromeres until sister chromatid separation at the onset of anaphase, while CID 
stained centromeres constitutively (Figure 413, see also Figure 313). DSA1 also stained the spindle 
poles and microtubules, especially during anaphase (Valdeolmillos, 2004). Centromeres were often 
stretched in the CAP-D2 RNAi cells (Figure 4C2-5, see also Figure 3C), while distinct double dots or 
cleanly separated sets of dots were observed in control metaphases and anaphases, respectively. 
Daughter nuclei connected by chromosome bridges still had centromeres extending between them 
(Figure 4C5 and 3C4). 
In order to quantitate these results, cells were categorised into different groups. 95% of the 
cells that displayed CID stretching between sister centromeres had lower levels of centromeric DSA 1 
and thus were considered to be in anaphase (Figure 40-5). 60% of these anaphase figures were in 
early anaphase, as deduced from the short distance between the centromeres of sister chromatids. The 
remaining 5% of cells displaying CID stretching were positive for DSA1 and considered to be in 
prometaphase/metaphase (Figure 4C2). The CID stretching in these cells was not as extreme as in 
anaphase cells. A prometaphase/metaphase cell with little or no CID stretching between sister 
centromeres is shown in Figure 4C 1. We observed that the distance between paired CID spots 
(measured in prometaphase/metaphase cells) was more than 2-fold higher in the CAP-132 RNAi cells 
compared to control cells (1.625 pm versus 0.75 pm, Figure 4D). This suggests that tension applied 
upon bipolar attachment accentuates the defect in resolution, and therefore in anaphase, the most 
extreme stretching of CID stained regions was detected (Figure 4C5). These results suggest that CAP-
D2, and likely the entire condensin complex, is primarily required for resolution of sister chromatids 
(arms and centromeres) rather than chromosome compaction in Drosophila. 
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CAP-H/Barren is unstable in cells depleted of CAP-D2 
As CAP-D2 is one subunit of a complex, it is possible that interacting proteins may be affected 
by its depletion. For this reason, the stability and localisation of the other subunits of the complex were 
analysed upon depletion of CAP-132. Immunoblotting RNAi cell extracts for CAP-H/Barren revealed 
that the level of this protein was decreased when CAP-D2 was depleted (Figure 5A). CAP-H/Barren 
may be more tightly associated with CAP-D2 compared to the SMC subunits, as suggested earlier. As 
no sequence similarity exists between the two proteins, the depletion by RNAi should be specifically 
directed against CAP-132. In contrast, no substantial change in SMC4 and SMC2 levels was observed 
(Figure 5A and 6A). To examine the localization of residual CAP-H, cells were cytospun onto poly-L-
lysine slides and processed for immunofluorescence. In control cells, CAP-H associated with the axial 
cores of sister chromatids (Figure SB). In the CAP-D2 depleted cells, residual CAP-H protein 
appeared to localise diffusely in the cytoplasm with no CAP-H detected on the chromosomes (Figure 
SC). 
Immunolocalisation of SMC4, SMC2 and Topoisomerase H in CAP-D2 depleted cells 
To examine the localisation of the SMC4 subunit after CAP-D2 RNAi, we performed double 
staining with CAP-D2 and SMC4 antibodies. In control cells, SMC4 was localised on mitotic 
chromosomes (Figure 5D). In the CAP-D2 depleted cells, SMC4 still localized to chromatin, even 
though chromosome morphology was abnormal (Figure 5E). Distribution was however not restricted 
to an axial core, presumably because of aberrant chromosome organisation. In approximately half of 
the abnormal cells, the SMC4 signal was more severely reduced (Figure 5E, top) than in other CAP-D2 
depleted cells (Figure SE, bottom). This may be the result of uneven RNAi efficiency across the cell 
population. 
We also examined SMC2 level and localisation. As observed for SMC4, the level of SMC2 
appeared largely unaffected when CAP-D2 was depleted (Figure 6A). Because both CAP-D2 and 
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SMC2 antibodies were raised in rabbits, double immunolabeling was not possible. Therefore, we 
double-labeled cells for SMC2 and topo II, a marker for the chromosome "scaffold". The overall level 
of topo II also appeared not to change (Supp Figure 2F). In control cells, both SMC2 and topo II 
associated with chromosomes in a striking axial pattern (Figure 613). After CAP-D2 depletion, SMC2 
localized to chromatin masses, albeit in an unrestricted localization, similar to SMC4. Variation in the 
level of SMC2 was also observed in these cells: cells with more reduced levels of SMC2 also had lower 
levels of topo II (Figure 6C, top vs bottom). Taken together, these results suggest that the axial 
localisation of SMC4, SMC2, and topo II correlates with proper chromosome resolution which requires 
CAP-132, and by inference CAP-H/Barren (as it is also depleted). 
Reciprocal dependence on stability: CAP-D2 is unstable in a barren mutant 
Depletion of the CAP-D2 protein by dsRNAi affected the stability of the CAP-H/Barren 
protein. To test if reciprocal stability was true (i.e. the level of CAP-D2 protein was dependent on the 
presence of CAP-H/Barren), a barren mutant (barr 305) was examined. harr' 30 is a null mutation 
which causes lethality late in embryogenesis (Bhat et al., 1996). Analysis of barr homozygous embryo 
extract (l2-13 hours old) showed that when Barren was decreased, CAP-D2 was greatly reduced as 
well (Figure 6D). Quantitation of protein levels by phosphorimaging revealed that Barren was reduced 
8-fold compared to wild type embryos while the level of CAP-D2 was 6-fold lower. The fact that both 
proteins were decreased to nearly the same extent strongly suggests that the two proteins are very likely 
interdependent for stability. When the same membrane was reprobed for SMC2 and SMC4, it was 
apparent that their levels were reduced, albeit not to the same extent (Figure 6D). SMC2 was reduced 
4-fold and SMC4 3.5-fold, consistent with a fraction of the two SMC proteins participating in a second 
complex. Quantitations were repeated twice in independent experiments. The presence and stability of 
Sccl/Drad2l, a member of the cohesin complex (Vass et al., 2003), and a-tubulin were analyzed and 
found to be unaffected by mutation of CAP-H/Barren (Figure 6D). 
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The stability of the condensin subunits was also examined in an SMC4 mutant, gluon' 7'. This 
is an embryonic lethal null mutation for SMC4, that removes 31 kb including the SMC4 gene 
(accession AJ543652). Analysis of gluon 17C  homozygous embryo extract ('12-l3 hours old) showed 
that the SMC4 protein decreased 5.9-fold relative to wild type embryos (Figure 6E). Residual protein 
may suggest that the maternal component is quite stable (and may also explain the SMC4 protein in 
barr extract). When the levels of other subunits was assessed, we observed that the SMC2 subunit was 
decreased to the same extent as SMC4 (5.6-fold), while CAP-D2 and CAP-H/Barren were reduced 4.7-
fold (Figure 6E). These results revealed that in the absence of one of the condensin subunits in 
Drosophila, the abundance and stability of the rest were affected. Furthermore, the strength of the 
interactions between the four examined members of the condensin complex supports the notion that the 
non-SMC subunits, CAP-D2 and CAP-H/Barren, show tight dependencies on one another for stability 
both in cultured cells and in the organism. 
A condensin II complex has been recently identified in vertebrate cells, consisting of SMC2 and 
SMC4, and three additional non-SMC subunits: CAP-D3, CAP-1-12 and CAP-G2 (Ono et al., 2003). 
CAP-133 and CAP-1-12, but not CAP-G2, have been found by sequence analysis in Drosophila. To 
assess the role of CAP-D3 in the experiments of this study, we generated an antibody to CAP-133 (Supp 
Figure 1B) and examined localization of the protein during mitosis in S2 cultured cells. 
Immunostaining revealed that the protein localised at the centromeres, partially overlapping with CID 
at prometaphase, metaphase and anaphase. However, the signal was reduced by telophase and less 
restricted to the centromeres (Supp Figure 3A). We attempted to deplete the protein with 2 different 
dsRNAs targeting different regions of the mRNA, but it remained even after 120 hrs, suggesting that 
CAP-D3 may be very stable. Furthermore, chromosome morphology and chromosome segregation 
appeared normal (data not shown). When the fractions immunoprecipitated from embryos using the 
CAP-132 antibody were probed for CAP-D3, no CAP-D3 was detected (data not shown). In addition, 
the overall localisation of CAP-D3 was not affected in the CAP-132 depleted cells. CAP-133 was 
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present at the centromeres in the CAP-132 depleted cells (Supp Figure 313) and when CID was 
stretched, CAP-D3 was also stretched (Supp Figure 313, top panel). These results suggest that functions 
of CAP-132 and CAP-D3 are probably independent of one another. Interestingly, flies homozygous for 
insertion of a P-element in the third exon of the CAP-D3 gene are viable, but male sterile. This 
strongly suggests a meiotic role for the CAP-D3 protein, and possibly the condensin II complex in 
Drosophila. 
Depletion of both CAP-D2 and topo H results in chromosome morphology no more severe than 
that observed in cells depleted of CAP-D2 alone 
Since the resolution of sister chromatids is compromised in the CAP-132 depleted cells and topo 
II is important for decatenating DNA strands, it is possible that condensin and topo II collaborate to 
organise mitotic chromosomes. Furthermore, the phenotype observed in this study after CAP-D2 
RNAi, was similar to the phenotype obtained after topo II depletion (Chang et al., 2003). In order to 
determine if these proteins have similar or distinct roles in organising mitotic chromosomes, CAP-
D2/topo II double RNAi was performed. Immunoblotting showed that both proteins were greatly 
depleted 72 hours after treatment (Figure 7A). The topo II level was not significantly affected after 
CAP-D2 RNAi, nor was the level of CAP-D2 affected in the topo IT-depleted cells (similar to previous 
observations for Barren (Chang et al., 2003). We observed only a 2-fold increase in mitotic index, 
using P1-13 as a mitotic marker. Immunofluorescence analysis at 96 hours revealed that cells depleted 
of both proteins exhibited abnormal chromosome morphology and behaviour no more severe than in 
either of the single depletions (Figure 7C). Surprisingly, the ability of chromosomes to compact 
appeared as it did in either single RNAi. Chromosomes in the double RNAi failed to resolve and 
formed bridges during anaphase. We also noted the unusual phenotype of chromosome arm 
congression defects observed previously after topo II depletion (Chang et al., 2003) (Figure 7C, top 
row). 
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In order to better assess the chromosome phenotypes of the single and double depletions, 
metaphase chromosome spreads were performed after cells were arrested in metaphase with colchicine. 
dsRNA treated and control cells were cytospun onto poly-L-lysine slides and stained for CAP-132, topo 
II and DNA. Control cells displayed the typical "X" shape indicative of proper sister chromatid 
resolution. Both CAP-D2 and topo II localised axially along the length of the chromosomes and the 
two proteins partially co-localised (Figure 8A1-2 and 813, control). In both single and the double 
depletions, chromosome morphology was highly abnormal. The structural integrity of these 
chromosomes was compromised and chromatin appeared torn and stretched. No axial staining could 
be observed in any of the experiments (Figure 8A3-5). Individual chromosomes, while compacted, 
were not resolved and appeared fuzzy and diffuse (Figure 813, RNAi panels). Since no difference in 
phenotype was observed at this level between the CAP-D2, topo II and CAP-D2/topo II doubly 
depleted cells, we believe that topo II and the condensin complex participate in the same pathway to 
resolve sister chromatids. We additionally noted no difference in the level of CAP-133 in either the 
single depletions or CAP-D2/topo II double depletion, suggesting that this protein was not affected 
(Supp Figure 3C). We therefore suggest that additional, as yet unidentified, factors are required to 
bring about appropriate chromosome condensation during mitosis. 
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Discussion 
In this study we have shown that CAP-132 is part of a complex containing other condensin 
subunits (SMC2, SMC4, CAP-H/Barren and CAP-G) in Drosophila. Interestingly, the non-SMC 
subunits, CAP-D2 and Barren, appear to be more tightly associated with each other than they are with 
SMC2 and SMC4. This finding is reminiscent of our studies of the cohesin complex in Drosophila 
where we showed that See I /Drad2 I and Scc3/SA 1 appeared to have a higher affinity for one another 
than for SMC1 and SMC3 (Vass et al., 2003). 
The subcellular localisation of CAP-D2 revealed that the protein was nuclear throughout 
interphase with levels increasing during S phase, and peaking in late G2/early prophase. This was 
intriguing as Drosophila SMC4 and Barren are cytoplasmic during interphase and associate with 
chromatin only during prophase (Steffensen et al., 2001). In human cells, the majority of CAP-D2, 
SMC2, and SMC4 is cytoplasmic during interphase, finally becoming nuclear during prophase, 
suggesting that distribution of the holocomplex may be regulated coordinately in human cells (Ball et 
al., 2002; Schmiesing et al., 2000). Differential localisation of condensin subunits during interphase in 
Drosophila suggests that CAP-D2 may be sequestered away from SMCs to regulate activity or may be 
utilized for a function other than that required of other condensin subunits during interphase. It has 
recently been shown in Xenopus that CAP-D2 (pEg7) along with SMC2 (XCAP-E) localise in the 
granular compartment of the nucleolus suggesting that these subunits may be involved in nucleolar 
organisation and/or ribosome biogenesis (Uzbekov et al., 2003). In S. cerevisiae, the CAP-D2 
orthologue Ycs4 is nuclear during interphase, implicated in suppressing inter-repeat rDNA 
recombination and required for silencing at the mating type loci (Bhalla et al., 2002). Thus, Drosophila 
CAP-132 may be involved in a non-mitotic function - possibly during S phase when its level increases. 
Alternatively, expression during S phase may be important to "template" the protein 
appropriately for a mitotic role (Loupart et al., 2000; Shelby et al., 1997). The increase of nuclear 
CAP-D2 during S phase could be because protein expression is up-regulated or because the protein is 
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preferentially imported into the nucleus. A potential nuclear bipartite targeting signal between amino 
acids 1347 and 1363 was identified in the Drosophila CAP-D2 sequence (this study). Human CAP-D2 
(CNAP1) has a functional bipartite nuclear localisation signal (Ball et al., 2002). During mitosis, CAP-
D2 localises to the chromatid cores and remains tightly associated with chromosomes until late 
telophase/cytokinesis, even as chromosomes are decondensing. In contrast, while DmSMC4 and 
Barren proteins are loaded onto chromosomes in early prophase, they dissociate from chromosomes 
late in anaphase/telophase when decondensation begins (Steffensen et al., 2001) (and this study). This 
distinct timing of condensin subunit dissociation is again suggestive of a role for CAP-132 beyond that 
of condensin. In human cells it has been shown that the C terminal-end of CAP-D2 possesses a mitotic 
chromosome-targeting domain that does not require the other condensin subunits (Ball et al., 2002). 
Perhaps a similar regulation occurs in Drosophila and CAP-D2 binds to chromosomes independently 
of the other subunits. 
We have shown that depletion of CAP-D2 by RNAi in Drosophila results in an abnormal 
mitotic phenotype. The major defect is the loss of sister chromatid (arm and centromere) resolution 
and the resulting failure of chromosomes to segregate normally during anaphase, a phenotype similar to 
that observed in barren, DmSMC4 and CICAP-G mutant alleles (Bhat etal., 1996; Dej KJ, 2004; 
Steffensen et al., 2001) and DmSMC4 RNAi (Coelho et al., 2003). Chromosome compaction still 
occurs, as in chicken cultured cells (Hudson et al., 2003), consistent with the existence of additional 
factors essential for this process. Although loss of Barren in Drosophila does not affect cell cycle 
progression (Bhat et al., 1996), loss of SMC4 causes a metaphase delay in embryos (Steffensen etal., 
2001) and even more pronounced prometaphase delay (data not shown). Similarly, loss of dCAP-G 
causes a prometaphase delay in embryos (Dej KJ, 2004). Depletion of CAP-D2 in S2 cells results in a 
prometaphase delay, though cells do eventually undergo aberrant anaphase and cytokinesis. The delay 
is possibly a consequence of kinetochore checkpoint activation, since chromosomes exhibit elevated 
levels of BubRi at centromeres persisting into anaphase and cytokinesis (data not shown). This may, 
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in turn, be a result of altered centromere resolution manifest as stretched centromeres in anaphase. 
Similar results have been observed after DmSMC4 RNAi where kinetochores associated with spindle 
microtubules were stretched polewards, sometimes well beyond the chromatin mass (Coelho et al., 
2003). 
In C. elegans, the condensin complex is required for the restricted orientation of centromeres 
towards spindle poles (Hagstrom et al., 2002), while in an S. cerevisiae BRN1 mutant, centromere 
function is defective and centromeres do not segregate normally (Ouspenski et al., 2000). Recently it 
has been shown that depletion of condensin I or condensin II in vertebrate cells results in structural 
distortions of the centromere/kinetochore region which affects the opposing orientation of sister 
kinetochores and interaction with the mitotic spindle (Ono et al., 2004). Taken together, these results 
suggest that the condensin complex may have a role in centromere organization and ensuing 
kinetochore-spindle interactions, which could impact the localization of chromosome passenger 
proteins. Indeed, we noted a temporal disruption of INCENP localisation following CAP-D2 depletion 
(date not shwon). We observed similar defects in IINCENP localization when the DRad21 cohesin 
subunit was depleted (Vass et al., 2003). These results argue that proper chromosome organisation is 
necessary for the correct temporal localisation of at least one chromosome passenger protein. 
Behaviour of different condensin subunits varies following depletion of CAP-D2. Barren is 
unstable when CAP-D2 is depleted and any residual protein is cytoplasmic. Barren localisation was 
also shown to be dependent on SMC4 (Coelho et al., 2003). In a Barren mutant, CAP-D2 was 
unstable, corroborating the interdependence of the two proteins on one another for stability. On the 
other hand, levels of SMC2 and SMC4 were not greatly affected by CAP-D2 depletion and the two 
proteins still localised to chromatin, albeit in a non-axial fashion. This is likely a reflection of 
compromised structural integrity of mitotic chromosomes as observed in chicken DT40 cells depleted 
of SMC2 (Hudson et al., 2003). In S. cerevisiae and S. pombe, the condensin SMCs bind chromatin 
only in the presence of non-SMC subunits (Freeman et al., 2000; Lavoie et al., 2002). One intriguing 
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question is whether the SMCs remaining on chromosomes are in any way functional? Should a 
condensin II complex exist in Drosophila, then the chromosomal SMCs remaining after CAP-D2 
depletion may be members of this complex. Consistent with this, we observed that SMC2 and SMC4 
are similarly reduced in a Barren mutant (but not as severely as Barren and CAP-132). We were unable 
to deplete the CAP-D3 subunit of the Drosophila condensin II complex by RNAi in S2 cells (perhaps 
due to long half-life), but mutation by P-element insertion in the CAP-133 gene caused male sterility 
(data not shown). It remains to be determined what precise role a putative condensin complex II has in 
meiosis in Drosophila. 
In this study, we also performed the first disruption in Drosophila of two components known to 
be involved in mitotic chromosome dynamics: condensin and topo Ii. When a double depletion of 
CAP-132/topo II was performed, abnormal chromosome appearance and behaviour similar to that 
observed in the single topo II and CAP-132 RNAi was observed. Chromosomes were fuzzy and not 
resolved, and formed chromosome bridges during anaphase and cytokinesis. Surprisingly, the double 
depletion phenotype was no more severe than in either of the single depletions. This result suggests not 
only that topo II and the condensin complex participate in the same pathway required to organise 
mitotic chromosomes into well-defined structures, but also that factors other than these proteins still 
remain to be identified for their essential roles in chromosome condensation. These may include 
proteins involved in DNA replication (Dej KJ, 2004; Loupart et al., 2000) or diverse factors such as 
kinases (Yu et al., 2004) and proteases (McHugh et al., 2004), demonstrating that much remains to be 
learnt about the full requirements for chromosome condensation. 
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Figure Legends 
Figure 1. Identification of a condensin complex in Drosophila and characterisation of CAP-D2 
during interphase. 
A. Identification of a condensin complex in 0-5 hr embryo extracts following immunoprecipitation 
with an antibody recognizing Drosophila CAP-132. Three 0.5M NaCl washes and three 2% SDS 
elutions are shown for preimmune and immune precipitations. The samples were analysed by 
immunoblotting with SMC2, SMC4, CAP-132 and CAP-H/Barren antibodies. A fraction of SMC2 and 
SMC4 eluted in the washes, but more so with the elutions, while CAP-132 and CAP-H/Barren only 
eluted with 2% SDS. B-D. S2 cultured cells were cytospun onto poly-L-lysine slides, then fixed and 
stained with various antibodies as described. B. CAP-132 localises in the nucleus during interphase. 
G  cells (using y-tubulin as a marker) show nuclear staining for CAP-D2 with a diffuse cytoplasmic 
staining. Cells in GI phase (single centrosome, arrow in upper panel) have less nuclear CAP-132 than 
cells with two centrosomes (cells in S or G2 phase, arrow in lower panel). y-tubulin (red), CAP-132 
(green), and DNA (blue). C. S phase cells (detected after BrdU incorporation) show strong nuclear 
staining for CAP-132, but at differing levels. BrdU (green), CAP-D2 (red), and DNA (blue). D. Cells 
in late G2/early prophase (arrow) show an intense staining for CAP-132. Cyclin B (nuclear during late 
G2/early prophase) was used as a marker for this stage. Cyclin B (green), CAP-132 (red), and DNA 
(blue). 
Figure 2. Characterisation of CAP-D2 during mitosis. 
A. CAP-132 localises to a central axis in chromatids and shows accumulation at the centromeres from 
prometaphase until telophase. P-H3 was used as a mitotic marker. During late anaphase and 
telophase, where chromosomes begin to decondense, CAP-D2 still associates with chromosomes. 
CAP-132 (red), P1-13 (green), and DNA (blue). B. CAP-132 accumulates at centromeres during 
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metaphase. CID was used as a centromere marker. CAP-132 (red), CID (green), and DNA (blue). C. 
CAP-132 is still strong in the daughter nuclei of a cell undergoing cytokinesis (arrow). CAP-132 (red), 
u-tubulin (green), and DNA (blue). 
Figure 3. CAP-D2 dsRNA-mediated interference in Drosophila S2 cells results in abnormal 
chromosome morphology and segregation. 
A. Immunoblot showing the depletion of CAP-132 after treatment with dsRNA. 5x 1 0 cells were 
loaded per lane. CAP-D2 levels start to decrease as early as 48 hours and the protein is undetectable at 
96 and 120 hours. cc-tubulin was used as a loading control. C (control dsRNA), - (no dsRNA), D 
(CAP-D2 dsRNA). B and C. Immunofluorescence analysis of control and CAP-D2 RNAi cells. Cells 
were cytospun onto poly-L-lysine slides 65 hours after treatment and stained for CAP-132 (green), CID 
(red), and DNA (blue). C. CAP-D2 depleted cells have no CAP-D2 on condensed chromosomes and 
exhibit abnormal chromosome morphology. Sister chromatids failed to resolve and segregate properly, 
and chromosomes were not properly aligned on the metaphase plate. Centromeres appeared stretched. 
D and E. Hypotonic treatment of control (D) and CAP-D2 depleted (E) cells 65 hours after dsRNA 
treatment shows that chromatid resolution is defective in the CAP-132 depleted cells. Cells were 
hypotonically treated, centrifuged onto poly-L-lysine slides, fixed and stained for CAP-132 (red), P1-13 
(green) and DNA (blue). Note that individual chromatids are not readily apparent after depletion of 
CAP-132. The scale bar represents l0l.lm. 
Figure 4. Chromosome arm and centromere resolution are compromised after CAP-D2 
depletion. 
A. Immunoblotting showing that the levels of DSA1 were not affected 72 hours after CAP-D2 RNAi 
treatment. C (control dsRNA), - (no dsRNA), D (CAP-D2 dsRNA). a-tubulin was used as a loading 
control. B and C. Centromere resolution is disrupted in the CAP-132 depleted cells. Control (B) and 
35 	 Savvidou, et al. 
CAP-D2 depleted (C) cells were cytospun onto poly-L-lysine slides 72 hours after dsRNAi treatment, 
fixed and stained for DSA1 (green), CID (red) and DNA (blue). The majority of 
prometaphase/metaphase cells had normal CID staining between sister chromatids (Cl and higher 
magnification), while a small percentage showed a slightly stretching for CID (C2 and higher 
magnification). Cells in anaphase showed severe centrornere stretching on chromosomes (C3-5 and 
higher magnification). The white boxes indicate the region from where the higher magnifications were 
taken. The scale bar represents lOj.tm, D. Graph showing the distance (in tim) between paired CID 
spots of cells in prometaphase/metaphase after staining for DSA1/CID/DAPI. The distance in CAP-D2 
depleted cells is more than 2-fold higher compared to control cells. 
Figure 5. Effect on Barren and SMC4 after CAP-D2 depletion. 
A. Immunoblotting of control and CAP-D2 depleted extracts with Barren and SMC4 antibodies 
demonstrates that Barren levels are reduced while SMC4 levels appear largely unaffected after loss of 
CAP-D2. a-tubulin was used as a loading control. C (control dsRNA), - (no RNA), D (CAP-D2 
d5RNA). B and C. Cells from both control (B) and CAP-D2 RNAi (C) experiments were cytospun 
onto poly-L-lysine slides 72 hours after treatment and stained for Barren (red), Cyclin B (green) and 
DNA (blue). Barren is absent from mitotic chromosomes and localised diffusely in the cytoplasm after 
CAP-D2 RNAi. D and E. Control (D) and CAP-D2 RNAi (E) cells were cytospun onto poly-L-lysine 
slides 65 hours after treatment, extracted during fixation, and stained for SMC4 (red), CAP-D2 (green) 
and DNA (blue). While cells have varying levels of SMC4 on chromatin, any axial localisation of 
SMC4 is lost in the CAP-D2 depleted cells. The scale bar is 10 .Lm. 
Figure 6. Effect on SMC2 and DNA topoisomerase II in CAP-D2 depleted cells. 
A. Immunoblotting of control and CAP-D2 depleted extracts with an antibody to SMC2 shows that the 
protein level is largely unaffected by the CAP-D2 depletion. ct-tubulin was used as a loading control. 
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C (control dsRNA), - (no RNA), D (CAP-D2 dsRNA). B and C. Immunolocalisation of SMC2 and 
topo II in control (B) and CAP-132 depleted (C) cells after 65 hours of dsRNA treatment. Cells were 
cytospun onto poly-L-lysine slides, extracted during fixation and stained for SMC2 (green), topo II 
(red), and DNA (blue). Despite the fact that SMC2 and topo II still localise to chromatin, albeit at 
varying levels, any axial definition is lost. The scale bar is 10 tm. D and E. Instability of condensin 
subunits after mutation of CAP-H and SMC4 in Drosophila. D. CAP-132 is unstable when Barren is 
absent in a harr' 305 mutant. Immunoblot of 12-13 hour wild type (Canton S) and barr' 30 homozygous 
embryo extracts shows that Barren is almost undetectable in mutant embryos. The remaining protein 
likely represents maternal contribution to the embryos. The membrane was probed for Barren, CAP-
D2, SMC2, SMC4 and Sec I. The decrease in protein level was determined using phosphorimaging (5 
embryos were loaded per lane). Barren levels decreased 8-fold, CAP-132 levels decreased 6-fold and 
SMC2 and SMC4 levels decreased 4-fold and 3.5-fold respectively. ct-tubulin was used as a loading 
control. E. Stability of condensin subunits in an SMC4 (gluon"') mutant. Immunoblot of 12-13 hour 
wild type (Canton 5) and gluon 17C  homozygous embryo extract with the SMC4, SMC2, CAP-132 and 
Barren antibodies. The levels of the four proteins were calculated using phosphorimaging (5 embryos 
were loaded per lane). SMC4 shows a 5.9-fold decrease in protein levels, SMC2 shows a 5.6-fold 
decrease, while Barren and CAP-132 show a 4.7-fold decrease. a-tubulin was used as a loading 
control. 
Figure 7. Depletion of CAP-D2 and DNA topoisomerase II by double RNAi in S2 cells. 
A. The depletion of CAP-D2 and topo II after treatment with two dsRNAs was assessed at 72 and 96 
hours by immunoblot analysis. Both proteins were similarly depleted and almost undetectable by 96 
hrs. o-tubulin was used as a loading control. - (no dsRNA), C (control dsRNA), D (CAP-D2 dsRNA), 
T (topoll dsRNA) , D/T  (CAP-D2/topo II dsRNA). B and C. Analysis of chromosome morphology in 
control (B) and CAP-D2/Topo II doubly-depleted (C) cells. Cells were cytospun onto poly-L-lysine 
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slides, extracted during fixation and stained for topo II (red), CAP-132 (green), CID (white) and DNA 
(blue), 96 hours after dsRNA treatment. Chromosome morphology was abnormal and remarkably 
similar to that observed after single CAP-D2 RNAi. Centromeres were stretched along the chromatin 
in anaphase as observed after CAP-132 depletion alone. The scale bar is 10 pm. 
Figure 8. Examination of CAP-D2 and DNA topoisomerase II in metaphase chromosomes after 
dsRNA treatment. 
A and B. Metaphase chromosome spreads of control (1-2), topo II depleted (3), CAP-D2 depleted (4) 
and CAP-D2/Topo II doubly-depleted (5) cells, after cells were arrested with colchicine. Cells were 
cytospun onto poly-L-lysine slides, extracted during fixation and stained for topo II (red), CAP-D2 
(green) and DNA (blue), 74 hours after dsRNA treatment. A. Control cells displayed the typical X-
shape and sister chromatids could be easily distinguished. Both CAP-D2 and topo II localised axially 
along the length of the chromosomes with partial colocalisation (A 1-2 and B, Control). In topo II, 
CAP-D2 single depletions, and in the CAP-D2/Topo II double depletion, no sister chromatid resolution 
could be observed and chromosomes appeared fuzzy. The scale bar is 10 pm. B. Individual 
chromosomes observed in chromosome spreads. The chromosome phenotype was similar between the 
two single and the double RNAi experiments. 
Supplemental Figure 1. Co-immunolocalisation of SMC4 and CAP-D2. 
A. Schematic representation of the protein region used to generate the CAP-D2 antibody (amino acids 
951 to 1162 amino acid residues). Immunoblot analysis against cell extract with the CAP-D2 antibody 
revealed that the antibody recognises a band of the expected size ('-l48 kDa, asterisk) using three 
different bleeds (1,2 and 3) in a dilution of 1:10,000. The band was absent from the pre-immune lane 
(1=1:1000, 2=1:5000, and 3=1:10,000 dilutions). B. Schematic representation of the protein region 
used to generate the CAP-D3 peptide antibody (15 terminal amino acid residues were used). 
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Immunoblot analysis against cell extract with the CAP-133 antibody revealed that the antibody 
recognises a prominent band of about 80 kDa (asterisk). The band was absent from the pre-immune 
lane. C. Co-immunolocalisation of CAP-132 and SMC4. Cells were cytospun onto poly-L-lysine 
slides, extracted during fixation and stained for SMC4 (red), CAP-132 (green), and DNA (blue). The 
two proteins co-localise during prometaphase. SMC4 dissociates from chromosomes as they 
decondense during anaphase, while CAP-D2 persists throughout the chromosomes. In telophase SMC4 
is diffuse in the cytoplasm and the nucleus, while CAP-132 is still tightly associated with chromosomes. 
The scale bar is 10 pm. 
Supplemental Figure 2. Quantitation of effects on cells after CAP-D2 RNAi. 
A. Growth curve showing the number of cells at different time points after CAP-D2 dsRNA treatment. 
Cells grew more slowly, plateaued at 72 hrs, and did not change significantly after that time. B. 
Histogram showing the percentage of mitotic cells in control and CAP-132 RNAi cells. The percentage 
of mitotic cells increased 2-3 fold in the CAP-132 RNAi between 36 and 72 hours (6.7% versus 2.2% at 
48 hrs). C. Histogram showing the percentage of abnormal mitotic cells in control and CAP-D2 RNAi 
cells. The majority of mitotic cells are abnormal 36 hrs and later after dsRNAi treatment. D. 
Histogram showing the percentage of cells in prometaphase after staining for Cyclin B/P'H3/a-tubulin 
in control and CAP-132 RNAi cells. Cells delay in prometaphase in the CAP-D2 depleted cells. E. 
Histogram showing the percentage of cells in anaphase after staining for Cyclin B/PH3/a-tubulin, in 
control and CAP-132 RNAi cells. The anaphase index in CAP-132 RNAi cells is lower than in control 
cells. F. Immunoblotting of control and CAP-132 depleted extracts for topo II shows that depletion of 
CAP-132 does not affect the level of topo II. o-tubulin was used as a loading control. C (control 
dsRNA), - (no RNA), D (CAP-132 dsRNA). 
Supplemental Figure 3. CAP-D3 localisation in mitotic control and CAP-D2 depleted cells. 
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A. Immunolocalisation of CAP-D3 in S2 cells. Cells were cytospun onto poly-L-lysine slides, 
extracted during fixation and stained for CAP-133 (green), CID (red), and DNA (blue). In control cells, 
CAP-133 localises at the centromeres and partially overlaps with CID at prometaphase, metaphase and 
anaphase. The antibody gives a non-specific centrosomal staining as well. B. CAP-132 RNAi cells 72 
hours after treatment. Cells were cytospun onto poly-L-lysine slides, extracted during fixation and 
stained for CAP-D3 (green), CID (red), and DNA (blue). CAP-D3 protein still localises to CID-
positive regions in the CAP-D2 depleted cells. The scale bar is 10 pm. C. Immunoblotting of control, 
CAP-D2 depleted, topo II depleted and CAP-D2/topo II doubly depleted cell extracts with the CAP-D3 
antibody. CAP-D3 levels are unaffected in either the single or the double depletions. a.-tubulin was 
used as a loading control. C (control dsRNA), - (no RNA), D (CAP-D2 dsRNA), T (topo II dsRNA) 
and 1 IT (CAP-D2/topo II double dsRNA). 
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